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Abstract 
 
Six new compounds were isolated from the aerial and root parts of S. viridis L. cv. 
Blue Jeans. Two new triterpenoids, lup-20(29)-ene-2α-acetate-3β-ol, and lup-20(29)-ene-2α-
ol-3β-acetate were found in the aerial part together with lup-20(29)-ene-2α-3β-diol, ursolic 
acid, oleanolic acid, β-sitosterol and β-sitosterol glucoside. Three new diterpenoids, 1-
oxomicrostegiol, viroxocane, viridoquinone, together with five known diterpenoids, 
ferruginol, salvinolonyl 12-methyl ether, microstegiol, 7α-acetoxy-14-hydroxy-8,13-
abietadiene-11,12-dione and 7α,14-dihydroxy-8,13-abietadiene-11,12-dione were found in 
roots. 1-Docosyl ferulate, 2'',3''-di-O-acetyl-martynoside and a mixture of 2-(4'-alkoxy-
phenyl) ethyl alkanoates were also isolated from roots. Seven caffeic acid derivatives, five 
flavonoid glycosides, and salidroside were found in the crude aerial fraction. Four caffeic 
acid derivatives were known phenylpropanoids, i.e. trans-, cis-verbascoside, leucosceptoside 
A and martynoside, which are now reported in the genus Salvia for the first time. The others 
were caffeic acid, rosmarinic acid and 6-O-caffeoyl-glucose. A new flavonoid glycoside, 
luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galactopyranoside was also identified in the aerial 
part with four known flavone glycosides:  luteolin-7-O-β-glucopyranoside, luteolin-7-O-β-
galactopyranoside, luteolin-7-O-rutinoside and apigenin-7-O-β-glucopyranoside.   
 
Verbascoside (acteoside), which is a major component in this plant, showed a 
significant protective effect against UVA induced damage in a human skin fibroblast model 
in vitro. It exhibited 1.4 fold protective effect against UVA induced necrosis with 1.4 fold 
higher in cell survival. 50 µM Verbascoside showed the same protective effect as 100 µM 
DFO at a high intensity UVA dose (500 kJ/m
2
). Further determination of organelle specific 
protection suggested a mechanism of action in mitochondria. 
 
Two terpenoids, lup-20(29)-ene-2α-acetate-3β-ol and 7α,14-dihydroxy-8,13-abieta-
diene-11,12-dione, exhibited antibacterial activity against Enterococcus faecalis with MIC 50 
µM. Microstegiol was also active against Staphylococcus aureus with MIC 50 µM. Ursolic 
acid, oleanolic acid and ferruginol showed appreciable antibacterial activity against three 
Gram-positive bacteria, Staphylococcus aureus, Enterococcus faecalis, and Bacillus cereus 
with MIC 12.5-50 µM. The other diterpenoids were active against all three Gram-positive 
bacteria with MIC 100-200 µM. None of crude fractions was active against three Gram-
negative bacteria, Klebsiella pneumoniae, Proteus vulgaris, and Escherichia coli. 
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Chapter 1 
     Introduction 
 
 
Salvia, or Sage, has been used as traditional medicine and in culinary purposes for a 
long time. This plant belongs to family Lamiaceae (or Labiatae), subfamily Nepetoideae, and 
tribe Mentheae. They are perennial, annual, or biennial shrubs, or herbs with erect stems up 
to 170 cm, lobed or pinnate or simple leaves, 2-8 flowers in axillary verticillasters with 
various coloured bracts (Hedge, 1972). There are over 900 species of Salvia around the 
world, half of them are widely distributed in Central and South America (500 species) while 
the others are in Central Asia and Mediterranean (250 species), Eastern Asia (90 species), 
and South Africa region (30 species) (Walker et al., 2004).  
 
The name Salvia is derived from the Latin word “salvere” meaning “to save” because 
of its medicinal properties (Dweck, 2000). Sage is traditionally used to treat common 
ailments, for instance, flatulence, stomach ache, mouth and throat infection, and also for 
culinary purposes (Barnes et al., 2007). 
                                
                 
          Figure 1.1 Salvia viridis L. cv. Blue Jeans (Synonym S. horminum L.) 
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The root of S. miltiorrhiza Bunge (Danshen) has been used in traditional Chinese 
medicine to treat coronary heart disease, cerebrovascular disease, various types of hepatitis, 
chronic renal failure, dysmenorrheal, and to stimulate blood circulation (Jiang et al., 2005; Li 
et al., 2008). Turkish Salvia species have been used as stomachic, diuretic, hemostatic, 
spasmolytic, carminative, mouth and throat infections including colds (Topcu et al., 2008). 
The Greek sage (S. fruticosa Miller) has been known as a spice or ingredient of folk remedies 
for toothache and intestinal complaints (Karousou et al., 2000). Infusions of certain Salvia 
species in South Africa have been used to treat colds, cough, flu, colic, diarrhoea, indigestion, 
abdominal complaints, and bacterial infections (Kamatou et al., 2008).  
  
Many species have been investigated for their biologically active chemical 
constituents. Phytochemical studies on Salvia species have been extensively carried out, and 
their main chemical constituents can be classified as polyphenols, and terpenoids. The major 
compounds of aerial parts are flavonoids, triterpenoids and volatile substances, mainly 
monoterpenes whereas diterpenoids are commonly found in roots (Topcu, 2006). Certain 
types of phenolic acid, i.e. caffeic acid derivatives, have predominantly been found in this 
genus (Lu and Foo, 2002).  
 
1.1. Terpenoids in the genus Salvia  
 
 Terpenoids are ubiquitous secondary metabolites in the plant kingdom. Many of 
them possess biological activities. A terpene containing oxygen atom is defined as a 
terpenoid, but the terms of terpenoid, and terpene can be interchangeable. Terpenoids can be 
classified into groups according to the number of carbon atoms in their skeleton, i.e. 
hemiterpenes (C5), monoterpene (C10), sesquiterpenes (C15), diterpenes (C20), sesterterpenes 
(C25), triterpenes (C30), and tetraterpenes (C40). These are derived from isoprene (C5) unit 
which are attached to another one by head to tail, or tail to tail linkages. Terpenoids are 
biosynthesised from dimethylallyl diphosphate (DMAPP), and isopentenyl diphosphate 
(IPP), and then rearrangement by cyclization reaction of the units (Dewick, 2009). 
Biosynthesis pathways of terpenoids are shown in Figures 1.3-1.6. 
 
                                                           
                                                  Figure 1.2 Isoprene  
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       Figure 1.3 Biosynthesis pathways of terpenoids 
 
 
Within plant cells, these two precursors, IPP and DMAPP, may be derived via the 
mevalonic acid (MVA) pathway in the cytoplasm, and via the methylerythritol phosphate 
(MEP) pathway in plastids (Bartram et al., 2006; Ikeda et al., 2008) as shown in Figure 1.3. 
The terpene synthases that are responsible for monoterpenes and diterpene biosynthesis are 
predominantly located in plastid whereas sesquiterpene synthases are mostly in the cytosol 
(Tholl, 2006). All terpenes are originally derived from DMAPP with further incorporation of 
IPP to yield geranyl diphosphate (GPP; C10), and farnesyl diphosphate (FPP; C15). The 
rearrangement of GPP with carbocation reactions catalyzed by the monoterpene synthase 
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enzymes results in a variety of monoterpenoids as shown in Figure 1.4. The cyclization of 
GPP into the menthyl/α-terpinyl cation is the key step in the formation of various derived 
monoterpenoids (Dewick, 2009). 
 
 GGPP (geranylgeranyl diphosphate; C20) is biosynthesized from FPP by further 
incorporation of IPP and is the essential precursor to generate diterpenes as shown in Figure 
1.5. The cyclization reactions of GPP mediated by carbocation formation include the 
diterpene synthase enzymes and rearrangement of products derive distinctive diterpene 
skeletons (Dewick, 2009). Figure 1.5 shows two different chair conformation arrangements 
of GGPP. One is catalyzed by the enzyme (-)-copalyl diphosphate synthase (ene-kaurene 
synthase A), and the other is by (+)-copalyl diphosphate synthase (abietadiene synthase). 
Consequently, the two products that arise, i.e. (-)-copalyl PP, and (+)-copalyl PP (labdadienyl 
PP) respectively, are the main starting compounds for various types of diterpenoids. The (+)-
copalyl PP is the substrate for reactions catalyzed by the enzyme KSL (kaurene synthase-like 
diterpene synthases) to yield abietane type ditepenoids such as ferruginol, and further 
modified to tanshinone derivatives (Wang and Wu, 2010). 
 
 FPP is the crucial precursor for sesquiterpene (C15), and triterpenes (C30) as shown 
in Figure 1.6. Sesquiterpene essential oils are biosynthesized by sesquiterpene cyclase 
enzymes to yield β-caryophyllene, α-humulene, and germacrenes (Dewick, 2009). The 
dimerization of FPP by tail to tail attachment yields squalene, the key intermediate in 
triterpenoid biosynthesis. The cyclization of intermediate, 2,3-oxidosqualene, results in 
various polycyclic triterpenes, and sterols (Volkman, 2005; Dewick, 2009). Figure 1.6 shows 
the pathway of pentacyclic tripenoid biosynthesis. The dammarenyl cation is generated from 
2,3-oxidosqualene, and further rearranged and cyclized by the aid of the enzyme lupeol 
synthase, and β-amyrin synthase to yield the final products of lupeol, β-amyrin, and α-
amyrin. These products are further oxidized to triterpenic acids, betulinic acid, oleanolic acid, 
and ursolic acid respectively.    
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Figure 1.4 Biosynthesis pathways of common monoterpenoids (Dewick, 2009) 
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Figure 1.5 Biosynthesis pathways of diterpenoids (Dewick, 2009) 
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Figure 1.6 Biosynthesis pathways of sesquiterpenoid, and pentacyclic triterpenoids (Dewick, 
2009) 
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1.1.1. Monoterpenoids (C10) 
  
 Monoterpenes comprise two isoprene units. As they are volatile with characteristic 
odours, they are common constituents in essential oils. Although essential oils are complex 
mixtures with various kinds of skeleton, 90% of them are monoterpene (Bakkali, et al., 
2008). They can be classified according to functional group in the molecule, i.e., alcohols, 
aldehydes, ketone, esters, and ethers (Bakkali, et al., 2008), or by the arrangement of carbon 
atoms, i.e. menthane type, pinane type, camphane/bornane type, thujane type (Dewick, 2009). 
The most common monoterpenes from Salvia are pinenes, borneol, camphor, and 1,8-cineole, 
thujones as shown in Figure 1.7.  
                                                                       
OH
                   
O
 
               Menthane type                                                      α-Terpinol                1,8- Cineol 
                                                                   
                   Pinane type                                                         α-Pinene                    β-Pinene 
                                                   
OH
               
O
  
               Camphane/bornane type                                          Borneol                       Camphor                    
                           
H
                   
H O
         
H O
 
                 Thujane type                                                     α-Thujone                     β-Thujone 
     
Figure 1.7 Common monoterpenoids in Salvia species  
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Aerial parts of certain Salvia spp. are rich in essential oils (Baser, 2002). The 
standard content of essential oil from S. officinalis L. should not less than 15 ml/kg for the 
whole drug while the minimal essential oil content of S. fruticosa Mill. is 18 ml/kg for the 
whole drug (British Pharmacopoeia, 2008). Environmental and genetic factors affect the 
production of the oil. Percentages of major essential oil components of S. officinalis L., S. 
lavandulaefolia Vahl., and S. fruticosa Mill. (Synonym S. triloba L.) varied as shown in 
Table 1.1. The essential oil of each species comprises more than 50 chemical components. 
Essential oil of S. macrochlamys Boiss et. Kotschy comprised 80 compounds mainly 1, 8-
cineole (27%), borneol (13%), and camphor (11%) whereas essential oil of S. recognita 
Fisch. & Meyer comprised 82 compounds mainly camphor (42%), and 1, 8-cineol (12%) 
(Tabanca et al., 2006).  
 
Sage oil is defined in the British Pharmacopoeia (2008) as the essential oil obtained 
by stream distillation from the fresh/dried flowering stems of Salvia sclarea L. The 
compositions of S. sclarea L. essential oil were mainly linalool, linalyl acetate, α-terpineol, 
geraniol, and sclareol (Giannouli and Kintzios, 2000; Pitarokili et al., 2002). British 
Pharmacopoeia (2008) states the standard percentage ranges of sage oil from S. sclarea L. as 
follows:  
α/β Thujone: less than 0.2 %    
Linalool: 6.5-24 % 
Linalyl acetate: 56-78 %    
α-Terpineol: less than 5 % 
Germacrene D: 1-12 %    
Sclareol: 0.4-2.6 % 
OH
           
OH
                   
O
O
                   
OH
OH
  
 
        (+)-Linalool        (-)-Linalool                 Linalyl acetate                          Sclareol  
 
Figure 1.8 Terpenoids in sage oil from S. sclarea L.  
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Table 1.1 Percentages of the common essential oils in three Salvia species 
 
% in oil 1,8- 
Cineol 
Camphor Pinenes Thujones Reference 
α β α β 
S. officinalis L. 
 
4 19 Less than 1 20 4 Bozin et al., 2007 
15 11 3  10 25 4 Delamare et al., 2007 
5 11 -  3 6 Savelev et al., 2004 
- 1-44 0.1-9 1-15 1-46 1-40 Giannouli and 
Kintzios, 2000 
5-16 1-14 1-5 2-19 15-53 2-13 Perry et al., 1999 
Total range 4-16 1-44 1-9 1-19 1-53 1-40  
S. 
lavandulaefolia  
Vahl. 
17 43 - - - - Savelev et al., 2004 
1-54 1-36 2-24 2-48 1-23 1-4 Giannouli and 
Kintzios, 2000 
17 27 5 12 - - Perry et al., 2000 
Total range 1-54 1-43 2-24 2-48 1-23 1-4  
S. fruticosa 
Mill.  
(S. triloba L.) 
16 13 1 4 20 5 Delamare et al., 2007 
20 49 2 2 - Savelev et al., 2004 
17-54 1-16 2-7 2-9 1-8 1-9 Pitarokili et al., 2003 
48 9 5 5 4 8 Sivropoulou et al., 
1997 
Total range 16-54 1-49 1-7 2-9 1-20 1-9  
 
 
1.1.2. Sesquiterpenoids (C15) 
 
 Sesquiterpenoids are not common in the genus Salvia. Hydrocarbon and oxygenated 
sesquiterpenes have been generally isolated together with other monoterpenoids in essential 
oils. β-Caryophyllene, α-humulene and caryophyllene oxide were generally reported in range 
of 1-11% in essential oil of S. officinalis L. while germacrene D was mainly isolated from S. 
sclarea L. in range of 1-48% (Giannouli and Kintzios, 2000). Spathulenol was reported to 
form 39% of oil from S. elegans Vahl. (Mathew and Thoppil, 2011), and also a small 
percentage from S. sclarea L. (Ulubelen et al., 1994a; Giannouli and Kintzios, 2000). 
Viridiflorol was reported from S. officinalis L., S. lavandulaefolia  Vahl., and S. triloba L. in 
  - 11 - 
range of  1-18% in oil (Giannouli and Kintzios, 2000; Bozin et al., 2007; Delamare et al., 
2007). 
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       Figure 1.9 Sesquiterpenoids in Salvia species 
  
 
1.1.3. Diterpenoids (C20) 
 
 Many and various diterpenoids have been found in the genus Salvia, many with 
interesting biological activity. Antibacterial, cytotoxic, and cardiovascular activities have 
been extensively reported (Topcu and Goren, 2007). Diterpenoids can be classified according 
to the ring number as acyclic, bicyclic, tricyclic, tetracyclic, macrocyclic, and miscellaneous 
(Hanson, 1998). Alvarenga et al. (2001) presented 91 diterpenoid skeletons from various 
genera in Lamiaceae by using a computer based system. From the total of 91 investigated 
Salvia species, there were 50 skeletons with 592 occurrences. The most common one was the 
abietane type (275 occurrences), and the others were clerodane, rearranged abietane, 
pimarane, icetexane, labdane, and kaurane as shown in Figure 1.10. 
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Figure 1.10 Common skeletons of diterpenoids in the genus Salvia  
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1.1.4. Triterpenoids  
 
Triterpenoids have been isolated from 105 Salvia spp., 89 of 461 compounds were 
reported as new ones (Topcu, 2006; Mehmood et al., 2006; Ahmad et al., 2007; Rauter et al., 
2007; Ahmad et al. 2008; Cioffi et al., 2008; Pan et al., 2010). There are more than 100 
skeleton structure-types of triterpenoids (Mahato and Sen, 1997). These can be classified of 
according to the ring number, for example monocyclic, tricyclic, pentacyclic rings, and others 
with rearranged skeleton. Those found in Salvia spp. include the pentacyclic fused-ring types 
such as oleanane, ursane, lupane, and taraxastane as shown in Figure 1.11. The tetracyclic 
dammarane type and sterols have also been reported (Figure 1.12). 
 
 Ursolic and oleanolic acids are the most common triterpenoids in Salvia species 
(Topcu, 2006). The contents in dry weight of 37 investigated Salvia species were 0.02-1.84% 
for oleanolic acid, and 0.05-4% for ursolic acid (Janicsak et al., 2006). Lupeol, betulin and 
betulinic acid are representative of pentacyclic lupane-type (Figure 1.13).  
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             Figure 1.11 Common skeletons of pentacyclic triterpenoid in the genus Salvia  
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                  Figure 1.12 Common skeletons of tetracyclic triterpenoid in the genus Salvia  
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   Figure 1.13 Representative triterpenoids in the genus Salvia  
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1.2 Polyphenols in the genus Salvia 
 
Polyphenolic compounds are abundant in plants and food. They have been reported 
to play a notable role in the prevention of degenerative diseases such as cancer and 
cardiovascular disease (Scalbert et al., 2005). Phenolic compounds in plants can be classified 
according to their basic skeleton, for example phenylpropanoids (C6-C3), and flavonoids (C6-
C3-C6). Flavonoids are found in many species of Salvia, particularly flavones, flavonols, 
anthocyanins and their glycosides (Lu and Foo, 2002). Lu and Foo (2001) reported the 
antioxidant activity of flavonoids, namely luteolin and apigenin glycosides from Salvia 
officinalis L., however, caffeic acid derivatives in this plant showed more potent activity. 
Caffeic acid derivatives which have been observed in this genus can be categorized into 5 
classes depending on the number of caffeic acid units present, namely caffeic acid- monomer, 
dimers, trimers, tetramers, and a miscellaneous group (Lu and Foo, 2002; Jiang et al., 2005). 
They possess antioxidant, anti-thrombosis, anti-hypertension, antivirus, antitumor activities 
and protective effects against cerebral and heart ischemia-reperfusion (Jiang et al., 2005). 
These phenolic compounds are biosynthesized via the shikimate pathway which produces L-
phenylalanine as a precursor for the other secondary metabolites. Figure 1.14 shows the C9 
unit building block (p-coumaric acid) from which can be derived a variety of phenolic 
compounds (Winkel-Shirley, 2001; Dewick, 2009). 
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Figure 1.14 Biosynthesis of phenolic compounds via shikimate pathway (Winkel-Shirley, 
2001; Dewick, 2009) 
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Figure 1.15 Biosynthesis pathways of caffeic acid derivatives (Dewick, 2009; Petersen et al., 
2009)   
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1.2.1 Caffeic acid derivatives 
 
In phenylpropranoid metabolism, the pathway starts from L-phenylalanine to 
cinnamic acid by the enzyme phenylalanine ammonia lyase (PAL), and then further 
hydroxylation to 4-coumaric acid (p-coumaric acid) as shown in Figure 1.15. Then, p-
coumaric acid is converted into caffeic acid by enzyme p-coumarate-3-hydroxylase. Caffeic 
acid, or 3,4-dihydroxycinnamic acid, is found in various fruits and vegetables.  
 
Other cinnamic derivatives, such as ferulic acid, sinapic acid, are further derived 
from caffeic acid by methylation and/or hydroxylation reactions. Besides caffeic acid, other 
mono-caffeic derivatives such as chlorogenic acid (5-caffeoylquinic acid), ferulic acid, and 3-
(3,4-dihydroxyphenyl)lactic acid (danshenshu) have also been found in Salvia species (Figure 
1.16). Chorogenic acid is an ester of caffeic acid, and quinic acid which can be generated 
from caffeoyl–CoA (Dewick, 2009), or 4-coumaroyl-CoA (Petersen et al., 2009) as shown in 
Figure 1.15. 
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Figure 1.16 Caffeic acid derivatives   
 
The caffeic acid dimer, rosmarinic acid, is found dominantly in Salvia species (Lu 
and Foo, 2002), and also distributed in other genera of Lamiaceae, Boraginaceae and 
Hydrophyllaceae (Petersen et al., 2009). It was firstly isolated from Rosmarinus officinalis 
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(Lamiaceae). Although rosmarinic acid is a caffeic acid dimer, each of the aromatic rings is 
derived from different aromatic amino acids (Dewick, 2009; Petersen et al., 2009) as shown 
in Figure 1.15. The caffeoyl residue is originally biosynthesized via the general pathway from 
L-phenylalanine, but the 3,4-dihydroxyphenyllactic acid residue arises from L-tyrosine. The 
two intermediate metabolites, 4-coumaroyl-CoA and 4-hydroxyphenyllactic acid are 
incorporated by the enzyme rosmarinic acid synthase (RAS), and the product is further 
hydroxylated at C-3, and C-3´ of each ring (Petersen et al., 2009).  
 
Figures 1.17-1.18 shows caffeic acid trimers, salvianolic A and lithospermic acid, 
and also caffeic acid tetramers, salvianolic acid B, in Figure 1.19. They were isolated from 
danshen root, S. miltiorrhiza Bunge (Jiang et al., 2005), and other Salvia such as S.  
cavaleriei Lev. (Zhang and Li, 1994).  Salvianolic B was reported in all samples in 18 species 
of Chinese Salvia together with lithospermic acid which was detected in 14 Salvia species (Li 
et al., 2008). Lithospermic acid was also found in certain plants in the genus Lithospermum 
and Tournefortia of the Boraginaceae family (Jiang et al., 2005). 
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                                      Figure 1.18 Lithospermic acid 
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Figure 1.19 Salvianolic acid B (Lithospermic acid B) 
 
 
1.2.2 Flavonoids 
 
 Flavonoids are a class of polyphenol that are biosynthesized via a combination of the 
shikimate and acetate pathways. They occur commonly in fruit, vegetables, nuts, seeds, stems 
and flowers (Cushnie and Lamb, 2005). They are mainly responsible for antioxidant, 
antimicrobial, photoreceptors, visual attractors, feeding repellants, and for light screening 
activities in plants (Pietta, 2000). Many findings have reported their activities as free radical 
scavenging or chelating agents which lead to protection from radical-induced cell damage.  
 
The flavonoid skeleton comprises of 3 rings with C6-C3-C6; they can be classified 
into groups according to substitution of ring C as shown in Figure 1.20 (Pietta, 2000; 
Robards, 2003). Flavones, and flavonols are commonly isolated from Salvia spp. especially 
apigenin, luteolin, and their 6-hydroxylated derivatives (Lu and Foo, 2002). Nikolova et al. 
(2006) examined seven Bulgarian Salvia spp., S. nemorosa L., S. glutinosa L., S. 
scabiosifolia lam., S. ringens Sibth. Et Sm., S. tomentosa Mill., S. argentea L., and S. 
officinalis L. Flavones were detected in all species; there were derivatives of luteolin, and 
apigenin, 6-hydroxyluteolin, and 6-hydroxyapigenin. Luteolin was the most abundant while 
flavonols, derivatives of quercetin and kaempferol were present in low concentration from S. 
glutinosa L. and S. ringens Sibth. Et Sm. Flavonoid glycosides were also frequently found in 
this genus particularly the flavone-7-glycosides, apigenin-7-glucoside, and luteolin-7 
glucoside (Lu and Foo, 2002). 
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1.2.3 Anthocyanins 
 
 Anthocyanins are glycoside of anthocyanidins which may comprise of 
monosaccharide, disaccharides and trisaccharides. Anthocyanins are water soluble pigments, 
and responsible for conspicuous colours, orange, pink, red, violet, and blue, in fruits, and 
flowers of certain plants (Castaneda-Ovando et al., 2009). At least 26 anthocyanins have been 
identified from flowers of 49 species in the Lamiaceae including Salvia species (Saito and 
Harborne, 1992). Pigments based on pelargonidin glycoside and cyanidin glycoside were 
distributed in species with scarlet flowers such as S. coccinea Buchoz, and S. greggii A Gray, 
and red-purple flowers such as S. lineate Benth. While cyanidin, delphinidin, and malvidin 
types were found in species with purple-violet flowers such as S. leucantha Cav., violet 
flowers such as S. viridis L., and blue flowers such as S. castanea Diels. 
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1.3 Biological activities of compounds in the genus Salvia 
 
1.3.1 Antibacterial activity 
 Essential oils of cultivated S. officinalis L., and S. triloba L. were tested against 
certain food borne bacteria strains (Delamare et al., 2007). Oils of S. officinalis L. not only 
inhibited the growth of Aeromonas hydrophila, Klebsiella oxytoca, Bacillus megatherium, B. 
cereus, B. subtilis, Pseudomonas fluorescens with MIC in range of 0.1-5 mg/ml but also 
showed bactericidal activity in the same range of concentration. The essential oil of S. triloba 
L. also showed both bacteriostatic and bactericidal against the same bacteria stains and 
Salmonella typhimurium, Staphylococcus aureus, and Staphylococcus epidermidis with MIC 
of this oil in range of 0.1-4 mg/ml. It also inhibited growth of Escherichia coli with MIC 5 
mg/ml. The major content of S. triloba L. oils were α-thujone (20%), 1,8-cineol (16%), 
camphor (13%), β-caryophyllene (12%), α-humulene (8%), and viridiflorol (6%). However, 
the main constituents of S. officinalis L. oil were somewhat similar, namely α-thujone (25%), 
1,8-cineol (15%), camphor (11%), β-pinene (10%) except those sesquiterpenoids which 
comprised 1-3% in oil. 
 
 Alim et al. (2009) reported 92 components from essential oils of S. cedronella Boiss 
mainly 1,8-cineol (13%), caryophyllene oxide (10%), α-pinene (10%), and sabinene (7%). 
This oil showed appreciable antibacterial activity against Bacillus cereus, B. subtilis, 
Staphylococcus aureus, S. epidermidis with MIC in range of 0.02-0.06 mg/ml. Essential oil 
of S. ringens Sibth. & Sm. showed antbacterial activity against Pseudomanas aeruginosa, 
Enterobactor cloacae, Klebsiella pneumoniae, and Escherichia coli with MIC in range of 
2.8-3.8 mg/ml while its main isolated components, namely 1,8-cineol (48%), and α-pinene 
(11%) were active against those bacteria at MIC 2-3 mg/ml, and 2-15 mg/ml respectively 
(Tzakou et al., 2001).  
 
The diterpenoid, salvipisone (Figure 1.22), from hairy roots of S. sclarea L. were 
reported as bacteriostatic, and bacteriocidal against Staphyococcus aureus (MIC 60 µM), and 
Staphylococcus epidermidis (MIC 30 µM) regarding its inhibition of bacterial adhesion and 
biofilm formation (Kuzma et al., 2007). Aethiopinone was also reported to possess 
antbacterial activity against Staphylococcus epidermidis and Bacillus subtilis with MIC 8.2 
µM, and 4.1 µM respectively (Hernandez-Perez et al., 1999). 
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Figure 1.22 Diterpenoids with antibacterial activity   
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Other diterpenes from Salvia species with activity against certain bacteria were 
described by Ulubelen (2003). Horminone and 7-acetylhorminone (Figure 1.22) from S. 
blepharochlaena Hedge and Hub. Mor. were active against Staphylococcus aureus (ATCC 
6538) with MIC at 19.5 µM and 26.7 µM respectively. 6-β-Hydroxyisopimaric acid (Figure 
1.22) from Salvia caespitosa Montbret and Aucher ex. Bentham was active against 
Staphylococcus aureus (ATCC 6538) at MIC 28.3 µM comparable to antibiotic drugs 
activity, i.e. cefoperazone 24.8 µM and kanamycin 33.1 µM. Those three compounds, 
horminone, 7-acetylhorminone, and 6-β-hydroxyisopimaric acid, also showed antibacterial 
activity against Staphylococcus epidermidis (ATCC 12228) (MIC range 4.5-56.6 µM) and 
Bacillus subtilis (ATCC 6633) (MIC range 4.5-28.3 µM).  Ferruginol, and taxodione (Figure 
1.22) from S. mellifera Greene showed active activity against Staphylococcus aureus (ATCC 
6538) at MIC 12.6 µM, and 9.6 µM respectively, and also Bacillus subtilis (CECT 39) at 
MIC 10.5 µM, and 9.6 µM respectively (Moujir et al., 1996).  
 
Ulubelen et al. (1997) reported bioactive diterpenoids from S. multicaulis Vahl. 
against Mycobacterium tuberculosis H37Rv. The norditerpenoid, 12-demethylmulticaulin 
(Figure 1.22) showed the most potent activity with a MIC 1.7 µM while 12-methyl-5-
dehydro-7-acetylhorminone, 12-methyl-5-dehydrohorminone, and 12-demethylmultiorthqui-
none (Figure 1.22) were appreciably active at MIC 2.3 µM, 3.5 µM, and 4.1 µM respectively.  
 
Oleanolic acid (Figure 1.13) was described as a promising antibacterial agent against 
various strains of bacteria, M. tuberculosis, vancomycin-resistant enterococci, Enterococcus 
faecalis, Bacillus subtilis, and Staphylococcus epidermidis, with MIC less than 22 µM 
(Wolska et al., 2010). Both oleanolic and ursolic acids showed appreciable effect against M. 
tuberculosis H37Rv with MIC 5.5 µM (Bamuamba et al., 2008). Ursolic acid (Figure 1.13) 
was found to be active against vancomycin-resistant enterococci with low MIC at 8.8 µM 
while oleanolic was at MIC 17.6 µM (Horiuchi et al., 2007). Furthermore, ursolic acid 
exhibited its antibacterial activity against Methicillin-resistant Staphylococcus aureus 
(MRSA) with MIC 11 µM (Da Silva Filho et al., 2008), and S. aureus with MIC 17.5 µM 
(Fontanay et al., 2008). Szakiel et al. (2008) investigated oleanolic acid and its glycosides 
against Gram-positive, and Gram-negative bacteria and parasites. Oleanolic acid decreased 
cell growth and cell survival, and also increased cell autolysis including cell morphology 
alteration. The results suggested that the agycone part was vital for antibacterial activity 
while its C-3 glycosides, i.e. glucuronide showed greater antiparasitic effect against 
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Heligmosomoides polygyrus. As oleanolic acid showed more activity against Gram-positive 
than Gram-negative species the authors suggested that it may influence only the Gram-
positive bacterial cell wall/envelope. Lupane triterpenoids, lupeol and betulinic acid (Figure 
1.13), were inactive against Staphylococcus aureus, Escherichia coli, and Pseudomanas 
aeroginosa, however, betulinic acid inhibited Enterococcus faecalis with MIC 35 µM (Shai 
et al., 2008). 
 
Apigenin and luteolin exhibited antibacterial activity against methicillin-resistant 
Staphylococcus aureus (Sato et al., 2000). Apigenin was active with MIC in range of 14-58 
µM while luteolin showed weak inhibitory activity with MIC in range of 218-437 µM. In 
contrast, luteolin showed inhibitory activity against Porphyromonas gingivalis with MIC in 
range of 44-175 µM while apigenin was inactive (Yamamoto and Ogawa, 2002). The 
antibacterial activity of various flavonoids could be due to three inhibitory actions; namely 
nucleic acid synthesis, cytoplasmic membrane function and energy metabolism (Cushnie and 
Lamb, 2005).  
 
 
1.3.2 Antiviral activity 
S. fruticosa Mill. essential oil and isolated compounds, 1,8-cineol, camphor, 
isoborneol, and mixture of thujones were reported to possess activity against herpes simplex 
virus 1 (Sivropoulou et al., 1997; Armaka et al., 1999). 0.06% Isoborneol inactivated HSV-1 
replication within 30 minutes of exposure. α-Pinene also showed HSV-1 inhibitory activity 
(Astani et al., 2010).   
 
Akihisa et al. (2001) reported the inhibitory effect of various triterpenoids on HIV-1 
reverse transcriptase. Among these, oleanolic acid and lupeol strongly inhibited this enzyme 
with IC50 3.1 µM, and 3.8 µM respectively whereas ursolic acid, and betulinic acid showed 
the inhibitory effect at IC50 6.4 µM, and 7.9 µM respectively.  
 
There was also a study of lupane derivatives against influenza A and herpes simplex 
type 1 (HSV-1) virus in vitro (Baltina et al., 2003). Betulinic acid were fairly active against 
HSV-1 with EC50 8.2 µM. Nevertheless, betulinic acid showed activity against influenza A 
with EC50 of more than 219 µM while a synthetic derivative of betulinic acid, betulonic acid, 
was active against influenza A  and HSV-1 with EC50 5.7 µM and 2.5 µM respectively. 
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Betulinic acid has been used as starting compounds for synthesizing more potent anti-viral 
agents. Betulinic acid derivatives, for instance 3-O-(3´, 3´-dimethylsuccinyl)-betulinic acid 
(DSB) is under clinical trials for treatment of HIV infection, and derivatives of DSB also 
showed strongly inhibitory effect against HIV-1 maturation in vitro (Gerrish et al., 2008).  
 
Tewtrakul et al. (2003) reported antiviral activity against human immunodeficiency 
virus type 1 (HIV-1 IN) of rosmarinic acid and derivatives and luteolin and its glycoside in 
vitro. Among tested compounds, rosmarinic derivatives, namely salvianolic acid B, 
magnesium lithospermate, lithospermic acid, calcium rosmarinate and magnesium 
rosmarinate were the most potent with IC50 in range of 0.7-1.4 µM. While rosmarinic acid 
was active at IC50 5 µM, its ester, rosmarinic methyl ester, exhibited lower IC50 value at 3 
µM. Luteolin showed moderate inhibitory activity with IC50 11 µM, however, it was the most 
potent among tested flavones (Figure 1.23). Luteolin-5-glucoside showed the weakest 
activity with IC50 58 µM while luteolin-7-glucoronide was active with IC50 20 µM. Methyl 
substitution showed superior inhibitory activity to sugar substitution at C-7 because luteolin-
7-methyl ether was active at IC5011 µM. 
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            Figure 1.23 Antiviral polyphenols 
 
 
1.3.3 Antifungal activity 
 Essential oils of Salvia cedronella Boiss showed appreciable inhibitory activity 
against Candida albicans with MIC 0.06 mg/ml (Alim et al., 2009). Tzakou et al. (2001) 
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reported antifungal activity of essential oil from S. ringens Sibth. & Sm., and its main 
isolated components, namely 1,8-cineol, and α-pinene against Candida albicans, Candida 
vaginalis and Torulopsis glabrata. 1,8-Cineol showed lowest MIC at 0.25 mg/ml while the 
essential oils, and α-pinene were active against those pathogenic fungi at MIC of 0.75 mg/ml, 
and 2-4  mg/ml respectively.  
 
 Shai et al. (2008) reported antifungal activity of lupeol and betulinic acid. Both were 
active against Sporothrix schenckii, and Microsporum canis in the similar MIC range of 26-
38 µM. Betulinic acid showed superior activity against Aspergillus fumigatus, Candida 
albicans, Candida guilliermondi with MIC in range of 35-53 µM while lupeol was inactive.
  
 
 
1.3.4 Antiparasite, insecticidal activity 
Essential oils of S. elegans Vahl. and S. splendens Sell ex Roem. & Schult (Blue 
Ribbon) showed appreciable inhibitory effect against Aedes albopictus mosquito larvae with 
LC50 46 ppm, and 59 ppm respectively. The oil compositions of S. elegans Vahl. were mainly 
sesquiterpene, namely spathulenol (39%), caryophyllene (10%) while the oil of S. splendens 
Sell ex Roem. & Schult (Blue Ribbon) comprised β-cubebene (23%), and caryophyllene 
(13%) (Mathew and Thoppil, 2011). 
 
Lupeol and betulinic acid have been reported to possess antiprotozoal activity against 
Plasmodium falciparum. Lupeol was active in various findings with IC50 in range of 28-105 
µM while betulinic acid showed higher sensitivity with IC50 in range of 14-57 µM (Gallo, 
and Sarachine, 2009). Semi-synthetic analogues of betulinic acid with substitution at C-28 
such as methyl betulinate exhibited more potent activity with IC50 7 µM (Ziegler et al., 2004). 
 
 In vitro antileishmanial activity of terpenoids from S. cilicica Boiss and Kotschy was 
detemined by Tan et al. (2002). Both oleanoic acid and ursolic acid showed strong activity 
against the intracellular amastigote forms of Leishmania donovani and L. major with IC50 
values of 7-120 nM while they were moderately active against extracellular promastigote 
form of both Leishmania with IC50 in range of 51-137 nM.  
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1.3.5 Cytotoxic activity 
 Diterpenoids have been investigated for their cytotoxicity. Topcu et al. (2008) 
examined isolated compounds from S. hypargeia Fisch. Et Mey. against a human ovarian 
cancer cell line. Two diterpenoids, 6-hydroxysalvinolone, and demethylcryptojaponol (Figure 
1.24) were active with IC50 values 11.8 µM and 3.8 µM respectively. 6-Hydroxysalvinolone 
also showed inhibitory activity against human breast cancer, colon cancer, and prostate 
cancer with IC50 in range of 12.1-14.2 µM (Ulubelen et al., 1999). Ulubelen et al. (1999) 
reported cytotoxic activity of diterpenoids from S. hypargeia Fisch. Et Mey against a variety 
of cancer cell lines. The most potent one was taxodione (Figure 1.22) which showed 
inhibitory effects against mouse lymphocytic leukemia, human breast cancer, colon cancer, 
prostate cancer with IC50 in range of 1-3.8 µM. Saprorthoquinone (Figure 1.24) was 
moderately active against mouse lymphocytic leukemia (IC50 7.8 µM), and human colon 
cancer (IC50 11.1 µM) while microstegiol was active against mouse lymphocytic leukemia 
with IC50 at 10.1 µM (Ulubelen et al., 1992).  
 
Derivatives of saprorthoquinone from S. prionitis Hance also showed cytotoxic 
activities (Chen et al., 2002). 4-Hydroxysaprorthoquinone (Figure 1.24) appreciably inhibited 
topoisomerase I enzyme from Ehrlich carcinoma cells at IC50 value 0.8 µM while 3-keto-4-
hydroxysaprorthoquinone (Figure 1.24) showed inhibitory activity against human leukemia 
and stomach cancer cell lines with IC50 values 4.6 µM, and 0.3 µM respectively. Chang et al. 
(2005) reported cytotoxic diterpenoids from the same species. Prionoid D (Figure 1.24) 
exhibited inhibitory activity against mouse lymphocytic leukemia with IC50 0.4 µM whereas 
prionoid E (Figure 1.24) showed cytotoxic activity against human lung adenocarcinoma with 
IC50 0.7 µM. 
 
Guerrero et al. (2006) reported three diterpenoids with cytotoxic activity, carnosol, 
20-deoxocarnosol, and 16-hydroxycarnosol (Figure 1.24) from S. pachyphylla Epling ex 
Munx, and S. clevelandii (Gray) Greene. They showed 50% growth inhibition in range of 
3.6-5.4 µM against ovarian A2780, and breast HBL-100 cancer cell lines. Moreover, 
different kinds of breast cancer cell lines were examined. They inhibited breast cancer cells 
without estrogen-receptors (HBL-100) with lower concentration than those with estrogen 
receptors (T-47D). An abietane diterpenoid, carnosol, was reviewed for its anti-cancer 
activity. It promoted G2 cell cycle arrest in prostate cancer cells decreasing cell viability. It 
also showed cytotoxicity against skin cancer, colon cancer, and leukemia (Johnson, 2011).  
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Figure 1.24 Diterpenoids with cytotoxic acitivity 
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Cytotoxicity against human cancer cell lines of three diterpenoids, danshenol A, C 
and yunnannin A (Figure 1.24), from S. yunnanensis C. H. Wright has been reported (Xu et 
al., 2006). Danshenol A showed an appreciable effect against chronic myelogenous leukemia 
cell line with IC50 at 1.6 µM while cisplatin was at 13.3 µM. It also inhibited growth of other 
cell lines, i.e. urinary carcinoma (IC50 at 23.6 µM), hepatocellular carcinoma (IC50 at 13.8 
µM), cervix epidermoid carcinoma (IC50 at 20.5 µM) whilst a stereoisomer, danshenol C, was 
inactive. Yunnannin A was moderately active against cervix epidermoid carcinoma at IC50 
20.3 µM. Aethiopinone from S. aethiopis L. also showed cytotoxic activity against the KB 
human carcinoma cell line with IC50 value of 2 µM (Hernandez-Perez et al., 1999). 
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                                      Figure 1.25 Tanshinones with cytotoxic activity 
 
Tanshinones from S. digitaloides Diels (Figure 1.25) were evaluated their 
cytotoxicity against five human cancer cell lines, i.e. acute leukemia, liver cancer, lung 
cancer, breast cancer, pancreatic cancer (Xu et al., 2010). Neotanshinlactone selectively 
inhibited only a breast cancer cell line with IC50 4 µM while its derivative, dihydroneo-
tanshinlactone, showed cytotoxicity against all cell lines with IC50 greater than 30 µM. 
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Orthoquinone tanshinones showed comparable cytotoxic activity with or without a double 
bond in the furan ring. Both tanshinone IIA, and cryptotanshinone inhibited a lung cancer and 
breast cancer cell lines with IC50 less than 6.4 µM. An aromatic ring A together with an 
orthoquinone in ring C increased cytotoxic activity against all five cancer cell lines. In 
comparison with cisplatin (IC50 2-20 µM), tanshinone I was the most potent one with IC50 in 
range of 2.4-5.2 µM while IC50 of dihydrotanshinone was in range of 3.2-14 µM. However, 
taxol
®
 was active in all cancer cell lines with IC50 value less than 0.2 µM.  
 
 A labdane diterpenoid, sclareol (Figure 1.8), was reported to possess cytotoxic 
activity against breast cancer cell lines by induction cell cycle arrest, and apoptosis (Dimas et 
al., 2006). It also showed a synergistic effect in vitro by increasing cytotoxicity of the 
chemotherapeutic agents, doxorubicin, etoposide, and cisplatin. The co-treatment of 50 µM 
sclareol and each of those chemotherapeutic agents were more active than single drug 
treatment. A liposome-incorporated sclareol formulation was prepared, and its activity 
evaluated against various cancer cell lines (Hatziantoniou et al., 2006). It showed cytotoxic 
activity against colon cancer, melanoma, prostate cancer, and leukemia cell lines with IC50 in 
range of 15-28 µM whereas empty liposome exhibited no cytotoxicity at the tested 
concentration. Nevertheless, the liposome-sclareol formulation was toxic against normal cell 
lines with IC50 more than 100 µM whilst the IC50 of free sclareol was at 34 µM. Furthermore, 
this formulation showed the reduction of the growth rate of human colon cancer tumors 
implanted in mice. Sclareol is found in the essential oil of S. triloba L. (Giannouli and 
Kintzios, 2000).  
 
Several cell lines were employed to test the cytotoxic effect of isolated triterpenoids 
from Salvia spp. In comparison with cisplatin, hyptadienic acid (Figure 1.26) from S. trijuga 
Diels showed moderate toxicity against acute leukemia (IC50 15.5 µM), liver cancer (IC50 21 
µM), lung cancer (IC50 24.7 µM), and colon cancer (IC50 10.9 µM) whereas IC50 of cisplatin 
to those cell lines were 0.8, 13, 15.2, and 12 µM respectively (Pan et al., 2010). For other cell 
lines, 1β,2α,3β,11α-tetrahydroxyurs-12-ene (Figure 1.26) from S. kronenburgii Rech. was 
reported as selectively active against renal, non-small cell lung, and breast cancer cell lines 
(Topcu et al., 2004). Wang et al. (2009a) isolated compounds from S. chinensis Bentham, and 
also determined the antiproliferative effects in human leukemia HL-60 cells. Pomolic acid 
(Figure 1.26) was found to be the most potent with IC50 7.8 µM compared with 5-fluorourasil 
(IC50 3 µM). 
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Figure 1.26 Triterpenoids with cytotoxic activity 
 
 
Lupeol and betulinic acid were reviewed for their cytotoxicity by Gallo and 
Sarachine (2009). Lupeol exhibited inhibitory activity against human melanoma, leukemia, 
pancreatic adrenocarcinoma, neuroblastoma and prostate cancer cell lines with IC50 in the 
range of 17-38 µM. The mechanism of action was possibly due to inhibition of enzymes such 
as topoisomerase II, DNA polymerase β, and farnesyltransferase. Wada et al. (2001) reported 
inhibitory activity of lupeol against DNA topoisomerase II with IC50 value of 10.4 µM whilst 
betulin was moderately active with IC50 38.6 µM. Besides lupeol, betulinic acid showed 
notable anticancer activity in various studies with a lower IC50 value than lupeol in certain 
type of cancer cell lines, namely melanoma (IC50 2-11 µM), lung cancer (IC50 7-27 µM), 
breast cancer (IC50 11-36 µM), prostate cancer (IC50 22-26 µM), cervical cancer (IC50 5-31 
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µM), ovarian cancer (IC50 6-25 µM), colon cancer (IC50 20-29 µM), and colorectal cancer 
(IC50 8-36 µM) (Gallo and Sarachine, 2009). 
  
 Ursolic and oleanolic acids have been extensively reviewed for their anticancer 
activity (Liu, 1995; Ikeda et al., 2008; Sultana and Ata, 2008). The suppression of the cancer 
promotion pathways are possibly due to the inhibition of inflammation produced by tumor 
promoters, the suppression of certain oncogene expression such as c-jun and c-fos, and the 
modulation of host immune system (Liu, 1995). Topical pharmaceutical products containing 
ursolic acid have been patented for skin cancer prevention in Japan (Ikeda et al., 2008). The 
possible mechanisms of anticancer activity in skin are through the inhibition of NF-κB 
causing down-regulation of the expression of certain oncogenes, and the induction of 
apoptosis (Ikeda et al., 2008).    
  
The use of phytosterols as anticancer compounds was reviewed by Bradford and 
Awad (2007). Dietary phytosterols were examined for cytotoxicity against colon cancer, 
breast cancer, and prostate cancer. The authors suggested the mechanisms of anticancer 
action were due to the effects on the host and on the tumour itself. Serum phytosterols 
affected tumour cell cycle, apoptosis induction, tumor metastasis, and signal transduction, 
while they also influenced the host by boosting immune function. 
 
The combination of β-caryophyllene (Figure 1.9) with α-humulene or paclitaxel 
showed potentiated cytotoxic effect against a human breast adenocarcinoma cell line (Legault 
and Pichette, 2007). The cytotoxicity activity of α-humulene alone was superior to β-
caryophyllene alone. α-Humulene alone showed inhibitory activity by 50% at concentration 
of 0.16 mM, and increased to 75% inhibition when combined with 0.05 mM β-caryophyllene, 
while β-caryophyllene alone was inactive in all tested concentrations. The combination of 
0.16 mM α-humulene, and 0.05 mM β-caryophyllene showed a similar inhibitory activity to 
0.32 mM α-humulene alone. Moreover, 0.05 mM β-caryophyllene elevated 10 fold the 
cytotoxicity of paclitaxel against colon adenocarcinoma, and murine fibroblast cell lines in 
vitro compared to paclitaxel alone.     
 
 Luteolin showed cytotoxic acitivity against a lung cancer cell line with IC50 33 µM 
(Zhao et al., 2011). It inhibited cancer cells by promoting cell arrest in G1 phase, and 
apoptosis. Brusselmans et al. (2005) reported the induction of cancer cell apoptosis by 
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flavonoids via inhibition of fatty acid synthase (FAS). At the same tested dose of 25 µM, 
luteolin and quercetin showed inhibitory activity against human prostate cancer cell 
lipogenesis with % inhibition more than 50%. Additionally, luteolin was also reported as a 
DNA topoisomerase I inhibitor in vitro (Chowdhury et al., 2002). Preincubation of luteolin 
for 4-10 minutes showed a lower IC50 of 0.66 µM while simultaneous addition together with 
substrate showed IC50 of 5 µM. At a dose of 40 µM, luteolin showed 100% inhibition.  
 
 
1.3.6 Anti-cholinesterase activity 
S. lavandulaefolia Vahl. was examined for anticholinesterase activity in vitro (Perry 
et al., 2000), and in vivo (Perry et al., 2002). They showed that certain essential oils, namely 
1,8-cineole and α-pinene, were responsible for acetylcholinesterase inhibition by this species. 
This activity was also reported from essential oils of S. leriifolia Benth which comprised 
mainly camphor, 1,8-cineol, camphene, and α-pinene (Loizzo et al., 2009). Additionally, the 
essential oils of S. lavandulaefolia Vahl., and extracts of S. officinalis L. were reported to 
improve of cognitive function assessment in healthy volunteers, and in patients with mild to 
moderate symptoms of Alzheimer’s disease (Houghton et al., 2006).  
 
An ethanolic extract of S. officinalis L. was prepared in the form of a coated tablet, 
and orally administered to healthy elderly people (Scholey et al., 2008). Assessments 
included memory tests, accuracy of attention, speed of memory, and speed of attention at 
tested times, 1, 2.5, 4, and 6 hour after administration. A dose of 333 mg tablet showed a 
significant enhancement of memory performance compared to placebo. Other in vivo 
cognitive function test were performed in healthy adults by Kennedy et al. (2010). Essential 
oils of S. lavandulaefolia Vahl. was encapsulated in dose of 50 µl plus olive oil per capsule, 
and tested against placebo (olive oil). Results showed improvement of cognitive 
performance, mental fatigue reduction, and increased alertness at the 1, and 4 hour post-
single dose. In vitro analysis of the essential oil showed a potent AChE inhibitory effect with 
IC50 value of 3 µg/ml. Monoterpenoids, camphor (37%), 1, 8-cineol (36.4%), camphene, α-
pinene, limonene, and endo-borneol were reported from this oil.  
 
Ren et al. (2004) examined the chemical constituents of S. miltiorrhiza Bunge root 
and determined the acetylcholinesterase inhibition activity of isolated compounds. 
Dihydrotanshinone, and cryptotanshinone (Figure 1.25) were reported as the most active 
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compounds among the other terpenes, namely tanshinone I, tanshinone IIA, argentatin A,  
1,8-cineole,  α-pinene.  
 
In vitro tests for cholinesterase inhibition activity have been carried out in several 
Salvia species. For example, the acetone extracts of S. sclareoides Brot. demonstrated 100% 
inhibition of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) at a 
concentration of 1 mg/ml (Rauter et al., 2007) while nonpolar extracts of S. albimaculata 
Hedge and Hub, and S. cyanescens Boiss and Bal. showed more than 80% inhibition of both 
enzymes at the same concentration (Orhan et al., 2007). A new triterpene, santolinoic acid 
(Figure 1.27) from S. santolinifolia Boiss. showed moderate inhibitory activity against the 
enzyme acetylcholinesterase with IC50 value 62.5 µM and butyrylcholinesterase with IC50 
value 54.8 µM (Ahmad et al., 2007) while an other triterpene, salvin A (Figure 1.27) from the 
same plant displayed inhibitory activity only against butyrylcholinesterase with IC50 value 
12.5 µM (Mehmood et al., 2006). 
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Figure 1.27 Tritepenoids with anti-cholinesterase activity 
 
 
1.3.7 Cardiovascular activity 
Various isolated terpenoids and steroids from three Salvia species, S. syriaca L., S. 
amplexicaulis Lam., and S. eriphora Boiss and Kotschy. were tested for cardioactive activity 
in Wistar Albino rats (Ulubelen, 2003). Arterial blood pressure and heart rate were evaluated 
in comparison with propranolol, and phentolamine. The diterpenoids, ferruginol, 7-oxo-
abieta-9,12,14-triene,4,14-dihydroxysaprorthoquinone, aethiopinone, 4,12-dihydroxysapripa-
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raquinone, and 6,7-dehydroroyleanone showed cardiovascular activity by reducing blood 
pressure significantly. Besides diterpenoids, the steroids, 3β-hydroxystigmast-5-en-7-one, 
and stigmast-4-en-3-one were also active as shown in Figure 1.28.  
 
The cardiotonic and antidysrhythmic effects of oleanolic acid and ursolic acid has 
been evaluated in a rat model (Somova et al., 2004). Pretreatment by triterpenoids decreased 
the vasopressor and the tachicardic effects of the β-receptor agonist, isoproterenol. Oleanolic 
acid, 10 mg/kg, was claimed to show a similar effect to pretreatment with propranolol at dose 
of 2 mg/kg. Oleanolic acid and ursolic acid in a dose of 40mg/kg showed an antidysrhythmic 
effect on both calcium chloride-, and adrenaline-induced arrhythmias. They were suggested 
as β-adrenergic antagonists due to their ability to block the effects of adrenaline and 
isoprenaline in the same way as propranolol.  
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Figure 1.28 Diterpenoids and steroids with cardiovascular activity 
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Salvianolic acid A-F, and lithospermic acid were isolated from Salvia miltiorrhiza 
Bunge which has been traditionally used to treat various cardiovascular diseases (Jiang et al., 
2005). Liu et al. (1992) studied the protective activity against peroxidation damage to 
biomembranes of phenolic compounds from this plant. The authors suggested that salvianolic 
acid A (Figure 1.17) possessed a potent activity against lipid peroxidation and erythrocyte 
hemolysis among other phenolic acids such as salvianolic acid B, danshenshu, rosmarinic 
acid, and caffeic acid. 
  
Salvianolic acid B (lithospermic acid B, Figure 1.19) showed Angiotensin Convert-
ing Enzyme (ACE) inhibition activity with IC50 120 µM in vitro (Kang et al., 2003a). Its 
effect on renal functional parameters in ischemia/reperfusion-induced acute renal failure 
(ARF) was further investigated in rats (Kang et al., 2004). Salvianolic acid B, at a dosage of 
40 mg/kg/day for 4 days, alleviated renal functional defects and protected renal tissue from 
ischemia-induced ARF in rats. It also showed antioxidant activity against lipid peroxidation 
in rat kidney homogenates, red blood cells, superoxide, and hydroxyl scavenging activity 
over the dose range 70-278 µM. The authors suggested that Salvianolic acid B (lithospermic 
acid B) improved renal defects in rats with ischemia-reperfusion induced acute renal failure 
possibly due to its radical scavenging activity.  
 
 
1.3.8 Central nervous system activity 
S. divinorum Epling et Jativa leaves have been used by the Mazatec people in Mexico 
for religious purposes (Roth et al., 2002) and for the treatment of various ailments (Siebert, 
1994). Salvinorin A (Figure 1.29), which is a main neoclerodane diterpene compound from 
leaves of S. divinorum Epling et Jativa, induced hallucinogenic symptoms after being inhaled 
in doses of 200-500 µg and these effects also depended on duration of absorption through 
oral mucosa after the fresh leaves were consumed (Siebert, 1994). Roth et al. (2002) 
evaluated radioligand-binding inhibitory activity of salvinorin A against many receptors, 
transporters, and ion channels. Salvinorin A inhibited only [
3
H]-bremazocine-labeled ĸ opioid 
receptor (KOR), and showed insignificant binding inhibition to cloned human µ (MOR) or δ 
opioid (DOR) receptors. It was reported as a potent and selective ĸ opioid receptor (KOR) 
agonist, the first nonalkaloid one, and was the main component responsible for the 
psychomimetic effects.  
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Figure 1.29 Salvinorin A (divinorin A) 
 
 Kavvadias et al. (2003) reported constituents from S. officinalis L. with in vitro 
affinity to human brain benzodiazepine receptor. This study aimed to find ligands which 
inhibited the binding of 
3
H-flumazenil to benzodiazepine receptors. In comparison with 
diazepam, 7-methoxyrosmanol, and galdosol (Figure 1.30) showed the appreciable binding 
activity to the benzodiazepine receptor with IC50 7.2 µM, and 0.8 µM while IC50 of diazepam 
was 0.05 µM. 
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Figure 1.30 Diterpenoids with benzodiazepine receptor binding activity 
 
 
1.3.9 Hepatoprotective activity 
Rosmarinic acid was investigated for its hepatoprotective effect in a hepatic fibrosis 
cell line in vitro. It showed proliferation inhibitory activity against the rat hepatic stellate 
cells (HSC-T6) with IC50 value 20 µM, and also induced apoptosis (Zhang et al., 2011). The 
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phosphorylation of signal transducer and activator of transcription protein-3 (STAT3) also 
decreased; therefore, the authors suggested the activity was possibly due to the inhibition of 
phosphorylation in STAT3 which mediates growth promoting activity. 
 
Salvianolic acid B (Figure 1.19) could reverse hepatic fibrosis in patients with 
chronic hepatitis B (Liu et al., 2002). Clinical efficacy of salvianolic acid B was evaluated in 
60 patients having liver fibrosis with chronic hepatitis B, in a double blinded, randomized, 
controlled trial. Patients given tablets containing 30 mg/tablet salvianolic acid B orally 
administered, two tablets three times daily for six months were compared with patients 
receiving intramuscular injection of Interferon-γ (INF- γ) once daily for the first month, and 
then every other day in the following five months. Salvianolic acid B group showed 
appreciable reduction of serum fibrotic markers (HA, IV-C, and PIIIP) compared to the 
content before treatment. Reverse rate of fibrotic stage was 37% in salvianolic acid B group, 
and 30% in INF- γ group. However, the difference of efficacy between both salvianolic acid 
B and INF- γ groups were insignificant; INF-γ showed certain side effects (fever, and 
transient decrease of leucocytes) in some patients, while salvianolic acid B showed no change 
in any monitoring tests, namely EKG, renal function, blood, and urine analysis. There was 
also no significant change in hepatitis B antigen and antibody system in both groups.  
 
The hepatoprotective effects of oleanolic acid, and ursolic acid were exhaustively 
reviewed by Liu (1995). Many findings reported protection against chemical damage such as 
carbon tetrachloride and acetaminophen induced liver damage. However, the mechanisms of 
hepatoprotection by both acids are not yet conclusive but may involve the inhibition of 
toxicant activation and the increase of the body defense systems (Liu, 1995). 
 
 
1.3.10 Anti-inflammatory activity 
Ursolic acid from the chloroform extracts of S. officinalis L. showed topical anti-
inflammatory activity by evaluation of the inhibition of croton-oil-induced ear oedema in 
mice, and its effect was more potent than indomethacin (Baricevic et al., 2001). Using the 
same model in mice, Felice et al. (2006) reported that 2-deoxyasiatic acid, maslinic acid, and 
arjunolic acid (Figure 1.31) from S. hierosolymitana Boiss showed the same oedema 
reduction effect in comparison with indomethacin. For the same topical dose of 0.3 
µmol/cm
2
, asiatic acid (Figure 1.31) showed 2.8 fold less oedema reduction than 2-
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deoxyasiatic acid. For the oleanane skeleton, a double bond at C-12(13) was advantageous 
because 2α,3β-Dihydroxyolean-28-oic acid (Figure 1.31) was 2.2 fold less active than 
maslinic acid. 24-Nor-2α,3β-dihydroxy-olean-4(23)-12-ene was 3.6 fold less active than 
maslinic acid. Moreover, the hydroxylation of C-23 in the oleanane type slightly increased 
the activity since arjunolic acid showed 60% of oedema reduction while maslinic acid 
showed 51% oedema reduction. 
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                     Figure 1.31 Tritepenoids with anti-inflammatory activity 
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The determination of anti-inflammatory activity of lupeol and lupeol linoleate was 
carried out in rats by using a paw swelling model (Geetha and Varalakshmi, 2001). Lupeol 
and lupeol linoleate (50 mg/kg in 0.5 ml olive oil), and indomethacin (3 mg/kg in 0.5 ml 
saline) were administered to arthritic rats. They showed a paw thickness reduction in 
arthritic-induced rats as follows:  lupeol 39%, lupeol linoleate 58%, and indomethacin 35%. 
Furthermore, rats orally administered with lupeol and lupeol linoleate (dose level of 100 and 
200 mg/kg) did not show ulcerogenic activity in the stomach whereas it was found in 
indomethacin (20 mg/kg) treated rats.  
 
The anti-inflammatory activity of triterpenic acids has been extensively reported for 
ursolic acid, oleanolic acid, lupeol, betulin, and betulinic acid (Liu, 1995; Ikeda et al. 2008; 
Sultana and Ata, 2008; Gallo and Sarachine, 2009). 
 
The suppression of arachidonic acid metabolism and cytokine production in vitro by 
1,8-cineol has been reported (Juergens et al., 1998). In vivo evaluation of 1,8-cineol anti-
inflammatory activity was further carried out in a double-blinded, placebo-controlled trial on 
steroid-dependent bronchial asthma patients (Juergens et al., 2003).  In a dose of 200 mg 
three times a day for 12 weeks, 1,8-cineol showed 36% daily prednisolone dosage reduction 
while the placebo group showed only 7% dose reduction.  
 
Anti-inflammatory activity of linalool, and linalyl acetate were evaluated by using a 
model of carrageenin-induced edema in rats (Peana et al., 2002). Rats were pretreated with   
(-)-linalool, (±)-linaool, linalyl acetate via subcutaneous abdominal injection. After 30 
minutes, paw edema was induced by carrageenan, and measured 1, 3, and 5 hours after 
induction. (-)-Linalool, at the dose of 25 mg/kg, showed strong inhibition of edema after 3, 
and 5 hours while the racemic compound showed the edema reduction only 1 hour after 
carrageenin administration without any effect after 3 and 5 hours. Linalyl acetate showed no 
effect at the same dose, however, it reduced inflammation only after 3 and 5 hour when the 
dose was increased to 64 mg/kg. The authors suggested the delayed effect of linalyl acetate 
was due to the biotransformation into the alcohol.    
 
 Luteolin was evaluated for anti-inflammatory activity in acute and chronic models in 
mice (Ziyan et al., 2007). Oral administration of luteolin in dose of 10 and 50 mg/kg 
significantly reduced paw edema in the acute carrageenan-induced model, and also reduced 
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the elevated level of 6-keto-PGF1α in exudates. In a chronic inflammation model, luteolin 
showed the inhibition of cotton pellet-induced granuloma formation which led to the 
reduction of fibroblasts and synthesis of collagen and mucopolysaccharides. Apigenin also 
inhibited of fibroblast growth (Koganov et al., 1999). Fibroblasts play a role in tissue 
formation and interact with the immune system during inflammation which may cause a 
delay in wound healing (Harborne and Williams, 2000).  
 
In addition, the human blood assay for cyclooxygenase (COX) activity was also 
carried out in vitro (Ziyan et al., 2007). Thromboxane B2 (TXB2), and prostacyclin (PGI2) 
were measured as markers of COX-1, and COX-2 activities respectively. Luteolin showed 
selective potency by decreasing the concentration of PGI2 (COX-2) while having no effect on 
TXB2. The authors suggested that luteolin could be a selective inhibitor for cyclooxygenase-2 
(COX-2). 
 
 
1.3.11 Antioxidant activity 
Tanshinone II-A (Figure 1.25) from S. miltiorrhiza Bunge showed inhibition of lipid 
peroxidation induced-DNA damage in liver cells (Cao et al., 1996). It was suggested to act as 
a lipid free radical scavenger and to inhibit the formation of malondialdehyde (MDA) and 
lipid-DNA adducts in a similar way to vitamin E and butylated hydroxyltoluene (BHT). 
Kabouche et al. (2007) reported a diterpene from the aerial part of from S. barrelieri Ettling, 
inuroyleanol (Figure 1.32) which also showed strong DPPH free radical scavenging activity, 
and the inhibition of lipid peroxidation in the β-carotene-linoleic acid system. Moreover, 
taxodione (Figure 1.22) from the root of the same species showed comparable antioxidant 
activity to the controls, BHT and vitamin E, in β-carotene bleaching, DPPH free radical 
scavenging activity, ABTS cation radical scavenging activity, and cupric reducing 
antioxidant capacity methods (Kolak et al., 2009). 
 
Abreu et al. (2008) examined 60 species of Salvia. The result indicated that the 
antioxidant diterpenes, carnosic acid and carnosol (Figure 1.32) were found in 48 and 27 
species respectively while α-tocopherol was detected in all species. Many findings have 
reported a promising antioxidant activity of carnosol, for example, inhibiting Cu
2+
 induced 
LDL oxidation and lipid free radicals in mouse microsomes, and enhancing glutathione-S-
transferase (GST) activity in the rat liver (Johnson, 2011).  
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    Figure 1.32 Diterpenoids with antioxidant activity 
 
 
The antioxidant activity of 42 flavonoids was determined against β-carotene 
oxidation inhibition, and DPPH scavenging activity (Burda and Oleszek, 2001). Among 
many classes of flavonoids, flavonols with a free hydroxyl group at the C-3 position 
exhibited high inhibitory activity against β-carotene oxidation. Kaempferol and quercetin 
showed comparable antioxidant activity, but kaempferol was slight higher. Moreover, the 
methylation or glycosylation substitution at C-3 showed a lower antioxidant activity than 
aglycone. In DPPH scavenging assay, the substitution at C-3 of flavonol showed no effect but 
ortho-dihydroxyl substitution at B ring (C-3', and C-4') with a hydroxyl group at C-3 and also 
a double bond (C-2 and C-3) are vital for radical scavenging activity. Kaempferol, rutin, 
quercetin and luteolin-7-glucoside showed comparable DPPH scavenging activity whereas 
apigenin-7-glucoside showed weak activity, and no activity for naringin and apigenin. The 
ortho-dihydroxy in the B ring stabilised the radical form while the conjugation of a double 
bond (C-2,3) and 4-oxo maintain electron delocalization in the aromatic nucleus (Rice-Evans 
et al., 1996).                                  
 
S. officinalis L. infusion was evaluated for antioxidant activity in vivo in mice and 
rats (Lima et al., 2005). Both mice and rats were given sage tea (2 g dried plant/150 ml 
boiling water) as beverage compared with tap water for 14 days. Plasma transminase 
activities, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and liver 
glutathione were measured from mouse blood samples. The sage tea drinking group showed 
no difference in plasma ALT and AST. However, the glutathione enzymes in liver, 
glutathione reductase (GR), and glutathione-S-transferase (GST), of the sage tea group were 
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10% higher than the water drinking group. Furthermore, isolated rat hepatocytes from sage 
tea feeding group were cultured and toxicity induced by tertiary-butyl hydroperoxide (t-BHP) 
in order to assess the protective effect of sage tea. t-BHP-induced lipid peroxidation effect 
between two groups were insignificant while the GSH level of sage tea group was higher than 
control after 4 h of culture. The authors suggested no toxicity to the liver of sage tea drinking 
in both mice and rats, but a positive effect on the antioxidant status of the liver. Sage tea 
contained the phenolic acid, rosmarinic acid (0.04%), luteolin-7-glucoside (0.01%), and 
volatile components (less than 0.01%) including 1,8-cineol, thujones, camphor, and borneol.  
 
Zhao et al. (2008) reported that the radical scavenging activity against free hydroxyl 
radicals, superoxide anion radicals, DPPH, and ABTS, of danshenshu and salvianolic acid B 
were higher than vitamin C while salvianolic acid B was the most potent with IC50 value 0.1 
mM. The protection effect against hydrogen peroxide induced human vein vascular 
endothelial cell damage corresponded to their antioxidant activity. 14 µM Salvianolic acid B 
exhibited the same % cell viability as untreated control culture.  
 
 
1.3.12 Polyphenol and UV protection 
In plants, flavonoids play a role as flavonoid pigment complexes in conspicuous 
flower colour, and also as UV filters in leaves due to their absorption in 280-320 nm region 
(Harborne and Williams, 2000). Flavone, and flavonol glycosides were commonly reported 
as the UVB protective flavonoids from various plant species, however, the ability to prevent 
damaging effect from UV radiation varied in plants ((Harborne and Williams, 2000). 
 
Ultraviolet (UV) radiation exposure induces the generation of free radicals which 
could further react with DNA and cause biological damage (Svobodova et al., 2003). 
Rosmarinic acid showed photoprotection activity against UVA-induced oxidative stress 
(Psotova et al., 2006). 25 µM Rosmarinic acid pre-treatment led to increased cell viability of 
human keratinocytes after exposure to UVA (100 and 200 kJ/m
2
). Caffeic acid, and ferulic 
acid also showed cytoprotection against UVB-induced erythema in vivo (Saija et al., 2000). 
The minimal erythema dose (MED) was firstly determined for each subject, and the 
irradiation dose corresponding to double the MED was used. After UVB exposure, 200 µl 
aqueous solution of caffeic acid, and ferulic acid were applied to the irradiated forearm skin 
area of six young healthy volunteers. Although both showed cytoprotection effect against 
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UVB, ferulic acid showed superior protection to caffeic acid with 1.8 fold higher percentage 
inhibition of UVB skin erythema. In addition, ferulic acid showed the better penetration 
through the stratum corneum in vitro which was possibly due to its greater lipophilicity. 
Hydroxycinnamic acids were previously reported by this research group to protect the 
phospholipid membrane from UV light by lipid peroxidation inhibition, and to react with 
nitrogen oxides.  
 
Caffeic acid and its derivatives were evaluated for protection against UVA-induced 
reactive oxygen species in the skin of hairless mice (Yamada et al., 2006). Topical use of 
caffeic acid and rosmarinic acid suppressed reactive oxygen species (ROS) in mouse skin as 
determined by chemiluminescence (CL). The tested compounds were applied to the 
abdominal skin area 30 minutes before UVA exposure (180 kJ/m
2
), and the CL light emission 
was measured. Caffeic acid showed better protection with IC50 1.2 mM while rosmarinic acid 
was at 2.8 mM. However, they both suppressed UVA-induced ROS in the concentration of 5-
10 mM. Furthermore, caffeic acid was given orally to the mice in dose of 200 mg/kg body 
weight for 3 consecutive days, and then followed by UVA exposure to the skin. The 
distribution of caffeic acid to the plasma and liver were detected after a single oral dose and 
to the skin after three consecutive days of oral administration. The ROS suppressive effect in 
skin exposed to UVA was also observed in the oral administration group. As caffeic acid can 
absorb certain wavelengths of UVA (320-400 nm), it possibly protected the skin by a 
sunscreen effect as well as ROS quenching activity.  
 
Tong et al. (2007) evaluated the effect of apigenin against cyclooxygenase 2 (COX-
2) enzyme expression which is induced by UVB exposure in vitro. Apigenin, at concentration 
of 50 µM, inhibited PGE2 production in mouse keratinocytes through modulation of COX-2 
gene. As carcinogenesis can cause COX-2 overexpression, the authors suggested the 
application of apigenin as alternative anticancer agent.  
 
Luteolin was reported to protect skin from UVB-induced damage in vitro and in vivo 
(Wolfle et al., 2011). It inhibited the formation of ROS induced the production by UVB with 
EC50 10.5 µM and by H2O2 with EC50 36 µM in human keratinocytes. An in vivo study was 
also carried out using the UVB erythema test. Luteolin was applied to the backs of volunteers 
30 minute before irradiation by UVB and the induced erythema was measured 
photometrically. 2.5% Luteolin showed a similar reduction of erythema as trolox (positive 
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control). Expression of COX-2 was also inhibited by luteolin which resulted in a reduction of 
PGE2 in human keratinocytes cell culture supernatants. The authors suggested the protective 
effect of luteolin against UVB-induced damage was due to UV-adsorbtion, DNA-protection, 
antioxidant and anti-inflammatory properties.  
 
 
1.3.13 Miscellaneous activities  
A hydroalcoholic crude extract of S. officinalis L. was investigated for gastropro-
tective effect in a rat model (Mayer et al., 2009). In comparison with omeprazole, oral 
administration of the extract showed a decrease in ethanol-induced gastric lesions and acetic 
acid induced-gastric ulcer. It also inhibited H
+
, K
+
-ATPase activity in vitro which is 
comparable to omeprazole. Carnosol was suggested as an active component in the extract. 
 
 A new secoisopimarane diterpenoid, 3,4-secoisopimara-4(18),7,15-triene-3-oic acid 
(Figure 1.33), from S. cinnabarina M. Martens et Galeotti was tested in isolated guinea-pig 
ileum for antispasmodic activity (Romussi et al., 2001). This study employed histamine, 
acetylcholine, and barium chloride as agonists to induce contraction. The result showed a 
non-selective inhibitory effect of this compound and a comparable IC50 to papaverine against 
all tested agonists. 
 
HOOC
 
     Figure 1.33 Antispasmodic diterpenoid 
 
 Oleanolic acid, ursolic acid, and lupeol were tested in an α-amylase assay (Ali et al., 
2006). Among these compounds, ursolic acid showed the strongest inhibition property on α-
amylase while lupeol was also active with the weakest inhibition. These findings suggested 
that the pentacyclic ring of the terpenoids may be responsible for this activity, however the 
structure activity relationship between cyclopentane E ring, and cyclohexane E ring was 
inconclusive. 
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Ninomiya et al. (2004) reported pancreatic lipase inhibitory activity of both carnosic 
acid and carnosol from leaves of S. offinalis L. Moreover, carnosic acid also showed 
decreased serum triglyceride elevation in olive oil-loaded mice including body weight and 
epidydimal fat reduction in high fat diet-fed mice. 
 
Diterpenoid compounds from the root part of S. miltiorrhiza Bunge, tanshinone II-A, 
tanshinone I, cryptotanshinone, and 15,16-dihydrotanshinone, were reported to possess 
antiosterporotic effect in vitro. They showed appreciable inhibitory effects on osteoclast 
differentiation in the mouse osteoblast/bone marrow cell coculture system (Lee et al., 2005). 
Tanshinone II-A, danshenols A and B, dihydrotanshinone I, tanshinone I, cryptotanshinone, 
and danshexinkun A were also reported to show inhibitory activity against aldose reductase 
(Fuente and Manzanaro, 2003).  
 
Luteolin-5-rutinoside from S. lavandulifolia Vahl. was evaluated for antidiabetic 
activity in streptozotocin (STZ)-induced diabetic rats (Zarzuelo et al., 1996). Oral 
administration of luteolin-5-rutinoside at dose of 2 mg/kg showed a 22% reduction of blood 
sugar with no effect on plasma insulin after a 20 day treatment in comparison with diabetic 
control. A combination of luteolin-5-rutinoside, and glibenclamide showed appreciable 
synergistic effects by 51% reduction of blood sugar, and 2.5 fold increase in blood insulin 
level. Moreover, body and pancreas weights of this group were higher than diabetic control.
  
 
 
1.4 Investigated plant: Salvia viridis L. 
 
S. viridis L. (Synonym S. horminum L.), or Red Topped Sage, is a perennial, annual, 
or biennial herb with erect stems up to 50 cm, 4-8 flowers in axillary verticillasters with 
various coloured bracts (Hedge, 1972). In Flora Europaea (1972), it is placed along side S. 
sclarea L. In the wild, this species is distributed in Europe, particularly the Mediterranean 
region (Hedge, 1972) and has widely been cultivated in Britain as an ornamental plant 
(Walker, 2002). It has been used in traditional medicine, for example, an infusion of leaves as 
a gargle for sore gums, and has also been employed to increase the quality of liquor by 
putting leaves and seeds into the fermentation tank (Dweck, 2000).  
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Ulubelen and Brieskorn (1975) isolated ursolic, oleanolic and micromeric acids from 
the aerial part. Three triterpenic alcohols, i.e. lupeol, lup-(20)29-ene-2α,3β-diol, and olean-
13(18)-ene-2β,3β-diol were additionally reported from the same plant part by Ulubelen et al. 
(1977). Kokkalou and Kapetanidis (1988) found phenolic acids and flavonoids including 
their glycosides, namely caffeic acid, chlorogenic acid, apigenin, luteolin, apigenin-7-
glucoside, apigenin-7-rutinoside, luteolin-7-glucoside, and luteolin-7-rutinoside. 
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 Figure 1.34. Triterpenoids in aerial part of Salvia viridis L.  
 
More recently, diterpenes, i.e. salviviridinol, viridinol, viridone, sugiol, 1-oxoferru-
ginol, ferruginol, aethiopinone, and microstegiol were isolated from roots, and 1-oxoferru-
ginol showed antibacterial activity against Bacillus subtilis, Staphylococcus aureus and 
Staphylococcus epidermidis (Ulubelen et al., 2000). Additionally, ferruginol, which was also 
isolated from S. ceratophylla L., S. caespitosa Montbret and Aucher ex. Bentham, and S. 
blepharochlaena Hedge and Hub. Mor., showed antihypertensive activity by reducing arterial 
blood pressure in rats (Ulubelen, 2003).  Carnosic acid, carnosol, and α-tocopherol have also 
been reported in S. viridis L. (Abreu et al., 2008). 
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Figure 1.35. Diterpenoids in root part of Salvia  viridis L.  
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Aims of this study 
 
 Previous phytochemical reports on S. viridis L. showed the presence of triterpenoids 
and flavonoids in the aerial part, and diterpenoids in the root part; several of which have been 
reported to possess interesting and varied biological activities. S. viridis L. cv. Blue Jeans is 
an ornamental cultivar selected for deep blue floral bracts (as opposed to violet, green, and 
pink) in the wild type. This is effectively, a chemical variant which might be expected to 
yield a generally novel chemistry when compared with the wild type.  
 
Accordingly, the phytochemical aim of the project was to isolate and identify as 
many compounds as possible across a wide range of structural and biosynthetic types. 
Moreover, many different types of biological activity have been reported from the genus 
Salvia. Thus, a biological aim of the project was to utilize a series of TLC-based chemo- and 
bioautographic techniques to secure a biological activity profile of as many as possible of the 
isolated compounds. A final aim was to proceed to a more detailed in vitro biological study 
of compounds of interest identified in the previous steps.   
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Chapter 2 
Experimental 
 
 
2.1 Plant Materials 
Salvia viridis L. cv. Blue Jeans (synonym: S. horminum L.) was grown in Bath from 
commercially available seed purchased from Thompson and Morgan, and harvested in 
September 2004. Roots and aerial parts were separated, air-dried at room temperature, ground 
and kept separately in airtight containers.  
 
2.2 Material 
2.2.1 Chemicals 
All solvents, which were analytical or HPLC grade, ferric chloride, formic acid and 
silica gel 60 (35-70 µM, 60 A°) were supplied by Fisher. DPPH (2,2- Diphenyl-1-picryl-
hydrazyl), p-iodonitrotetrazolium chloride (INT), caffeic acid, chlorogenic acid, rutin, 2-
aminoethyl-diphenyl borinate, and polyethylene glycol 300 were purchased from Sigma. 
Deuterated-methanol, deuterated-chloroform, deuterated-DMSO, anisaldehyde, rosmarinic 
acid, and phosphomolybdic acid were purchased from Aldrich. Sulfuric acid and acetic acid 
were purchased from BDH chemical Ltd. Water was purified by Milli Q Plus PF.  
  
2.2.2 Test organisms and media 
The panel of test organisms consisted of the Gram-positive bacteria, Staphylococcus 
aureus (ATCC 6571), Enterococcus faecalis (ATCC 775), Bacillus cereus (ATCC 2599), 
and the Gram-negative bacteria, Klebsiella pneumoniae (ATCC 9633), Proteus vulgaris 
(ATCC 4636), and Escherichia coli (ATCC 86). Nutrient agar, Nutrient broth, ampicillin 
impregnated disc were supplied from Oxoid. Chloramphenical and ampicillin sodium, 
erythromycin powder were supplied from Sigma. All procedures were carried out under 
sterile conditions.  
 
 
2.3. Thin layer chromatography (TLC) 
TLC plates, aluminium-backed sheets coated with silica GF254 60 in 0.25 mm 
thickness, were purchased from Merck. All crude extracts were dissolved in the appropriate 
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solvent, i.e. methanol and chloroform before being spotted on to the plate. The following 
standard compounds, naringin, rosmarinic acid, caffeic acid, chlorogenic acid, and rutin were 
applied side by side on the same plate.  Two mobile phases were used to develop the TLC 
plates as follows: ethyl acetate: methanol:formic acid:water (50:3:3:6) and 
chloroform:methanol (9:1). The developed TLC plates were observed in visible light and 
under UV light at 254 nm and 365 nm, and then were sprayed with reagents as shown in 
Table 2.1. 
 
Table 2.1 Spraying reagents (Reich and Schibli, 2007) 
 
Reagent Composition and Use Examination Type of compound 
Anisaldehyde-
Sulfuric acid 
 
0.5% Anisaldehyde in solution of 
methanol:acetic acid:sulfuric acid 
(85:10:5) 
The plate was sprayed, and then 
heated at 100ºC for 2-5 minutes 
Visible light,  
UV 366 nm 
Terpenoids, saponin, 
sterols, iridoid, most 
lipophilic compounds 
Iron (III) chloride 1% iron (III) chloride in ethanol 
The plate was sprayed then heated 
at 100ºC for 10 minutes 
Visible light Phenols, flavonoids, 
tannins, plant acids 
Natural products/ 
polyethylene 
glycol (NP/PEG) 
spraying solutions 
Solution A: 1% 2-aminoethyl- 
diphenyl borinate in methanol 
Solution B: 5% PEG in ethanol  
The plate was heated at 100ºC for 3 
minutes then sprayed while still hot 
with solution A and B 
consecutively. 
UV 366 nm Flavonoids, 
carbohydrates, 
anthocyanins and 
plant acids 
Phosphomolybdic 
acid 
5% Phosphomolybdic acid in 
ethanol 
The plate was sprayed and then 
heated at 100ºC for 5 minutes. 
Visible light Fatty oils, reducing 
substances, steroids, 
essential oils 
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2.3.1 TLC-chemoautographic method: DPPH radical scavenging activity 
 This method was carried out as described by Cimpoiu (2006) and Tasdemir et al. 
(2004). Developed TLC plates were sprayed with 0.2 % DPPH solution in methanol, and left 
at room temperature for 30 minutes. Yellow spots or bands on a purple background were 
observed in visible light. 
 
2.3.2 Antibacterial activity 
2.3.2.1 TLC-bioautographic method; Agar overlay   
This method was carried out as described by Raman et al. (1995) with slight 
modification. Nutrient agar (28 g/L) and nutrient broth (13 g/L) were dissolved in water as 
described by manufacturer, and sterilized by autoclave prior to use. Test organism was 
seeded in the Nutrient broth, and incubated in a shaking bath (Fisher Scientific DMS360) for 
24 h at 37ºC. On the day of testing, a TLC plate was developed in the appropriate mobile 
phase, air-dried thoroughly, and placed in a sterile Petri dish. To 100 ml of Nutrient agar, 1 
ml of the overnight broth cultures (1x10
8
 CFU/ml) was added at 45ºC to make a final 
concentration of organism 1x10
6
 CFU/ml. Then, a developed TLC plate was carefully 
overlaid by the inoculated agar. Total volume of the inoculated agar was approximately 20 ml 
per 10x10 cm TLC plate. The agar overlaid plate was allowed to solidify at ambient 
temperature, further incubated for 24 h at 37º C, and then sprayed with an INT solution (2 
mg/ml in water). The plate was further incubated for 30 min at 37ºC. Compounds with 
inhibitory activity were seen as clear or pale yellow zones against a purple background. 
Positive control of antibiotic, chloramphenicol, ampicillin, and erythromycin, were used by 
either spotting a solution or placing an impregnated disc on the developed plate.  
 
2.3.2.2 Microorganism calibration 
 Viable bacteria counts were carried out by a serial dilution technique, and defined as 
the number of colony forming units/ml (CFU/ml) (Baker et al., 2011) as depicted in Figure 
2.1. Test organism was seeded in the Nutrient broth, and incubated in a shaking bath (Fisher 
Scientific DMS360) for 24 h at 37ºC. To the first test tube containing 9 ml Nutrient broth, 1 
ml the overnight inoculated broth was added, and mixed thoroughly. 0.1 ml of inoculated 
broth solution was seeded on an agar plate, and incubated 24 h at 37ºC. For the second serial 
dilution, 1 ml of the first inoculated broth was added to 9 ml of the fresh nutrient broth tube. 
The second one was also seeded in an agar plate, and further incubated 24 h at 37ºC. The 
inoculated nutrient broth was serially diluted to the appropriate tube at which it was possible 
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to count the number of colonies on an agar plate. Figure 2.1 demonstrates 5 dilutions from 
the overnight inoculated nutrient broth. Hundred colonies are counted in the fifth agar plate 
which referred to 1000 CFU/ml for this dilution. Therefore, the overnight inoculated nutrient 
broth would approximately be 1x10
8
 CFU/ml.  
 
 
 
 
Figure 2.1 The serial dilution technique for calibration bacterial concentration 
 
2.3.2.3 Minimum inhibitory concentration (MIC) 
 A 96 well microplate technique for MIC assay was based on Eloff (1998) with slight 
modification. Bacteria of choice, Staphylococcus aureus (ATCC 6571), Enterococcus 
faecalis (ATCC 775), Bacillus cereus (ATCC 2599), were seeded separately in the nutrient 
broth as described above. All crude fractions and isolated compounds were dissolved in 
DMSO to make stock solutions 200 mg/ml for crude fractions and 20 mM for isolated 
compounds, and further diluted in water to 2 mg/ml for crude fractions, and 200 µM for 
isolated compounds. Each crude fraction/compound was serially diluted to make two fold 
dilution for six wells. To each well was added 100 µl cell suspension (1x10
5
 CFU/ml), and 
then 100 µl diluted crude fraction/compound was added, and mix thoroughly. The plate was 
incubated for 24 h at 37ºC on a microplate shaker. To visualize the bacterial growth, 50 µl 
INT solution (2 mg/ml in water) was added into each well, and further incubated for 30 min 
at 37ºC on a microplate shaker. A clear well was observed for the inhibitory activity of 
compounds/crude extracts while the presences of bacteria were seen as a purple colour. The 
MIC was reported as the minimum concentration of crude extracts/compounds that inhibited 
the growth of bacteria. The nutrient broth was used as blank, and the inoculated nutrient broth 
9 ml 9 ml 9 ml 9 ml 9 ml 
1 ml 
0.1 ml 0.1 ml 0.1 ml 0.1 ml 0.1 ml 
1 ml 1 ml 1 ml 1 ml 
10-1 10-2 10-3 10-4 10-5 
~ 1x108 CFU/ml 
~ 1x103 CFU/ml 
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was the negative control. Chloramphenical was employed as the positive control. The final 
concentration of DMSO was not more than 1% in each well of tested compounds. %Toxicity 
of DMSO was also evaluated starting from 10% with two fold dilution for six serial wells.  
 
2.3.3 Acetylcholinesterase inhibitory activity 
Acetylcholinesterase from electric eel (type VI-s, lyophilized powder, 1.17 mg solid/ 
425.94 u/mg) was purchased from Sigma. To the lyophilized enzyme powder, 498 µl Tris 
buffer solution (50 mM Tris-HCl, pH 8) was added to make the stock solution of 1000 U/ml 
enzyme. The enzyme stock solution was prepared, and kept at -20ºC under dark condition. 
Further dilution of enzyme was made by mixing with solution of Tris buffer and 0.1% BSA. 
ACTI and DTNB were freshly prepared by dissolving in water, and Tris buffer solution 
respectively. Physostigmine was used as positive control. 
 
2.3.3.1 TLC-bioautographic method 
 This AChE inhibitory activity assay was carried out as described by Rhee et al. 
(2003) with slight modification. The developed TLC plate was sprayed with 5 mM ACTI 
solution, and followed by 5 mM DTNB solution. The sprayed plate was allowed to dry for 
15-20 min, and then further sprayed by 5 U/ml AChE enzyme solution. After 10 min, a white 
band/spot against a yellow background was observed as compound with enzyme inhibitory 
activity. The yellow background gradually faded, and disappeared within 30 min. 
Physostigmine (5 µl of 3.6 mM in methanol) was spotted as positive control.   
 
2.3.3.2 Microplate assay 
 This AChE inhibitory activity assay was carried out as described by Rhee et al. 
(2003) with slight modification. To each well was added 125 µl of 3 mM DTNB, 25 µl of 15 
mM ATCI, and 50 µl of Tris with 0.1% BSA. 25 µl Test sample solution (10 mg/ml in 
methanol) was finally added, and measured the absorbance by VERSAmaxTM (Molecular 
devices, California) at 405 nm every 10 seconds for five times. Enzyme solution (25 µl of 1 
U/ml) was then added to each well, and the absorbance was read every 10 seconds for 3 
minutes.  The rates of reaction both before and after adding the enzyme were calculated by 
Microsoft Excel 2003. The reaction rate of spontaneous hydrolysis before adding the enzyme 
was subtracted from the rate after adding the enzyme. Enzyme activity of test samples was 
calculated compared to the blank (methanol). Percentage enzyme inhibitory activity was 
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reported by subtracting % enzyme activity from 100. Each experiment was carried out in 
triplicate.  Physostigmine (1, 5 µl of 3.6 mM in methanol) was used as positive control.  
 
 
2.4 High performance liquid chromatography (HPLC) 
The HPLC instruments used were: Jasco PU-980 pump, Jasco UV-975 detector, 
Goerz Metrawatt Servogor 120 recorder, and commercial reversed-phase HPLC columns, i.e. 
Phenomenex Luna PFP 150x4.6 mm, and 250x10 mm. Detection wavelength at 330 nm was 
used for all crude samples. All mobile phase systems used HPLC grade solvents, filtered 
through a 0.45 µm nylon filter, and sonicated 30 minutes by a Decon ultrasonicater before 
being used. The sample was dissolved in methanol, and also filtered through 0.45 µm nylon 
Acrodisc prior to load into injection loop. For semi-preparative HPLC, sample was 
repeatedly injected, and eluent was collected separately according to each peak from a 
recorder. After being evaporated to dryness, the isolated compounds were submitted to Mass 
Spectrometry (MS) and Nuclear Magnetic Resonance spectroscopy (NMR). 
 
 
2.5 Spectroscopic examinations 
2.5.1 Mass Spectrometry (MS) 
 All mass spectra were performed on a Bruker micrOTOF mass spectrometer using 
electrospray ionization (ESI) at the Department of Chemistry, and Department of Pharmacy 
and Pharmacology, University of Bath. GC-CI-MS was analyzed by EPSRC National Mass 
Spectrometry Service Centre, School of Medicine, University of Swansea. 
 
2.5.2 Nuclear Magnetic Resonance Spectroscopy (NMR) 
 NMR experiments were carried out by JEOL GX 270 (270 MHz for 
1
H, and 67.8 
MHz for 
13
C) or Varian Mercury spectrometer (400 MHz for 
1
H, and 100 MHz for 
13
C) or 
Bruker spectrometer (500 MHz for 
1
H, and 125 MHz for 
13
C). Chemical shifts (δ) and 
coupling constant (J) were recorded in parts per million (ppm), and Hertz (Hz) respectively. 
Multiplicities were reported as singlet (s), doublet (d), doublet of doublet (dd), doublet of 
doublet of doublet (ddd), triplet (t), multiplet (m) and broad (br). All crude extracts or 
fractions or isolated compound were dissolved in appropriate solvents, i.e. deuterated-
methanol (CD3OD), deuterated-chloroform (CDCl3), deuterated-water (D2O) and deuterated-
dimethyl sulfoxide (DMSO-d6). 
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2.5.3 Ultraviolet Spectrometry (UV) 
UV-visible spectra were carried out by UV/VIS spectrometer (Lambda EZ 201, 
Perkin Elmer) at the Department of Pharmacy and Pharmacology, University of Bath. 
 
 
2.6 Extraction procedures of aerial part  
Dried powdered aerial part of Salvia viridis L. cv. Blue Jeans (300 g) was extracted 
with 3 x 2.5 L acetone for one day each, and then with 3 x 2.5 L methanol for another three 
consecutive days. Both of filtrates were collected separately and evaporated under reduced 
pressure to dryness. Each of crude extracts, i.e. acetone and methanol was partitioned 
between petroleum ether (500 ml x 3) and methanol:water (9:1) (500 ml x 3). After 
evaporating each layer to dryness, the methanol fraction was subsequently partitioned 
between ethyl acetate (500 ml x 3) and water (500 ml x 3). Each fraction was evaporated to 
dryness and kept at 0-5 degree Celsius. The extraction procedures are shown in Scheme 2.1. 
The extraction procedure was carried out twice on a total weight 600 g dried plant material to 
yield totals of crude fractions AP (7.04 g), AE (7.75 g), AW (2.95 g), MP (1.04 g), ME (3.95 
g), and MW (31.77 g). The fractions AW, and MW (water fractions from the original acetone 
and methanol extract respectively) were partitioned between 1-butanol (500 ml x 3), and 
water (500 ml x 3). Each layer was evaporated to dryness, and finally gave 4 fractions, i.e. 
AB (1.73 g), AWW (1.22 g), MB (6.37 g), and MWW (23.39 g). Fractions from these 
procedures were monitored by TLC, HPLC, and 
1
H NMR spectroscopy. Subsequently, AE, 
and ME were further separated by open column chromatography while AB and MB were 
separated by semi-preparative HPLC. This method was selected for all subsequent 
extractions of plant material as shown in Scheme 2.2.   
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Scheme 2.1 Extraction procedures 
 
 
Scheme 2.2 Isolation steps  
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2.7 Chromatography of aerial part 
 
2.7.1 Reversed-phase HPLC of the AB (Acetone-Butanol), and MB (Methanol-Butanol) 
fractions 
A Phenomenex Luna PFP (250x10 mm) column was employed in separating 
fractions from AB (1.73 g), and MB (2.50 g) crude fraction. All crude fractions were 
dissolved in methanol, and then the solution (100 µl) was injected each time through column 
by using methanol:water (45:55) as mobile phase, flow rate 5 ml/min, and detection 
wavelength at 330 nm. HPLC chromatograms and TLC pattern of AB, and MB crude 
fractions were similar. A peak of each retention time represented the same compound in both 
fractions.   
 
Sub-fractions and peaks were collected separately over the total retention time 45 
min, i.e. peaks of retention time 2-7.5 min, 7.5-13.5 min, 14.5 min, 16.7 min, 18.3 min, and 
19-45 min.  
 
The sub-fraction from retention time 2-7.5 min was further chromatographed on the 
same column using 13% acetonitrile in water as mobile phase. Caffeic acid (14 mg), 
rosmarinic acid (3 mg), 6-caffeoyl-glucose (9 mg) were collected at retention time 6, 6.3 and 
8.9 min respectively. 
 
The sub-fraction from retention time 7.5-13.5 min was further purified by the same 
mobile phase, i.e., 45% methanol in water. Salidroside (4 mg) was isolated as a peak at 
retention time 8.2 min. The major peak at retention time 9.2 min was identified as 
verbascoside (or acteoside). The total weight of the MB crude fraction 2 g yielded 104 mg 
verbascoside (or acteoside). A peak at retention time 11.2 min was identified as a mixture of 
trans- and cis-verbascoside 15 mg. 
 
Leucosceptocide A (10 mg) was collected from a peak at retention time 15.5 min by 
the same mobile phase, i.e., 45% methanol in water. The peak at retention time 16.7 min was 
identified as luteolin-7-O-rutinoside (9 mg) and luteolin-7-α-rhamnopyranosyl-(1→6)-β-
galactopyranoside (compound 6; 4 mg). The peak at retention time 18.7 min was luteolin-7-
O-glucoside (14 mg). 
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The sub-fraction from retention time 19-45 min was further separated by 25% 
acetonitrile in water on the same column. Peaks at retention time 5.1, 7.9, and 9.5 min were 
identified as luteolin-7-O-galactoside (5 mg), apigenin-7-O-glucoside (6 mg), and 
martynoside (6 mg) respectively. 
 
 
2.7.2 Open column chromatography of the AE (Acetone-Ethyl acetate) fraction 
2.7.2.1 Fractionation of AE crude fraction  
An open glass column, diameter 4 cm with sintered disc, was packed by slurry of 
silica gel 60 (80 g) in solvent of choice. After the silica gel was stably packed, fine sand was 
carefully poured over silica gel to protect the smooth surface of silica gel. The separation of 
AE crude extract was carried out twice by different mobile systems. The first one was eluted 
by a mixture of chloroform and methanol while the other one was eluted by a mixture of 
toluene and ethyl acetate. 
 
(a) AE crude fraction (1.5 g) was dissolved in chloroform, and loaded on to the silica 
gel packed column. The fraction was eluted by 1 L of 100% chloroform, and then with 
increasing polarity by adding methanol from 1-10%, 20%, 30%, 50%, and finally 100% 
methanol. Fractions (40 ml) were collected separately and monitored by TLC using the 
mobile phase chloroform:methanol (9:1). The developed plate was visulised by 
Anisaldehyde-Sulfuric acid Spraying Reagent and fractions with the same Rf value were 
combined. Fifteen fractions were collected and evaporated to dryness; two gave white 
powders. The fraction of 2% methanol in chloroform yielded a mixture of ursolic and 
oleanolic acids (15 mg), while the fractions of 5-6% methanol in chloroform gave β-sitosterol 
glucoside (10 mg). Trace amount of triterpenoids were observed in the 1% methanol in 
chloroform fraction. 
 
(b) AE crude fraction (2.5 g) was dissolved in toluene, and then loaded on to the 
column. The column was eluted by 1 L of 100% toluene and followed by the mixture of 
toluene and ethyl acetate in order to increase polarity. The step gradients solvent system 
started from 1 to 10 %, and then 20%, 30%, 40%, 50%, 80% of ethyl acetate in toluene and 
finally 100% of ethyl acetate. Each solvent system was 1 L. Fractions (40 ml) were collected 
separately and evaporated to dryness. Thereafter, they were monitored by TLC using mobile 
phase toluene:ethyl acetate (7:3). The developed TLC plates were sprayed by Anisaldehyde-
  - 62 - 
Sulfuric acid Spraying Reagent in order to combine fractions with similar Rf values.  
Fourteen fractions were collected, i.e. AE1 (fractions 1-10), AE2 (fractions 11-45), AE3 
(fractions 46-80), AE4 (fractions 85-109), AE5 (fractions 110-140), AE6 (fractions 141-160), 
AE7 (fractions 161-195), AE8 (fractions 196-220), AE9 (fractions 221-230), AE10 (fractions 
231-250), AE11 (fractions 251-265), AE12 (fractions 266-290), AE13 (fractions 291-319), 
and AE14 (fractions 320-340). They were evaporated to dryness, kept at 0-5ºC, and then 
further separated by open column chromatography.  
 
2.7.2.2 Isolation of compounds from AE subfractions  
 AE3 (fractions 46-84; 2-3% ethyl acetate in toluene) was repeatedly 
chromatographed over silica gel (80 g) eluting with 800 ml each of mobile phases as follows: 
100% toluene, 1-5%, 10%, 20%, 30%, 50% of ethyl acetate in toluene and finally 100% ethyl 
acetate. Forty ml eluent was collected, evaporated to dryness, monitored by TLC using 
mobile phase toluene:ethyl acetate (7:3). Fractions 48-55 were combined to yield β-sitosterol 
(10 mg). 
  
AE4 (fractions 85-109; 4-5% ethyl acetate in toluene) was rechromatographed over 
silica gel (80 g) eluting with 800 ml each of mobile phases as follows: 100% toluene, 1-5%, 
10%, 20%, 30%, 50% of ethyl acetate in toluene and finally 100% ethyl acetate. Fifty ml 
eluent was collected, evaporated to dryness, monitored by TLC using mobile phase 
toluene:ethyl acetate (7:3). Nine fractions were collected, and one of those, subfractions 41-
69 was further separated by column chromatography over silica gel (80 gm), and eluted with 
a step gradient of cyclohexane and ethyl acetate as follows: 5%, 10%, 15%, 20%, 50% of 
ethyl acetate in cyclohexane, and finally 100% ethyl acetate. Fractions 21-28 afforded 
compound 1 (6 mg) while fractions 34-45 were further rechromatographed over silica gel 
eluting with step gradient between chloroform and ethyl acetate, i.e. 10%, 20% of ethyl 
acetate in chloroform, and finally 100% ethyl acetate. Finally, this column afforded five 
fractions of which the fraction 31-35 gave compound 2 (5 mg).  
 
 AE6 (fractions 141-160; 7% ethyl acetate in toluene) was repeatedly 
chromatographed over silica gel (80 g) eluting with 800 ml each of mobile phases as follows: 
100% chloroform, 5%, 10%, 15%, 20%, 50% of ethyl acetate in chloroform and finally 100% 
ethyl acetate. Forty ml eluent was collected, evaporated to dryness, monitored by TLC using 
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mobile phase chloroform:ethyl acetate (4:1). Fractions 60-65 yielded a compound identified 
as oleanolic acid (10 mg). 
 
 AE7 (fractions 161-195; 8% ethyl acetate in toluene) was repeatedly 
chromatographed over silica gel (80 g) eluting with 800 ml each of mobile phases as follows: 
100% chloroform, 5%, 10%, 15%, 20%, 50% of ethyl acetate in chloroform and finally 100% 
ethyl acetate. Forty ml eluent was collected, evaporated to dryness, monitored by TLC using 
mobile phase chloroform:ethyl acetate (4:1). Fractions 104-112 yielded ursolic acid (12 mg). 
Fractions 120-130 afforded lup-(20)29-ene-2α, 3β-diol (6 mg). 
  
 AE11 (fractions 251-265; 30% ethyl acetate in toluene) was repeatedly 
chromatographed over silica gel (80 g) eluting with 800 ml each of mobile phases as follows: 
100% chloroform, 10%, 20%, 50% of ethyl acetate in chloroform and finally 100% ethyl 
acetate. Forty ml eluent was collected, evaporated to dryness, monitored by TLC using 
mobile phase chloroform:ethyl acetate (4:1). Fractions 68-73 yielded ursolic acid (10 mg). 
 
 
 
Scheme 2.3 Isolation of compounds from AE subfractions of aerial part by chromatography 
over silica gel 60 
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2.7.3. Open column chromatography of the ME (Methanol-Ethyl acetate) fraction 
 
 ME crude fraction (1 g) was dissolved in chloroform, and chromatographed over 
silica gel (60 g) eluting with 100% chloroform, and then the mixture of 
chloroform:methanol:water as follows: 80:20:2, 75:25:2.5, 70:30:3, 60:40:4, 50:50:5, and 
finally washed out with 100% methanol. Each solvent system was 600 ml, and 40 ml 
fractions were collected separately. They were evaporated to dryness, and monitored by TLC 
using solvent system ethyl acetate:formic acid:methanol:water (50:3:3:6). Developed TLC 
plates were sprayed by Natural Products Spraying Reagent. Fractions 60-65 
(chloroform:methanol:water, 60:40:4) was further separated by reversed-phase HPLC using 
Phenomenex Luna PFP 250x10 mm, mobile phase 13% acetonitrile in water. A peak at 
retention time 6.3 min was identified as rosmarinic acid (10 mg) by MS and NMR 
spectroscopic data 
 
 
2.8 Extraction procedures of root part  
 
 Dried powdered root (300 g) was extracted and partitioned by the same set of 
solvents as described in aerial part (Scheme 2.1). Eight crude fractions included: RAP (0.65 
g), RAE (1 g), RAB (0.055 g), RAW (0.04 g), RMP (0.005 g), RME (0.87 g), RMB (0.63 g), 
and RMW (4.55 g). They were further separated by either open column chromatography 
(RAP and RAE) or reversed-phase HPLC (RAB) as described for the aerial parts. 
 
 
2.9 Chromatography of root part 
 
2.9.1 Acetone-ethyl acetate from root part (RAE) 
 Acetone-ethyl acetate from root part (RAE; 0.44 g) was chromatographed over 60 g 
silica gel by open glass column chromatography. The fraction was eluted by 100% toluene 
600 ml, and then 600 ml each of the mixture of toluene and ethyl acetate with increasing 
polarity, i.e. 1-10%, 20%, 30%, 50% of ethyl acetate in toluene and finally 100% ethyl 
acetate. Fractions (40 ml) were collected separately and monitored by TLC using the mobile 
phase toluene:ethyl acetate (7:3). Fractions with the same Rf value were combined as shown 
in Scheme 2.4, and evaporated to dryness. RAE1-RAE17 were kept at 0-5°C.  
  - 65 - 
 The first fraction RAE1 (column fractions 1-7; 100% toluene) was further purified by 
column chromatography eluting by the mixture of cyclohexane and chloroform as follows: 
100:0, 90:10, 80:20, 50:50, and 0:100. Fractions from 50% chloroform in cyclohexane gave 
ferruginol (4 mg).  
 
 Fraction RAE4 (column fractions 29-35; 1% ethyl acetate in toluene) was further 
separated over silica gel eluting with 100% cyclohexane followed by a mixture of 
cyclohexane and ethyl acetate was used as follows: 95:5, 90:10, 80:20, 50:50, and 0:100. 
Fractions from 10% ethyl acetate gave two compounds which were further purified by 
precipitation in methanol: 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione (8 mg) and 
7α,14-dihydroxy-8,13-abietadiene-11,12-dione (5 mg). 
  
Fraction RAE5 (column fractions 36-42; 2% ethyl acetate in toluene) was further 
purified by precipitation in cyclohexane. The precipitate was an off-white diterpenoid 
compound; salvinolonyl-12-methyl ether (8 mg). 
 
 Fraction RAE6 (column fractions 43-49; 2% ethyl acetate in toluene) was repeatedly 
chromatograped over silica gel eluting with a mixture of cyclohexane and ethyl acetate as 
follows: 100:0, 95:5, 90:10, 85:15, 80:20, 50:50, and 0:100.  Fractions from 20% ethyl 
acetate gave 9 mg β-sitosterol. 
 
 Fraction RAE7 (column fractions 50-70; 2-4% ethyl acetate in toluene) was further 
separated by open column chromatography. A mixture of cyclohexane and ethyl acetate was 
used as mobile phase as follows: 100:0, 95:5, 90:10, 85:15, 80:20, 50:50, and 0:100. Two 
fractions from 15% ethyl acetate in cyclohexane gave compound 3 (1-oxomicrostegiol; 6 
mg), and compound 4 (viroxocane; 5 mg). 
 
Fraction RAE11 (column fractions 124-139; 9% ethyl acetate in toluene) was 
precipitated in cyclohexane. The white precipitate was further identified as the mixture of 
oleanolic acid and ursolic acid (5 mg). 
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Scheme 2.4 Isolation of compounds from RAE subfractions of root part by chromatography 
over silica gel 60 
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2.9.2 Acetone-petroleum ether from root part (RAP)  
RAP (0.55 g) was chromatographed over 60 g silica gel 60 through open glass 
column chromatography. The fraction was first eluted by 100% toluene 600 ml, and then 600 
ml each of the mixture of toluene and ethyl acetate with increasing polarity, i.e. 1-10% and 
finally 100% ethyl acetate. Fractions (40 ml) were collected 40 ml separately and monitored 
by TLC using mobile phase toluene:ethyl acetate (7:3). Fractions with the same Rf value 
were combined, and evaporated to dryness. The dried fractions RAP1-RAP11 were kept at 0-
5°C. 
  
Fraction RAP2 (column fractions 16-20; 1% ethyl acetate in toluene) was further 
eluted over silica gel with 2% ethyl acetate in cyclohexane to yield microstegiol (7 mg). 
 
Fraction RAP4 (column fractions 31-34; 2% ethyl acetate in toluene) was repeatedly 
chromatographed eluting with 100% toluene. Fractions 17-23 were comprised of two 
compounds. Methanol precipitation gave an off-white powder, 1-docosyl ferulate (5 mg), and 
a methanol soluble purple diterpenoid compound 5 (viridoquinone; 6 mg). 
 
Fraction RAP5 (column fractions 46-52; 3% ethyl acetate in toluene) was further 
rechromatographed over silical gel eluting with the mixture of cyclohexane and ethyl acetate. 
The 10% ethyl acetate in cyclohexane fractions gave a mixture of 2-(4'-alkoxyphenyl) ethyl 
alkanoates (6 mg). 
       
2.9.3 Methanol-ethyl acetate fraction from root part (RME) 
RME (0.77 g) was chromatographed over 60 g silica gel 60 by open glass column 
chromatography. The fraction was first eluted by 100% chloroform 600 ml, and then 600 ml 
each of the mixture of chloroform and methanol with increasing polarity, i.e. 1-10%, 20%, 
30%, 50% of methanol and finally 100% methanol. Fractions (40 ml) were collected 
separately and monitored by TLC using mobile phase chloroform:methanol (9:1). Fractions 
with the same Rf value were combined, evaporated to dryness and kept at 0-5°C. 
  
Fractions 80-103 (5-6% methanol in chloroform) was rechromatographed over silica 
gel eluting by 100% dichloromethane, and adding methanol from 1-10%, and finally 100% 
methanol. Fraction of 4% methanol in dichloromethane was further purified by reversed-
phase HPLC. The conditions and column were the same as described for the aerial parts. A 
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peak at retention time 6.7 min was eluted by 40% acetonitrile in water, and identified as 2'', 
3''-di-O-acetyl-martynoside (7 mg) by MS and NMR data.   
 
2.9.4 Methanol-butanol fraction from root part (RMB) 
 RMB (0.57 g) was chromatographed over 60 g silica gel through open glass column 
chromatography eluting with 100% chloroform 600 ml, and then 600 ml each of the mixture 
of chloroform, methanol, and water with increasing polarity, i.e. 90:10:1, 80:20:2, 70:30:3, 
60:40:4, 50:50:5, and 100% methanol. Fractions (40 ml) were collected separately and 
monitored by TLC using mobile phase ethyl acetate:methanol:formic acid:water (50:3:3:6). 
The developed TLC plate was visualized by UV 365 nm, and fractions with the same Rf 
value combined, and then evaporated to dryness and kept at 0-5°C.  
 
Fractions of the mixture 60:40:4 was further purified by reversed-phase HPLC. The 
condition and column were the same as described in aerial part. A peak at retention time 3.7 
min was eluted by 20% aqueous acetonitrile, and identified as rosmarinic acid (5 mg) 
 
 RMB crude fraction (0.5 g) was dissolved in methanol, and analysed by reversed-
phase HPLC. The condition and column were the same as described for the aerial parts. 
Verbascoside was detected at retention time 9.2 min eluting with 45% methanol in water. 
HR-ESI-MS of this crude fraction showed two main constituents which were rosmarinic acid 
and verbascoside.  
 
 
2.10 Spectroscopic data of isolated compounds from aerial part (see appendices for 
NMR spectra and section 3.6 for discussion of these data) 
 
2.10.1. Caffeic acid 
Caffeic acid (C9H8O4; Figure 3.22) was obtained as light brown yellow amorphous 
powder. HR-ESI-MS (negative ion mode) showed a peak at m/z 179.0353; C9H7O4 requires 
179.0338. 
1
H NMR data (500 MHz, CD3OD): δ 7.51 (1H, d, J = 16 Hz, H-7), 7.03 (1H, d, J = 
2 Hz, H-2), 6.93 (1H, dd, J = 8, 2 Hz, H-6), 6.77 (1H, d, J = 8 Hz, H-5), 6.20 (1H, d, J = 16 
Hz, H-8). 
13
C NMR data (125 MHz, CD3OD): δ 171.1 (C-9), 149.4 (C-4), 146.9 (C-3), 146.8 
(C-7), 127.8 (C-1), 122.8 (C-6), 116.5 (C-5), 115.7 (C-8), 115.1 (C-2).  
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2.10.2 Trans-verbascoside 
 Trans-verbascoside (acteoside; C29H36O15; Figure 3.25) was obtained as yellow 
powder. HR-ESI-MS (positive ion mode) showed a peak at m/z 647.1921; C29H36O15Na 
requires 647.1943 while negative ion mode found m/z 623.1971; C29H35O15 requires 
623.1965. 
1
H NMR data (400 MHz, CD3OD): δ 7.60 (1H, d, J = 16 Hz, H-7'), 7.05 (1H, d, J 
= 2 Hz, H-2'), 6.95 (1H, dd, J = 8.2, 2 Hz, H-6'), 6.78 (1H, d, J = 8.2 Hz, H-5'), 6.69 (1H, d, J 
= 1.6 Hz, H-2), 6.68 (1H, d, J = 8 Hz, H-5), 6.56 (1H, dd, J = 8, 1.6 Hz, H-6), 6.29 (1H, d, J 
= 16 Hz, H-8'), 5.18 (1H, s, H-1r), 4.91 (1H, t, J = 9 Hz, H-4g), 4.38 (1H, d, J = 7.8 Hz, H-
1g), 4.05 (1H, m, H-8), 3.91 (1H, d, J = 1.6 Hz, H-2r), 3.81 (1H, t, J = 9 Hz, H-3g), 3.70 (1H, 
m, H-8), 3.64 (1H, m, H-6g), 3.58 (1H, m, H-3r), 3.56 (1H, m, H-5r), 3.53 (1H, m, H-5g), 
3.49 (1H, m, H-6g), 3.38 (1H, t, J = 9 Hz, H-2g), 3.29 (1H, t, J = 9.8 Hz, H-4r), 2.78 (2H, m, 
H-7), 1.09 (3H, d, J = 6.2 Hz, H-6r). 
13
C NMR data (100 MHz, CD3OD): δ 168.3 (C-9'), 
149.7 (C-4'), 148.0 (C-7'), 146.8 (C-3'), 146.1 (C-3), 144.6 (C-4), 131.4 (C-1), 127.6 (C-1'), 
123.2 (C-6'), 121.2 (C-6), 117.1 (C-2), 116.5 (C-5'), 116.3 (C-5), 115.2 (C-2'), 114.7 (C-8'), 
104.2 (C-1g), 103.0 (C-1r), 81.6 (C-3g), 76.2 (C-2g), 76.0 (C-5g), 73.8 (C-4r), 72.3 (C-2r), 
72.2 (C-8), 72.0 (C-3r), 70.5 (C-4g), 70.4 (C-5r), 60.9 (C-6g), 36.5 (C-7), 18.4 (C-6r).   
 
2.10.3 Cis-verbascoside 
 Cis-verbascoside (acteoside; C29H36O15; Figure 3.35) was obtained as yellow powder. 
HR-ESI-MS (positive ion mode) showed a peak at m/z 647.1926; C29H36O15Na requires 
647.1943 while negative ion mode found m/z 623.1981; C29H35O15 requires 623.1965. 
1
H 
NMR data (400 MHz, CD3OD): δ 7.52 (1H, d, J = 1.5 Hz, H-2'), 7.09 (1H, dd, J = 8.2, 2 Hz, 
H-6'), 6.86 (1H, d, J = 12.8 Hz, H-7'), 6.77 (1H, d, J = 8.2 Hz, H-5'), 6.73 (1H, d, J = 8.2 Hz, 
H-5), 6.69 (1H, d, J = 2 Hz, H-2), 6.55 (1H, dd, J = 8.2, 2 Hz, H-6), 5.75 (1H, d, J = 12.8 Hz, 
H-8'), 5.16 (1H, s, H-1r), 4.92 (1H, overlapped, H-4g), 4.34 (1H, d, J = 7.8 Hz, H-1g), 4.02 
(1H, m, H-8), 3.92 (1H, br s, H-2r), 3.76 (1H, t, J = 9.4 Hz, H-3g), 3.70 (1H, m, H-8), 3.64 
(1H, m, H-6g), 3.58 (1H, m, H-3r), 3.56 (1H, m, H-5r), 3.53 (1H, m, H-5g), 3.49 (1H, m, H-
6g), 3.35 (1H, t, J = 8.2 Hz, H-2g), 3.32 (1H, overlapped, H-4r), 2.77 (2H, m, H-7), 1.16 (3H, 
d, J = 6.2 Hz, H-6r). 
13
C NMR data (100 MHz, CD3OD): δ 168.3 (C-9'), 149.4 (C-4'), 148.6 
(C-7'), 146.8 (C-3'), 146.1 (C-3), 144.6 (C-4), 131.4 (C-1), 128.0 (C-1'), 125.9 (C-6'), 121.2 
(C-6), 119.0 (C-2'), 116.5 (C-5), 116.3 (C-2), 115.2 (C-5'), 114.7 (C-8'), 104.1 (C-1g), 103.1 
(C-1r), 81.9 (C-3g), 76.1 (C-2g), 76.0 (C-5g), 73.9 (C-4r), 73.9 (C-8), 72.3 (C-2r), 72.0 (C-
3r), 70.6 (C-4g), 70.4 (C-5r), 62.3 (C-6g), 36.6 (C-7), 18.2 (C-6r).   
 
  - 70 - 
2.10.4 Leucosceptoside A 
Leucosceptoside A (C30H38O15; Figure 3.39) was obtained as a brown-yellow 
amorphous powder. HR-ESI-MS (positive ion mode) showed a peak at m/z 661.2124; 
C30H38O15Na requires 661.2103 while the negative mode found m/z 637.2161; C30H37O15 
requires 637.2138. 
1
H NMR data (500 MHz, CD3OD): δ 7.64 (1H, d, J = 16 Hz, H-7'), 7.20 
(1H, d, J = 2 Hz, H-2'), 7.07 (1H, dd, J = 8, 2 Hz, H-6'), 6.80 (1H, d, J = 8 Hz, H-5'), 6.69 
(1H, d, J = 2 Hz, H-2), 6.66 (1H, d, J = 8 Hz, H-5), 6.56 (1H, dd, J = 8, 2.5 Hz, H-6), 6.35 
(1H, d, J = 15.5 Hz, H-8'), 5.20 (1H, br s, J = 1.5 Hz, H-1r), 4.91 (1H, m, H-4g), 4.37 (1H, d, 
J = 8 Hz, H-1g), 4.05 (1H, m, H-8), 3.91 (1H, dd, J = 3.5, 2 Hz, H-2r), 3.89 (3H, s, H-3'-
OCH3), 3.82 (1H, t, J = 9 Hz, H-3g), 3.75 (1H, m, H-8), 3.64 (1H, m, H-6g), 3.59 (1H, m, H-
5r), 3.56 (1H, m, H-3r), 3.54 (2H, m, H-5g and H-6g), 3.40 (1H, t, J = 9 Hz, H-2g), 3.30 (1H, 
m, H-4r), 2.78 (2H, m, H-7), 1.09 (3H, d, J = 6 Hz, H-6r).  
13
C NMR data (125 MHz, 
CD3OD): δ 168.2 (C-9'), 150.9 (C-4'), 149.5 (C-3'), 147.9 (C-7'), 146.2 (C-3), 144.5 (C-4), 
131.5 (C-1), 127.7 (C-1'), 124.4 (C-6'), 121.3 (C-6), 117.1 (C-2), 116.5 (C-5'), 116.3 (C-5), 
115.1 (C-8'), 111.8 (C-2'), 104.2 (C-1g), 103.0 (C-1r), 81.5 (C-3g), 76.2 (C-2g), 76.1 (C-5g), 
73.8 (C-4r), 72.4 (C-2r), 72.3 (C-8), 72.1 (C-3r), 70.7 (C-4g), 70.4 (C-5r), 62.4 (C-6g), 56.5 
(C-3'-OCH3), 36.6 (C-7), 18.4 (C-6r). 
 
2.10.5 Martynoside 
Martynoside (C31H40O15; Figure 3.42) was obtained as a brown-yellow amorphous 
powder. HR-ESI-MS (positive ion mode) showed a peak at m/z 675.2245; C31H40O15Na 
requires 675.2259 while the negative mode found m/z 651.2314; C31H39O15 requires 
651.2294. 
1
H NMR data (500 MHz, CD3OD): δ 7.64 (1H, d, J = 16 Hz, H-7'), 7.19 (1H, d, J 
= 2 Hz, H-2'), 7.07 (1H, dd, J = 8, 2 Hz, H-6'), 6.83 (1H, d, J = 7.5 Hz, H-5), 6.80 (1H, d, J = 
8 Hz, H-5'), 6.74 (1H, d, J = 2 Hz, H-2), 6.68 (1H, dd, J = 8, 2.5 Hz, H-6), 6.35 (1H, d, J = 16 
Hz, H-8'), 5.20 (1H, br s, J = 2 Hz, H-1r), 4.88 (1H, m, H-4g), 4.37 (1H, d, J = 8 Hz, H-1g), 
4.08 (1H, m, H-8), 3.92 (1H, dd, J = 3, 1.5 Hz, H-2r), 3.89 (3H, s, H-3'-OCH3), 3.84 (1H, m, 
H-3g), 3.81 (3H, s, H-4-OCH3), 3.75 (1H, m, H-8), 3.64 (1H, m, H-6g), 3.59 (1H, m, H-5r), 
3.56 (1H, m, H-3r), 3.53 (2H, m, H-5g and H-6g), 3.40 (1H, t, J = 9 Hz, H-2g), 3.29 (1H, m, 
H-4r), 2.82 (2H, m, H-7), 1.10 (3H, d, J = 6 Hz, H-6r). 
13
C NMR data (125 MHz, CD3OD): δ 
168.2 (C-9'), 151.0 (C-4'), 149.4 (C-3'), 147.9 (C-7'), 147.6 (C-4), 147.4 (C-3), 132.9 (C-1), 
127.6 (C-1'), 124.4 (C-6'), 121.1 (C-6), 117.1 (C-2), 116.5 (C-5'), 115.1 (C-8'), 112.9 (C-5), 
111.8 (C-2'), 104.2 (C-1g), 103.0 (C-1r), 81.5 (C-3g), 76.2 (C-2g), 76.1 (C-5g), 73.8 (C-4r), 
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72.4 (C-2r), 72.1 (C-3r), 72.1 (C-8), 70.6 (C-5r), 70.4 (C-4g), 62.4 (C-6g), 56.5 (C-4-OCH3), 
56.4 (C-3'-OCH3), 36.6 (C-7), 18.4 (C-6r). 
 
2.10.6 Rosmarinic acid 
Rosmarinic acid (C18H16O8; Figure 3.45) was obtained as light brown yellow 
amorphous powder. HR-ESI-MS (negative ion mode) showed m/z 359.0784; C18H15O8 
requires 359.0767. 
1
H NMR data (500 MHz, CD3OD): δ 7.48 (1H, d, J = 16 Hz, H-7), 7.02 
(1H, d, J = 2 Hz, H-2), 6.91 (1H, dd, J = 8, 2 Hz, H-6), 6.76 (1H, d, J = 2 Hz, H-2'), 6.75 (1H, 
d, J = 8 Hz, H-5), 6.65 (1H, d, J = 8 Hz, H-5'), 6.63 (1H, dd, J = 8, 2 Hz, H-6'), 6.25 (1H, d, J 
= 15.5 Hz, H-8), 5.07 (1H, dd, J = 10, 3 Hz, H-8'), 3.08 (1H, dd, J = 14, 3 Hz, H-7'), 2.92 
(1H, dd, J = 14, 10 Hz, H-7'). 
13
C NMR data (125 MHz, CD3OD): δ 177.5 (C-9'), 169.1 (C-
9), 149.3 (C-4), 146.7 (C-3), 146.5 (C-7), 146.0 (C-3'), 144.8 (C-4'), 131.3 (C-1'), 128.0 (C-
1), 122.9 (C-6), 121.7 (C-6'), 117.5 (C-2'), 116.4 (C-5), 116.2 (C-5'), 115.8 (C-8), 115.1 (C-
2), 77.8 (C-8'), 38.9 (C-7'). 
 
2.10.7 6-O-Caffeoyl-glucose 
6-O-Caffeoyl-glucose (C15H18O9; Figure 3.47) was obtained as light brown yellow 
amorphous powder. HR-ESI-MS (negative ion mode) showed m/z 341.0882; C15H17O9 
requires 341.0873. 
1
H NMR data (500 MHz, CD3OD): δ 7.55 (1H, d, J = 16 Hz, H-7), 7.04 
(1H, d, J = 2 Hz, H-2), 6.94 (1H, d, J = 8, 2 Hz, H-6), 6.77 (1H, d, J = 8.5 Hz, H-5), 6.25 
(1H, d, J = 16 Hz, H-8), 5.10 (1H, d, J = 4 Hz, H-1g-α), 4.50 (1H, d, J = 7.5 Hz, H-1g-β), 
4.43 (1H, m, H-6g), 4.30 (1H, m, H-6g), 3.65 (1H, m, H-3g), 3.55 (1H, m, H-5g), 3.38 (1H, 
m, H-4g), 3.34 (1H, m, H-2g). 
13
C NMR data (125 MHz, CD3OD): δ 169.2 (C-9), 149.6 (C-
4), 147.1 (C-7), 146.8 (C-3), 127.7 (C-1), 123.0 (C-6), 116.5 (C-5), 115.1 (C-2), 114.9 (C-8), 
98.3 (C-1g-β), 94.0 (C-1g-α), 75.5 (C-5g), 74.8 (C-3g), 73.8 (C-4g), 71.8 (C-2g), 64.9 (C-
6g). 
 
2.10.8 Luteolin-7-O-β-glucopyranoside 
Luteolin-7-O-β-glucopyranoside (C21H20O11; Figure 3.49) was obtained as a yellow 
amorphous powder. HR-ESI-MS (negative ion mode) showed a peak at m/z 447.0955; 
C21H19O11 requires 447.0927. 
1
H NMR data (500 MHz, DMSO-d6): δ 7.47 (1H, dd, J = 8.5, 
2, H-6'), 7.41 (1H, d, J = 2, H-2'), 6.89 (1H, d, J = 8, H-5'), 6.78 (1H, d, J = 2, H-8), 6.74 (1H, 
s, H-3), 6.44 (1H, d, J = 2, H-6), 5.06 (1H, d, J = 7.5, H-1g), 3.70 (1H, m, H-6g), 3.49 (1H, 
m, H-6g), 3.46 (1H, m, H-5g), 3.31 (1H, m, H-3g), 3.28 (1H, m, H-2g), 3.18 (1H, m, H-4g).  
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13
C NMR data (125 MHz, DMSO-d6): δ 181.9 (C-4), 164.5 (C-2), 163.0 (C-7), 161.1 (C-5), 
157.0 (C-9), 150.0 (C-4'), 145.8 (C-3'), 121.3 (C-1'), 119.2 (C-6'), 116.0 (C-5'), 113.6 (C-2'), 
105.3 (C-10), 103.1 (C-3), 99.9 (C-1g), 99.5 (C-6), 94.7 (C-8), 77.2 (C-5g), 76.4 (C-3g), 73.1 
(C-2g), 69.6 (C-4g), 60.6 (C-6g).                                   
 
2.10.9 Luteolin-7-O –β-galactopyranoside 
Luteolin-7-O–β-galactopyranoside (C21H20O11; Figure 3.52) was obtained as a yellow 
amorphous powder. HR-ESI-MS (negative ion mode) showed a peak at m/z 447.0934; 
C21H19O11 447.0927. 
1
H NMR data (500 MHz, CD3OD): δ 7.43 (1H, dd, J = 8.5, 2 Hz, H-5'), 
7.40 (1H, d, J = 2 Hz, H-2'), 6.89 (1H, d, J = 8.5 Hz, H-6'), 6.79 (1H, d, J = 2 Hz, H-8), 6.60 
(1H, s, H-3), 6.50 (1H, d, J = 2 Hz, H-6), 5.06 (1H, d, J = 7 Hz, H-1gal), 3.92 (1H, br d, J = 
12 Hz, H-6gal), 3.71 (1H, dd, J = 12.5, 6 Hz, H-6gal), 3.54 (1H, m, H-5gal), 3.49 (2H, m, H-
2gal and H-4gal), 3.40 (1H, d, J = 8.5 Hz, H-3gal).  
13
C NMR data (125 MHz, CD3OD): δ 
184.0 (C-4), 166.9 (C-2), 164.8 (C-7), 162.9 (C-5), 159.0 (C-9), 151.9 (C-4'), 147.1 (C-3'), 
123.4 (C-1'), 119.2 (C-5'), 116.8 (C-6'), 114.2 (C-2'), 107.1 (C-10), 104.1 (C-3), 101.7 (C-
1gal), 101.1 (C-6), 96.0 (C-8), 78.4 (C-5gal), 77.9 (C-4gal), 74.7 (C-2gal), 71.3 (C-3gal), 
62.4 (C-6gal).   
 
2.10.10 Luteolin-7-O-rutinoside  
Luteolin-7-O-rutinoside (C27H30O15; Figure 3.55) was obtained as a yellow 
amorphous powder. HR-ESI-MS (negative ion mode) showed a peak at m/z 593.1554; 
C27H29O15 requires 593.1506. 
1
H NMR data (500 MHz, DMSO-d6): δ 7.44 (1H, dd, J = 8, 2 
Hz, H-6'), 7.41 (1H, br s, H-2'), 6.90 (1H, d, J = 8.5 Hz, H-5'), 6.74 (2H, m, H-3 and H-8), 
6.45 (1H, d, J = 2 Hz, H-6), 5.06 (1H, d, J = 7.5 Hz, H-1g), 4.54 (1H, br s, H-1r), 3.83 (1H, 
br d, J = 10.5 Hz, H-6g), 3.65 (1H, d, J = 2 Hz, H-2r), 3.59 (1H, t, J = 7.5 Hz, H-5g), 3.45 
(1H, m, H-3r), 3.43 (1H, m, H-6g), 3.41 (1H, m, H-5r), 3.30 (1H, m, H-3g), 3.26 (1H, m, H-
2g), 3.15 (1H, m, H-4g), 3.14 (1H, m, H-4r), 1.06 (3H, d, J = 6 Hz, H-6r). 
13
C NMR data 
(125 MHz, DMSO-d6): δ 181.9 (C-4), 164.6 (C-2), 162.9 (C-7), 161.2 (C-5), 156.9 (C-9), 
150.1 (C-4'), 145.8 (C-3'), 121.3 (C-1'), 119.2 (C-6'), 116.1 (C-5'), 113.5 (C-2'), 105.4 (C-10), 
103.1 (C-3), 100.5 (C-1r), 99.9 (C-1g), 99.5 (C-6), 94.8 (C-8), 76.3 (C-3g), 75.6 (C-5g), 73.1 
(C-2g), 72.1 (C-4r), 70.7 (C-3r), 70.3 (C-2r), 69.6 (C-4g), 68.3 (C-5r), 66.1 (C-6g), 17.8 (C-
6r).   
 
 
  - 73 - 
2.10.11 Luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galactopyranoside (compound 6) 
Luteolin-7-O-α--rhamnopyranosyl-(1→6)-β-galactopyranoside (C27H30O15; Figure 
3.57) was obtained as a pale yellow amorphous powder. HR-ESI-MS (negative ion mode) 
showed a peak at m/z 593.1563; C27H29O15 requires 593.1506. 
1
H NMR data (500 MHz, 
CD3OD): δ 7.42 (1H, m, H-6'), 7.41 (1H, br s, H-2'), 6.92 (1H, d, J = 9 Hz, H-5'), 6.75 (1H, d, 
J = 2 Hz, H-8), 6.61 (1H, s, H-3), 6.52 (1H, d, J = 2 Hz, H-6), 5.03 (1H, d, J = 7 Hz, H-1gal), 
4.72 (1H, br s, H-1r), 4.05 (1H, br d, J = 9.5 Hz, H-6gal), 3.91 (1H, dd, J = 3.5, 1.5 Hz, H-
2r), 3.72 (1H, dd, J = 9.5, 3.5 Hz, H-3r), 3.65 (1H, m, H-4gal), 3.64 (1H, m, H-5r), 3.63 (1H, 
m, H-6gal), 3.50 (1H, m, H-5gal), 3.49 (1H, m, H-2gal), 3.40 (1H, d, J = 9 Hz, H-3gal), 3.34 
(1H, t, J = 10 Hz, H-4r), 1.18 (3H, d, J = 6.5 Hz, H-6r). 
13
C NMR data (125 MHz, CD3OD): δ 
184.0 (C-4), 167.0 (C-2), 164.7 (C-7), 163.0 (C-5), 158.9 (C-9), 151.2 (C-4'), 147.0 (C-3'), 
123.5 (C-1'), 120.6 (C-6'), 116.9 (C-5'), 114.3 (C-2'), 107.1 (C-10), 104.3 (C-3), 102.1 (C-1r), 
101.6 (C-1gal), 101.1 (C-6), 96.1 (C-8), 77.8 (C-5gal), 77.2 (C-4gal), 74.7 (C-2gal), 74.1 (C-
4r), 72.4 (C-3r), 72.1 (C-2r), 71.3 (C-3gal), 69.8 (C-5r), 67.5 (C-6gal), 17.9 (C-6r).   
 
2.10.12 Apigenin-7-O-β-glucopyranoside 
Apigenin-7-O-β-glucopyranoside (C21H20O10; Figure 3.61) was obtained as a yellow 
amorphous powder. HR-ESI-MS (negative ion mode) showed a peak at m/z 431.0984; 
C21H19O10 requires 431.0978. 
1
H NMR data (500 MHz, CD3OD): δ 7.88 (2H, d, J = 9 Hz, H-
2' and H-6'), 6.92 (2H, d, J = 9 Hz, H-3' and H-5'), 6.82 (1H, d, J = 2 Hz, H-8), 6.66 (1H, s, 
H-3), 6.50 (1H, d, J = 2 Hz, H-6), 5.06 (1H, d, J = 9 Hz, H-1g), 3.92 (1H, m, H-6g), 3.70 
(1H, m, H-6g), 3.50 (1H, m, H-5g), 3.45 (1H, m, H-3g), 3.44 (1H, m, H-2g), 3.40 (1H, m, H-
4g). 
13
C NMR data (125 MHz, CD3OD): δ 184.1 (C-4), 166.8 (C-2), 164.9 (C-7), 162.9 (C-
4'), 162.8 (C-9), 159.0 (C-5), 129.6 (C-2' and C-6'), 123.1 (C-1'), 117.2 (C-3' and C-5'), 107.1 
(C-10), 104.1 (C-3), 101.7 (C-1g), 101.2 (C-6), 96.1 (C-8), 78.4 (C-5g), 77.9 (C-3g), 74.8 (C-
2g), 71.3 (C-4g), 62.5 (C-6g). 
 
2.10.13 Ursolic acid  
 Ursolic acid (C30H48O3; Figure 3.63) was obtained as a white powder. HR-ESI-MS 
(positive ion mode) showed peak at m/z 479.3509; C30H48NaO3 requires 479.3496. 
1
H NMR 
data (500 MHz, a mixture of CD3OD and CDCl3): δ 5.21 (1H, t, J = 3.5 Hz, H-12), 3.14 (1H, 
dd, J = 11, 5 Hz, H-3-α), 2.16 (1H, d, J = 11 Hz, H-18), 1.98 (1H, m, H-16), 1.89 (1H, m, H-
11), 1.88 (1H, m, H-15), 1.67 (2H, m, H-22), 1.63 (2H, m, H-1 and H-19), 1.62 (1H, m, H-
16), 1.54 (2H, m, H-2), 1.53 (2H, m, H-9 and H-6), 1.52 (1H, m, H-7), 1.51 (2H, m, H-21), 
  - 74 - 
1.37 (1H, m, H-6-α), 1.36 (1H, m, H-20), 1.35 (1H, m, H-7), 1.09 (3H, s, H-27-α), 1.09 (1H, 
overlapped, H-11), 1.05 (1H, m, H-15), 0.93 (3H, s, H-23-α), 0.93 (1H, overlapped, H-1), 
0.92 (3H, d, J = 6.5 Hz, H-30-α), 0.91 (3H, s, H-25-β), 0.84 (3H, d, J = 6.5 Hz, H-29-β), 0.82 
(3H, s, H-26-β), 0.76 (3H, s, H-24-β), 0.73 (1H, d, J = 11.5 Hz, H-5-α). 13C NMR data (125 
MHz, a mixture of CD3OD and CDCl3): δ 181.3 (C-28), 139.1 (C-13), 126.4 (C-12), 79.3 (C-
3), 56.2 (C-5), 53.8 (C-18), 48.5 (C-17), 48.2 (C-9), 42.8 (C-14), 40.3 (C-8), 39.9 (C-20), 
39.8 (C-19), 39.6 (C-1), 39.4 (C-4), 37.7 (C-22), 37.6 (C-10), 33.9 (C-7), 31.4 (C-21), 28.8 
(C-15), 28.6 (C-23), 27.4 (C-2), 24.9 (C-16), 24.0 (C-11), 24.0 (C-27), 21.5 (C-30), 19.1 (C-
6), 17.5 (C-26), 17.1 (C-29), 16.1 (C-24), 15.9 (C-25). 
 
2.10.14 Oleanolic acid  
 Oleanolic acid (C30H48O3; Figure 3.70) was obtained as a white powder. Judging 
from the NMR spectra, this material was about 70% pure, with ursolic acid as the major 
impurity. HR-ESI-MS (positive ion mode) showed peak at m/z 479.3493; C30H48NaO3 
requires 479.3496. 
1
H NMR data (500 MHz, a mixture of CD3OD and CDCl3): δ 5.23 (1H, t, 
J = 3 Hz, H-12), 3.14 (1H, dd, J = 10.5, 5 Hz, H-3), 2.80 (1H, dd, J = 13.5, 4 Hz, H-18-β), 
1.96 (1H, m, H-16), 1.84 (1H, m, H-11), 1.71 (2H, m, H-15 and H-22), 1.63 (1H, m, H-19), 
1.60 (1H, m, H-1), 1.58 (1H, m, H-16), 1.56 (2H, m, H-2), 1.54 (1H, m, H-9), 1.53 (1H, m, 
H-6), 1.52 (1H, m, H-22), 1.46 (1H, m, H-7), 1.37 (1H, m, H-6), 1.33 (1H, m, H-21), 1.29 
(1H, m, H-7), 1.18 (1H, m, H-21), 1.11 (3H, s, H-27-α), 1.10 (1H, m, H-19), 1.07 (1H, m, H-
11), 1.04 (1H, m, H-15), 0.94 (3H, s, H-23-α), 0.94 (1H, m, H-1), 0.90 (3H, s, H-30-β), 0.89 
(3H, s, H-25-β), 0.87 (3H, s, H-29-α), 0.77 (3H, s, H-26-β), 0.74 (3H, s, H-24-β), 0.70 (1H, d, 
J =10 Hz, H-5-α). 13C NMR data (125 MHz, a mixture of CD3OD and CDCl3): δ 181.4 (C-
28), 144.5 (C-13), 123.0 (C-12), 79.2 (C-3), 56.0 (C-5), 49.0 (C-9), 47.0 (C-17), 46.6 (C-19), 
42.3 (C-14), 41.9 (C-18), 39.9 (C-8), 39.3 (C-1), 39.2 (C-4), 37.6 (C-10), 34.4 (C-21), 33.7 
(C-7), 33.4 (C-29), 33.2 (C-22), 31.2 (C-20), 28.4 (C-23), 28.3 (C-15), 27.2 (C-2), 26.3 (C-
27), 24.0 (C-11), 23.9 (C-30), 23.6 (C-16), 18.9 (C-6), 17.3 (C-26), 16.0 (C-24), 15.7 (C-25).  
 
2.10.15 Lup-(20)29-ene-2α, 3β-diol   
 Lup-(20)29-ene-2α, 3β-diol (C30H50O2; Figure 3.73) was obtained as a white powder. 
HR-ESI-MS (positive ion mode) showed a peak at m/z 465.3690; C30H50O2Na requires 
465.3703. 
1
H NMR data (500 MHz, CDCl3): δ 4.69 (1H, d, J = 2 Hz, H-29), 4.57 (1H, d, J = 
2 Hz, H-29), 3.67 (1H, ddd, J = 10, 9.5, 4.5 Hz, H-2-β), 2.97 (1H, d, J = 9.5 Hz, H-3-α), 2.36 
(1H, ddd, J = 11, 11, 6 Hz, H-19), 2.03 (1H, dd, J = 12, 4 Hz, H-1-β), 1.92 (1H, m, H-21), 
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1.74 (1H, m, H-15), 1.67 (3H, s, H-30), 1.67 (1H, overlapped, H-12), 1.65 (1H, m, H-13), 
1.52 (1H, m, H-6), 1.47 (1H, m, H-16), 1.45 (1H, m, H-11), 1.40 (1H, m, H-6), 1.39 (2H, m, 
H-7), 1.38 (2H, m, H-16 and H-22), 1.35 (1H, m, H-18), 1.32 (2H, m, H-9 and H-21), 1.26 
(1H, m, H-11), 1.20 (1H, m, H-22), 1.08 (1H, m, H-12), 1.05 (1H, m, H-15), 1.02 (3H, s, H-
26-β), 1.01 (3H, s, H-23-α), 0.94 (3H, s, H-27-α), 0.90 (3H, s, H-25-β), 0.83 (1H, dd, J = 12, 
7 Hz, H-1-α), 0.80 (3H, s, H-24-β), 0.79 (1H, overlapped, H-5), 0.78 (3H, s, H-28-β). 13C 
NMR data (125 MHz, CDCl3): δ 150.9 (C-20), 109.4 (C-29), 83.9 (C-3), 69.3 (C-2), 55.4 (C-
5), 50.4 (C-9), 48.3 (C-18), 48.0 (C-19), 46.7 (C-1), 43.0 (C-17), 42.9 (C-14), 40.9 (C-8), 
40.0 (C-22), 39.2 (C-10), 38.6 (C-4), 38.0 (C-13), 35.6 (C-16), 34.2 (C-7), 29.8 (C-21), 28.5 
(C-23), 27.4 (C-15), 25.0 (C-12), 21.0 (C-11), 19.3 (C-30), 18.3 (C-6), 18.0 (C-28), 17.4 (C-
25), 16.5 (C-24), 16.0 (C-26), 14.5 (C-27).  
 
2.10.16 Compound 1 (lup-(20)29-ene-2α-acetate-3β-ol)   
Compound 1 (C32H52O3; Figure 3.80) was obtained as white powder. HR-ESI-MS 
(positive ion mode) showed a peak at m/z 507.3784; C32H52O3Na requires 507.3809. 
1
H 
NMR data (500 MHz, CDCl3): δ 4.86 (1H, ddd, J = 10, 10, 5 Hz, H-2-β), 4.67 (1H, d, J = 2 
Hz, H-29), 4.55 (1H, d, J = 2 Hz, H-29), 3.15 (1H, d, J =10 Hz, H-3-α), 2.37 (1H, ddd, J = 
11, 11, 6 Hz, H-19-β), 2.05 (3H, s, H-OCOCH3), 2.04 (1H, m, H-1), 1.92 (1H, m, H-21), 1.66 
(2H, m, H-12 and H-15), 1.65 (3H, s, H-30), 1.64 (1H, m, H-13-β), 1.53 (1H, m, H-6), 1.47 
(1H, m, H-16), 1.43 (2H, m, H-7), 1.40 (1H, m, H-6), 1.38 (2H, m, H-11 and H-21), 1.38 
(1H, m, H-22), 1.37 (1H, m, H-16), 1.34 (1H, overlapped, H-18-α), 1.31 (1H, m, H-9), 1.25 
(1H, m, H-11), 1.19 (1H, m, H-22), 1.07 (1H, m, H-12), 1.03 (3H, s, H-23-α), 1.02 (3H, s, H-
26-β), 0.98 (1H, m, H-15), 0.94 (3H, s, H-25-β), 0.93 (3H, s, H-27-α), 0.90 (1H, m, H-1), 
0.84 (3H, s, H-24-β), 0.78 (3H, s, H-28-β), 0.76 (1H, overlapped, H-5).  13C NMR data (125 
MHz, CDCl3): δ 171.6 (C-OCOCH3), 150.8 (C-20), 109.4 (C-29), 80.9 (C-3), 73.6 (C-2), 
55.2 (C-5), 50.4 (C-9), 48.3 (C-18), 47.9 (C-19), 44.0 (C-1), 43.0 (C-17), 42.9 (C-14), 40.9 
(C-8), 40.0 (C-22), 39.8 (C-4), 38.5 (C-10), 38.0 (C-13), 35.6 (C-16), 34.1 (C-7), 29.7 (C-21), 
28.4 (C-23), 27.4 (C-15), 25.0 (C-12), 21.3 (C-OCOCH3), 21.1 (C-11), 19.3 (C-30), 18.2 (C-
6), 18.0 (C-28), 17.1 (C-25), 16.4 (C-24), 16.0 (C-26), 14.5 (C-27). 
 
2.10.17 Compound 2 (lup-(20)29-ene-2α-ol-3β-acetate)   
Compound 2 (C32H52O3; Figure 3.85) was obtained as white powder. HR-ESI-MS 
(positive ion mode) showed a peak at m/z 507.3794; C32H52O3Na requires 507.3809 while 
negative ion mode found at m/z 483.3462; C32H51O3 requires 483.3480. 
1
H NMR data (500 
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MHz, CDCl3): δ 4.68 (1H, d, J = 2.5 Hz, H-29), 4.57 (1H, d, J = 2.5 Hz, H-29), 4.46 (1H, d, J 
= 10 Hz, H-3-α), 3.77 (1H, ddd, J = 10, 10, 5 Hz, H-2-β). 2.37 (1H, ddd, J = 11, 11, 6 Hz, H-
19-β), 2.13 (3H, s, H-OCOCH3), 2.09 (1H, m, H-1), 1.90 (1H, m, H-21), 1.68 (3H, s, H-30), 
1.68 (2H, overlapped, H-12 and H-15), 1.65 (1H, m, H-13), 1.50 (1H, m, H-6), 1.46 (1H, m, 
H-16), 1.43 (1H, m, H-11), 1.40 (4H, m, H-6 and H-7 and H-22), 1.38 (1H, m, H-16), 1.36 
(1H, m, H-18-α), 1.34 (1H, m, H-9), 1.32 (1H, m, H-21), 1.26 (1H, m, H-11), 1.20 (1H, m, 
H-22), 1.08 (1H, m, H-12), 1.02 (3H, s, H-26-β), 0.98 (1H, m, H-15), 0.94 (3H, s, H-27-α), 
0.91 (3H, s, H-25-β), 0.90 (1H, m, H-1), 0.88 (1H, m, H-5), 0.87 (3H, s, H-23-α), 0.85 (3H, s, 
H-24-β), 0.78 (3H, s, H-28-β). 13C NMR data (125 MHz, CDCl3): δ 172.4 (C-OCOCH3), 
150.8 (C-20), 109.4 (C-29), 85.0 (C-3), 67.8 (C-2), 55.3 (C-5), 50.3 (C-9), 48.2 (C-18), 48.1 
(C-1), 48.0 (C-19), 43.0 (C-17), 42.9 (C-14), 40.9 (C-8), 40.0 (C-22), 39.3 (C-4), 38.4 (C-10), 
37.9 (C-13), 35.5 (C-16), 34.1 (C-7), 29.8 (C-21), 28.4 (C-23), 27.4 (C-15), 25.0 (C-12), 21.1 
(C-11), 21.0 (C-OCOCH3), 19.3 (C-30), 18.3 (C-6), 18.0 (C-28), 17.4 (C-24), 17.3 (C-25), 
16.0 (C-26), 14.5 (C-27).  
 
2.10.18 β-Sitosterol  
β-Sitosterol (C29H50O; Figure 3.90) was obtained as a white amorphous powder. HR-
ESI-MS (positive ion mode) showed a peak at m/z 437.3797; C29H50ONa requires 437.3759. 
1
H NMR data (500 MHz, CDCl3): δ 5.35 (1H, d, J = 5.5 Hz, H-6), 3.52 (1H, m, J = 11, 4.5 
Hz, H-3-α), 2.29 (1H, m, H-4), 2.23 (1H, m, H-4), 1.99 (1H, m, H-12), 1.96 (2H, m, H-7), 
1.86 (1H, m, H-1), 1.84 (3H, m, H-2 and H-16), 1.55 (1H, m, H-15), 1.50 (1H, m, H-11), 
1.49 (1H, m, H-2), 1.43 (1H, m, H-8), 1.34 (2H, m, H-20 and H-22), 1.28 (1H, m, H-28), 
1.25 (1H, m, H-25), 1.16 (3H, m, H-12 and H-23), 1.08 (3H, m, H-15, H-17 and H-28), 1.05 
(3H, m, H-1, H-11 and H-22), 1.03 (3H, s, H-19), 0.99 (1H, m, H-14), 0.92 (2H, m, H-9 and 
H-24), 0.90 (3H, m, H-21), 0.84 (3H, s, H-29), 0.83 (3H, d, J = 7 Hz, H-26), 0.81 (3H, d, J = 
7 Hz, H-27), 0.68 (3H, s, H-18). 
13
C NMR data (125 MHz, CDCl3): δ 140.8 (C-5), 121.7 (C-
6),  71.8 (C-3), 56.8 (C-14), 56.1 (C-17), 50.1 (C-9), 45.8 (C-24), 42.3 (C-4 and C-13), 39.8 
(C-12), 37.2 (C-1), 36.5 (C-10), 36.1 (C-20), 33.9 (C-22), 31.9 (C-7 and C-8), 31.7 (C-2), 
29.1 (C-25), 28.2 (C-16), 26.1 (C-23), 24.3 (C-15), 23.1 (C-28), 21.1 (C-11), 19.8 (C-26), 
19.4 (C-19), 19.0 (C-27), 18.7 (C-21), 12.0 (C-29), 11.9 (C-18). 
 
2.10.19 β-Sitosterol-3-O-β-glucoside  
β-Sitosterol-3-O-β-glucoside (C35H60O6; Figure 3.94) was obtained as a white 
amorphous powder. HR-ESI-MS (positive ion mode) showed a peak at m/z 599.4258; 
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C35H60O6Na requires 599.4282 while negative ion mode found at 575.4335; C35H59O6 
requires 575.4367. 
1
H NMR data (500 MHz, a mixture of CD3OD and CDCl3): δ 5.35 (1H, d, 
J = 5.5, 2.5 Hz, H-6), 4.37 (1H, d, J = 8 Hz, H-1g), 3.82 (1H, dd, J = 12, 3 Hz, H-6g), 3.72 
(1H, dd, J = 12, 4.5 Hz, H-6g), 3.56 (1H, m, J = 9.5, 5 Hz, H-3-α), 3.39 (2H, overlapped, H-
3g and H-4g), 3.25 (1H, m, H-5g), 3.20 (1H, t, J = 9.5 Hz, H-2g), 2.36 (1H, m, H-4), 2.23 
(1H, m, H-4), 1.99 (1H, m, H-12), 1.92 (1H, m, H-7), 1.87 (1H, m, H-2), 1.83 (1H, m, H-1), 
1.63 (1H, m, H-25), 1.56 (1H, m, H-2), 1.53 (1H, m, H-15), 1.49 (1H, m, H-7), 1.46 (2H, m, 
H-11), 1.41 (1H, m, H-8), 1.32 (1H, m, H-20), 1.29 (1H, m, H-22), 1.23 (1H, m, H-16), 1.22 
(2H, m, H-28), 1.18 (1H, m, H-16), 1.12 (3H, m, H-12 and H-23), 1.08 (1H, m, H-17), 1.03 
(2H, m, H-1 and H-15), 0.99 (1H, m, H-22), 0.97 (3H, s, H-19), 0.96 (1H, m, H-14), 0.90 
(1H, m, H-9), 0.89 (1H, m, H-24), 0.87 (3H, overlapped, H-21), 0.80 (3H, s, H-29), 0.78 (3H, 
d, J = 7 Hz, H-26), 0.76 (3H, d, J = 7 Hz, H-27), 0.64 (3H, s, H-18). 
13
C NMR data (125 
MHz, a mixture of CD3OD and CDCl3): δ 140.6 (C-5), 122.4 (C-6), 101.4 (C-1g), 79.4 (C-3), 
76.8 (C-4g), 76.2 (C-5g), 73.9 (C-2g), 70.5 (C-3g), 62.1 (C-6g), 57.1 (C-14), 56.4 (C-17), 
50.5 (C-9), 46.2 (C-24), 42.6 (C-13), 40.1 (C-12), 38.9 (C-4), 37.6 (C-1), 37.0 (C-10), 36.4 
(C-20), 34.2 (C-22), 32.2 (C-7 and C-8), 29.9 (C-2), 29.4 (C-25), 28.5 (C-16), 26.3 (C-23), 
24.5 (C-15), 23.3 (C-28), 21.3 (C-11), 19.9 (C-26), 19.5 (C-19), 19.2 (C-27), 19.0 (C-21), 
12.1 (C-29), 12.0 (C-18). 
 
2.10.20 Salidroside 
Salidroside (2-(4'-hydroxyphenyl) ethyl β-glucopyranoside) (C14H20O7; Figure 3.96) 
was obtained as a brown-yellow amorphous powder. HR-ESI-MS (positive ion mode) 
showed a peak at m/z 323.1132; C14H20O7Na requires 323.1107. 
1
H NMR data (500 MHz, 
CD3OD): δ 7.06 (2H, d, J = 8 Hz, H-3 and H-5), 6.68 (2H, d, J = 8.5 Hz, H-2 and H-6), 4.28 
(1H, d, J = 8 Hz, H-1g), 4.04 (1H, m, H-8), 3.86 (1H, m, H-6g), 3.70 (1H, m, H-8), 3.68 (1H, 
m, H-6g), 3.34 (1H, m, H-4g), 3.26 (1H, m, H-3g), 3.25 (1H, m, H-5g), 3.18 (1H, t, J = 8 Hz, 
H-2g), 2.81 (2H, m, H-7). 
13
C NMR data (125 MHz, CD3OD): δ 156.8 (C-4), 130.9 (C-3 and 
C-5), 130.7 (C-1), 116.1 (C-2 and C-6), 104.2 (C-1g), 78.1 (C-4g), 77.9 (C-5g), 75.1 (C-2g), 
72.1 (C-8), 71.6 (C-3g), 62.7 (C-6g), 36.4 (C-7). 
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2.11 Spectroscopic data of isolated compounds from root part (see appendices for NMR 
spectra and section 3.8 for discussion of these data) 
 
2.11.1  2'',3''-Di-O-acetyl-martynoside 
2'',3''-Di-O-acetyl-martynoside (C35H44O17; Figure 3.99) was obtained as a brown-
yellow amorphous powder. HR-ESI-MS in the negative ion mode found m/z 735.2495; 
C35H43O17 requires 735.2506 while the positive mode showed a peak at m/z 759.2416; 
C35H44O17Na requires 759.2471. 
1
H NMR data (500 MHz, CDCl3): δ 7.67 (1H, d, J = 15.5 
Hz, H-7'), 7.07 (1H, dd, J = 8, 2 Hz, H-6'), 7.02 (1H, d, J = 2 Hz, H-2'), 6.90 (1H, d, J = 8.5 
Hz, H-5'), 6.80 (1H, d, J = 2 Hz, H-2), 6.77 (1H, d, J = 8 Hz, H-5), 6.67 (1H, dd, J = 8.5, 2 
Hz, H-6), 6.26 (1H, d, J = 15.5 Hz, H-8'), 5.89 (1H, s, 4'-OH), 5.62 (1H, s, 3-OH), 5.29 (1H, 
dd, J =  3.5, 1.5 Hz, H-2r), 5.19 (1H, br s, J = 1.5 Hz, H-1r), 5.04 (1H, t, J = 10 Hz, H-4g), 
5.01 (1H, dd, J = 10, 3.5 Hz, H-3r), 4.28 (1H, d, J = 8 Hz, H-1g), 4.13 (1H, m, H-8), 3.92 
(3H, s, H-3'-OCH3), 3.86 (3H, s, H-4-OCH3), 3.86 (1H, overlapped, H-3g), 3.77 (1H, m, H-
4r), 3.74 (1H, m, H-6g), 3.70 (1H, m, H-8), 3.62 (1H, m, H-6g), 3.60 (1H, m, H-2g), 3.50 
(1H, m, H-5r), 3.48 (1H, m, H-5g), 2.83 (2H, m, H-7), 2.12 (3H, s, H-2''-OCOCH3), 2.03 
(3H, s, H-3''-OCOCH3), 1.22 (3H, d, J = 6.5 Hz, H-6r).  
13
C NMR data (125 MHz, CDCl3): δ 
171.3 (C-2''-OCOCH3), 170.0 (C-3''-OCOCH3), 167.0 (C-9'), 148.4 (C-4'), 147.1 (C-7'), 
147.0 (C-3'), 145.5 (C-4), 145.2 (C-3), 131.5 (C-1), 126.5 (C-1'), 123.4 (C-6'), 120.3 (C-6), 
115.0 (C-2), 114.8 (C-5'), 113.8 (C-'), 110.7 (C-5), 109.6 (C-2'), 102.7 (C-1g), 98.3 (C-1r), 
79.0 (C-3g), 74.8 (C-2g), 74.5 (C-5g), 72.1 (C-3r), 71.3 (C-5r), 70.9 (C-8), 70.1 (C-2r), 69.1 
(C-4r), 68.9 (C-4g), 61.4 (C-6g), 56.0 (C-4-OCH3), 55.9 (C-3'-OCH3), 35.4 (C-7), 20.9 (C-2''-
OCOCH3 and C-3''-OCOCH3), 17.7 (C-6r).  
 
2.11.2 1-Docosyl ferulate 
1-Docosyl ferulate (C32H54O4; Figure 3.101) was obtained as a white powder. HR-
ESI-MS (negative ion mode) showed a peak at m/z 501.3942; C32H53O4 requires 501.3949. 
1
H 
NMR data (500 MHz, CDCl3): δ 7.58 (1H, d, J = 16 Hz, H-7'), 7.06 (1H, d, J = 8, 2 Hz, H-
6'), 7.03 (1H, d, J = 2 Hz, H-2'), 6.90 (1H, d, J = 8 Hz, H-5'), 6.27 (1H, d, J = 16 Hz, H-8'), 
5.82 (1H, s, 4'-OH), 4.18 (2H, t, J = 7 Hz, H-1), 3.92 (3H, s, H-3'-OCH3), 1.67 (2H, quintet, J 
= 8 Hz, H-2), 1.38 (2H, m, H-3), 1.25 (36H, m, H-4 to H-21), 0.86 (3H, t, J = 7 Hz, H-22). 
13
C NMR data (125 MHz, CDCl3): δ 167.4 (C-9'), 147.9 (C-4'), 146.7 (C-3'), 144.6 (C-7'), 
127.1 (C-1'), 123.0 (C-6'), 115.7 (C-8'), 114.7 (C-5'), 109.3 (C-2'), 64.6 (C-1), 55.9 (C-3'-
OCH3), 29.3-31.9 (C-4 to C-20), 28.8 (C-2), 26.0 (C-3), 22.7 (C-21), 14.1 (C-22). 
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2.11.3 Ferruginol 
Ferruginol (C20H30O; Figure 3.104) was obtained as yellow powder. HR-ESI-MS 
(negative ion mode) showed a peak at m/z 285.2221; C20H29O requires 285.2224. 
1
H NMR 
data (500 MHz, CDCl3): δ 6.82 (1H, s, H-14), 6.62 (1H, s, H-11), 4.46 (1H, s, 12-OH), 3.10 
(1H, septet, J = 7 Hz, H-15), 2.83 (1H, ddd, J = 17, 6, 1.5 Hz, H-7-β), 2.76 (1H, ddd, J = 17, 
11, 7.5 Hz, H-7-α), 2.15 (1H, dt, J = 12.5, 4, 1 Hz, H-1-β), 1.85 (1H, dddd, J = 17, 6, 3.5, 2 
Hz, H-6-α), 1.73 (1H, ddd, J = 13.5, 6.5, 3 Hz, H-2-α), 1.65 (1H, m,  H-6-β), 1.59 (1H, ddd, J 
= 14, 10, 3.5 Hz, H-2-β), 1.46 (1H, ddd, J = 13.5, 3.5, 1.5 Hz, H-3-β), 1.37 (1H, m, H-1-α), 
1.31 (1H, dd, J = 12.5, 2 Hz, H-5-α), 1.23 (3H, d, J = 7 Hz, H-16), 1.21 (3H, d, J = 7 Hz, H-
17), 1.19 (1H, m, H-3-α), 1.16 (3H, s, H-20-β), 0.93 (3H, s, H-18-α), 0.91 (3H, s, H-19-β). 
13
C NMR data (125 MHz, CDCl3): δ 150.6 (C-12), 148.7 (C-9), 130.9 (C-13), 127.3 (C-8), 
126.6 (C-14), 110.9 (C-11), 50.3 (C-5), 41.7 (C-3), 38.8 (C-1), 37.5 (C-10), 33.4 (C-4), 33.3 
(C-18), 29.7 (C-7), 26.8 (C-15), 24.8 (C-20), 22.7 (C-16), 22.5 (C-17), 21.6 (C-19), 19.3 (C-
2), 19.2 (C-6).  
 
2.11.4 Salvinolonyl 12-methyl ether 
Salvinolonyl 12-methyl ether (C21H28O3; Figure 3.109) was obtained as off white 
powder. HR-ESI-MS (positive ion mode) showed a peak at m/z 351.1919; C21H28O3Na 
requires 351.1931. 
1
H NMR data (500 MHz, CDCl3): δ 7.73 (1H, s, H-14), 6.47 (1H, s, H-6), 
6.25 (1H, s, 11-OH), 3.83 (3H, s, H-OCH3), 3.27 (1H, ddd, J = 14, 4, 2 Hz, H-1-β), 3.25 (1H, 
septet, J = 7 Hz, H-15), 1.97 (1H, m, H-2), 1.73 (1H, ddd, J = 13, 7, 2 Hz, H-3-β), 1.65 (3H, 
s, H-20-β), 1.62 (1H, m, H-2), 1.43 (2H, ddd, J = 14, 12, 4 Hz, H-1-α and H-3-α), 1.36 (3H, 
s, H-19-β), 1.28 (3H, d, J = 7 Hz, H-16), 1.27 (3H, s, H-18-α), 1.26 (3H, d, J = 7 Hz, H-17). 
13
C NMR data (125 MHz, CDCl3): δ 185.4 (C-7), 175.3 (C-5), 148.2 (C-12), 145.8 (C-11), 
139.7 (C-13), 136.7 (C-9), 127.4 (C-8), 123.6 (C-6), 115.9 (C-14), 61.9 (C-OCH3), 42.2 (C-
10), 40.4 (C-3), 38.1 (C-4), 34.2 (C-1), 33.1 (C-18), 29.3 (C-19), 26.8 (C-15), 24.8 (C-20), 
23.6 (C-16), 23.5 (C-17), 18.7 (C-2)  
 
2.11.5 7α-Acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
7α-Acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione (C22H30O5; Figure 3.113) was 
obtained as yellow powder. HR-ESI-MS (positive ion mode) showed a peak at m/z 397.1974; 
C22H30O5Na requires 397.1985 while the negative ion mode found at m/z 373.2004; C22H29O5 
requires 373.2020. 
1
H NMR data (500 MHz, CDCl3): δ 7.12 (1H, s, 14-OH), 5.92 (1H, dd, J 
= 4, 1.5 Hz, H-7-β), 3.15 (1H, septet, J = 7 Hz, H-15), 2.71(1H, ddd, J = 13, 4, 1 Hz, H-1-β), 
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2.03 (3H, s, H-OCOCH3), 1.92 (1H, br d, J = 15 Hz, H-6-β), 1.72 (1H, dddd, J = 13, 6, 2 Hz, 
H-2-α), 1.59 (1H, ddd, J = 15, 11, 1.5 Hz, H-6-α), 1.57 (1H, m, H-2-β), 1.49 (2H, br d, J = 
13, 1 Hz, H-3-α and H-5-α), 1.22 (3H, s, H-20-β), 1.20 (3H, d, J = 7 Hz, H-16), 1.20 (2H, 
overlapped, H-1-α and H-3-β), 1.18 (3H, d, J = 7 Hz, H-17), 0.88 (3H, s, H-18-α), 0.87 (3H, 
s, H-19-β). 13C NMR data (125 MHz, CDCl3): δ 185.4 (C-11), 183.7 (C-12), 169.4 (C-
OCOCH3), 150.7 (C-14), 149.9 (C-9), 139.4 (C-8), 124.6 (C-13), 64.5 (C-7), 46.1 (C-5), 41.0 
(C-3), 39.0 (C-10), 35.8 (C-1), 32.9 (C-4 and C-18), 24.6 (C-6), 24.1 (C-15), 21.6 (C-19), 
21.1 (C-OCOCH3), 19.8 (C-16), 19.7 (C-17) 18.8 (C-2), 18.5 (C-20). 
 
2.11.6 7α,14-Dihydroxy-8,13-abietadiene-11,12-dione 
7α,14-Dihydroxy-8,13-abietadiene-11,12-dione (C20H28O4; Figure 3.116) was 
obtained as yellow powder HR-ESI-MS (positive ion mode) showed a peak at m/z 355.1880; 
C20H28O4Na requires 355.1880 while the negative ion mode showed a peak at m/z 331.1898; 
C20H27O4 requires 331.1915. 
1
H NMR data (500 MHz, CDCl3): δ 7.20 (1H, s, 14-OH), 4.72 
(1H, dd, J = 3.5, 2 Hz, H-7-β), 3.15 (1H, septet, H-15), 3.00 (1H, s, 4-OH-α), 2.70 (1H, dt, J 
= 13.5, 2.5 Hz, H-1-β), 1.94 (1H, ddd, J = 15 Hz, H-6-β), 1.70 (1H, m, H-2), 1.60 (1H, m, H-
6-α), 1.53 (1H, m, H-2), 1.49 (1H,  br d, J = 10.5 Hz, H-5-α), 1.46 (1H, m, H-3), 1.25 (1H, m, 
H-3), 1.22 (3H, s, H-20-β), 1.20 (6H, J = 7 Hz, H-16 and H-17), 1.18 (1H, m, H-1-α), 0.98 
(3H, s, H-18-β), 0.90 (3H, s, H-19-β). 13C NMR data (125 MHz, CDCl3): δ 189.1 (C-12), 
185.0 (C-11), 151.0 (C-14), 147.8 (C-9), 143.2 (C-8), 124.2 (C-13), 63.2 (C-7), 45.7 (C-5), 
41.0 (C-3), 39.1 (C-10), 35.8 (C-1), 33.1 (C-18), 32.9 (C-4), 25.8 (C-6), 24.0 (C-15), 21.7 (C-
19), 19.9 (C-16), 19.8 (C-17), 18.8 (C-2), 18.4 (C-20). 
 
2.11.7 Microstegiol 
Microstegiol (C20H26O2; Figure 3.119) was obtained as yellow powder. HR-ESI-MS 
(positive ion mode) showed a peak at m/z 321.1820; C20H26O2Na requires 321.1825. 
1
H 
NMR data (500 MHz, CDCl3): δ 7.05 (1H, d, J = 7.5 Hz, H-6), 6.95 (1H, s, H-14), 6.88 (1H, 
d, J = 7.5 Hz, H-7), 4.50 (1H, s, 11-OH),  3.59 (1H, ddd, J = 14, 12, 2 Hz, H-1-β), 3.00 (1H, 
septet, J = 6 Hz, H-15), 2.79 (1H, ddd, J = 14, 6, 2.5 Hz, H-1-α), 2.35 (1H, m, H-3), 2.31 
(3H, s, H-20), 1.78 (1H, m, H-2-β), 1.41 (1H, m, H-2-α), 1.24 (1H, m, H-3), 1.19 (3H, d, J = 
7 Hz, H-17), 1.14 (3H, d, J = 7 Hz, H-16), 0.79 (3H, s, H-18-α), 0.78 (3H, s, H-19-β). 13C 
NMR data (125 MHz, CDCl3): δ 206.1 (C-12), 143.3 (C-10), 141.0 (C-13), 140.9 (C-14), 
139.3 (C-9), 137.4 (C-5), 130.1 (C-6), 129.0 (C-8), 126.7 (C-7), 84.4 (C-11), 42.9 (C-3), 39.0 
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(C-4), 28.0 (C-19), 27.0 (C-1), 26.8 (C-15), 23.5 (C-2), 22.1 (C-16), 21.4 (C-18 and C-20), 
21.1 (C-17). 
 
2.11.8 Compound 3 (1-oxomicrostegiol; 10aS-8,9,10,10a-tetrahydro-10a-hydroxy-
6,10,10-trimethyl-2-(1-methylethyl)-cyclohepta[de]naphthalene-1,7-dione)  
Compound 3 (C20H24O3; Figure 3.123) was obtained as brown-yellow powder. HR-
ESI-MS (positive ion mode) showed a peak at m/z 335.1610; C20H24O3Na requires 335.1618. 
UV (MeOH): λmax (log ε) = 312 (3.87), 278 (3.71), 253 (4.17), 236 (4.11).  
1
H NMR data 
(500 MHz, CDCl3): δ 7.22 (1H, d, J = 7.5 Hz, H-6), 7.20 (1H, d, J = 7.5 Hz, H-7), 7.07 (1H, 
s, H-14), 3.88 (1H, s, 11-OH), 3.11 (1H, ddd, J = 14, 11.5, 2.5 Hz, H-2-α), 2.98 (1H, septet, J 
= 7 Hz, H-15), 2.34 (3H, s, H-20), 2.30 (1H, ddd, J = 14, 5, 3 Hz, H-2-β), 1.54 (1H, dd, J = 
14, 3 Hz, H-3-β), 1.42 (1H, ddd, J = 14, 5, 3 Hz, H-3-α), 1.18 (3H, d, J = 7 Hz, H-17), 1.16 
(3H, d, J = 7 Hz, H-16), 1.05 (3H, s, H-18-α), 0.80 (3H, s, H-19-β). 13C NMR data (125 
MHz, CDCl3): δ 207.2 (C-1), 203.5 (C-12), 141.5 (C-13), 139.1 (C-14), 138.1 (C-9), 137.6 
(C-10), 136.9 (C-5), 131.2 (C-6), 129.6 (C-7), 127.6 (C-8), 81.5 (C-11), 40.9 (C-4), 38.2 (C-
2), 37.5 (C-3), 26.9 (C-15), 26.9 (C-19), 21.9 (C-16), 21.5 (C-17), 19.9 (C-20), 17.4 (C-18). 
 
2.11.9 Compound 4 (viroxocane; 3,4-dihydro-11-hydroxy-10-(1-methylethyl)-2,2,6-
trimethyl-naphtha[1,8-bc]oxocin-5(2H)-one) 
Compound 4 (C20H24O3; Figure 3.127) was obtained as brown-yellow powder. HR-
ESI-MS (positive ion mode) showed a peak at m/z 335.1628; C20H24O3Na requires 335.1618 
while the negative mode showed a peak at m/z 311.1642; C20H23O3 requires 311.1653. UV 
(MeOH): λmax (log ε) = 337 (3.56), 294 (3.72), 237 (4.45). 
1
H NMR data (500 MHz, CDCl3): 
δ 7.61 (1H, d, J = 8 Hz, H-7), 7.41 (1H, s, H-14), 7.11 (1H, d, J = 8 Hz, H-6), 5.90 (1H, s, 12-
OH), 3.34 (1H, septet, J = 7 Hz, H-15), 3.02 (1H, ddd, J = 14, 10.5, 3.5 Hz, H-2-α), 2.60 (1H, 
ddd, J = 14, 4, 4 Hz, H-2-β), 2.33 (3H, s, H-20), 2.17 (1H, ddd, J = 14, 10.8, 4 Hz, H-3-β), 
1.62 (3H, s, H-19-β), 1.60 (1H, m, H-3-α), 1.33 (3H, d, J = 7 Hz, H-16), 1.28 (3H, d, J = 7 
Hz, H-17), 1.23 (3H, s, H-18-α). 13C NMR data (125 MHz, CDCl3): δ 210.85 (C-1), 147.38 
(C-12), 136.58 (C-13), 132.20 (C-10), 132.08 (C-11), 130.37 (C-5), 128.15 (C-7), 126.96 (C-
9), 126.77 (C-8), 126.27 (C-6), 121.16 (C-14), 84.27 (C-4), 41.20 (C-2), 35.10 (C-3), 27.82 
(C-15), 26.24 (C-19), 26.02 (C-18), 22.33 (C-16), 22.29 (C-17), 18.89 (C-20).   
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2.11.10 Compound 5 (viridoquinone; 5-methyl-20-nor-abieta-1(10),6,8,13-tetraen-11,12-
dione) 
Compound 5 (C20H24O2; Figure 3.131) was obtained as purple powder. HR-ESI-MS 
(positive ion mode) showed a peak at m/z 319.1662; C20H24O2Na requires 319.1669. UV 
(MeOH): λmax (log ε) = 460 (2.42), 325 (3.86), 285 (3.99), 246 (4.32). 
1
H NMR data (500 
MHz, CDCl3): δ 6.72 (1H, t, J = 4.5 Hz, H-1), 6.58 (1H, s, H-14), 6.46 (1H, d, J = 9.5 Hz, H-
6), 5.97 (1H, d, J = 9.5 Hz, H-7), 2.95 (1H, septet, J = 6 Hz, H-15), 2.30 (2H, m, H-2), 1.86 
(1H, ddd, J = 14, 10, 5 Hz, H-3-β), 1.26 (1H, m, H-3-α), 1.12 (3H, d, J = 7 Hz, H-16), 1.10 
(3H, d, J = 7 Hz, H-17), 1.08 (3H, s, H-20-β), 1.02 (3H, s, H-19-β), 0.91 (3H, s, H-18-α). 13C 
NMR data (125 MHz, CDCl3): δ 180.53 (C-11), 180.48 (C-12), 146.90 (C-13), 146.57 (C-6), 
137.17 (C-8), 137.01 (C-14), 134.35 (C-1), 132.44 (C-10), 125.41 (C-9), 123.90 (C-7), 43.37 
(C-5), 33.10 (C-4), 31.83 (C-3), 27.18 (C-15), 25.74 (C-18), 24.51 (C-19), 23.84 (C-2), 23.44 
(C-20), 21.55 (C-16), 21.41 (C-17). 
 
2.11.11 A mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates 
A mixture of 2-(4'-alkoxyphenyl) ethyl alkanoate (Figure 3.135) was obtained as 
white powder. CIMS and GC-CI-MS carried out using NH3 as reagent gas at the EPSRC 
National Mass Spectrometry Service Centre, School of Medicine, University of Swansea. 
The GC-CI-MS data (positive ion mode) showed three main components at m/z 478.4245; 
C30H52O3NH4 requires 478.4255, 506.4557; C32H56O3NH4 requires 506.4593 and 534.4869; 
C34H60O3NH4 requires 534.4881. 
1
H NMR data (500 MHz, CDCl3): δ 7.07 (2H, d, J = 8.5 Hz, 
H-2' and H-6'), 6.75 (2H, d, J = 8.5 Hz, H-3' and H-5'), 4.23 (2H, t, J = 7 Hz, H-2), 3.64 (2H, 
t, J = 6.5 Hz, H-α-alkoxy), 2.85 (2H, t, J = 7 Hz, H-1), 2.27 (2H, t, J = 7.5 Hz, H-β-
alkanoate), 1.25-1.56 (-CH2-), 0.88 (6H, t, J = 7 Hz, -CH3 of alkoxy and alkanoate). 
13
C NMR 
data (125 MHz, CDCl3): δ 173.85 (C-α-alkanoate), 154.16 (C-4'), 130.04 (C-1', C-2' and C-
6'), 115.28 (C-3' and C-5'), 64.89 (C-2), 63.12 (C-α-alkoxy), 34.34 (C-1), 34.26 (C-β-
alkanoate), 32.80 (C-β-alkoxy), 22.68-29.45 (-CH2-), 14.11 (CH3 of alkoxy and alkanoate). 
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  Chapter 3 
Results and discussions 
 
 
3.1 TLC patterns of crude fractions and their detection 
 
The developed TLC plates were sprayed by different reagents according to Table 2.1 
in order to screen their type of chemical compounds. Figures 3.1-3.2 show the various TLC 
patterns from two mobile phases with different detection methods. The Rf values of the 
standards and extract fractions are shown in Table 3.1. 
 
It can be seen in Figure 3.1A-B that various compounds were detected under UV at 
254 nm and 366 nm in four polar fractions from the aerial parts, i.e. AWW, AB, MWW, and 
MB by using mobile phase: ethyl acetate:methanol:formic acid:water (50:3:3:6). 
Fluorescence of those compounds was enhanced under UV at 366 nm after a plate was 
sprayed by Natural Products Reagent (Figure 3.1C). Water and 1-butanol fractions (tracks 6-
7, 10-11) may contain flavonoids, and polyphenolic compounds such as cinnamic acid 
derivatives. The plate sprayed with Iron (III) chloride Reagent indicated phenol group 
containing compounds as shown in Figure 3.1D. The other two reagents were sprayed on a 
less polar mobile phase (chloroform:methanol, 9:1). Many lipophilic compounds which 
might be terpenoids, and steroids in both AE (Figure 3.2, track 5), and ME (Figure 3.2, track 
9) (ethyl acetate fractions from acetone, and methanol extracts respectively) gave various 
colours in visible light after being sprayed with Anisaldehyde-Sulfuric acid Reagent and 
Phosphomolybdic acid Reagent.  
 
The similar patterns of track 6, 7, 10, and 11 (Figures 3.1-3.3), which are polar 
fractions from acetone, and methanol, indicated the comparable solubility of those 
compounds in both solvents. TLC of root part crude fraction exhibited a similar pattern as 
aerial part as shown in Figure 3.4. However, the bands of compounds in polar crude fractions 
(tracks 13-14 and 17-18) were relatively less intense than in aerial crude fractions (tracks 3-4 
and 7-8). 
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                A. Under UV at 254 nm                                              B. Under UV at 366 nm 
 
C. Natural Products Reagent, under UV at 366 nm          D. Iron (III) chloride Reagent, white light 
Figure 3.1 A-D Separation of Salvia viridis L. cv. Blue Jeans aerial part crude fractions. 
Mobile phase: ethyl acetate:methanol:formic acid:water (50:3:3:6). 
 
 
A. Anisaldehyde-Sulfuric acid Reagent, white light   B. Phosphomolybdic acid Reagent, white light 
Figure 3.2 A-B Separation of Salvia viridis L. cv. Blue Jeans aerial part crude fractions. 
Mobile phase: chloroform:methanol (9:1)  
                                                                                                                                    
                                                                  
 
 
  1     2    3    4    5     6     7     8    9   10   11   12  13  14     1   2    3    4     5     6     7    8     9   10   11  12   13  14 
1     2      3    4     5      6    7      8    9    10   11   12   13  14 1    2    3    4      5     6     7      8    9    10   11   12    13 
  1       2      3      4      5    6     7     8     9    10   11    12   13   1      2      3      4     5     6      7      8     9     10   11   12  13 
Figure 3.3 DPPH stained plate of 
aerial part, white light. Mobile phase: 
ethyl acetate, methanol, formic acid, 
water (50:3:3:6). 
   1     2     3     4     5      6     7     8    9    10   11  12   13 
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Table 3.1 Rf values of all aerial part extract fractions and standard 
 
Track Name Rf values of compounds 
Mobile phase:  
ethyl acetate:methanol: 
formic acid:water (50:3:3:6). 
Mobile phase: 
chloroform:methanol (9:1) 
1 Naringin 0.20 - 
2 Rosmarinic acid 0.70 - 
3 Caffeic acid 0.75 0.05 
4 AP (Acetone-PE) - 0.25, 0.45, 0.55, 0.63, 0.73 
5 AE (Acetone-Ethyl 
acetate) 
- 0.18, 0.23, 0.30, 0.35, 0.45, 
0.55, 0.60, 0.63, 0.73 
6 AW  
(Acetone-Water) 
0.08, 0.13, 0.23, 0.25, 0.43  - 
7 AB  
(Acetone-1-Butanol) 
0.08, 0.13, 0.23, 0.25, 0.27, 
0.43, 0.70, 0.75 
0.25, 0.45, 0.55, 0.63, 0.73 
8 MP (Methanol-PE) - 0.18, 0.23, 0.40, 0.63, 0.73 
9 ME (Methanol-Ethyl 
acetate) 
0.70, 0.75 0.18, 0.23, 0.30, 0.35, 0.45, 
0.55, 0.60, 0.63, 0.73 
10 MW  
(Methanol-Water) 
0.08, 0.13, 0.23, 0.25, 0.43 - 
11 MB  
(Methanol-1-Butanol) 
0.08, 0.13, 0.23, 0.25, 0.27, 
0.43, 0.70  
0.18 
12 Chlorogenic acid 0.25 - 
13 Rutin 0.13 - 
14 Verbascoside 0.25 - 
 
 
TLC of crude fraction from the root extracts exhibited a similar broad pattern to the 
aerial part as shown in Figure 3.4. However, the root extracts showed a greater 
preponderance of non-polar constituents. 
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                        A. White light                                          B. Natural Product Reagent, under UV at 366 nm 
 
Figure 3.4 A-B Separation of Salvia viridis L. cv. Blue Jeans root part crude fractions (tracks 
11-18). Mobile phase: ethyl acetate, methanol, formic acid, water (50:3:3:6). Labeling of 
each track is given in Table 3.2. 
 
Table 3.2 Crude fractions abbreviations and track labeling 
 
Track Part Crude fraction 
1 Aerial AP Acetone-Petroluem ether crude fraction 
2 Aerial AE Acetone-Ethyl acetate crude fraction  
3 Aerial AB Acetone-1-Butanol crude fraction 
4 Aerial AW Acetone-Water crude fraction 
5 Aerial MP Methanol-Petroleum ether crude fraction 
6 Aerial ME Methanol-Ethyl acetate crude fraction 
7 Aerial MB Methanol-1-Butanol crude fraction 
8 Aerial MW Methanol-Water crude fraction 
9 Standard RA Rosmarinic acid 
10 Standard CA Caffeic acid 
11 Root RAP Acetone-Petroluem ether crude fraction 
12 Root RAE Acetone-Ethyl acetate crude fraction 
13 Root RAB Acetone-1-Butanol crude fraction 
14 Root RAW Acetone-Water crude fraction 
15 Root RMP Methanol-Petroleum ether crude fraction 
16 Root RME Methanol-Ethyl acetate crude fraction 
17 Root RMB Methanol-1-Butanol crude fraction 
18 Root RMW Methanol-Water crude fraction 
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For preliminary screening, the detecting reagents are a useful guide to compound 
type, and also to aid the isolation. Under UV 366 nm, compounds are commonly seen as blue 
or red fluorescent spots, Natural Product Reagent can differentiate compounds by enhancing 
fluorescence intensity and colour. Natural Product Reagent contains 2-aminoethyl-diphenyl 
borinate (or diphenylboric acid-2-aminoethyl ester) which possibly forms a complex with 
certain substances, for example, flavonoids, and results in a bathochromic shift of the 
complex. PEG (Polyethylene glycol) in solution B was sprayed on the TLC plate in order to 
increase and stabilize the fluorescence (Jork et al., 1990).  
     
       Flavonol                    Diphenylboric acid-2-aminoethyl ester  
 
Figure 3.5 Reaction of flavonol and diphenylboric acid-2-aminoethyl ester (Jork et al., 1990) 
 
Iron (III) chloride Reagent is widely used to detect phenols, flavonoids, and plant 
acids. A range of colours with polyphenols (deep violet to orange) are detected in visible 
light due to the d-d transitions in the octahedral complex between iron (III) ion and hydroxyl 
groups of phenols. 
                                           
O
O
O
O
O
OFe
3-
 
              
       Figure 3.6 Proposed complex between iron (III) ion and catechols  
 
There is no specific reaction of Anisaldehyde-Sulfuric acid Reagent with various 
compounds. However, colour changes were observed after the TLC plate was heated possibly 
due to condensation of anisaldehyde with certain functional groups of compounds. Reactive 
B
O
O
N
HO
O
O
OH
B
NH2O
+ + H2O 
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aldehyde can react with nucleophiles to add a substituted styrene group to the analyte. In 
addition, sulfuric acid can dehydrate analyte molecules to generate double bond systems to 
give conjugated chromophores. 
                                                     
CHO
OCH3  
                                               
Figure 3.7 Anisaldehyde 
 
Phosphomolybdic acid reagent was sprayed to detect terpenoids, fatty oils, and 
reducing substances. Blue bands were observed on a yellow background. The mechanism of 
reaction is due to the reduction of Molybdenum. Mo (VI) is reduced to Mo (IV), which forms 
blue-grey mixed oxides with the remaining Mo (VI) (Jork et al., 1990). 
 
                                2MoO3                           MoO2 • MoO3 
                                                        
 Figure 3.8 Reaction of Phosphomolybdic acid reagent  
 
 
3.2 TLC-chemoautographic method (DPPH radical scavenging activity) 
 
As a preliminary test for biological antioxidant activity, a TLC-chemoautographic 
method was introduced to monitor antioxidant activity in the fractions (Cimpoiu, 2006; 
Tasdemir et al., 2004). This method offers a simple activity test and the result is also used as 
a guideline for isolating active compounds. 2, 2- Diphenyl-1-picrylhydrazyl (DPPH) is a 
relatively stable free radical that is frequently used to detect free radical scavengers. The 
radical form of DPPH absorbs at 515 nm as seen in purple colour. When its electron is paired 
off because of either an antioxidant or a radical species, the absorption disappears. As can be 
seen in Figure 3.9, the equations II, and III are considered to be termination reactions but 
equation II is very slow because of steric hindrance. The rate of reaction in equation III 
depends on the molecular structure of the phenol, and aromatic substituent volumes 
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(Cimpoiu, 2006). The dimerization between two phenoxyl radicals depends on a free ortho, 
or para position (Brand-Williams et al., 1995). 
 
        
                            
Figure 3.9 Proposed reaction of DPPH
•
 with phenol 
 
Compounds that possess this activity were seen as yellow bands or spots on a purple 
background in visible light shortly after a developed TLC plate was sprayed with DPPH 
solution as shown in Figure 3.3. All crude fractions indicate compounds which possess this 
activity except the petroleum ether fraction from both acetone and methanol extracts. The 1-
butanol fractions that contained many radical scavengers were, therefore, further separated by 
HPLC.  
 
The isolated compounds from HPLC revealed that the yellow bands of DPPH 
scavenging activity belonged to phenylpropanoids and flavonoids. The Rf values of each 
compounds were given in Table 3.5. Previously reported DPPH scavenging activity in regard 
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to IC50 and percentage of DPPH inhibition are given in Table 3.3.  Structure activity 
relationships of DPPH scavenging activity suggests that ortho-dihydroxyl substitution at the 
aromatic ring yields high activity. Among these isolated compounds, verbascoside would be 
the most potent one against DPPH according to those finding. 
  
Table 3.3 Review of DPPH scavenging activity of main isolated compounds 
 
Compound IC50 
(µM) 
% DPPH 
inhibition 
Reference 
Verbascoside 9
a
,12
b
, 15
c
 - 
a
Ono et al., 2008 
b
Galvez et al., 2005 
c
Gao et al., 1999 
d
Gu et al., 2009  
e
Wang et al., 1998 
f
 Seyoum et al., 2006 
 
Leucosceptoside A 26
a
 - 
Martynoside 23
a
 - 
Rosmarinic acid 9
d
 88
e
 
(20 µM) 
Caffeic acid 16
a
 - 
Luteolin-7-O-glucoside 28
f
 62
e 
(20 µM) 
6-O-caffeoyl-glucose >30
c
 - 
IC50 is defined as the concentration of tested sample to inhibit 50% DPPH radical.  
%DPPH inhibition is percentage of scavenging activity at the certain concentration (in 
parenthesis). 
 
 
3.3 Antibacterial activity  
 
3.3.1 TLC-bioautographic method; agar overlay technique  
 In order to determine the antibacterial activity, all crude fractions were tested against 
certain bacteria by using the TLC-bioautographic assay. The agar-overlay technique offered 
the direct and localized detection of antibacterial activity over the developed TLC plate 
(Hamburger and Cordell, 1987). The panel of test organisms consisted of both the Gram-
positive cocci, Staphylococcus aureus (ATCC 6571) and Enterococcus faecalis (ATCC 775), 
the spore-forming Gram-positive rod Bacillus cereus (ATCC 2599), and the three Gram-
negative bacteria, Escherichia coli (ATCC 86), Klebsiella pnueminiae (ATCC 9633) and 
Proteus vulgaris (ATCC 4636). 
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.  Results of the TLC-bioautographic method against three bacteria are shown in 
Figures 3.10-3.12. For the Gram-positive bacteria, the non-polar crude fractions exhibited the 
inhibition zone encircling the spots particularly acetone crude fraction from root part (RAP 
and RAE) as shown in Figures 3.10-3.12 (plate A). Acetone crude fraction (AE) from aerial 
part also showed clear zone against those three bacteria (Figures 3.10-3.12, plate B). 
According to the Rf values, compounds with antibacterial activity were identified as 
triterpenoids and diterpenoids. The MIC values of compounds isolated from the fractions 
(AE, RAP and RAE) against the three Gram-positive bacteria were measured by a 96 well 
microplate assay. On the other hand, the polar crude fractions (AB, AW, MB and MW) 
showed little activity in comparison with the positive control. However, an ambiguous yellow 
zone was observed at these polyphenol fractions as shown in Figures 3.10-3.12 (plate C). 
Compounds such as verbascoside and luteolin-7-glucoside could possibly show only 
bacteriostatic effect. As they are water miscible compounds, the overlaid agar which 
consisted of water could partly dissolve those particular components in the crude fraction and 
caused the yellow zone. To determine their activity, the MIC values of the crude fraction 
(MB) and the main isolated compound, verbascoside, were determined by 96 well microplate 
assay.    
 
All crude fractions failed to show antibacterial activity against the three Gram-
negative bacteria. The agar-overlaid TLC plates were completely seen as a purple colour 
except the clear zone of positive control. These results corresponded to previously published 
findings. Diterpenoids and triterpenoids isolated from various Salvia species which were 
either inactive or active with MIC greater than 200 µM against Gram-negative bacteria 
(Moujir et al., 1996; Ulubelen, 2003; Kuzma et al., 2007; Shai et al., 2008; Wolska et al., 
2010).  
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               A. Root part                             B. Aerial part                                 C. Aerial part  
Figure 3.10A-C TLC-bioautographic method* against Staphylococcus aureus (ATCC 6571) 
 
        
               A. Root part                                     B. Aerial part                                  C. Aerial part 
Figure 3.11A-C TLC-bioautographic method* against Bacillus cereus (ATCC 2599) 
 
 
           A. Root part                                      B. Aerial part                                   C. Aerial part     
Figure 3.12A-C TLC-bioautographic method* against Enterococcus faecalis (ATCC 775) 
*Conditions: (a) Crude fractions: 10 µl of 10 mg/ml in either methanol (AB, AW, MB, MW, RAB, 
RAW, RMB, RMW), or chloroform (AP, AE, MP, ME, RAP, RAE, RMP, RME). Crude fractions 
abbreviations see Table 3.2. (b) Standard: 10 µl caffeic acid (CA) solution (10 mg/ml in methanol), 
10µl rosmarinic acid (RA) solution (10 mg/ml in methanol), and 10 µl β-sitosterol (BS) solution (10 
mg/ml in chloroform). (c) Positive control: Inpregnated ampicillin disc (Oxoid), 5 µl Chloramphenicol 
(C) solution (50 mg/ml in methanol), and 5 µl Erythomycin (E) solution (50 mg/ml in methanol). (d) 
Mobile phase: chloroform, methanol (9:1) for plates A and B, and ethyl acetate, methanol, formic acid, 
water (50:3:3:6) for plate C. 
RAP RAE RME RMP A AB AW MW MB C RA CA AP AE ME MP C BS 
AB 
AW MW 
MB C RA 
CA 
AP AE ME MP C BS 
E 
RAP RAE RME RMP A 
AB 
AW MW 
MB C RA 
CA 
RAB 
RAW 
RMB C RA 
CA AP AE ME MP C BS 
E 
RAP RAE RME RMP C 
E 
RMW 
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3.3.2 Minimum inhibitory concentration (MIC) 
 MIC of crude fractions and isolated compounds were determined by the 96 well 
microplate dilution technique. Results are presented in Figures 3.14-3.16 and Table 3.4. 
Three crude fractions, AE (aerial part), RAE (root part), and RAP (root part), exhibited 
notable inhibition zones against three Gram-positive bacteria on the TLC-bioautographic 
method (Figures 3.10-3.12, plates A and B). MIC of these crude fractions corroborated the 
preliminary screening technique, particularly the two fractions from root parts. RAE and 
RAP showed MIC against Enterococcus faecalis (ATCC 775) at 62.5 µg/ml and 125 µg/ml 
respectively. Both fractions also inhibited the growth of the other two bacteria with MIC 
values at 250 µg/ml against Staphylococcus aureus (ATCC 6571) and 125 µg/ml against 
Bacillus cereus (ATCC 2599) as shown in Table 3.4. On the other hand, the aerial part crude 
fraction AE showed a less potent MIC of 500 µg/ml against Enterococcus faecalis (ATCC 
775) and 1000 µg/ml against both Staphylococcus aureus (ATCC 6571) and Bacillus cereus 
(ATCC 2599).  The polar crude fraction MB showed poor antibacterial activity with MIC 
value 2000 µg/ml which corresponded to results of the agar overlaid TLC assay.  
   
 
                                  Template A                                                      Template B 
 
 
                                    Figure 3.13 Templates of MIC 96 well microplate assay 
 
Negative control Inoculated nutrient broth Blank Nutrient broth 
Positive control chloramphenicol  DMSO toxicity testing 
Serial crude fraction concentration (µg/ml): 2000, 1000, 500, 250, 125, 62.5 
Serial isolated compound concentration (µM): 200, 100, 50, 25, 12.5, 6.3 
UA 
OA 
LD 
C1 
C2 
BS 
SG 
PS 
VB 
CA 
LG 
RA 
AE 
MB 
FG 
AA 
HA 
SM 
C3 
C4 
MG 
C5 
DF 
RAP 
RAE 
CR 
DMSO 
NB INB NB INB 
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     A.                                                                              B. 
       Figure 3.14A-B MIC microplate assay against Staphylococcus aureus (ATCC 6571) 
 
 
 
     A.                                                                              B. 
           Figure 3.15A-B MIC microplate assay against Bacillus cereus (ATCC 2599) 
 
 
 
     A.                                                                              B. 
                 Figure 3.16A-B MIC microplate assay against Enterococcus faecalis (ATCC 775) 
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Table 3.4. MIC of crude fractions and isolated compounds from S. viridis L. cv. Blue Jeans  
Sample
a
 Rf 
value
b
 
Staphylococcus 
aureus  
(ATCC 6571) 
Bacillus cereus  
(ATCC 2599) 
Enterococcus 
faecalis  
(ATCC 775) 
AE crude fraction - 1000 1000 500 
UA Ursolic acid  0.48 25 50 12.5 
OA Oleanolic acid  0.48 50 12.5 12.5 
LD Lup-20(29)-ene-2α-3β-diol  0.43 100 100 100 
C1 Compound 1  0.63 100 100 50 
C2 Compound 2 0.63 100 100 100 
BS β-Sitosterol  0.60 100 50 100 
SG β-Sitosterol glucoside  0.23 >200 100 >200 
PS A mixture of phytosterols 0.60 100 100 100 
MB crude fraction - >2000 2000 2000 
VB Verbascoside  0.25 100 100 100 
CA Caffeic acid  0.80 100 100 100 
LG Luteolin-7-O-glucoside  0.25 100 100 200 
RA Rosmarinic acid  0.78 200 100 200 
RAE crude fraction - 250 125 62.5 
FG Ferruginol  0.84 25 50 25 
AA 7α-Acetoxy-14-hydroxy-8,13-
abietadiene-11,12-dione 
0.79 100 200 100 
HA 7α,14-dihydroxy-8,13-
abietadiene-11,12-dione 
0.79 100 100 50 
SM Salvinolonyl-12-methyl-ether  0.80 200 200 200 
C3 Compound 3  0.75 200 200 100 
C4 Compound 4  0.75 100 200 100 
RAP crude fraction - 250 125 125 
MG Microstegiol 0.80 50 100 100 
C5 Compound 5 0.80 100 100 100 
DF 1-Docasyl ferulate 0.80 200 200 >200 
Chloramphenicol (µM) - 7.8 1 2 
DMSO (%) - >10 10 >10 
a
MIC of crude fractions (µg/ml), isolated compounds (µM). 
b
mobile phases: ethyl acetate, 
methanol, formic acid, water (50:3:3:6) for MB, and chloroform, methanol (9:1) for AE, 
RAE, RAP. 
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The fractionation of these four crude fractions led to the isolation of terpenoids from 
aerial part (AE crude fraction), and diterpenoids from root part (RAE and RAP crude 
fractions). A novel terpenoid compound, compound 1, exhibited antibacterial activity against 
Enterococcus faecalis (ATCC 775) with MIC value of 50 µM. 7α,14-Dihydroxy-8,13-
abietadiene-11,12-dione was also active against  Enterococcus faecalis (ATCC 775) with 
MIC 50 µM. A diterpenoid from root part, ferruginol, also inhibited Staphylococcus aureus 
(ATCC 6571) and Enterococcus faecalis (ATCC 775) with MIC value of 25 µM and a higher 
MIC value of 50 µM against Bacillus cereus (ATCC 2599). Oleanolic acid inhibited those 
Gram-positive bacteria with MIC 12.5 µM against both Bacillus cereus (ATCC 2599) and 
Enterococcus faecalis (ATCC 775), and 50 µM against Staphylococcus aureus (ATCC 
6571). Ursolic acid was also active with MIC 12.5-50 µM against the three tested bacteria. 
Verbascoside, and caffeic acid from the polar crude fraction were moderately active with 
MIC value at 100 µM against those three bacteria (Table 3.4). In addition, the solvent DMSO 
exhibited the toxicity at a concentration 10%. 
 
INT (p-iodonitrotetrazolium chloride) solution was employed to detect the presence 
of bacteria on the agar overlaid TLC plates and also in the MIC microplate assay. INT was 
converted into formazan product by viable bacteria as shown in Figure 3.17. Besides INT, 
other tetrazolium salts such as MTT (thiazolyl blue) can also be used in this assay 
(Hamburger and Cordell, 1987; Eloff, 1998). However INT was preferred because it gave a 
pale yellow solution which facilitated the observation (Hamburger and Cordell, 1987) and 
also no colour change in the absence of bacteria (Eloff, 1998). The concentration of INT 
solution also influenced the shade of the purple colour. The optimum concentration of INT 
solution was 2 mg/ml to observe the purple colour within 30 minutes incubation period. 
Nevertheless, the more incubation time, the deeper violet was developed. 
         
                        INT                                                                                          Formazan        
                        Figure 3.17 The formation of deep purple formazan product from INT 
N
N
N
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3.4 Acetylcholinesterase inhibitory activity 
Based on Ellman’s method (Ellman et al., 1961), the enzyme (AChE) reacts with 
substrate (ACTI), and produces thiocholine and acetate. Then, the thiocholine rapidly reacts 
with the reagent DTNB to yield a yellow product as shown in Figure 3.18. The enzyme 
activity can be determined by measuring the increase of the absorbance at 405 nm.  
                                 
            
Figure 3.18  Reactions of colorimetric assay of Acetylcholinesterase activity (Ellman et al., 
1961).  
  
TLC-bioautographic methods exhibited the presence of yellow colour product (5-
thio-2-nitro-benzoate) of the reaction on the plate background as shown in Figure 3.19. 
Physostigmine showed a white zone which denoted the inhibitory activity of the enzyme. 
Polar crude fractions showed no activity (Figure 3.19, plate B). In addition, polar compounds 
at certain Rf values partly dissolved in the process of spraying. However, no white spot was 
observed in the Rf value of the main constituent, verbascoside. On the other hand, white 
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spots/bands were seen in AE, RAP, RAE, RMP crude fractions including β-sitosterol (BS), 
ursolic acid (UA), and oleanolic acid (OA) as shown in Figure 3.19 (Plate A). These white 
spots were likely to be due to the deposit of lipophilic compounds on the plate as seen in AE 
crude fraction. To determine their activity, these fractions were further tested in a microplate 
assay. 
 
                                A.                                                                             B. 
Figure 3.19A-B TLC-bioautographic method of Acetylcholinesterase inhibitory activity.  
Plate A mobile phase: chloroform:methanol (9:1); Plate B mobile phase: ethyl 
acetate:methanol:formic acid:water (50:3:3:6). Plate was developed by corresponded mobile 
phase for 10 cm, and physostigmine (P) was spotted before spraying. Crude fractions 
abbreviations are given in Table 3.2. 
 
 
Figure 3.20 % AChE inhibitory activity of crude fractions. Data were reported as mean ± SD 
(n = 3). Physostigmine was used as a positive control at concentration of 1 µl (P1) and 5 µl 
(P5) of 3.6 mM.  
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 As can be seen from Figure 3.20, AE and AP crude fractions showed % inhibitory 
more than 90% compare to 96% of physostigmine (14.4 µM, P1 1 µl of 3.6 mM). The others 
showed % inhibition more than 50% but RMP at 39%. However, these crude fractions were 
precipitated in the water based testing solvent which can cause inaccuracies in absorbance 
measurement.  
 
3.5 Separation compounds from aerial part 
  
The dried aerial part was macerated by two steps of solvents, acetone and methanol, 
in order to extract as many compounds as possible. Each of those crude extracts was further 
separated by liquid-liquid partition to achieve a preliminary fractionation. 
1
H NMR spectra at 
270 MHz of crude fractions were examined. Spectra of petroleum ether fractions (AP and 
MP) and ethyl acetate fractions (AE and ME) showed mainly aliphatic proton peaks. 
Compounds of petroleum ether fractions were certainly fats while ethyl acetate fractions were 
possibly comprised of fats and terpenoids. There were aromatic proton peaks in the water, 
and 1-butanol extract from both acetone and methanol fractions. Thus, this water fraction was 
further partitioned with 1-butanol. All aromatic compounds were successfully extracted from 
the water fraction (AW, MW) to 1-butanol fraction (AB, MB). NMR spectra of water 
fractions (after partitioned with 1-butanol) contained mainly sugar peaks while spectra of 1-
butanol fractions showed aromatic glycoside peaks. According to the partition process, it can 
be concluded that 1-butanol was the suitable solvent for screening those polyphenol 
compounds from water fraction prior to the isolation process.  
 
3.5.1 HPLC of aerial part crude fractions 
 
Figure 3.21 shows HPLC chromatograms of MB and AB crude fractions. All the 
peaks were isolated using repeated semi-preparative HPLC; the main peak at retention time 
9.2 min was identified as verbascoside (also known as acteoside). The chemical structures of 
all peaks were determined by MS and NMR as described below in structure elucidation 
section. Table 3.5 shows all identified compounds from MB of aerial part of S. viridis L. cv. 
Blue Jeans. Comparison between AB (Acetone-Butanol fraction) and MB (Methanol-Butanol 
fraction), as seen in Figure 3.21 shows a very similar pattern of compounds. However, the 
dried weight of AB (1.73 gm; 0.29% of dried aerial part) was 3.7 fold less than MB (6.37 gm; 
1.06% of dried aerial part).  
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A. MB crude fraction 
       
 
 
B. AB crude fraction 
 
Figure 3.21A-B Chromatograms of MB and AB crude fractions from retention time 0-25 
minutes. Condition: Phenomenex Luna PFP 250x10mm, injection volume 20 µl of 10 mg/ml, 
mobile phase methanol:water (45:55), flow rate 5 ml/min, wavelength at 330 nm. 
Trans-verbascoside 
9.2 min 
Cis-verbascoside 
11.2 min 
Leucosceptoside A 
15.5 min 
Luteolin-7-rutinoside 
 16.7 min 
Luteolin-7-glucoside 
 18.7 min 
Rosmarinic acid 
Caffeic acid 
6-Caffeoyl-glucose 
Salidroside 
8.2 min 
Trans-verbascoside 
9.2 min 
Luteolin-7-rutinoside 
16.7 min 
Luteolin-7-glucoside 
 18.7 min 
Injection point 
Injection point 
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     Table 3.5  Isolated compounds from methanol-1-butanol (MB) crude fraction of aerial part  
  
Retention time
a
 
(minute) 
Identification Formula MW Rf value
b
 
4.6 Caffeic acid  C9H8O4 180 0.75 
4.5 Rosmarinic acid C18H16O8 360 0.78 
5.7 6-O-Caffeoyl-glucose C15H18O9 342 0.25 
8.2 Salidroside C14H20O7 300 0.25 
9.2 Trans-verbascoside C29H36O15 624 0.25 
11.2 Cis-verbascoside C29H36O15 624 0.25 
15.5 Leucosceptoside A C30H38O15 638 0.25 
16.7 Luteolin-7-O-rutinoside C27H30O15 594 0.13 
16.7 Luteolin-7-O-α-rhamnosyl 
(1→6)-β-galactopyranoside 
C27H30O15 594 0.13 
18.7 Luteolin-7-O-glucoside C21H20O11 448 0.23 
19.5 Luteolin-7-O-galactoside C21H20O11 448 0.27 
34.7 Apigenin-7-O-glucoside C21H20O10 432 0.25 
39.5 Martynoside C31H40O15 652 0.25 
a
Mobile phase: methanol:water (45:50); column Phenomenex Luna PFP 250x10mm 
b
Mobile phase: ethyl acetate:methanol:formic acid:water (50:3:3:6); silica gel GF254 
 
 
3.5.2 Open column chromatography of aerial part crude fractions 
 
 Terpenoids were isolated from the AE fraction of aerial part including ursolic acid, 
oleanolic acid, lup-(20)29-ene-2α,3β-diol, two new triterpenoids, β-sitosterol, and β-sitosterol 
glucoside as shown in Table 3.6. A main spot at Rf 0.45 using chloroform:methanol (9:1) 
constituted a mixture of ursolic acid and oleanolic acid while the other one at Rf 0.60 was 
plant sterol, β-sitosterol (Figure 3.2A, track 5). Their structures are described below in 
section 3.6. 
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Table 3.6 Isolated compounds from acetone-ethyl acetate (AE) crude fraction of aerial part 
 
Identification Formula MW Rf value
a
 
Compound 1 C32H52O3 484 0.63 
Compound 2 C32H52O3 484 0.63 
β-Sitosterol C29H50O 414 0.60 
Oleanolic acid C30H48O3 456 0.45 
Ursolic acid C30H48O3 456 0.45 
Lup-(20)29-ene-2α, 3β-diol C30H50O2 442 0.43 
β-Sitosterol glucoside C35H60O6 576 0.23 
a
Mobile phase: chloroform:methanol (9:1); silica gel GF254 
 
 
3.6. Structure elucidations of isolated compounds from aerial part 
 
3.6.1 Caffeic acid derivatives 
 The polar fractions, MB and AB contained a series of compounds of varied 
molecular weight with NMR signals in the aromatic region that were characteristic of caffeic 
acid. 
 
3.6.1.1 Caffeic acid 
Caffic acid (C9H8O4; Figure 3.22) was identified by comparison of its NMR spectra 
with literatures values and an authentic sample. 
1
H and 
13
C NMR data of the isolated 
compound are shown in Table 3.7 and NMR spectra are shown in Appendix 1.  
                   
OH
O
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4
 
 
                             Figure 3.22 Caffeic acid 
 
13
C NMR displayed 9 signals with 4 quaternary carbon and 5 methine groups from 
DEPT-135. 
1
H NMR displayed 5 signals in the aromatic and alkene region with two 
noticeable signals of trans configuration, δ 6.20 ppm (H-8) and 7.51 ppm (H-7) with a 
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coupling constant of 16 Hz. Figure 3.24 shows the coupling pattern of a 3, 4-disubstituted 
phenyl ring with related coupling constants. H-5 (δ 6.77 ppm) and H-6 (δ 6.93 ppm) were 
coupled to each other with 
3
J value 8 Hz. While H-2 (δ 7.03 ppm) displayed meta coupling to 
H-6 (δ 6.93 ppm) with 4J value 2 Hz as a doublet, H-6 exhibited a doublets of doublet (J 
value = 8, 2 Hz) signal due to being coupled to both H-5, and H-2. COSY, NOESY and 
HMBC correlations are shown in Figure 3.23.  
 
                      
            Figure 3.23 Salient signals of caffeic acid  
COSY (bold line), NOESY (dot arrow), and HMBC (arrow) 
 
                          
                            
 Figure 3.24 Coupling patterns of a 3, 4-disubstituted phenyl ring (
1
H NMR, 500 MHz; in 
CD3OD)   
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 Caffeic acid has previously been reported in S. viridis L. (Kokkalou and Kapetanidis, 
1988). It has commonly been found in other Salvia species (Lu and Foo, 2002), and in dietary 
sources such as orange, grape, berry, kiwi, and olives (Robbins, 2003). 
 
Table 3.7 1D and 2D NMR data of caffeic acid (
1
H, 500 MHz; 
13
C, 125 MHz; in CD3OD; δ 
in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 127.8 - - - 6.20 
6.77 
7.51 
2 115.1 7.03 (d, J = 2) - 6.20 
7.51 
6.93 
7.51 
3 146.9
§
 - - - 6.77 
6.93 
7.03 
4 149.4
§
 - - - 6.20 
7.51 
5 116.5 6.77 (d, J = 8) 6.93 6.93 6.93 
6 122.8 6.93 (dd, J = 8, 2) 6.77 6.20 
6.77 
7.51 
6.77 
7.03 
7.51 
7 146.8 7.51 (d, J = 16) 6.20 6.20 6.77 
6.93 
7.03 
8 115.7 6.20 (d, J = 16) 7.51 7.51 6.93 
7.51 
9 171.1 - - - - 
§
Interchangeable 
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3.6.1.2 Trans-verbascoside 
 Verbascoside or acteoside (Figure 3.25) was identified by 1D and 2D NMR spectra 
and by comparing its NMR spectra to previous reports (Andary et al., 1982; Owen et al., 
2003; Li et al., 2005). The structure of verbascoside (or acteoside) is comprised of caffeic 
acid, a dihydroxy-phenylethyl part, and saccharides i.e., glucose and rhamnose. All 1D and 
2D NMR data are given in Table 3.8.  
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 Figure 3.25 Verbascoside (or acteoside) 
 
Aromatic protons from the caffeic acid and dihydroxyphenylethyl parts resonated at 
6-8 ppm as seen in Figure 3.26. Signals of H-2 and H-5 showed splitting pattern as doublet 
with coupling constant 1.6 and 8 Hz respectively while signal of H-6 was doublet of doublet 
with coupling constant 8 and 1.6 Hz. Although the splitting patterns of aromatic protons from 
the caffeic acid and the dihydroxyphenylethyl part were similar, the aromatic protons of 
caffeic acid resonated slightly more downfield due to the conjugated double bond of the side 
chain. According to H-H COSY spectrum (Appendix 2.2), there were correlations between 
H-7' and H-8' of the caffeic acid moiety, and they were coupled to each other with Jtrans 16 
Hz.   
      
            
              Figure 3.26 
1
H NMR expansion of verbascoside (400 MHz; CD3OD) 
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Table 3.8 1D and 2D NMR data of trans-verbascoside (
1
H 400 MHz; 
13
C 100 MHz in 
CD3OD; δ in ppm; J in Hz) 
Position 
13
C 
1
H   
 
COSY NOESY HMBC 
1 131.4 - - - 2.78 
3.70 
4.05 
6.68 
2 117.1 6.69 (d, J = 1.6) 6.56 - 2.78 
6.56 
3 146.1
§
 - - - 6.68 
4 144.6
§
 - - - 6.56 
6.69 
5 116.3 6.68 (d, J = 8) 6.56 - - 
6 121.2 6.56 (dd, J = 8, 1.6) 6.68 
6.69 
- 2.78 
6.68 
6.69 
7 36.5 2.78 (2H, m) 3.70 
4.05 
 
3.70 
4.05 
6.56 
6.69* 
6.56 
6.69 
8 
 
72.2 3.70 (m) 
 
2.78 
4.05 
2.78 2.78 
4.38 
4.05 (m) 2.78 
3.70 
2.78 
1' 127.6 - - - 6.29 
6.78 
7.60 
2' 115.2 7.05 (d, J = 2) 6.95 - 6.95 
7.60 
3' 146.8
¶
 - - - 6.78 
7.05 
4' 149.7
 ¶
 - - - 6.78 
6.95 
7.05 
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Table 3.8 (continued)    
Position 
13
C 
1
H   
 
COSY NOESY HMBC 
5' 116.5 6.78 (d, J = 8.2) 6.95 - 6.95 
7.60 
6' 123.2 6.95 (dd, J = 8.2, 2) 7.05 
6.78 
 
- 6.78 
7.05 
7.60 
7' 148.0 7.60 (d, J = 16) 6.29 6.29
†
 
 
6.95 
7.05 
8' 114.7 6.29 (d, J = 16) 7.60 7.60
†
 
 
7.60 
9' 168.3 - - - 4.91 
6.29 
7.60 
1g 104.2 4.38 (d, J = 7.8) 3.38 - 3.38 
3.70 
2g 76.2 3.38 (t, J = 9) 4.38 
3.81 
- 3.53* 
3.81 
3g 81.6 3.81 (t, J = 9) 4.91 
3.38 
5.18 3.38 
5.18 
4g 70.5 4.91 (t, J = 9) 3.81* 
3.53* 
- 3.53* 
3.81 
5.18 
5g 76.0 3.53* (m) 4.91 
3.64* 
3.56* 
- 3.81 
6g 60.9 3.49 (m) 
3.64 (m) 
3.53* - - 
1r 103.0 5.18 (s) 3.91 3.91 
3.81 
3.81 
2r 72.3 3.91 (d, J = 1.6) 5.18 5.18 3.29* 
5.18 
3r 72.0 3.58* (m) 3.56* 
3.29 
- 3.29* 
5.18 
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Table 3.8 (continued)    
Position 
13
C 
1
H   
 
COSY NOESY HMBC 
4r 73.8 3.29* (m) 3.58* 
3.56* 
1.09 1.09 
3.91 
5r 70.4 3.56* (m) 3.29* 
1.09* 
1.09 1.09 
5.18 
6r 18.4 1.09 (3H, d, J = 6.2) 3.56* 3.56* 
3.29 
3.29* 
* Overlapped signal; 
§ ¶ 
Interchangeable  
 † 
Coupling constant shows that these protons are trans with respect to each other. NOESY 
interaction may be an artefact. 
g-glucose; r-rhamnose 
  
O
HO
HO
OH
OH
OH
1g3g
6g
4g
H
H
               
A. β-Glucose 
 
O
HO
HO
OH
H
OH
1g3g
6g
4g
HO
H
                  
       B. α-Glucose 
                                Figure 3.27 β- and α-Configurations of D-glucose* 
*Optical rotation and chiral NMR were not obtained, D-glucose commonly occurs (Dewick, 
2009).  
 
A downfield shift of glucose proton of H-4g, a triplet signal with coupling constant 
9.3 Hz at δ 4.91 ppm was due to caffeic acid substitution. The anomeric glucose proton gave 
a doublet signal at δ 4.38 ppm with vicinal coupling 7.8 Hz that indicated axial, axial bond 
angle 180º between H-1g and H-2g as shown in Figure 3.27A. Therefore, the configuration of 
glucose is the β-anomer. 
Ha-1g
OH
Ha-2g
OH
180° 
60° 
OH
He-1g
Ha-2g
OH
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The methyl protons of rhamnose showed a conspicuous signal in the alkane region at 
δ 1.09 ppm as a doublet while the anomeric proton (H-1r) resonated at δ 5.18 ppm as a broad 
singlet. Many findings have reported the splitting pattern of the anomeric rhamnose proton as 
a doublet with a small coupling constant (1-1.8 Hz) (Andary et al., 1982; Owen et al., 2003; 
Li et al., 2005). According to the Karplus equation, a small vicinal coupling constant of H-1r 
and H-2r indicated a dihedral angle about 60º between them. Both α-, and β-anomers of 
rhamnose would give a small coupling constant as shown in Figure 3.28. However, NOESY 
showed that the anomeric rhamnose proton was close in space to both H-3g and H-2r, and 
examination of models suggested that rhamnose was present as the α-anomer (Figure 3.28A, 
and 3.29).  
             
HO
O
OH
HO
HO
H3C
1r
6r
2r
H
H
                  
A. α-Rhamnose                     
                         
H
O
OH
HO
HO
H3C
1r
6r
2r
OH
H
                   
   B. β-Rhamnose                                       
                                    Figure 3.28 α- and β-Configurations of L-rhamnose* 
*Optical rotation and chiral NMR were not obtained, L-rhamnose commonly occurs 
(Dewick, 2009).  
 
                                             Figure 3.29 Selected NOESY correlations 
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The coupling pattern of H-2r and H-3r were characteristic of rhamnose besides the 
doublet of methyl proton. H-2r is β-equatorial orientation; therefore, its coupling constants 
between H-1r (Jee), and H-3r (Jea), would be small around 2-5 Hz (Williams and Fleming, 
2008). The observed coupling constants of H-2r were 3, and 1.6 Hz which should result in the 
dd pattern but it could likely be seen as broad singlet as shown in Figures 3.31. On the other 
hand, the coupling pattern of H-3r with β-axial orientation would be dd because it was 
coupled to H-4r, and H-2r with 
3
Jaa, and 
3
Jae respectively. The expected coupling constant 
should be around 9-13 Hz (H-3r and H-4r, Jaa) and 2-5 HZ (H-3r and H-2r, Jae) (Williams and 
Fleming, 2008), but H-3r of verbascoside was overlapped by other sugar peaks as shown in 
Figure 3.31. H-2g is typically a triplet with 
3
J value 9 Hz in the β-anomer configuration from 
glucose.  
 
   
Figure 3.30 Coupling constants of H-2r and H-3r 
 
 Figure 3.31 
1
H NMR expansion in sugar region of verbascoside (400 MHz; CD3OD) 
H-1g 
H-2r 
H-3g 
H-8a H-8b 
H-5g, H-6g 
H-3r, H-5r 
(Overlapped) 
H-2g 
H-4r 
(overlapped) 
H-7 
OH
H1rO
OH
C1 H2r
OH
C1 H2r
H3r
OHC4
H3r
OHC2
H4r
C6 OH
3
Jee ~ 2-5 Hz 
3
Jae ~ 2-5 Hz 
3
Jaa ~ 9-13 Hz 
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A cross peak of the anomeric rhamnose proton from H-H COSY (Figure 3.32) 
indicated a signal of H-2r at δ 3.91 ppm. The anomeric glucose proton was correlated to peak 
at δ 3.38 ppm which was a signal of H-2g. H-4g was correlated to two peaks at δ 3.81 ppm 
and δ 3.53 ppm, and the former had a cross peak with H-2g. Therefore, this triplet peak at δ 
3.81 ppm must be H-3g. The signal of H-7 at δ 2.78 ppm related to two signals of H-8 at δ 
3.70 ppm, and δ 4.05 ppm. These two proton of H-8 were correlated to each other as seen in 
H-H COSY (Figure 3.32). Moreover, HMQC indicated one signal of C at δ 72.2 ppm that 
matched those two signals of H-8 at δ 3.70 ppm, and 4.05 ppm.  HMQC also showed the two 
protons with different chemical shifts of methylene group at glucose H-6g attached to one 
carbon at 60.9 ppm.   
 
 
Figure 3.32 Selected H-H COSY correlations  
 
Chemical shifts of carbon can be assigned by HMQC and HMBC. 
13
C spectra 
(Appendix 2.3) indicated 29 signals of carbon with three signals of CH2 and seven signals of 
quarternary carbon. Three quaternary carbon atoms belonged to the dihydroxyphenylethyl 
moiety, namely C-1, C-3, and C-4, and can be assigned by HMBC. There were three signals 
at δ 131.4 ppm, 144.6 ppm, and 146.1 ppm that were correlated to other protons in this 
moiety. The HMBC of H-7 involved four signals at δ 131.4 ppm, 121.2 ppm, 117.1 ppm, and 
72.2 ppm, therefore, quaternary carbon C-1 must be a signal at δ 131.4 ppm. C-3 resonated at 
δ 146.1 ppm because of a weak correlation in HMBC between this signal and proton at H-6. 
Accordingly, C-4 was a signal at δ 144.6 ppm, however, these two signals of C-3 and C-4 
may be interchangeable.  
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                                                                    (A) 
 
                                                                                 (B) 
 
Figure 3.33A-B Selected HMBC correlations  
 
The other quaternary carbon signals were at δ 127.6 ppm, 146.8 ppm, 149.7 ppm, and 
168.3 ppm and belonged to the caffeic acid group. HMBC correlated a signal at δ 168.3 ppm 
to three proton of H-7', H-8', and H-4g, consequently, this was a downfield signal of carbonyl 
carbon. A signals of C-1' at δ 127.6 ppm had a strong correlation to H-7', H-8', H-5' while a 
weak HMBC correlation between a signal at δ 146.8 ppm and H-6' indicated C-3', and then 
C-4' resonated at δ 149.7 ppm. However, the signals of C-3' and C-4' may be interchangeable.  
 
Verbascoside can be classified according to its structure as a phenylethanoid 
glycoside (Jimenez and Riguera, 1994) or as a phenylpropanoid (Kurkin, 2003). Ellis (1983) 
reported that phenylalanine was the main precursor of the caffeic acid moiety while the 
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dihydroxyphenylethanol moiety was derived from either tyrosine or tyramine in cell cultures 
of Syringa vulgaris L. provided with various radioactive precursors as a starter to synthesize 
verbascoside.  
 
Verbascoside is widely distributed in plants from a variety of families such as 
Lamiaceae, Plantaginaceae, Oleaceae. This is however, the first report of its occurrence in the 
genus Salvia. Its bioactivities have been extensively studied as shown in Table 3.9. As can be 
seen, many and various activities have been assigned to this compound including radical 
scavenging and metal chelating activities. For example, the Fenton reaction was used to 
induce DNA damage by generating hydroxyl radical (OH·) from hydrogen peroxide and 
metal ion (either Fe(II), or Fe(III)) In the presence of verbascoside, DNA damage was 
inhibited, possibly due to the complex between verbacoside and metal ion (Zhao et al., 2005). 
Besides Fe(II) or Fe(III),  Kang et al. (2003b) suggested that verbascoside might chelate the 
zinc ion of Angiotensin Converting Enzyme (ACE), resulting in an inhibitory effect. 
 
A comparison of cytotoxic activity of phenylpropanoid glycosides against cancer cell 
lines was reported by Saracoglu et al. (1995). The authors suggested the ortho-dihydroxy 
aromatic systems were responsible for the cytotoxic and cytostatic activities because 
leucosceptoside A, and martynoside were inactive against all tested cell lines. Verbascoside 
showed appreciable IC50 values of 0.99 µM and 0.47 µM against rat hepatoma, and sarcoma 
respectively. It also inhibited human epithelial carcinoma cell growth with IC50 0.13 µM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  - 114 - 
Table 3.9 Biological activities of verbascoside  
 
Activity 
 
Source of verbascoside Reference 
Cytoprotective against  
UV-C induced necrosis 
Syringa vulgaris L., Oleaceae Kostyuk et al., 2008; 
Pastore et al., 2009 
Antioxidant  Orobanche caerulescens Steph., 
Orobanchaceae  
Chiou et al., 2004 
Plantago bellardii All., 
Plantaginaceae 
Galvez et al., 2005 
Caryopteris incana (Thunb.) 
Miq., Verbenaceae 
Gao et al., 1999 
Antibacterial activity Verbascum sinuatum L., 
Scrophulariaceae 
Senatore et al., 2007 
Buddleja cordata Kunth, 
Loganiaceae 
Avila et al., 1999 
Protection of DNA damage 
by radicals from Fenton 
reaction 
Pedicularis striata Pall, 
Scrophulariaceae 
 
Zhao et al., 2005  
Anti-inflammatory activity Scrophularia scorodonia L., 
Scrophulariaceae 
Diaz et al., 2004 
Plantago lanceolata L., 
Plantaginaceae 
Murai et al., 1995 
Forsythia viridissima Lindley, 
Oleaceae 
Kimura et al., 1987 
Anti-hepatotoxic activity 
against carbon tetrachloride 
Buddleia officinalis Maxim., 
Loganiaceae 
Lee et al., 2004 
Cistanche deserticola Y.C. Ma, 
Orobanchaceae 
Xiong et al., 1998 
Angiotensin converting 
enzyme (ACE) inhibition 
Clerodendron trichotomum 
Thunb., Verbenaceae 
Kang et al., 2003b 
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Table 3.9 (Continued)   
Activity 
 
Source of verbascoside Reference 
Cardioactivity Eremophila alternifolia R. Br., 
Myoporaceae 
Pennacchio et al., 1999 
Inhibitor of protein kinase C Lantana Camara L., 
Verbenaceae 
Herbert et al., 1991 
Cytotoxic Phlomis armeniaca Willd, and  
Scutellaria salviifolia Bentham, 
Labiatae 
Saracoglu et al., 1995; 
Inoue et al., 1998 
Castilleja linariaefolia Benth., 
Scrophulariaceae 
Pettit et al., 1990 
Inhibition of oxidative 
hemolysis of erythrocytes 
Pedicularis striata Pall, 
Scrophulariaceae 
Ji et al., 1993 
Aldose reductase inhibition Plantago asiatica L., 
Plataginaceae 
Ravn et al., 1990 
Phytoalexin and antibacterial 
activity 
Rehmannia glutinosa var. 
purpurea Makino, Phrymaceae 
Shoyama et al., 1987 
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3.6.1.3 Cis-verbascoside 
 The HPLC chromatogram in Figure 3.21 shows a shoulder on the peak of trans-
verbascoside at retention time 11.2 min. This was separately collected and further identified 
as a mixture of trans- and cis-verbascoside by NMR and HR-ESI-MS spectroscopic data, and 
also by comparison with previous published literature (Nishimura et. al, 1991). NMR spectra 
exhibited 2 sets of signals, however, certain dissimilar signals were observed. Two pairs of 
doublets were individually coupled to each other with coupling constant 16 Hz, and 12.8 Hz. 
The first pair, δ 6.29 and 7.60 ppm, showed 3J value 16 Hz and also correlated to aromatic 
signals of the caffeic acid moiety as described in trans-verbascoside. The second pair, δ 5.75 
ppm and 6.86 ppm, exhibited 
3
J value 12.8 Hz, and showed the same correlation pattern to 
certain aromatic signals as the trans-isomer. The dihedral angle of vicinal trans protons is 
180°, and the cis protons was 0° as shown in Figure 3.34.  
                                            
                               Figure 3.34 Vicinal coupling constant of trans- and cis isomer 
  
The coupling constant of 180° dihedral angle is normally around 11-18 Hz while the 
coupling constant of 0° dihedral angle is approximately 6-15 Hz (Pavia et al., 2009). The 
observed coupling constant of cis- isomer at 12.8 Hz accorded with previous findings for cis-
verbascoside (Nishimura et al., 1991; Budzianowski and Skrzypczak, 1995).  
 
The cis double bond affected the chemical shifts of protons in caffeic acid moiety 
particularly H-2'. It was deshieled at δ 7.52 ppm in cis isomer while it was at δ 7.05 ppm in 
trans. The arrangement of cis-configuration may cause the downfield chemical shift of H-2' 
by an anisotropic effect of the carbonyl group as shown in Figure 3.35. In addition to the 
change of coupling constant, the cis isomer showed a substantial upfield shift of both alkene 
protons to values more closely resembling the alkene in a non-aromatic system. This may be 
because steric hindrance of the bulky sugar moieties forces the aromatic group out of a 
conformation in which the whole cinnamoyl group can be coplanar. All HMBC, COSY, and 
NOESY correlations were the same as trans-verbascoside as described above. NMR data 
comparison between trans- and cis-isomers are given in Table 3.10. NMR spectra of cis-
isomer are presented in Appendix 3.  
180° 
0° 
3J trans ~ 11-18 Hz 
Hb
Ha
Hb
Ha
3J cis ~ 6-15 Hz 
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Table 3.10 NMR data of trans- and cis-verbascoside (
1
H, 400 MHz; 
13
C, 100 MHz; in 
CD3OD; δ in ppm; J in Hz) 
Moiety Position Trans-verbascoside Cis-verbascoside 
δC δH δC  δH  
Dihydroxyp
henyl ethyl 
1 131.4 - 131.4 - 
2 117.1 6.69 (d, 1.6) 116.3 6.69 (d, 2) 
3 146.1
a
 - 146.1
c
 - 
4 144.6
a
 - 144.6
c
 - 
5 116.3 6.68 (d, 8) 116.5 6.73 (d, 8.2) 
6 121.2 6.56 (dd, 8, 1.6) 121.2 6.55 (dd, 8.2, 2) 
7 36.5 2.78 (2H, m) 36.6 2.77 (2H, m) 
8 72.2 3.70 (m) 73.9 3.70 (m) 
4.05 (m) 4.02 (m) 
Caffeic acid 1' 127.6 - 128.0 - 
2' 115.2 7.05 (d, 2) 119.0 7.52 (d, 1.5)  
3' 146.8
b
 - 146.8
d
 - 
4' 149.7
b
 - 149.7
d
 - 
5' 116.5 6.78 (d, 8.2) 115.2 6.77 (d 8.2) 
6' 123.2 6.95 (dd, 8.2, 2)  125.9 7.09 (dd, 8.2, 2)  
7' 148.0 7.60 (d, 16) 148.6 6.86 (d, 12.8) 
8' 114.7 6.29 (d, 16) 114.7 5.75 (d, 12.8) 
9' 168.3 - 168.3 - 
Glucose 1g 104.2 4.38 (d, 7.8) 104.1 4.34 (d, 7.8)  
2g 76.2 3.38 (t, 9) 76.1 3.35 (t, 8.2) 
3g 81.6 3.81 (t, 9) 81.9 3.76 (t, 9.4) 
4g 70.5 4.91 (t, 9) 70.6 4.92* 
5g 76.0 3.53*  76.0 3.53* 
6g 60.9 3.49* 62.3 3.49* 
3.64* 3.64* 
Rhamnose 1r 103.0 5.18 (s) 103.1 5.16 (s) 
2r 72.3 3.91 (d, 1.6) 72.3 3.92 (br s) 
3r 72.0 3.58*  72.0 3.58*  
4r 73.8 3.29* (m)  73.9 3.32* (m)  
5r 70.4 3.56* 70.4 3.56* 
6r 18.4 1.09 (3H, d, 6.2)  18.2 1.16 (3H, d, 6.2) 
*Overlapped signal; 
a, b, c, d
 Interchangeable 
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      Figure 3.35 Salient chemical shifts of cis-verbascoside 
 
On the basis of the integrals of the alkene protons, the cis isomer comprised about 
67% of the mixture (
1
H NMR spectra ratio cis:trans, 2:1; Appendix 3.1). Previous published 
literature reported the ratio of cis:trans content as 1:9 (Nishimura et al., 1991), and 1:6 
(Budzianowski and Skrzypczak, 1995). Cis-isomer was suggested to be converted to trans-
isomer in daylight (Nishimura et al., 1991).  
 
In the present study, the conversion of trans- to cis-isomer was observed under UVA 
(wavelength 350-400 nm) light at 500 kJ/m
2
. This UVA intensity is equivalent to the amount 
on a cloudless summer day around noon at a northern latitude of 30-35º (Frederick and 
Lubin, 1988). Result showed trans-isomer was able to convert to cis-isomer at amount of 
approximately 30% under this condition as shown in Figures 3.37-3.38. UVA can cause the 
transition of an electron from the ground state to the excited state of the olefinic bond and 
initiate the radicals as shown in Figure 3.36. Then, the rotation of this single bond followed 
by reformation of the double bond results in the cis-configuration.  
 
Whist it is clearly possible that cis-derivatives may arise by photoisomerisation, 
recent studies have demonstrated that in the biosynthesis of coumarins in Cassava, trans→cis 
isomerisation of cinnamic acid intermediate involves a non-light dependent, enzymic process 
(Bayoumi et al., 2008). Therefore, cis-verbascoside may not be an artifact of the isolation 
process. 
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Trans-isomer                                                                                                  Cis-isomer 
   
                 Figure 3.36 The conversion of trans- to cis-isomer by UVA 
 
    Figure 3.37 
1
H NMR spectra of trans-verbascoside (400 MHz; CD3OD) before irradiation 
 
 
Figure 3.38 
1
H NMR spectra of a mixture of trans- and cis-verbascoside (400 MHz; CD3OD) 
after irradiation by UVA light. 
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3.6.1.4 Leucosceptoside A 
The MS of leucosceptoside A (C30H38O15; Figure 3.39) showed a molecular mass 14 
mass units greater than verbascoside 
1
H and 
13
C NMR data are shown in Table 3.11 and 
NMR data are given in Appendix 4. 
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                                                    Figure 3.39 Leucosceptoside A 
 
  Both 
1
H and 
13
C signals resonated in the same pattern as verbascoside but this 
compound showed an additional 3H singlet at δ 3.89 ppm in the 1H NMR spectrum 
(Appendix 4.1), and an extra carbon signal at δ 56.5 ppm in the 13C spectrum (Appendix 4.3). 
This singlet exhibited a NOESY correlation to H-2' at δ 7.20 ppm, and also a HMBC cross 
peak to C-3' at δ 149.5 ppm of acyl moiety as shown in Figure 3.40. Therefore, the methoxyl 
group was likely substituted at C-3' which referred to a ferulic acid acyl group instead of 
caffeic acid.  Verbascoside with a feruloyl moiety is known as leucosceptoside A. The 
configurations of glucose and rhamnose moieties were the same as verbascoside as described 
above. 
 
          
 
                        Figure 3.40 Certain salient signals of leucosceptoside A  
                      H-H COSY (bold line), NOESY (dot arrow), HMBC (arrow)  
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Table 3.11 1D and 2D NMR data of leucosceptoside A (
1
H, 500 MHz; 
13
C, 125 MHz; in 
CD3OD; δ in ppm; J in Hz) 
Position 
 
13
C 
1
H COSY NOESY HMBC 
1 131.5 - - - 2.82 
6.66 
6.69 
2 117.1 6.69 (d, J = 2 ) - - 2.78 
6.56 
3 146.2 - - - 6.66 
6.69 
4 144.5 - - - 6.56 
6.69 
5 116.3 6.66 (d, J = 8) 6.56 6.56 6.56 
6 121.3 6.56 (dd, J = 8, 2.5) 6.66 6.66 2.78 
6.69 
7 36.6 2.78 (2H, m) 3.75* 
4.05 
3.75* 
4.05 
6.56 
6.69 
8 72.3 3.75* (m) 2.78 
4.05 
2.78 2.78 
4.37 
4.05 (m) 2.78 
3.75* 
2.78 
3.75* 
1' 127.7 - - - 6.35 
6.80 
2' 111.8 7.20 (d, J = 2) - 3.89 7.07 
7.64 
3' 149.5 - - - 3.89 
6.80 
7.20 
4' 150.9 - - - 6.80 
7.07 
7.20 
5' 116.5 6.80 (d, J = 8) 7.07 7.07 - 
6' 124.4 7.07 (dd, J = 8, 2) 6.80 6.80 7.20 
7.64 
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Table 3.11 (continued)
 
   
Position 
 
13
C 
1
H COSY NOESY HMBC 
7' 147.9 7.64 (d, J = 16) 6.35 6.35 7.07 
7.20 
8' 115.1 6.35 (d, J = 15.5) 7.64 7.64 7.64 
9' 168.2 - - - 4.91 
6.35 
7.64 
1g 104.2 4.37 (d, J = 8) 3.40 - 3.40 
2g 76.2 3.40 (t, J = 9) 4.37 - 3.82 
4.91* 
3g 81.5 3.82* (t, J = 9) 3.40 
4.91* 
- 3.40 
4.91* 
5.20 
4g 70.7 4.91* 3.54* 
3.82* 
3.54* 3.54* 
3.82* 
5.20 
5g 76.1 3.54* (m) - - 4.91* 
6g 62.4 3.64* (m) 3.54* * 4.91* 
3.54* (m) 3.64* * 
1r 103.0 5.20 (br s, J = 1.5 ) 3.91 3.82* 
3.91 
3.82* 
2r 72.4 3.91 (dd, J = 3.5, 2) 5.20 5.20 5.20 
3r 72.1 3.56* (m) - - 5.20 
4r 73.8 3.30* (m) - - 1.09 
3.59* 
5r 70.4 3.59* (m) - - 1.10 
6r 18.4 1.09 (d, J = 6) 3.59* 3.59* 3.30* 
3'-
OCH3 
56.5 3.89 (3H, s) - 7.20 - 
*Overlapped signal; g- glucose; r-rhamnose 
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                                 Figure 3.41 Selected HMBC correlations of leucosceptoside A 
 
Leucosceptoside A has not been reported from the genus Salvia before. It was 
reported together with verbascoside and/or martynoside in Clerodendron trichotomum 
Thunb. (Kim et al., 2001). Leucosceptrum japonicum (Miq.) Kitamura et Murata (Miyase et 
al., 1982), Sideritis perfoliata L. subsp. perfoliata (Charami et al., 2008), Lippia canescens 
Kunth (Abe et al., 2002), and Plantago asiatica L. (Miyase et al., 1991).  
 
 
3.6.1.5 Martynoside 
The MS of martynoside (C31H40O15; Figure 3.42) showed a molecular mass 14 mass 
units greater than leucosceptoside A. 
1
H and 
13
C NMR data are shown in Table 3.12 and 
NMR spectra are given in Appendix 5. 
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             Figure 3.42 Martynoside 
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Table 3.12 1D and 2D NMR data of martynoside (
1
H, 500 MHz; 
13
C, 125 MHz; in CD3OD;  
δ in ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 132.9 - - - 2.82 
6.83 
2 117.1 6.74 (d, J = 2 ) - - 2.82 
3 147.4 - - - 3.81 
6.68 
6.74 
6.83 
4 147.6 - - - 3.81 
6.68 
6.74 
6.83 
5 112.9 6.83 (d, J = 7.5) 6.68 3.81 
6.68 
- 
6 121.1 6.68 (dd, J = 8, 2.5) 6.83 6.83 2.82 
6.74 
6.83 
7 36.6 2.82 (2H, m) 3.75 
4.08 
3.75 
4.08 
6.74 
8 72.1 3.75 (m) 2.82 2.82 2.82 
4.37 4.08 (m) 2.82 
3.75 
2.82 
3.75 
1' 127.6 - - - 6.35 
6.80 
2' 111.8 7.19 (d, J = 2) - 3.89 7.07 
7.64 
3' 149.4 - - - 3.89 
6.80 
7.19 
4' 151.0 - - - 6.80 
7.07 
7.19 
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Table 3.12 (continued)
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
5' 116.5 6.80 (d, J = 8) 7.07 7.07 - 
6' 124.4 7.07 (dd, J = 8, 2) 6.80 6.80 7.19 
7.64 
7' 147.9 7.64 (d, J = 16) 6.35 6.35 7.07 
7.20 
8' 115.1 6.35 (d, J = 16) 7.64 7.64 - 
9' 168.2 - - - 4.88 
6.35 
7.64 
1g 104.2 4.37 (d, J = 8) 3.40 - 3.40 
2g 76.2 3.40 (t, J = 9) 4.37 - 3.84 
4.88* 
3g 81.5 3.84* (t, J = 6) 4.88* - 3.40 
5.20 
4g 70.4 4.88* 3.84* - 3.84 
5.20 
5g 76.1 3.53* (m) - - 3.84* 
4.88* 
6g 62.4 3.64* (m) 3.53* * 4.88* 
3.53* (m) 3.64* * 
1r 103.0 5.20 (br s, J = 2 ) 3.92 3.84* 
3.92 
3.84* 
2r 72.4 3.92 (dd, J = 3, 1.5) 5.20 5.20 5.20 
3r 72.1 3.56* (m) - - 5.20 
4r 73.8 3.29* (m) - - 1.10 
5r 70.6 3.59* (m) - - 1.10 
6r 18.4 1.10 (d, J = 6) 3.59* 3.59* 3.29* 
4-OCH3 56.5 3.81 (3H, s) - 6.83  
3'-
OCH3 
56.4 3.89 (3H, s) - 7.19  
*Overlapped signal; g-glucose; r-rhamnose 
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1
H and 
13
C NMR spectra of martynoside show similar signals to verbascoside except 
two 
1
H singlet signals at δ 3.81 ppm and 3.89 ppm each integration to three protons. HMQC 
correlated these two singlets to 
13C signals at δ 56.5 ppm and 56.4 ppm respectively. 
Therefore, this compound was likely to be a verbascoside derivative substituted with two 
methoxyl groups.  
 
There was no HMBC or NOESY correlation between these two methoxyl groups 
which suggests the substitution of different aromatic rings. Figures 3.43-3.44 show salient 
correlations of martynoside. HMBC correlated a singlet at δ 3.81 ppm to 13C at 147.4 ppm 
(C-3), and 147.6 ppm (C-4), and also had a NOESY correlation to a doublet signal at δ 6.83 
ppm (H-5). While the other singlet at δ 3.89 ppm had a NOESY cross peak to 1H signal at δ 
7.19 ppm (H-2') of the caffeoyl moiety. Due to the methoxyl substitution, both C-5 
(dihydroxyphenylethyl moiety), and C-2' (caffeoyl moiety) resonated more upfield at δ 112.9 
ppm, and 111.8 ppm respectively in comparison with verbascoside at δ 116.3 ppm (C-5), and 
115.2 ppm (C-2'). This compound was thus assigned as martynoside. Structure elucidation of 
martynoside, e.g. sugar configulations and coupling patterns, was similar to verbascoside as 
described above.  
 
 
 
Figure 3.43 Salient signals of martynoside  
COSY (bold line), NOESY (dot arrow), and HMBC (arrow) 
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           Figure 3.44 Selected HMBC correlations of martynoside 
 
Martynoside has not been reported in the genus Salvia before but it was previously 
isolated from other genera in the family Lamiaceae, for example Leucosceptrum japonicum 
(Miq.) Kitamura et Murata (Miyase et al., 1982), Ballota nigra L. (Toth et al., 2007), and 
Sideritis perfoliata L. subsp. perfoliata (Charami et al., 2008) and  from Verbenaceae family, 
Lippia dulcis Trev. (Abe et al., 2002), Clerodendron trichotomum Thunb. (Kim et al., 2001), 
and also from Plantaginaceae, Plantago asiatica L. (Miyase et al., 1991). Its spectroscopic 
data are comparable to those described in the literature.  
 
 
3.6.1.6 Rosmarinic acid 
Rosmarinic acid (C18H16O8; Figure 3.45) was identified by comparison of its NMR 
spectra with literature values and an authentic sample. 
1
H and 
13
C NMR data are given in 
Table 3.13 and NMR spectra are shown in Appendix 6.  
                              
O
O
HO
HO
COOH
OH
OH
3 1
4
7
4 '2 '
1'
7 '
9 '
8 '9
8 6 '
3 '
5
2
6
5 '
 
Figure 3.45  Rosmarinic acid 
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Table 3.13 1D and 2D NMR data of rosmarinic acid (
1
H, 500 MHz; 
13
C, 125 MHz; in 
CD3OD; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 128.0 - - - 6.25 
6.75 
2 115.1 7.02 (d, J = 2) - 6.25 
7.48 
6.91 
7.48 
3 146.7 - - - 6.75 
6.91 
7.02 
4 149.3 - - - 6.75 
6.91 
7.02 
5 116.4 6.75 (d, J = 8) 6.91 6.91 6.91 
6 122.9 6.91 (dd, J = 8, 2) 6.75 6.25 
6.75 
7.48 
6.75 
7.02 
7.48 
7 146.5 7.48 (d, J = 16) 6.25 6.25 
6.91 
7.02 
6.75 
7.02 
8 115.8 6.25 (d, J = 15.5) 7.48 6.91 
7.02 
7.48 
6.91 
9 169.1 - - - 5.07 
6.25 
7.48 
1' 131.3 - - - 2.92 
3.08 
5.07 
6.65 
2' 117.5 6.76 (d, J = 2) - 5.07 2.92 
3.08 
6.63 
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Table 3.13 (continued)
    
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
3' 146.0 - - - 6.65 
4' 144.8 - - - 6.63 
6.76 
5' 116.2 6.65 (d, J = 8) * * - 
6' 121.7 6.63 (dd, J = 8, 2) * * 2.92 
3.08 
6.76 
7' 38.9 2.92 (dd, J = 14, 10) 3.08 3.08 
5.07 
6.63 
6.76 
3.08 (dd, J = 14, 3) 2.92 2.92 
5.07 
8' 77.8 5.07 (dd, J = 10, 3) 2.92 
3.08 
2.92 
3.08 
2.92 
9' 177.5 - - - 2.92 
5.07 
* Overlapped signal 
  
 
There were 18 signals of 
13
C NMR which distributed to nine methine groups, eight 
quaternary carbon atoms, and only one methylene group. 
1
H displayed 11 signals of alkane 
and aromatic protons. Two of them, δ 6.25 ppm and 7.48 ppm, exhibited the coupling 
patterns of the trans configuration protons with 
3
J value 16 Hz. Two sets of six signals were 
shown as 3,4-disubstituted coupling patterns the same as caffeic acid (Figure 3.24). There 
were three signals, δ 2.92 ppm, 3.08 ppm, and 5.07 ppm, which coupled to each other, and 
13C showed two corresponding signals of those three protons at δ 38.9 ppm (CH2), and 77.8 
ppm (CH). The downfield methylene atoms implied the attachment of an aromatic ring or an 
electronegative group. In addition, these methylene atoms had HMBC correlation to signals 
of aromatic protons at δ 6.63 ppm and 6.76 ppm. The molecular formula C18H16O8 was twice 
of caffeic acid plus the coupling patterns; therefore, this compound was identified as 
rosmarinic acid. Salient two dimensional correlations are shown in Figure 3.46. 
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Figure 3.46 Salient correlations of rosmarinic acid 
COSY (bold line), NOESY (dot arrow), and HMBC (arrow) 
 
Rosmarinic has never been reported in S. viridis L. before but it has been reported in 
other Salvia species, for example S. officinalis L. (Wang et al., 1998). It has also been found 
in families Boraginaceae, Cucurbitaceae, Rubiaceae, Araliaceae, and Plantaginaceae 
(Petersen and Simmonds, 2003). 
 
 
3.6.1.7 6-O-Caffeoyl-glucose 
The HR-ESI-MS of 6-O-caffeoyl-glucose (Figure 3.47) gave a molecular mass of 
342, consistent with the molecular formula C15H18O9. 
1
H and 
13
C NMR data are shown in 
Table 3.14 and NMR spectra are shown in Appendix 7. 
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                                              Figure 3.47  6-O-Caffeoyl-glucose 
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Table 3.14 1D and 2D NMR data of 6-O-caffeoyl-glucose (
1
H, 500 MHz; 
13
C, 125 MHz; 
CD3OD; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 127.7 - - - 6.25 
7.55 
2 115.1 7.04 (d, J = 2) - 6.25 
7.55 
6.77 
6.94 
7.55 
3 146.8 - - - 6.77 
6.94 
7.04 
4 149.6 - - - 6.77 
6.94 
7.04 
5 116.5 6.77 (d, J = 8.5) 6.94 6.94 6.94 
6 123.0 6.94 (dd, J = 8, 2) 6.77 6.25 
6.77 
7.55 
6.77 
7.04 
7.55 
7 147.1 7.55 (d, J = 16) 6.25 6.25 
6.94 
6.77 
6.94 
7.04 
8 114.9 6.25 (d, J = 16) 7.55 6.94 
7.04 
7.55 
6.94 
7.55 
9 169.2 - - - 4.30* 
4.43* 
6.25 
7.55 
1' 98.3
§
 1β  4.50 (d, J = 7.5) - 3.34* 
3.55* 
- 
94.0
§
 1α  5.10 (d, J = 4) 3.34* 3.34* - 
2' 71.8 3.34* (m) 5.10 4.50 
5.10 
3.55* 
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Table 3.14 (continued)
    
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
3' 74.8 3.65* (m) * * 3.34* 
5.10 
4' 73.8 3.38* * 4.43* 3.55* 
5' 75.5 3.55* (m) - 4.30* 
4.50 
4.30* 
6' 64.9 4.30* (m) 4.43 - 3.38* 
4.43* (m) 4.30* - 
*Overlapped signal; 
§
Interchangeable 
  
1
H NMR showed the aromatic signals of caffeic acid plus signals in the sugar 
region which from the molecular formula was likely to be a hexose unit. Two signals of 
anomeric protons were observed at δ 4.50 ppm (J value 7.5 Hz) and 5.10 ppm (J value 4 
Hz). The only methylene carbon at δ 64.9 ppm correlated to two protons at δ 4.30 and 
4.43 ppm which was somewhat deshielded compared to C-6 of a glucose unit of 
verbascoside at 60.9 ppm and 3.49/3.64 ppm. In addition, HMBC correlated a carbonyl 
carbon signal at δ 169.2 ppm to these methylene protons. Therefore, this compound was 
identified 6-O-caffeoyl-glucose with the free configuration of the anomeric proton. The 
free interconversion of the anomeric centre contributed to a highly complex spectrum for 
the sugar part of the molecule. All NMR data were similar to a previous finding (Gao et 
al., 1999). Selected salient signals are given in Figure 3.48. 6-O-Caffeoyl-glucose was 
reported from the whole plants of Caryopteris incana (Thunb.) Miq., family Verbenaceae 
(Gao et al., 1999). 
                                  
Figure 3.48 Selected correlations of 6-O-caffeoyl-glucose 
COSY (bold line), NOESY (dot arrow), and HMBC (arrow) 
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3.6.2 Flavonoid glycosides 
 The polar fractions also included a series of compounds with 
1
H NMR signals 
characteristic of flavone including a singlet for H-3 and finely coupled doublets for H-6 and 
H-8 in the aromatic/alkene region of the spectrum together with signals for a second aromatic 
ring. MS showed that these compounds fell into two molecular weight classes consistent with 
mono- and di-glycosides. All the diglycoside compounds showed NMR signals characteristic 
of the deoxyhexose, rhamnose. 
 
3.6.2.1 Luteolin-7-O-β-glucopyranoside 
The MS data of luteolin-7-O-β-glucopyranoside (Figure 3.49) gave a molecular mass 
of 448 and a molecular formula of C21H20O11. It was identified as luteolin-7-O-β-D-
glucopyranoside by comparison of its NMR data with an authentic standard. 
1
H and 
13
C NMR 
data are shown in Table 3.15 and NMR spectra are given in Appendix 8.   
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   Figure 3.49 Luteolin-7-O-β-glucopyranoside   
 
1
H NMR showed six signals in aromatic proton region with the ordinary doublet 
signal of the β-anomeric glucose proton at δ 5.06 ppm. 13C and DEPT-135 NMR displayed 21 
signals with nine signals of quaternary carbon, and only one methylene signal. The COSY, 
NOESY and HMBC correlations indicated two sets of aromatic protons in separate ring 
system typical of the flavone skeleton. Three of proton signals, δ 6.89 ppm (d), 7.41 ppm (br 
s), 7.47 ppm (dd), were observed in the same ring system by the HMBC, COSY, and NOESY 
correlations. The patterns of splitting indicated a 3, 4-disubstituted aromatic ring B of 
flavonoid. A finely coupled doublet at δ 6.44 ppm (J = 2 Hz) showed COSY cross correlation 
to a doublet signal at δ 6.78 ppm (J = 2 Hz). This correlation suggested two protons of H-6 
and H-8 respectively. A singlet proton signal at δ 6.74 ppm had HMBC correlations to 13C 
signals at δ 164.5 ppm and 181.9 ppm suggested the proton H-3 of flavone skeleton. 
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Table 3.15 1D and 2D NMR data of luteolin-7-O-β-glucopyranoside (1H, 500 MHz; 13C, 125 
Mz; DMSO-d6; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 - - - - - 
2 164.5 - - - 6.74 
7.47 
3 103.1 6.74 (s) - 7.41 
7.47 
- 
4 181.9 - - - 6.74 
5 161.1 - - - 6.44 
6 99.5 6.44 (d, J = 2) 6.78 5.06 6.78 
7 163.0 - - - 6.44 
6.78 
8 94.7 6.78 (d, J = 2) 6.44 5.06 6.44 
9 157.0 - - - 6.78 
10 105.3 - - - 6.44 
6.74 
6.78 
1' 121.3 - - - 6.89 
2' 113.6 7.41 (d, J = 2) - 6.74 7.47 
3' 145.8 - - - 6.89 
7.41 
4' 150.0 - - - 6.89 
7.41 
7.47 
5' 116.0 6.89 (d, J = 8) 7.47 7.43 - 
6' 119.2 7.47 (dd, J = 8.5, 2) 6.89 6.74 
6.89 
7.41 
1g 99.9 5.06 (d, J = 7.5) 3.28* 6.44 
6.78 
3.28* 
6.78 
2g 73.1 3.28* * * 3.31* 
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Table 3.15 (continued)
    
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
3g 76.4 3.31* * * 3.28* 
4g 69.6 3.18* * * 3.31* 
3.70 
5g 77.2 3.46* * * 3.49* 
6g 60.6 3.49* 3.70* * 3.18* 
3.70 3.49* 
*Overlapped signal; g-glucose 
 
 
    
 
 
Figure 3.50 Selected COSY (bold line), and NOESY (arrow) of luteolin-7-O-β-glucopyrano-
side 
 
The broad overlapped signals at 3-4 ppm may be cause by the hydroxyl groups of the 
sugar which are observed when using DMSO-d6 as solvent. The anomeric proton signal and 
one methylene group suggested a glucose containing compound. The β-anomeric glucose 
signal correlated to two proton signals at 6.44 ppm, and 6.78 ppm in NOESY revealing the 
attachment of glucose to the aglycone at C-7. All assignments were compared to previous 
literature (Siciliano et al., 2004).  
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Figure 3.51 HMBC correlation of luteolin-7-O-β-glucopyranoside  
 
This compound was previously reported in this plant (Kokkalou and Kapetanidis, 
1988), and also from many Salvia species (Lu and Foo, 2002).  
 
 
3.6.2.2 Luteolin-7-O-β-galactopyranoside 
 
The MS data of luteolin-7-O-β-galactopyranoside (Figure 3.52) gave a molecular 
mass of 448 and a molecular formula C21H20O11.  
1
H and 
13
C NMR data are shown in Table 
3.16 and NMR spectra are shown in Appendix 9. 
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   Figure 3.52 Luteolin-7-O-β-galactopyranoside  
 
This compound exhibited the same aromatic proton NMR signals as its isomer 
luteolin-7-glucoside. Unlike luteolin-7-glucoside, this compound dissolved in deuterated-
methanol; therefore, all sugar signals were clearly seen in 
1
H NMR.  
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Table 3.16 1D and 2D NMR data of luteolin-7-O-β-galactopyranoside (1H, 500 MHz; 13C, 
125 Mz; CD3OD; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 - - - - - 
2 166.9 - - - 6.60 
7.40 
7.42 
3 104.1 6.60 (s) - 7.40 
7.42 
- 
4 184.0 - - - 6.60 
5 162.9 - - - 6.50 
6 101.1 6.50 (d, J = 2) 6.79 5.06 6.79 
7 164.8 - - - 5.06 
6.50 
6.79 
8 96.0 6.79 (d, J = 2) 6.50 5.06 6.50 
9 159.0 - - - 6.79 
10 107.1 -  - 6.50 
6.60 
6.79 
1' 123.4 - - - 6.60 
6.89 
2' 114.2 7.40 (d, J = 2) 6.89 6.89 7.42 
3' 147.1 - - - 6.89 
7.40 
4' 151.9 - - - 6.89 
7.40 
7.42 
5' 119.2 7.43 (dd, J = 8.5, 2) 6.89 6.74     
6.89 
7.41 
6' 116.8 6.89 (d, J = 8.5) 7.40 
7.42 
7.40 
7.42 
- 
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Table 3.16 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1gal 101.7 5.06 (d, J = 7) 3.49* 3.54 
6.50 
6.79 
- 
2gal 74.7
§
 3.49* 3.40 * - 
3gal 71.3 3.40 (d, J = 8.5) 3.40 
3.49 
* - 
4gal 77.9
§
 3.49* 3.40 * 3.40 
3.49* 
5gal 78.4 3.54 (m) 3.71 5.06 - 
6gal 62.4 3.71 (dd, J = 12.5, 6) 3.54 
3.92 
* - 
3.92 (d, J = 12) 3.71 
*Overlapped signal; 
§ 
Interchangeable; gal-galactose 
  
  
 
The doublet signal at δ 5.06 ppm indicated the anomeric sugar proton attachment to 
aglycone luteolin. NOESY correlated this anomeric proton to two signals at δ 6.50 ppm (H-6) 
and 6.79 ppm (H-8) which implied the substitution at C-7. A methylene proton of the sugar 
had a COSY correlation to a signal at δ 3.54 ppm which implied H-5gal. In addition, a 
NOESY cross-peak of this signal at δ 3.54 ppm (H-5gal) to the anomeric proton was also 
observed. COSY correlated the anomeric signal to H-2gal at δ 3.49 ppm, and H-2 further had 
a COSY correlation to H-3gal at δ 3.40 ppm.  
 
In comparison with verbascoside (Figure 3.31), the peak shapes of sugar proton did 
not appear as ordinary triplets of axial-axial orientation. As glucose protons of position 2-5 
resonated as triplet signal with 
3
J value around 9-10 Hz, a signal at δ 3.40 ppm (H-3gal) 
exhibited a broad doublet (
3
J = 9 Hz) due to smaller coupling constant of axial-equatorial 
orientation (
3
J between H-3gal and H-4gal) (Figure 3.53). This compound was likely to be a 
galactose substitution. Certain salient correlations are given in Figure 3.54.  
 
  - 139 - 
                      
O
OH
H
H
HO
H
H
OHH
OH
OH
O
H
HO
H
HO
H
H
OHH
OH
OH
                                                     
                                                β-glucose                                   β-galactose 
                      
                                       Figure 3.53 Pyranose rings of glucose and galactose 
 
         
 
Figure 3.54 Certain salient correlations of luteolin-7-O-β-galactopyranoside  
H-H COSY (bold line), NOESY (dot arrow), HMBC (arrow) 
  
Luteolin-7-O-β-galactoside was reported in Verbena officinalis L. and V. supina L., 
family Verbenaceae (Kawashty and El-Garf, 2000) and also in Cynara scolimus L., family 
Asteraceae (Sanchez-Rabaneda et al., 2003). 
 
 
3.6.2.3 Luteolin-7-O-rutinoside  
The MS data of luteolin-7-O-rutinoside (luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-
glucopyranoside, Figure 3.55) gave a molecular mass of 594, consistent with a flavonoid 
glycoside with two monosaccharides units. 
1
H and 
13
C NMR data are shown in Table 3.17 
and NMR spectra are given in Appendix 10. 
O
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H
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Figure 3.55 Luteolin-7-O-rutinoside 
 
 
1
H NMR showed the five signals of protons in the aromatic and alkene region of the 
spectrum. Three of them, δ 6.90 ppm (d), 7.41 ppm (s), 7.44 ppm (dd), were observed to be in 
the same ring system by the HMBC, COSY, and NOESY correlations. The patterns of 
splitting indicated a 3,4-disubstituted aromatic ring B of flavonoid. A coupled doublet at δ 
6.45 ppm (J = 2 Hz) showed COSY cross correlation to a broad, two proton, singlet at δ 6.74 
ppm. This latter signal was cross correlated by HMBC to two separate carbon signals at δ 
94.8 ppm and 103.1 ppm. Thus, the proton at δ 6.45 ppm was assigned to H-6 of the 
flavonoid A ring, and the two protons at δ 6.74 ppm to H-8 of A ring and H-3 of flavone 
skeleton.  
 
13
C and 
1
H spectra showed signals corresponding to the methylene group of glucose 
and a methyl group of rhamnose, also two anomeric proton signals at δ 4.54 ppm (s) of 
rhamnose, and 5.06 ppm (d, J = 7.5 Hz) of glucose as described in verbascoside structure 
elucidation (Figures 3.27-3.28). The attachment of glucose to rhamnose was at C-6g which 
was shifted downfield to δ 66.1 ppm (C-6g) when compared with C-6g in verbascoside at δ 
60.9 ppm. There was also a HMBC correlation from C-6g to the anomeric proton of 
rhamnose at δ 4.54 ppm (H-1r). On the other hand, the attachment of anomeric glucose at δ 
5.06 ppm (H-1g) to luteolin was at δ 162.9 ppm (C-7) due to a HMBC correlation between 
them. In addition, NOESY correlated this anomeric glucose to two proton signals at δ 6.45 
ppm (H-6), and δ 6.74 ppm (H-8).  
 
 
 
 
  - 141 - 
Table 3.17 1D and 2D NMR data of luteolin-7-O-rutinoside (
1
H, 500 MHz; 
13
C, 125 MHz;  
 DMSO-d6; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 - - - - - 
2 164.6 - - - 6.74 
7.44 
3 103.1 6.74* (s) - 5.06 
7.41 
7.44 
- 
4 181.9 - - - 6.74 
5 161.2 - - - 6.45 
6 99.5 6.45 (d, J = 2) 6.74 5.06 6.74 
7 162.9 - - - 5.06 
6.45 
6.74 
8 94.8 6.74* (s) 6.45 5.06 6.45 
9 156.9 - - - 6.74 
10 105.4 - - - 6.45 
6.74 
1' 121.3 - - - 6.74 
6.90 
2' 113.5 7.41 ( br s) - 6.74 7.44 
3' 145.8 - - - 6.90 
7.41 
4' 150.1 - - - 7.41 
7.44 
5' 116.1 6.90 (d, J = 8.5) 7.44 7.44 7.44
Φ
 
6' 119.2 7.44 (dd, J = 8, 2) 6.90 6.90 6.90
 Φ
 
7.41 
1g 99.9 5.06 (d, J = 7.5) 3.26* 3.59 
6.45 
6.74 
3.26
 Φ
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Table 3.17 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
2g 73.1 3.26*  5.06 - 3.30* 
5.06
 Φ
 
3g 76.3 3.30* - - 3.26* 
4g 69.6 3.15* * - 3.59
 Φ
 
5g 75.6 3.59 (t, J = 7.5) 3.15* 
3.83 
5.06 3.15* 
Φ 
 
6g 66.1 3.43* 3.83 - 4.54 
3.83 (d, J = 10.5) 3.43* 
1r 100.5 4.54 (br s) 3.65 3.65 - 
2r 70.3 3.65 (d, J = 2) 4.54 4.54 - 
3r 70.7 3.45* - - 3.14*
 Φ
 
4.54 
4r 72.1 3.14* - - 3.65 
5r 68.3 3.41* - - 3.14*
 Φ
 
6r 17.8 1.06 (3H, d, J = 6) - - 3.14* 
3.41*
 Φ
 
*Overlapped signal; 
Φ 
H2BC; g-glucose; r-rhamnose 
 
 
                 
 
  Figure 3.56 Selected salient correlations of luteolin-7-O-rutinoside 
                   H-H COSY (bold line), NOESY (dot arrow), HMBC (arrow)  
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Though DMSO-d6 overlapped peaks extensively within the sugar region as shown in 
Appendix 10.1, the chemical shifts of sugar could be assigned by HMBC, NOSY, and COSY 
correlations. In brief, the anomeric rhamnose proton at δ 4.54 ppm (H-1r) had a NOESY 
cross peak to H-2r at δ 3.65 ppm. H-2r was further correlated to C-4r at δ 72.1 ppm by 
HMBC. H-4r had HMBC correlations to C-3r, C-5r, and C-6r. For glucose, H-1g at δ 5.06 
ppm had a COSY correlation to H-2g at δ 3.26 ppm, and also a NOESY correlation to H-5g 
at δ 3.59 ppm. H-5g showed a COSY cross-peak to H-6g, and further correlated to C-4g.  
 
All NMR data were identical to a published literature (Siciliano et al. 2004). 
Therefore, this compound was identified as luteolin-7-O-rutinoside. Certain salient 
correlations are shown in Figure 3.56. Luteolin-7-O-rutinoside was previously reported in 
this species (Kokkalou and Kapetanidis, 1988).  
 
 
3.6.2.4 Luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galactopyranoside  
This compound was eluted together with luteolin-7-rutinoside at retention time 16.7 
minutes but it precipitated out from the eluent in 20% aqueous acetonitrile. The solubility in 
deuterated solvent of luteolin-7-rutinoside and this compound also differed. This powder 
dissolved in deuterated-methanol while luteolin-7-rutinoside dissolved only in deuterated-
DMSO and D2O. Accordingly, all 
1
H signals of sugar were clearly seen in deuterated 
methanol (Appendix 11.1) compared to signals of luteolin-7-O-rutinoside in deuterated-
DMSO (Appendix 10.1). 
 
MS showed a molecular mass of 594 as in luteolin-7-O-rutinoside. 
1
H and 
13
C NMR 
data are shown in Table 3.18, and NMR spectra are given in Appendix 11. 
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       Figure 3.57 Luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galactopyranoside  
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Table 3.18 1D and 2D NMR data of luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galacto-
pyranoside (
1
H, 500 MHz; 
13
C, 125 MHz; CD3OD; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 - - - - - 
2 167.0 - - - 6.61 
3 104.3 6.61 (s) - 7.41* 
7.42* 
- 
4 184.0 - - - 6.61 
5 163.0 - - - 6.52 
6 101.1 6.52 (d, J = 2) 6.75 5.03 
6.75 
6.75 
7 164.7 - - - 5.03 
6.52 
6.75 
8 96.1 6.75 (d, J = 2) 6.52 5.03 6.52 
9 158.9 - - - 6.75 
10 107.1 - - - 6.52 
6.61 
6.75 
1' 123.5 - - - 6.61 
6.92 
2' 114.3 7.41* ( br s) - 6.61 7.42 
3' 147.0 - - - 6.92 
7.41 
4' 151.2 - - - 7.41 
7.42 
5' 116.9 6.92 (d, J = 9) 7.42 7.42 7.42Φ 
6' 120.6 7.42* 6.92 6.92 6.92 Φ 
7.41 
7.42 
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Table 3.18 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1gal 101.6 5.03 (d, J = 7) 3.49 3.49* 
3.50* 
3.65 
6.52 
6.75 
- 
2gal 74.7 3.49*  3.40 
5.03 
- 3.50* 
5.03
Φ
 
3gal 71.3 3.40 (d, J = 9) 3.49* 
3.65 
- 3.49* 
3.65*  
4gal 77.2 3.65*  3.49* - 3.40
Φ
  
3.63* 
5gal 77.8 3.50* - 5.03* 3.40
 
 
3.49 
6gal 67.5 3.63* 4.05 - 4.72 
4.05 (d, J = 9.5) 3.63* 3.63* 
4.05 
4.72 
1r 102.1 4.72 (br s) 3.91 3.63* 
3.91 
4.05 
4.05 
2r 72.1 3.91 (dd, J = 3.5, 1.5) 4.72 4.72 3.34 
4.72 
3r 72.4 3.72 (dd, J = 9.5, 3.5) - 1.18 
3.91 
4.72 
4r 74.1 3.34 (t, J = 10) * * 1.18 
3.72
Φ
 
3.91 
5r 69.8 3.64* - - 1.18
Φ
 
3.34 
4.72 
6r 17.9 1.18 (3H, d, J = 6.5) 3.64* 3.72 3.34 
3.64*
Φ
 
*Overlapped signal; 
Φ 
H2BC; gal- galactose; r- rhamnose 
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1
H and 
13
C signals of this compound were very similar to luteolin-7-O-rutinoside but 
chemical shifts differences due to the different solvents were observed. In general, the 
chemical shifts of a compound in CD3OD were a few ppm higher than one in DMSO-d6. For 
example, the only carbonyl carbon of luteolin-7-rutinoside resonated at δ 181.9 ppm in 
DMSO-d6 while C-4 of this compound was at δ 184.0 ppm in CD3OD. Higher chemical 
shifts of aromatic 
1
H were also observed. All COSY, HMBC, NOESY correlations were 
matched to luteolin-7-O-rutinoside, for instance the NOESY correlation of the anomeric 
proton of galactose at δ 5.03 ppm to two aromatic protons at δ 6.52 ppm (H-6) and 6.75 ppm 
(H-8) which confirmed the substitution of sugar at C-7. Also, the attachment of rhamnose 
was verified by a HMBC cross-peak between the anomeric proton of rhamnose at δ 4.72 ppm 
and C-6gal at δ 67.48 ppm. Selected correlations are shown in Figures 3.59-3.60. 
 
NOESY correlated the anomeric proton of galactose at δ 5.03 ppm to a signal at δ 
3.50 ppm (H-5gal). The anomeric proton had a COSY correlation to H-2gal (δ 3.49 ppm). 
Then, H-2gal had a COSY correlation to H-3gal at δ 3.40 ppm which further correlated to H-
4gal at δ 3.65 ppm as shown in Figure 3.58. For rhamnose assignments, the pattern of H-2r 
and H-3r splitting were clearly identified as described in verbascoside.  
                           
Figure 3.58 H-H COSY (bold line) and NOESY (dot arrow) correlations of disaccharide of 
luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galactopyranoside.  
 
H-2r was a dd with two small coupling constants (3.5 Hz and 1.5 Hz) and can be seen 
as broad singlet while H-3r was a dd with 
3
J values 9.5 and 3.5 Hz. H-2r also had a NOESY 
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correlation to the anomeric rhamnose proton. C-5r at δ 69.8 ppm and C-4r at δ 74.1 ppm had 
HMBC correlation to the only methyl doublet signal at δ 1.18 ppm. A cross peak of C-5r at δ 
69.8 ppm to the doublet of H-6r was observed in two bond correlation. 
 
            
Figure 3.59 Selected salient correlations of luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-
galactopyranoside. H-H COSY (bold line), NOESY (arrow) 
 
               
Figure 3.60 Partial HMBC correlations of luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galacto-
pyranoside  
 
As many of the sugar signals of luteolin-7-O-rutinoside were overlapped by hydroxyl 
signals stabilized by DMSO-d6, it proved difficult to make a direct comparison between 
luteolin-7-rutinoside and luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-galactopyranoside. 
O
OH
OH
OOH
O
O
OH
HO
O
O
HO
OH
OH
CH3
OH
H
H
H
HH
H
H
H
H
7.41 
3.65 
5.03 
6.75 
6.52 
7.42 
6.61 
114.3 
4.72 
1.18 
17.9 
147.0 
151.2 
116.9 
120.6 
123.5 
167.0 
104.3 
184.0 
107.1 
158.9 
96.1 
164.7 
101.1 
163.0 
101.6 
77.8 
67.5 
102.1 
69.8 
74.1 
72.1 
74.7 
77.2 
O
OH
OH
OOH
O
O
OH
HO
O
O
HO
OH
OH
CH3
OH
H
H
H
HH
H
H
H
H
7.41 
5.03 
6.75 
6.52 
7.42 
6.61 
6.92 
114.3 
4.72 
1.18 
17.9 
147.0 
151.2 
116.9 
120.6 
123.5 
167.0 
104.3 
184.0 
107.1 
158.9 
96.1 
164.7 
101.1 
163.0 
101.6 
77.8 
67.5 
102.1 
3.91 
H 
  - 148 - 
However, this compound displays the different triplet signal of H-3gal. H-3gal (δ 
3.40 ppm) exhibited a broad doublet (
3
J = 9 Hz) due to smaller coupling constant of axial-
equatorial orientation (
3
J between H-3gal and H-4gal) as shown in Figure 3.53.  
 
Therefore, this compound was identified luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-
galactopyranoside. To the best of literature searching, this compound appears to be a new 
flavonoid glycoside. 
 
 
3.6.2.5 Apigenin-7-O-β-glucopyranoside 
The MS data of apigenin-7-O-β-glucopyranoside (Figure 3.61) suggested a molecular 
mass of 432 and the molecular formula C21H20O10. 
1
H and 
13
C NMR data are shown in Table 
3.19 and NMR spectra are given in Appendix 12. 
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Figure 3.61 Apigenin-7-O-β-glucopyranoside 
 
1
H NMR showed a similar overall pattern to luteolin-7-O-β-glucopyranoside which 
comprised a group of monosaccharide signals and certain signals in aromatic region. Two 
pairs of doublets were coupled to each other with coupling constants 9 Hz and 2 Hz. HMBC 
correlations exhibited the same patterns as luteolin-7-O-β-glucopyranoside except there were 
only two doublet signals instead of three signals in ring B. The MW of 432 suggested one 
oxygen atom less than luteolin-7-O-β-glucopyranoside. 13C NMR showed 19 signals 
including two strong signals at δ 117.1 ppm (C-3' and C-5') and 129.7 ppm (C-2' and C-6'). 
This compound was thus identified apigenin-7-O-β-glucopyranoside.  
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Table 3.19 1D and 2D NMR data of apigenin-7-O-β-glucopyranoside (1H, 500 MHz; 13C, 125 
Mz; CD3OD; δ ppm; J, Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 - - - - - 
2 166.8 - - - 7.88 
3 104.1 6.66 (s) - 7.88 - 
4 184.1 - - - - 
5 159.0 - - - - 
6 101.2 6.50 (d, J = 2) 6.82 5.06 - 
7 164.9 - - - 6.50 
8 96.1 6.82 (d, J = 2) 6.50 5.06 6.50 
9 162.8 - - - 6.50 
10 107.1 - - - 6.50 
6.66 
1' 123.1 - - - 6.66 
6.92 
2', 6' 129.6 7.88 (d, J = 9) 6.92 6.66 
6.92 
- 
3', 5' 117.2 6.92 (d, J = 9) 7.88 7.88 - 
4' 162.9 - - - 6.92 
7.88 
1g 101.7 5.06 (d, J = 7.5) 3.44 
3.45 
3.44 
3.45 
- 
2g 74.8 3.44 * * - 
3g 77.9 3.45 * * - 
4g 71.3 3.40 * * - 
5g 78.4 3.50 * * - 
6g 62.5 3.70 (m) 3.92 3.92 - 
3.92 (m) 3.70 3.70 
*Overlapped signal; g-glucose 
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Figure 3.62 Selected correlations of apigenin-7-O-β-glucopyranoside 
         COSY (bold line), NOESY (dotted arrow), HMBC (arrow) 
 
The NOESY correlations of anomeric proton at δ 5.06 ppm to two signals at δ 6.50 
ppm (H-6) and δ 6.82 ppm (H-8) were observed the same as previous described in luteolin 
glycoside which verified the attachment of the anomeric position to C-7 of the aglycone 
apigenin.  
 
Apigenin-7-O-β-glucopyranoside was previously reported in S. viridis L. (Kokkalou 
and Kapetanidis, 1988), and also is commonly found in other species (Lu and Foo, 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
OH
OOH
O
O
OH
HO
HO
OH
H
H
H
H
H
H H
H
7.88 
6.92 
6.82 
5.06 
117.2 
129.6 
123.1 
104.1 
184.1 
166.8 164.9 
96.1 
101.2 
62.5 162.9 
6.66 
6.50 
  - 151 - 
3.6.3 Triterpenoids and steroids 
 The non-polar fractions of the aerial parts (AE) contained a series of relatively high 
molecular weight compounds with molecular formula and NMR spectra consistent with 
triterpenoids. 
 
3.6.3.1 Ursolic acid  
Ursolic acid (Figure 3.63) was obtained as a white powder by silica column 
chromatography. Mass spectral data showed a molecular mass of 456 and a molecular 
formula of C30H48O3. 
1
H and 
13
C NMR data are shown in Table 3.20 and NMR spectra are 
presented in Appendix 13. 
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Figure 3.63 Ursolic acid 
 
The formula C30H48O3 indicated seven double bond equivalent (DBE). 
13
C NMR and 
DEPT-135 also corresponded to the formula C30H48O3 with 30 signals of carbon atoms, and 
nine negative signals of methylene groups with seven signals of quaternary carbon atoms at δ  
181.3, 139.1, 48.5, 42.8, 40.3, 39.4, and 37.6 ppm. The two conspicuous proton signals 
(Figure 3.64) at δ 5.21 ppm and 3.14 ppm implied the deshielded protons of a trisubstituted 
double bond (H-12), and hydroxyl group substitution (H-3) respectively. The proton NMR 
spectrum showed five, three proton singlets and two, three proton doublets indicative of five 
methyl group attached at quaternary centre and two attached to methine carbon atoms. 
Therefore, the structure of this formula is likely to be an ursane type triterpenoid, ursolic 
acid. 
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Table 3.20 1D and 2D NMR data of ursolic acid (
1
H, 500 MHz; 
13
C, 125 MHz in a mixture of 
CD3OD and CDCl3, δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 39.6 0.93* 
 
 
- - 0.73 
0.76 
0.91 
0.93 1.63* 3.14 - 
2 27.4 1.54* 3.14 - 0.76 
3 79.3 α3.14 (dd, J = 11, 5)   1.63 
1.54 
1.54* 
0.91 
0.73 
0.73 
0.76 
0.91 
0.93 
1.54* 
1.63* 
4 39.4 - - - 0.76 
0.93 
5 56.2 α0.73 (d, J = 11.5) - 1.53* 0.76 
0.91 
0.93 
1.52 
1.63* 
6 19.1 α1.37 - 1.53* 0.73 
β1.53* - 1.35* 
7 33.9 1.35 - - 0.76 
0.82 1.52* - - 
8 40.3 - - - 0.82 
1.09 
1.53* 
9 48.2 1.53* - - 0.82 
0.91 
2.16 
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Table 3.20 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
10 37.6 - - - 0.73 
0.91 
1.53* 
1.63* 
11 24.0 1.09* - - 0.84 
5.21 1.89* - 5.21 
12 126.4 5.21 (t, J = 3.5) 1.89* 1.09 
1.89 
2.16 
1.89* 
2.16 
13 139.1 - - - 1.09 
1.89* 
2.16 
14 42.8 - - - 0.82 
1.09 
1.52* 
1.89* 
2.16 
5.21 
15 28.8 1.05* - - 1.09 
1.98 1.88* 1.98 - 
16 24.9 1.62 - - 1.89* 
2.16 1.98 1.88* - 
17 48.5 - - - 2.16 
18 53.8 2.16 (d, J = 11) 1.36* 5.21 0.84 
5.21 
19 39.8 1.63* - - 0.84 
0.92 
2.16 
20 39.9 1.36* 0.84 
2.16 
- 0.84 
0.92 
2.16 
21 31.4 1.51 - - 0.84 
0.92 
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Table 3.20 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
22 37.7 1.67 - - 0.84 
1.51* 
23 28.6 α0.93* (3H, s) 0.76 - 0.73 
0.76 
3.14 
24 16.1 β0.76 (3H, s) 0.93 - 0.73 
0.91 
0.93 
1.54* 
25 15.9 β0.91 (3H, s) - - 0.73 
0.91 
0.93 
1.54* 
26 17.5 β0.82 (3H, s) - - 1.52* 
1.53* 
27 24.0 α1.09* (3H, s) - - 1.05* 
1.62* 
1.89* 
2.16 
28 181.3 - - - 1.98 
2.16 
29 17.1 β0.84 (3H, d, J = 6.5) 1.36* - 1.51* 
2.16 
30 21.5 α0.92 (3H, d, J = 6.5) - - 1.36* 
*Overlapped signal 
          
           
        Figure 3.64 
1
H NMR of ursolic acid (500 MHz; a mixture of CD3OD and CDCl3) 
H-3  
 
H-12  
 H-18  
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 The configuration of proton at positions 3, 5, and 18 were assigned by their coupling 
constant values. The proton H-3 resonated at δ 3.14 ppm as a doublet of doublets with 
coupling constants 11, and 5 Hz indicating β-hydroxyl group (equatorial) substitution at 
position C-3 as shown in Figure 3.65A. 
                 
         A. β-Hydroxyl group substitution                           B. α-Hydroxyl group substitution 
 
Figure 3.65 Newman projections of C-2, and C-3 of ursolic acid 
 
The other noticeable signal of the ursane type triterpenoid is one proton doublet at H-
18 (Figure 3.64). It was deshielded at δ 2.16 ppm because of double bond at position 12-13. 
Its coupling constant to H-19 is 11 Hz (di-axial) which indicates the β-substitution 
(equatorial) of the methyl group at C-19. 
  
Proton H-5 of the triterpenic acids with geminal methyl groups at C-4 was obviously 
seen in 
1
H NMR as the first low-field broad doublet signal at δ 0.73 with coupling constant 
11 Hz, and it had a HMQC correlation to carbon at δ 56.2 ppm (Figure 3.67). A large vicinal 
coupling constant denoted 180° dihedral angle, and thus the H-5 is likely to be an axial 
proton as shown in Figure 3.66. Figures 3.68-3.69 illustrate the chemical shift assignments of 
carbon and proton by using HMBC, COSY, and NOESY correlations. 
                                  
                                    A. H-5 axial                                                     B. H-5 equatorial 
                         
Figure 3.66 Newman projections of C-5, and C-6 of ursolic acid 
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Figure 3.67 HMQC expansion of ursolic acid (
1
H, 500 MHz; 
13
C, 125 MHz in mixture of 
CD3OD and CDCl3) 
          
      Figure 3.68 Selected COSY (bold line) and NOESY (arrow) correlations of ursolic acid 
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              A.    
         B.                 
 
Figure 3.69A-B Selected HMBC correlations of ursolic acid 
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3.6.3.2 Oleanolic acid  
 Oleanolic acid (Figure 3.70) was obtained as a white powder by silica column 
chromatography. Judging from the NMR spectra, this material was about 70% pure, with 
ursolic acid as the major impurity. MS data gave a molecular mass of 456, corresponding to a 
molecular formula of C30H48O3. 
1
H and 
13
C NMR data are shown in Table 3.21 and NMR 
spectra are given Appendix 14.  
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                                                      Figure 3.70 Oleanolic acid 
 
 The formula C30H48O3 indicated seven double bond equivalent (DBE). 
13
C NMR and 
DEPT-135 also corresponded to the formula C30H48O3 with 30 signals of carbon atoms, and 
10 negative signals of methylene groups and eight signals of quaternary carbon atoms at δ 
181.4, 144.5, 47.0, 42.3, 39.9, 39.2, 37.6, and 31.2 ppm. The two conspicuous protons at δ 
5.23, and 3.13 ppm, pointed to deshielded protons of a trisubstitutd double bond (position 
12), and hydroxyl group substitution (position 3) respectively. A doublet of doublet at δ 2.80 
ppm indicated H-18 with two protons nearby whereas the H-18 of ursane triterpenoid has 
only one proton adjacent and resonated as a doublet. Moreover, in the 
1
H NMR spectrum all 
the methyl groups were three proton singlets, indicating that all were attached at quaternary 
centres. Therefore, the structure of this formula is likely to be an oleanane type triterpenoid, 
oleanolic acid.  
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Table 3.21 1D and 2D NMR data of oleanolic acid (
1
H, 500 MHz; 
13
C, 125 MHz in a mixture 
of CD3OD and CDCl3, δ in ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 39.3 0.94* - - 0.70 
0.74 
0.89 
0.94 
1.60 - - 
2 27.2 1.56* 3.14 3.14 - 
3 79.2 3.14 (dd, J = 10.5, 5) 1.56 0.70 
0.94 
1.56 
0.74 
0.94 
1.60 
4 39.2 - - - 0.70 
0.74 
0.89 
0.94 
5 56.0 α0.70 (d, J = 10) 1.37 3.14 0.74 
0.89 
0.94 
6 18.9 1.37 0.70 - 0.70 
1.53*  - 
7 33.7 1.29 - - 0.77 
1.46 - - 
8 39.9 - - - 0.77 
1.11 
1.54* 
9 49.0 1.54* 1.84 - 0.77 
0.89 
10 37.6 - - - 0.70 
0.89 
1.54* 
1.56* 
11 24.0 1.07 
 
5.23 
 
- 
 
1.54* 
1.60* 
1.84 1.54 5.23 
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Table 3.21 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
12 123.0 5.23 (t, J = 3) 1.84 1.84 
2.80 
1.84 
2.80 
13 144.5 - - - 1.11 
1.84 
2.80 
14 42.3 - - - 0.77 
1.11 
1.71 
15 28.3 1.04 
 
1.96 
 
- 1.11 
1.71* 1.04 - 
16 23.6 1.58 - - 1.58 
1.71 1.96 1.04 - 
17 47.0 - - - 1.11 
1.71 
1.96 
18 41.9 2.80 (dd, J = 13.5, 4) 1.10 
1.63 
0.90 
5.23 
1.11 
1.63* 
19 46.6 1.10 2.80 - 0.87 
0.90 1.63*   
20 31.2 - - - 0.87 
0.90 
1.33 
1.63* 
21 34.4 1.18 - - 0.87 
1.71* 1.33 - - 
22 33.2 1.52* - - 1.33 
1.71* - - 
23 28.4 α0.94 (3H, s) 0.74 - 0.74 
24 16.0 β0.74 (3H, s) 0.94 - 0.70 
0.94 
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Table 3.21 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
25 15.7 β0.89 (3H, s) - - 0.70 
0.94 
1.53* 
26 17.3 β0.77 (3H, s) - - 0.89 
1.54* 
27 26.3 α1.11 (3H, s) - - - 
28 181.4 - - - 1.71 
1.96 
29 33.4 α 0.87 (3H, s) - - 0.90 
1.33 
30 23.9 β0.90 (3H, s) - 2.80 0.87 
1.63* 
*Overlapped signal  
 
 
The configurations of protons at position 3, 5, and 18 were assigned by coupling 
constant values as described in ursolic acid. The H-3 resonated at δ 3.14 ppm as doublets of 
doublets with coupling constant 10.5, and 5 Hz indicating the β-hydroxyl group (equatorial) 
substitution at position C-3. The other noticeable signal of the oleanane type triterpenoid is a 
doublet of doublet of proton H-18. It was deshielded at δ 2.80 ppm because of double bond at 
position 12-13. Its coupling constants are 13.5, and 4 Hz which indicates its axial (β) 
configuration and the fact that it is adjacent to a methylene group. H-5 of oleanolic acid is 
also seen in 
1
H NMR as the first low-field doublet signal at δ 0.70 with coupling constant 10 
Hz. The configuration of H-5 was similar to ursolic acid as described above.  
 
Figures 3.71-3.72 illustrates the chemical shift assignment of carbon and proton by 
using HMBC, COSY, and NOESY correlations.  
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A. 
B.                  
                                     
                 Figure 3.71A-B Selected HMBC correlations of oleanolic acid 
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Figure 3.72 Selected COSY (bold line) and NOESY (arrow) correlations of oleanolic acid 
 
 Both ursolic and oleanolic acids have been previously reported in S. viridis L. 
(Ulubelen and Brieskorn, 1975), and are also common in other Salvia species (Topcu, 2006).  
 
 
3.6.3.3 Lup-(20)29-ene-2α,3β-diol   
 The MS data of lup-(20)29-ene-2α,3β-diol (Figure 3.73) gave a molecular mass of 
442 and a molecular formula of C30H50O2. 
1
H and 
13
C NMR data are shown in Table 3.22, and 
the NMR spectra are given in Appendix 15. 
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                                        Figure 3.73 Lup-(20)29-ene-2α,3β-diol  
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Table 3.22 1D and 2D NMR data of lup-(20)29-ene-2α,3β-diol (1H, 500 MHz; 13C, 125 MHz 
in CDCl3; δ in ppm; J in Hz)  
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 46.7 α0.83 (dd, J = 12, 7) 2.03 2.03 0.90 
β2.03 (dd, J = 12, 4) 0.83 
3.67 
0.83 
3.67 
2 69.3 β3.67 
(ddd, J = 10, 9.5, 4.5) 
0.83 
2.03 
2.97 
0.80 
0.90 
2.03 
2.97 
0.80 
0.83 
1.26* 
2.03 
2.97 
3 83.9 α2.97 (d, J = 9.5) 3.67 0.80 
0.83 
1.01 
3.67 
0.80 
0.83 
1.01 
2.03 
4 38.6 - - - 1.52 
2.03 
5 55.4 0.79* * * 0.80 
0.90 
1.01 
2.03 
6 18.3 1.40* - - 1.40* 
1.52 0.79* 0.80 
1.01 
7 34.2 1.39 * * 1.02 
8 40.9 - - - 0.94 
1.02 
9 50.4 1.32* - - 0.90 
1.02 
10 39.2 - - - 0.80 
0.90 
1.01 
1.02 
2.97 
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Table 3.22 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
11 21.0 1.26* * * 1.32 
1.45* 
12 25.0 1.08 1.26* - 0.94 
1.67* * 1.02 
13 38.0 1.65* 1.35* - 0.94 
1.02 
1.35* 
2.36 
14 42.9
§
 - - - 0.78 
0.94 
1.02 
15 27.4 1.74* - - - 
16 35.6 1.38* * * 0.78 
1.35* 1.47* 
17 43.0
§
 - - - 0.78 
0.94 
1.02 
18 48.3 1.35* * * 0.78 
1.39 
1.67 
2.36 
4.57 
4.69 
19 48.0 2.36  
(ddd, J = 11, 11, 6) 
1.39 
1.92 
0.78 
1.67 
1.92 
0.78 
1.39 
1.67 
2.36 
4.57 
4.69 
20 150.9 - - - 1.35* 
1.67 
2.36 
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Table 3.22 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
21 29.8 1.32* * * 2.36 
1.92 1.39* 0.78 
1.20 
2.36 
22 40.0 1.20 * * 0.78 
1.38* 
23 28.5 α1.01 (3H, s) 0.80 * 0.80 
0.90 
2.97 
24 16.5 β0.80 (3H, s) 1.01 * 1.01 
2.97 
25 17.4 β0.90 (3H, s) - 2.03 
3.67 
2.03 
26 16.0 β1.02 (3H, s) - - 1.39 
27 14.5 α0.94 (3H, s) - - 1.65 
28 18.0 β0.78 (3H, s) 1.20 2.36 - 
29 109.4 4.57 (d, J = 2) 1.67 
4.69 
1.67 
4.69 
1.67 
2.36 
4.69 (d, J = 2) 1.67 
4.57 
1.67 
2.36 
4.57 
30 19.3 1.67* (3H, s) 4.57 
4.69 
4.57 
4.69 
2.36 
4.57 
4.69 
*Overlapped signal; 
§
 Interchangeable 
 
 
The NMR spectra indicated a lupane type triterpenoid due to certain typical signals, 
i.e., exo-methylene protons (H-29) at δ 4.57 ppm, and 4.69 ppm, carbon signals at δ 109.4 
ppm (C-29) and 150.9 ppm (C-20), and the carbon atom at position 3 with hydroxyl group 
substitution δ 83.4 ppm (Mahato and Kundu, 1994). 1H NMR spectrum showed seven, three 
proton methyl singlets, one of which was deshielded at δ 1.67 ppm (H-30).  
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An additional deshielded carbon signal at δ 69.3 ppm together with the extra oxygen 
atom in the molecular formula pointed to a second hydroxyl group substitution to the lupeol 
skeleton. A doublet proton signal at δ 2.97 ppm with coupling constant 9.5 Hz revealed only 
one adjacent proton with di-axial coupling. Moreover, there is a COSY correlation between 
the signal at δ 2.97 ppm, and 3.67 ppm. Thus, these signals were assigned to H-3 and H-2 
respectively and the compound was identified as a lupene diol with 2α-OH, and 3β-OH 
substitutions. Configurations of each chiral carbon were assigned according to coupling 
constants, and NOESY correlations.  
                        
        Figure 3.74 
1
H expansion of lup-(20)29-ene-2α,3β-diol (500 MHz; CDCl3; δ in ppm) 
 
Figure 3.75 illustrates the configurations of 2-OH, and 3-OH subsititution by using 
Newman projection. The doublet of H-3 had a coupling constant 9.5 Hz, and the ddd of H-2 
had three coupling constant values, 10, 9.5 and 4.5 Hz. These indicated the large dihedral 
angle between them, thus the substitution must be 2α-OH, and 3β-OH (Figure 3.75A). 
                                   
                     A. 2α-OH, and 3β-OH                                                      B. 2β-OH, and 3β-OH 
                                        
             C. 2α-OH, and 3α-OH                                                            D. 2β-OH, and 3α-OH 
                                
                  Figure 3.75 Newman projections of C-2, and C-3 of lup-(20)29-ene-2α,3β-diol  
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 The other salient configuration is H-19 at δ 2.36 ppm. It was coupled to the H-18, 
and H-21a, 21b nearby with coupling constant 11, 11 and 6 Hz. As the large coupling 
constant, H-19, and H-18 must be an axial-axial as shown in Figure 3.76.  
 
                     
HO
H18HO
H19
 
 
               Figure 3.76 Chair conformation of lup-(20)29-ene-2α,3β-diol  
 
 Figures 3.77-3.79 show chemical shifts of protons and carbon atoms at salient 
positions assigned by using HMBC, COSY, and NOESY. HMBC correlated the exo-
methylene protons to signals at δ 19.3 ppm (C-30), and 48.0 ppm (C-19). Accordingly, H-19 
was correlated to C-21 at δ 29.8 ppm, and a singlet signal of methyl group at δ 0.78 ppm (C-
28; δ 18.0 ppm) by NOESY. HMBC showed correlations between the doublet signal of H-3 
at δ 2.97 ppm to signals, at δ 28.5 ppm (C-23), 16.5 ppm (C-24), 39.2 ppm (C-10), and 69.3 
ppm (C-2). In addition, there is a COSY correlation between 2 singlet signals, 1.01 ppm (H-
23), and 0.80 ppm (H-24). H-23, and H-24 were assigned by NOESY as shown in Figure 
3.79.                            
 
             Lup-(20)29-ene-2α,3β-diol was first isolated from Pterocarpus santalinus L. f., 
family Leguminosae (Kumar and Seshadri, 1976) and also reported in S. viridis L. (Ulubelen 
et al., 1977). 
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    A.                        
 
B.                                           
 
                  
              Figure 3.77A-B Selected HMBC correlations of lup-(20)29-ene-2α,3β-diol  
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                  Figure 3.78 Selected COSY correlations of lup-(20)29-ene-2α,3β-diol  
 
                             
  
                          
                   Figure 3.79 Selected NOESY correlations of lup-(20)29-ene-2α,3β-diol  
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3.6.3.4 Compound 1 (lup-(20)29-ene-2α-acetate-3β-ol)   
The MS data of compound 1 (Figure 3.80) gave a molecular mass of 484 and a 
molecular formula of C32H52O3. 
1
H and 
13
C NMR data are shown in Table 3.23 and NMR 
spectra are given in Appendix 16. 
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      Figure 3.80 Compound 1 (lup-(20)29-ene-2α-acetate-3β-ol)   
 
 Both 
1
H and 
13
C NMR spectrum corresponded to the lupane type triterpenoid as 
described for the previous compound. A doublet signal at δ 3.15 ppm had a COSY 
correlation to a downfield methine signal at δ 4.86 ppm. Therefore, this C32H52O3 is likely to 
be a lupane skeleton with 2 oxygen functions at C-2, and C-3; the additional deshielding of δ 
4.86 ppm.suggested acetylation. All salient signals were assigned as shown in Figure 3.81. 
 
     
        Figure 3.81 Salient HMBC signals of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol)   
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Table 3.23 1D and 2D NMR data of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) (1H, 500 
MHz; 
13
C, 125 MHz; CDCl3; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H COSY NOESY HMBC 
1 44.0 2.04* - - 0.94 
0.90 4.86 2.05 
2 73.6 4.86  
(ddd, J = 10, 10, 5) 
0.90* 
2.05 
3.15 
0.84 
0.94 
2.05 
0.90 
2.05 
3.15 
3 80.9 3.15 (d, J = 10) 4.86 0.76* 
0.90 
1.03 
0.84 
1.03 
2.04* 
2.05 
4 39.8 - - - 0.94 
1.03 
3.15 
5 55.2 0.76* 1.53 - 0.84 
0.94 
1.03 
2.04* 
6 18.2 1.40 - - - 
1.53 0.76* - 
7 34.1 1.43* (2H) - - 1.02 
8 40.9 - - - 0.93 
0.94 
1.02 
9 50.4 1.31 - - 0.93 
0.94 
1.02 
10 38.5 - - - 0.93 
0.94 
1.38* 
2.05 
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Table 3.23 (continued) 
Position 
13
C 
 
1
H COSY NOESY HMBC 
11 21.1 1.25* - - - 
1.38* - - 
12 25.0 1.07 - - - 
1.66* - 1.02 
13 38.0 1.64* - 1.02 0.93 
1.38* 
14 42.9
§
 - - - 0.78 
0.93 
1.02 
1.38* 
15 27.4 0.98* - - 0.93 
1.19 1.66* - - 
16 35.6 1.37* - - 0.78 
1.47 - - 
17 43.0
§
 - - - 0.78 
0.93 
1.02 
1.38* 
18 48.3 1.34* - - 1.38* 
2.37 
4.55 
4.67 
19 47.9 2.37  
(ddd, J = 11, 11, 6) 
1.38* 
1.92 
 
0.78 
1.65 
1.92 
0.78 
1.38* 
1.65 
4.55 
4.67 
20 150.8 - - - 1.34* 
1.65 
2.37 
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Table 3.23 (continued) 
Position 
13
C 
 
1
H COSY NOESY HMBC 
21 29.7 1.38* 1.92 
2.37 
- 2.37 
 
1.92 1.38* 
2.37 
- 
22 40.0 1.19 - - - 
1.38* - - 
23 28.4 α1.03 (3H, s) 0.84 3.15 0.84 
3.15 
24 16.4 β0.84 (3H, s) 1.03 4.86 0.76* 
1.03 
3.15 
25 17.1 β0.94 (3H, s) - - 0.90* 
2.04* 
26 16.0 β1.02 (3H, s) - - 1.40* 
27 14.5 α0.93 (3H, s) - - 1.64* 
28 18.0 β0.78 (3H, s) - 2.37 1.19 
1.38* 
29 109.4 4.55 (d, J = 2) 1.65 
4.67 
1.65 
4.67 
1.34* 
2.37 
4.67 (d, J = 2) 1.65 
4.55 
1.38 
1.65 
2.37 
4.55 
30 19.3 1.65 (3H, s) 1.34* 
1.38* 
4.55 
4.67 
2.37 
4.55 
4.67 
2.37 
4.55 
4.67 
Acetyl 
group 
21.3 2.05 (3H, s) 0.90* 
4.86 
0.90 - 
171.6 - - - 2.05 
* Overlapped peak; 
§
 Interchangeable 
  
. 
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13
C NMR showed 32 signals with seven quaternary carbon atoms, and ten methylene 
groups from DEPT-135. An extra carbonyl carbon signal at δ 171.6 ppm had a HMBC 
correlation to a 
1H singlet signal at δ 2.05 ppm. Moreover, this singlet showed NOESY and 
HMBC correlations to the proton at δ 4.86 ppm and the carbon at δ 73.6 ppm respectively. 
Thus, these signals are assigned to an acetate ester attached to the lupane pentacyclic ring at 
C-2. All configurations of compound 1 were assigned as described above in structure 
elucidation of lup-(20)29-ene-2α,3β-diol. The other chemical shift of protons and carbons 
were assigned by using HMBC, COSY, and NOESY as shown in Figures 3.82-3.84.  
             A.                     
                   B.  
Figure 3.82A-B Selected HMBC correlations of compound 1 (lup-(20)29-ene-2α-acetate-3β-
ol) 
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Figure 3.83 Selected COSY correlations of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) 
 
                
 
 
Figure 3.84 Selected NOESY correlations of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) 
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 Therefore, compound 1 was identified as lup-(20)29-ene-2α-acetate-3β-ol established 
by its molecular formula C32H52O3 (MW 484) and NMR spectroscopic data. This compound 
is now reported here for the first time. 
 
 
3.6.3.5 Compound 2 (lup-(20)29-ene-2α-ol-3β-acetate)   
The MS data showed compound 2 (Figure 3.85) to be an isomer of compound 1 with 
a molecular mass of 484 and a molecular formula of C32H52O3. 
1
H and 
13
C NMR data are 
shown in Table 3.24 and NMR spectra are given in Appendix 17. 
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Figure 3.85 Compound 2 (lup-(20)29-ene-2α-ol,3β-acetate) 
 
All NMR data were similar to compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) except 
two methine proton signals; the downfield doublet at δ 4.46 ppm, and the ddd at δ 3.77 ppm. 
The doublet indicated that there was only one vicinal proton, and it had a COSY correlation 
to the methine signal at δ 3.77 ppm, and also HMBC correlations to the carbonyl carbon 
signal at δ 172.4 ppm, and to one methyl group at δ 21.04 ppm. These pointed to an acetate 
ester group attached to the C-3 hydroxyl group of lup-(20)29-ene-2α,3β-diol and thus, this 
structure is an isomer of compound 1. The configurations at each position were the same as 
compound 1. Selected HMBC, NOESY and COSY correlations are presented in Figures 
3.87-3.89. 
 
 
 
 
 
  - 178 - 
Table 3.24 1D and 2D NMR data of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate) (1H, 500 
MHz; 
13
C, 125 MHz in CDCl3; δ in ppm; J in Hz) 
Position 
13
C 
 
1
H COSY NOESY HMBC 
1 48.1 2.09 - 0.91 
3.77 
0.91 
4.46 
0.90* - 2.13 
2 67.8 3.77  
(ddd, J = 10, 10, 5) 
0.90* 
2.09 
4.46 
0.85 
2.09 
2.13 
4.46 
0.91 
2.09* 
2.13 
4.46 
3 85.0 4.46 (d, J = 10) 3.77 0.87 
3.77 
0.85 
0.87 
2.09* 
2.13 
3.77 
4 39.3 - - - 0.85 
0.87 
4.46 
5 55.3 0.88* 1.40* 
1.50* 
1.50 0.85 
0.87 
0.91 
1.02 
2.09* 
2.13 
6 18.3 1.40* 0.88* - 1.34 
1.40* 1.50* 0.88* - 
7 34.1 1.40* (2H) 0.88* - 1.02 
8 40.9 - - - 0.94 
1.02 
9 50.3 1.34 - - 0.91 
1.02 
10 38.4 - - - 0.91 
1.34* 
2.09* 
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Table 3.24 (continued) 
Position 
13
C 
 
1
H COSY NOESY HMBC 
11 21.1 1.26 1.43 - - 
1.43 - - 
12 25.0 1.08 1.68*  - 
1.68* 1.02 
1.08 
- 
13 37.9 1.65* - - 0.94 
1.08 
1.36* 
2.37 
14 42.9
§
 - - - 0.78 
0.94 
1.02 
1.20 
1.40* 
1.65* 
15 27.4 0.98* - - 0.94 
1.68* - - 
16 35.5 1.38* - - 0.78 
1.46 - - 
17 43.0
§
 - - - 0.78 
0.94 
1.02 
1.20 
1.40* 
1.65* 
18 48.2 1.36 - - 0.78 
1.38* 
1.40* 
1.68* 
4.57 
4.68 
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Table 3.24 (continued) 
Position 
13
C 
 
1
H COSY NOESY HMBC 
19 48.0 β2.37 
(ddd, J = 11, 11, 6) 
0.78 
1.40* 
1.90 
0.78 
1.68 
4.68 
0.78 
1.38* 
1.40* 
1.68* 
4.57 
4.68 
20 150.8 - - - 1.36* 
1.40* 
1.68 
2.37 
21 29.8 1.32* - - 2.37 
1.90 1.20 
1.32* 
- 
22 40.0 1.20 0.78 - 0.78 
1.40* - - 
23 28.4 α0.87 (3H, s) - 1.50 0.85 
4.46 
24 17.4 β0.85 (3H, s) - - 0.87 
0.88* 
0.91 
2.09* 
2.13 
4.46 
25 17.3 β0.91 (3H, s) - 2.09 
 
0.87 
0.88* 
0.91 
2.09* 
2.13 
26 16.0 β1.02 (3H, s) - - 1.34* 
1.40* 
27 14.5 α0.94 (3H, s) - - 1.65* 
 
 
   
 
 
   
 
 
   
  - 181 - 
Table 3.24 (continued) 
Position 
13
C 
 
1
H COSY NOESY HMBC 
28 18.0 β0.78 (3H, s) - 1.46* 
1.65* 
1.90 
2.37 
1.20 
1.38* 
1.40* 
29 109.4 4.57 (d, J = 2.5) 1.68 
4.68 
1.68 
4.68 
1.68 
2.37 
4.68 (d, J = 2.5) 1.68 
4.57 
1.36* 
2.37 
4.57 
30 19.3 1.68* (3H, s) 4.57 
4.68 
2.37 
4.57 
4.68 
2.37 
4.57 
4.68 
Acetyl 
group 
21.0 2.13 (3H, s) 0.88* 
3.77 
2.09 
2.13 
3.77 
- 
172.4 - - - 2.13 
4.46 
* Overlapped signal; 
§
 Interchangeable 
                                
           Figure 3.86 Salient HMBC signals of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate)  
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              A.  
             B.       
 
Figure 3.87A-B Selected HMBC correlations of compound 2 (lup-(20)29-ene-2α-ol-3β-
acetate)  
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Figure 3.88 Selected COSY correlations of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate)  
  
              
Figure 3.89 Selected NOESY correlations of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate)   
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Therefore, compound 2 was identified as lup-(20)29-ene-2α-ol-3β-acetate established 
by its molecular formula C32H52O3 (MW 484) and NMR spectroscopic data. It is now 
reported here for the first time. 
 
Table 3.25 shows the comparison data of three isolated lupane triterpenoids. Lup-
(20)29-ene-2α,3β-diol has been previously reported in S. viridis L. (Ulubelen et al., 1977). 
The two acetate esters described here have not previously been reported. As can be seen, the 
acetyl substitution caused the deshielding of the chemical shifts of both 
1
H and 
13
C at the 
position of substitution.  
 
An isomer of compound 2, lup-(20)29-ene-2α-ol-3α-acetate, was recently found in S. 
trijuga Diels as shown in Table 3.25 (Pan et al., 2010).  
 
Table 3.25 
1
H, and 
13
C NMR comparison of two novel lupane triterpenoids (
1
H, 500 MHz; 
13
C, 125 MHz in CDCl3; δ in ppm; J in Hz) 
 
Position Lup-(20)29-2n2-2α, 3β-
diol 
Compound 1 
Lup-(20)29-ene-2α-
acetate-3β-ol 
Compound 2 
Lup-(20)29-ene-2α-ol- 
3β-acetate 
Lup-(20)29-ene- 
2α-ol-3α-acetate 
(Pan et al., 2010) 
δC δH δC δH δC δH δC
 δH
 
1 46.7 0.83* 44.0 0.90 48.1 0.90* 42.3 1.09* 
2.03 2.04* 2.09 1.76 
2 69.3 3.67 (ddd, 
10, 10, 4.5) 
73.6 4.86 (ddd,  
10, 10, 5)  
67.8 3.77 (ddd, 
10, 10, 5) 
65.8 4.08  
(td, 15, 5 ) 
3 83.9 2.97  
(d, 9.5) 
80.9 3.15  
(d, 10) 
85.0 4.46  
(d, 10) 
80.6 4.87  
(d, 3) 
4 38.6 - 39.8 - 39.3 - 38.2 - 
5 55.4 0.79* 55.2 0.76* 55.3 0.88* 49.6 1.09* 
6 18.3 1.40* 18.2 1.40 18.3 1.40* 17.8 1.35* 
1.52 1.53 1.50* 1.40* 
7 34.2 1.39* 34.1 1.43* 34.1 1.40* 33.9 1.40* 
8 40.9 - 40.9 - 40.9 - 40.9 - 
9 50.4 1.32* 50.4 1.31 50.3 1.34 50.1 1.41* 
10 39.2 - 38.5 - 38.4 - 38.5 - 
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Table 3.25 (continued)    
Position Lup-(20)29-2n2-2α, 3β-
diol 
Compound 1 
Lup-(20)29-ene-2α-
acetate-3β-ol 
Compound 2 
Lup-(20)29-ene-2α-ol- 
3β-acetate 
Lup-(20)29-ene- 
2α-ol-3α-acetate 
(Pan et al., 2010) 
δC δH δC δH δC δH δC
 δH
 
11 21.0 1.26* 21.1 1.25* 21.1 1.26 21.1 1.26* 
1.45* 1.38* 1.43 1.44* 
12 25.0 1.08 25.0 1.07 25.0 1.08 24.9 1.08* 
1.67* 1.66* 1.68* 1.68* 
13 38.0 1.65* 38.0 1.64* 37.9 1.65* 37.9 1.65* 
14 42.9 - 42.9 - 42.9 - 42.9 - 
15 27.4 1.05 27.4 0.98* 27.4 0.98* 27.4 1.00* 
1.74 1.66* 1.68* 1.69* 
16 35.6 1.38* 35.6 1.37 35.5 1.38 35.5 1.38* 
1.47* 1.47 1.46 1.48* 
17 43.0 - 43.0 - 43.0 - 42.9 - 
18 48.3 1.35* 48.3 1.34 48.2 1.36 48.2 1.35* 
19 48.0 2.36 (ddd, 
11, 11, 6) 
47.9 2.37 (ddd, 
11, 11, 6 ) 
47.9 2.37 (ddd, 
11, 11, 6 ) 
47.9 2.37 (td, 
13.5, 7.5) 
20 150.9 - 150.8 - 150.8 - 150.7 - 
21 29.8 1.32 29.7 1.38* 29.8 1.32* 29.8 1.32* 
1.92 1.92 1.90 1.91 
22 40.0 1.20 40.0 1.19 40.0 1.20 39.9 1.20* 
1.38* 1.38* 1.40* 1.38* 
23 28.5 1.01 (s) 28.4 1.03 (s) 28.4 0.87 (s) 27.9 0.86 (s) 
24 16.5 0.80 (s) 16.4 0.84 (s) 17.4 0.85 (s) 21.6 0.91 (s) 
25 17.4 0.90 (s) 17.1 0.94 (s) 17.3 0.91 (s) 17.0 0.88 (s) 
26 16.0 1.02 (s) 16.0 1.02 (s) 16.0 1.02 (s) 16.0 1.02 (s) 
27 14.5 0.94 (s) 14.5 0.93 (s) 14.5 0.94 (s) 14.7 0.98 (s) 
28 18.0 0.78 (s) 18.0 0.78 (s) 18.0 0.78 (s) 17.9 0.78 (s) 
29 109.4 4.57  109.4 4.55  109.4 4.57  109.3 4.57  
4.69  4.67  4.68  4.69  
30 19.3 1.67 (s) 19.3 1.65 (s) 19.3 1.68 (s) 19.2 1.67 (s) 
Acetyl 
group 
- - 
21.3 2.05 (s) 21.0 2.13 (s) 20.8 2.14 (s) 
-
 - 171.6 - 172.4 - 172.0  
*Overlapped signal 
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3.6.3.6 β-Sitosterol  
β-Sitosterol (C29H50O; Figure 3.90) was identified by NMR data with those of an 
authentic specimen. NMR data are shown in Table 3.26 and NMR spectra are given in 
Appendix 18. 
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                             Figure 3.90 β-Sitosterol 
  
 
13
C NMR showed 29 signals which comprised six methyl signals, 11 methylene 
signals, nine methine signals and three quaternary carbon atoms from DEPT-90 and DEPT-
135. The 
1
H spectrum displayed two recognized signals of sterols at δ 3.52 ppm and δ 5.35 
ppm which belonged to hydroxyl substitution proton (H-3) and the alkene proton (H-6) 
respectively. This compound was thus identified as β-sitosterol. Its spectra were identical to 
the commercial standard, and to previous published data (Kojima et al., 1990). 
                          
Figure 3.91 Selected signals of β-sitosterol   
COSY (bold line), NOESY (dot arrow), and HMBC (arrow) 
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Table 3.26 1D and 2D NMR data of β-sitosterol (1H, 500 MHz; 13C, 125 MHz; CDCl3; δ in 
ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 37.2 1.05* 1.86* - 1.49* 
1.86* 1.05* 
2 31.7 1.49* 3.52  1.84* 
1.86* 
2.23 
2.29 
1.84* 3.52  
3 71.8 3.52 (m, J = 11, 4.5) 2.23 
2.29 
- 1.05* 
1.49* 
1.84* 
1.86* 
2.23* 
2.29* 
4 42.3 2.23 (m ) - - 0.68 
1.08* 
1.16* 
1.50* 
1.84* 
1.99* 
2.29 (m)   
5 140.8 - - - 1.03* 
1.84* 
1.86* 
2.23 
2.29 
6 121.7 5.35 (d, J = 5.5) 1.96* 1.96* 
2.23 
2.29 
2.23 
2.29 
7 31.9 1.96* (2H) 
 
1.43* 1.43* 0.92* 
0.99* 
1.03* 
1.08* 
1.43* 
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Table 3.26 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
8 31.9 1.43* 1.96* 1.96* 0.92* 
0.99* 
1.03* 
1.08* 
1.43* 
9 50.1 0.92* * * 1.43* 
1.50* 
1.96* 
1.99* 
10 36.5 - - - 0.92* 
1.03* 
1.05* 
1.86* 
2.23 
2.29 
5.35 
11 21.1 1.05* * * 0.92* 
1.16* 1.50* 
12 39.8 1.16* * * 0.68 
1.05* 
1.50* 
1.99* 
13 42.3 - - - 0.68 
1.08* 
1.16* 
1.50* 
1.84* 
1.99* 
14 56.8 0.99* * * 0.68 
0.90 
1.08* 
1.43* 
1.55* 
1.96* 
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Table 3.26 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
15 24.3 1.08* * * 0.99* 
1.55* 
16 28.2 1.84* (2H) * * 1.08* 
17 56.1 1.08* * * 0.68 
0.90 
1.05* 
18 11.9 0.68 (3H, s) - - 0.90 
0.99 
1.08* 
1.16* 
19 19.4 1.03 (3H, s) - - 0.92* 
1.05* 
1.86* 
20 36.1 1.34* - - 0.90* 
1.05* 
1.08* 
1.84* 
21 18.7 0.90* (3H) * - 1.05* 
1.16* 
22 33.9 1.05* * * 0.90* 
1.05* 
1.08* 
1.34* 
23 26.1 1.16* (2H) * - 0.90* 
1.25* 
24 45.8 0.92* * * 0.81 
0.83 
0.84 
1.25* 
25 29.1 1.25* * * 0.81 
0.83 
0.84 
26 19.8
§
 0.83 (3H, d, J = 7) - - 0.92* 
1.08* 
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Table 3.26 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
27 19.0
§
 0.81 (3H) 
(d, J = 7) 
- - 0.92* 
1.08* 
28 23.1 1.08* * * 0.81 
0.83 
0.84 
1.28* 
29 12.0    0.84 (3H, s) * - 0.92* 
1.08* 
1.25* 
* 
Overlapped signal; 
§ 
Interchangeable  
 
 Figure 3.91 shows the salient correlations of β-sitosterol. The peak at δ 3.52 ppm (H-
3) was correlated to a carbon at δ 71.8 ppm (C-3) by HMQC, and also had COSY 
correlations to two protons of H-4 at δ 2.23 ppm, and 2.29 ppm. The coupling constants of H-
3 were 11 and 4.5 Hz which implied the α-axial orientation. HMBC correlated C-3 to H-1 
and H-2, consequently, C-1, and C-2 were assigned at δ 37.2 ppm and 31.7 ppm. The other 
conspicuous signal at δ 5.35 ppm (H-6) was correlated to protons of H-4, and also two 
protons of H-7 at δ 1.96 ppm; accordingly C-7 was at δ 31.9 ppm.  
 
The β-sitosterol was only partially resolved from other plant sterols. In a mixed sterol 
fraction, campesterol (C28H48O) was tentatively identified in 
13
C NMR spectra concomitant 
with β-sitosterol (C29H50O). In the 
1H NMR spectrum, the characteristic of signals of a Δ22 
double bond could be seen as illustrated in Figure 3.92. This amounted to about 12% of the 
total sterol in the fraction and was possibly due to stigmasterol (Figure 3.93). 
                             
                    Figure 3.92 
1
H NMR expansion of the sterols sample (500 MHz; CDCl3) 
H-22 and H-23 
of stigmasterol  
H-3 H-6 
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                                 Figure 3.93 Plant sterols 
  
 
3.6.3.7 β-Sitosterol glucoside  
The MS data of β-sitosterol glucoside (Figure 3.94) gave a molecular mass of 576 
and a molecular formula of C35H60O6. NMR data are shown in Table 3.27 and NMR spectra 
are given in Appendix 19. 
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Figure 3.94  β-sitosterol-3-O-glycoside (daucosterol) 
 
 This agrees with that of β-sitosterol with glucose substitution. This is supported by 
1
H NMR and 
13
C NMR. 
13C NMR displayed 6 signals more than β-sitosterol while resonated 
in the sugar region at δ 62-101 ppm. 1H NMR exhibited the signals of glucose at δ 3.2-3.8 
ppm with the anomeric proton at δ 4.37 ppm (d, J = 8 Hz). The chemical shifts of glucose 
were assigned by HMBC, COSY, and NOESY correlations.  
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Table 3.27 1D and 2D NMR data of β-sitosterol glucoside (1H, 500 MHz; 13C, 125 MHz; in a 
mixture of CD3OD and CDCl3; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 37.6 1.03* * 1.83* 0.90 
1.83* - 1.03* 
2 29.9 1.56* 1.87* - 2.36 
1.87* 1.56* 
3 79.4 3.56 (m, J = 9.5, 5) 1.56 
2.23 
2.36 
4.37 1.87* 
2.23 
2.36 
4.37 
4 38.9 2.23 (m) 2.36 2.36 0.97 
5.35 
 
2.36 (m) 2.23 2.23 
5.35 
5 140.6 - - - 0.97 
1.49* 
1.83* 
2.36 
6 122.4 5.35 (d, J = 5.5) 1.92* 2.36 1.49* 
2.36 
7 32.2 1.92* 
 
5.35 - 0.89* 
1.41* 
5.35 1.49* * 
8 32.2 1.41* * * 0.89* 
1.49* 
5.35 
9 50.5 0.90* * * 0.97 
1.49* 
1.99* 
10 37.0 - - - 0.97 
2.36 
5.35 
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Table 3.27 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
11 21.3 1.46* (2H) - * 1.12 
12 40.1 1.12* - * 0.64 
0.97 
1.03 
1.99* 
13 42.6 - - - 0.64 
1.03* 
1.99* 
14 57.1 0.96 * * 0.64 
0.87 
15 24.5 1.03* * * 0.87 
1.53* 
16 28.5 1.18 - * 0.87 
1.23  
17 56.4 1.08* - * 0.64 
0.87 
18 12.0 0.64 (3H, s) - - 0.87 
1.12* 
1.32* 
19 19.5 0.97 (3H, s) - - 0.90 
1.83 
20 36.4 1.32* - - 0.87* 
0.99* 
21 19.0 0.87 (3H) * - 1.08 
1.63* 
22 34.2 0.99 * * 0.87 
0.89 
0.99* 
1.12* 
1.29 
23 26.3 1.12 (2H) - - 1.22 
1.63 
 
  
   
 
  
   
  - 194 - 
Table 3.27 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
24 46.2 0.89 * * 0.76 
0.78 
0.80 
0.87 
1.22* 
1.29* 
1.63 
25 29.4 1.63* * * 0.76 
0.78 
26 19.9
§
 0.78  
(3H, d, J = 7) 
* - 0.76* 
0.80* 
1.12* 
1.63 
27 19.2
§
 0.76  
(3H, d, J = 7) 
* - 0.76* 
0.80* 
1.12* 
1.63 
28 23.3 1.22* (2H) * * 0.76* 
0.78* 
0.89* 
1.12* 
1.63 
29 12.1 0.80 (3H, s) * - 0.89* 
1.12* 
1.22 
1' 101.4 4.37 (d, J = 8) 3.20 2.36 
3.25 
3.36 
3.56 
3.20 
3.56 
2' 73.9 3.20 (t, J = 9.5) 3.39 
4.37 
- 3.39* 
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Table 3.27 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
3' 70.5
¤
 3.39* 3.20 
3.25 
3.72 
4.37 
3.25 
3.39* 
3.72 
3.82 
4' 76.8
¤
 3.39* 3.20 
3.25 
3.72 
4.37 
3.20 
3.25 
3.39 
4.37 
5' 76.2 3.25 3.39 3.72 
3.82 
4.37 
3.72 
3.39 
4.37 
6' 62.1 3.72 (dd, J = 12, 4.5) 3.82 3.82 3.39 
3.82 (dd, J = 12, 3) 3.72 3.72 
* 
Overlapped signal; 
§, ¤ 
Interchangeable 
        
      
Figure 3.95 Selected correlations of β-sitosterol-3-O-glucoside 
                    NOESY (dot arrow), and HMBC (arrow) 
 
HMBC correlated C-3 to the anomeric proton of glucose (δ 4.37 ppm) and also C-1' 
to H-3. The large coupling constant of the anomeric proton of glucose with 
3
J = 8 Hz, 
indicated the β-configuration of glucose. The hydroxyl substitution was β-equatorial 
orientation because the coupling constants of H-3 were 9.5 and 5 Hz. A NOESY cross-peak 
of H-3α at δ 3.56 ppm to the anomeric H-1' was also observed.  
CH3
CH3
H3C CH3
CH3
CH3
O
H
O
OH
HOHO
OH
H H
4.37 
3.56 
79.4 
101.4 
140.6 
5.35 
0.97 
19.5 
122.4 
32.2 
38.9 
37.0 
  - 196 - 
This compound was thus identified as β-sitosterol-3-O-glycoside. It is also known as 
daucosterol isolated from Daucus carota L., family Apiaceae (Fu et al., 2010). Its spectra 
were compared to previous published data (Kojima et al., 1990). β-Sitosterol and its 
glycoside have commonly been found in plants particularly high lipid content ones such as 
nuts and legumes (Kojima et al., 1990; Bradford and Awad, 2007). 
 
 
3.6.4 Miscellaneous 
3.6.4.1 Salidroside 
The MS data of salidroside (2-(4'-hydroxyphenyl) ethyl β-glucopyranoside) (Figure 
3.96) was consistent with a molecular mass of 300 mass units and a molecular formula of 
C14H20O7. 
1
H and 
13
C NMR data are shown in Table 3.28 and NMR spectra are given in 
Appendix 20.  
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O
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                             Figure 3.96 Salidroside 
 
1H NMR showed the characteristics of glucose substitution, an anomeric proton at δ 
4.28 ppm (J = 8 Hz), and many signals in δ 3-4 ppm, and also two noticeable methylene 
signals of phenylethanol at δ 2.81 ppm (H-7), and 4.04 ppm (H8a). Two doublets were shown 
in aromatic region, δ 6.68 ppm and 7.06 ppm, which represented a para-disubstituted 
coupling pattern. These two signals were correlated to a downfield carbon atom at δ 156.8 
ppm (C-4). Figure 3.97 shows the assignment of δ 6.68 ppm (H-3, 5) and 7.06 ppm (H-2, 6) 
because there was a NOESY cross peak between a methylene signal at δ 2.81 ppm (H-7) to a 
1H signal at δ 7.06 ppm (H-2, 6). The attachment of glucose to aglycone part was indicated 
by HMBC correlation of the anomeric carbon at δ 104.2 ppm to H-8. The glucose 
assignments were based on HMBC, COSY, and NOESY correlations. Certain overlapping 
correlations are compared to one in the verbascoside.  
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Table 3.28 1D and 2D NMR data of salidroside (
1
H, 500 MHz; 
13
C, 125 MHz; CD3OD; δ in 
ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 130.7 - - - 2.81 
3.70* 
4.04 
6.68 
7.06 
2, 6 116.1 6.68 (d, J = 8.5) 7.06 7.06 6.68 
7.06 
3, 5 130.9 7.06 (d, J = 8) 6.68 6.68 2.81 
3.70* 
4.04 
6.68 
7.06 
4 156.8 - - - 6.68 
7.06 
7 36.4 2.81  
(2H, m) 
3.70* 
4.04 
3.70* 
4.04 
3.70* 
4.04 
7.06 
8 72.1 3.70* (m) 4.04 2.83 
3.70* 
2.83 
4.28 
4.04 (m) 3.70* 
4.28 
3.70* 
4.28 
1' 104.2 4.28 (d, J = 8) 3.18 
4.04 
3.25* 3.18 
3.70* 
4.04 
2' 75.1 3.18 (t, J = 8) 4.28 - 3.34* 
3' 71.6 3.26* (m) * 4.28 3.34* 
3.86* 
4.28 
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Table 3.28 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
4' 78.1 3.34* (m) * - 3.18 
3.25* 
3.26* 
3.68* 
5' 77.9 3.25* (m) * - 3.68* 
4.28 
6' 62.7 3.86* (m) * - 3.25* 
3.26* 3.68* (m) * - 
* 
Overlapped signal 
 
 
 
                          
         Figure 3.97 Salient signals of salidroside  
COSY (bold line), NOESY (dot arrow), and HMBC (arrow) 
 
 Salidroside was reported in many Rhodiola species (family Crassulaceae), for 
example, R. sacra (Prain ex. Hamet) S. H. Fu, R. yunnanensis (Franch.) S. H. Fu and R. 
coccinea (Royle) Borrisour (Chen et al., 2008) and also in Cistanche deserticola Y. C. Ma. 
(family Orobanchaceae) (Yu et al., 2007). Certain biological activities have been noted such 
as antiviral (Wang et al., 2009b), and antioxidant effects (Yu et al., 2007). Its spectroscopic 
data are comparable to a published literature (Yu et al., 2007). 
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4.28 4.04 
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3.7 Separation compounds from root part 
Dried root of this plant was also macerated by two steps of solvents, acetone and 
methanol, and partitioned by the same set of solvents as the aerial part (Scheme 2.1). Eight 
crude fractions were RAP (Acetone-Petroleum ether fraction; 0.65 gm), RAE (Acetone-Ethyl 
acetate fraction; 1 gm), RAB (Acetone-1-Butanol fraction; 0.055 gm), RAW (Acetone-Water 
fraction; 0.04 gm), RMP (Methanol-Petroleum ether fraction; 0.005 gm), RME (Methanol-
Ethyl acetate fraction; 0.87 gm), RMB (Methanol-1-Butanol fraction; 0.63 gm), and RMW 
(Methanol-Water fraction; 4.55 gm). Terpenoids and fatty acid ester were isolated from RAP 
and RAE over silica gel by open column chromatography while certain polyphenols were 
detected in RME and RMB crude fractions.  
 
3.7.1 Open column chromatography and HPLC of root part crude fractions 
3.7.1.1 RME crude fraction 
 RME (ethyl acetate fraction from methanol fraction) was first separated by open 
column chromatography, and then further purified by reversed phase HPLC. A 
phenylpropanoid compound was isolated from RME identified as 2'', 3''-di-O-acetyl- 
martynoside. This compound was not detected in aerial part of this plant. 
 
3.7.1.2 RMB crude fraction 
 Figure 3.98 shows a HPLC chromatogram of RMB (1-butanol fraction from 
methanol fraction). MS spectra indicated two main compounds in this crude extract, 
verbascoside and rosmarinic acid, which corresponded to the two main peaks at retention 
time 9.2 min, and a broad peak at 3-5 min respectively. Separation of this crude fraction by 
open column chromatography and reversed phased HPLC afforded rosmarinic acid, and a 
trace amount of verbascoside. 
       
    Table 3.29 Isolated compounds from RME and RMB root part crude fractions 
 
Identification Formula MW Rf value
a
 
2'', 3''-Di-O-acetyl-martynoside C35H44O17 736 0.75 
Rosmarinic acid C18H16O8 360 0.70 
Verbascoside C29H36O15 624 0.25 
         a
Mobile phase: ethyl acetate:methanol:formic acid:water (50:3:3:6); silica gel GF254 
 
  - 200 - 
 
Figure 3.98 A chromatogram of RMB crude fraction from retention time 0-24 minutes. 
Condition: Phenomenex Luna PFP 250x10mm, injection volume 20 µl of 10 mg/ml, mobile 
phase methanol:water (45:55), flow rate 5 ml/min, wavelength at 330 nm. 
 
            Table 3.30 Isolated compounds from RAE and RAP root part crude fractions 
 
Identification Formula MW Rf value
a
 
Ferruginol C20H30O 286 0.78 
7α-Acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione C22H30O5 374 0.71 
7α,14-Dihydroxy-8,13-abietadiene-11,12-dione C20H28O4 332 0.71 
Salvinolonyl-12 methyl ether C21H28O3 328 0.64 
Compound 3 (1-oxomicrostegiol) C20H24O3 312 0.59 
Compound 4 (viroxocane) C20H24O3 312 0.58 
Microstegiol C20H26O2 298 0.75 
Compound 5 (viridoquinone) C20H24O2 296 0.71 
1-Docosyl ferulate C32H54O4 502 0.65 
A mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates - - 0.76 
A mixture of oleanolic acid and ursolic acid C30H48O3 456 0.45 
β-Sitosterol C29H50O 414 0.60 
          a
Mobile phase: chloroform:methanol (9:1); silica gel GF254 
Verbascoside 
9.2 min Injection point 
Rosmarinic acid 
4.5 min 
  - 201 - 
3.7.2 Open column chromatography of root part crude fractions 
 Three new diterpenoids were isolated from RAE and RAP crude fractions plus five 
known, ferruginol, salvinoloyl-12-methyl-ether, 7α-Acetoxy-14-hydroxy-8,13-abietadiene-
11,12-dione, 7α,14-dihydroxy-8,13-abietadiene-11,12-dione and microstegiol. β-Sitosterol 
and a mixture of ursolic acid and oleanolic acid were also found in the root part (Table 3.30). 
Their structures are given and elucidated in section 3.8.  
 
 
3.8 Structure elucidations of compounds from root part 
3.8.1 Caffeic acid derivatives 
 In addition to verbascoside and rosmarinic acid also isolated from aerial part and 
discussed in section 3.6, the roots also yield two caffeic acid derivatives not found in aerial 
part. 
 
3.8.1.1 2'',3''-Di-O-acetyl-martynoside 
The MS data of 2'',3''-di-O-acetyl-martynoside (Figure 3.99) gave a molecular mass 
of 736 and a molecular formula of C35H44O17. 
1
H and 
13
C NMR data are shown in Table 3.31 
and NMR spectra give in Appendix 21.  
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             Figure 3.99 2'',3''-Di-O-acetyl-martynoside  
 
1
H and 
13
C NMR spectra of this compound show similar signals to martynoside plus 
two 
1H singlet signals at δ 2.03 ppm, 2.12 ppm, each integrating to three protons and also 
carbonyl carbon signals at δ 170.0 ppm, and 171.3 ppm. The signals at δ 2.03 ppm, and 2.12 
ppm had HMBC correlation to these carbonyl 
13C signals at δ 170.0 ppm, and 171.3 ppm 
respectively. The MW at 736 was consistent with a diacetylated martynoside.  
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Table 3.31 1D and 2D NMR data of 2'',3''-di-O-acetyl-martynoside (
1
H, 500 MHz; 
13
C, 125 
MHz;  CDCl3; δ in ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 131.5 - - - 2.83 
6.77 
2 115.0 6.80 (d, J = 2 ) - - 2.83 
5.62 
3 145.2
§
 5.62 (OH, s) - - 3.86 
5.62 
6.67 
6.77 
6.80 
4 145.5
§
 - - - 3.86 
5.62 
6.67 
6.77 
6.80 
5 110.7 6.77 (d, J = 8) 6.67 3.86 - 
6 120.3 6.67 (dd, J = 8.5, 2) 6.77 6.77 2.83 
6.80 
7 35.4 2.83 (2H, m) 
 
3.70* 
4.13 
3.70* 
4.13 
- 
8 70.9 3.70* (m) 2.83 2.83 2.83 
4.28 4.13 (m) 2.83 
3.70* 
2.83 
3.70* 
1' 126.5 - - - 6.26 
6.90 
2' 109.6 7.02 (d, J = 2) - 3.92 7.07 
7.67 
3' 147.0 - - - 3.92 
5.89 
6.90 
7.02 
7.07 
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Table 3.31 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
4' 148.4 5.89 (OH, s) - - 5.89 
7.02 
7.07 
5' 114.8 6.90 (d, J = 8.5) 7.07 7.07 5.89 
6' 123.4 7.07 (dd, J = 8, 2) 6.90 6.90 7.02 
7.67 
7' 147.1 7.67 (d, J = 15.5) 6.26 6.26 6.90 
7.02 
7.07 
8' 113.8 6.26 (d, J = 15.5) 7.67 7.67 - 
9' 167.0 - - - 5.04 
6.26 
7.67 
1g 102.7 4.28 (d, J = 8) 3.60* 3.48 3.70* 
2g 74.8 3.60* (m) 4.28 - 3.86* 
4.88* 
3g 79.0 3.86*  - 5.19 5.19 
4g 68.9 5.04 (t, J = 10) 3.48 - 3.86* 
5.19 
5g 74.5 3.48 (m) 5.04 - 5.04 
6g 61.4 3.62* (m) 3.74* - - 
3.74* (m) 3.62* - 
1r 98.3 5.19 (br s, J = 1.5 ) - 3.86* 3.86* 
2r 70.1 5.29 (dd, J = 3.5, 1.5) 5.01 - 1.22 
3r 72.1 5.01 (dd, J = 10, 3.5)  5.29 3.50* 5.19 
4r 69.1 3.77* (m) 1.22 1.22 1.22 
5.19 
5r 71.3 3.50* (m) - - 1.22 
6r 17.7 1.22 (d, J = 6.5) 3.50* 3.50* - 
4-OCH3 56.0 3.86 (3H, s) - 6.77 - 
3'-OCH3 55.9 3.92 (3H, s) - 7.02 - 
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Table 3.31 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
2'' (2r)-
Acetyl 
171.3 - - - 2.03 
20.9* 2.03 (3H, s) - - - 
3'' (3r)-
Acetyl 
170.0 - - - 2.12 
20.9* 2.12 (3H, s) - - - 
* 
Overlapped signal; g-glucose; r-rhamnose 
 
 
The 
1
H spectrum of this compound in deuterated-chloroform exhibited four singlets 
of methyl groups and anomeric protons of glucose (H-1g) and rhamnose (H-1r) at δ 4.28 ppm 
(d, 
3
J = 8 Hz), and 5.19 ppm (br s, 
3
J = 1.5 Hz) respectively, and also an upfield doublet at δ 
1.22 ppm (rhamnose H-6). Deuterium exchange indicated 2 hydroxyl groups at δ 5.62 ppm 
(s), and 5.89 ppm (s). The downfield triplet peak at δ 5.04 ppm (3J = 10 Hz) was assigned as 
H-4g due to a HMBC correlation to a carbonyl at δ 167.0 ppm (C-9') of the feruloyl moiety. 
This H-4g peak was partly masked in the verbascoside spectrum because there was an 
overlapping -OH peak caused by deuterated methanol.  
 
The other 
1H signals at δ 5.01 ppm and 5.29 ppm resonated as doublets of doublet 
with two sets of vicinal coupling constant, i.e. 10 and 3.5 Hz, and 3.5 and 1.5 Hz 
respectively. The 
3
J values indicated the coupling patterns of H-3r (axial orientation), and H-
2r (equatorial orientation) as previous structure elucidation of verbascoside (Figure 3.30). In 
addition, there was a COSY cross peak between these two signals at δ 5.01 ppm and 5.29 
ppm. There was also HMBC correlation between C-3r to the anomeric proton of rhamnose 
(H-1r). The downfield chemical shifts were likely due to the substitution of acetyl groups. 
Therefore, this compound was assigned as diacetylmartynoside with 2r- and 3r-acetyl sub-
stitution. Sugar configurations and coupling patterns were similar to verbascoside, 
martynoside, and leucosceptoside A as described above.  
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Figure 3.100 Salient signals of 2'',3''-Di-O-acetyl-martynoside   
COSY (bold line), NOESY (dot arrow), and HMBC (arrow) 
 
 
2'',3''-Di-O-acetyl martynoside has not been reported in the genus Salvia before but it 
was first isolated from Lippia dulcis Trev. in family Verbenaceae (Abe et al., 2002).  
 
 
3.8.1.2 1-Docosyl ferulate 
The MS data of 1-docosyl ferulate (Figure 3.101) gave a molecular mass of 502 and 
a molecular formula of C32H54O4. 
1
H and 
13
C NMR data are shown in Table 3.32 and NMR 
spectra are given in Appendix 22.  
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      Figure 3.101 1-Docosyl ferulate   
 
 
1
H NMR exhibited six signals in aromatic and alkene region, a triplet at δ 4.18 ppm, 
a three protons singlet at δ 3.92 ppm and a strong broad -CH2- signal in the alkane region 
(Appendix 22.1). The typical signals of the ferulic acid trans protons were observed at δ 6.27 
ppm and 7.58 ppm with coupling constant 16 Hz. Three signals, at δ 6.90 (d), 7.03 (d), 7.06 
(dd) ppm, were noticeable as the 3, 4-disubstitued coupling pattern which was similar to 
O
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caffeic acid (Figure 3.24). There was also a NOESY cross-peak between δ 7.03 ppm and a 
singlet signal at δ 3.92 ppm which implied the ferulic acid moiety. In addition, a singlet 
signal at δ 5.82 ppm was exchangeable with D2O which implied hydroxyl group substitution.  
 
13C NMR showed 16 signals include strong methylene signals around δ 29.3 ppm 
which clearly corresponded to several carbon atoms. These methylene protons also correlated 
by HMBC to a triplet signal at δ 0.86 ppm (H-22) which implied the long chain alkane 
moiety. The other deshielded triplet at δ 4.18 ppm had COSY, NOESY, HMBC correlations 
to a quintet signal at 1.67 ppm. The deshielded triplet at 4.18 ppm was thus assigned H-1 
while the quintet was H-2. These data all suggested a ferulic acid moiety esterified to a n-
alkanol which, from the molecular weight, was deduced to be docosanol. Salient COSY, 
NOESY and HMBC correlations are presented in Figures 3.102-3.103.  
 
1-Docosyl ferulate was previously reported from the stem bark of Pavetta owariensis 
P. Beauv., family Rubiaceae (Balde et al., 1991), and the whole plant of Teucrium 
divaricatum subsp. villosum (Celak) Rech. fil., family Lamiaceae (Ulubelen et al., 1994b).  
  
                 
Figure 3.102 H-H COSY (bold line) and NOESY (arrow) correlations of 1-docosyl ferulate 
                     
  Figure 3.103 HMBC correlations of 1-docosyl ferulate (* overlapped signal) 
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Table 3.32 1D and 2D NMR data of 1-docosyl ferulate (
1
H, 500 MHz; 
13
C, 125 MHz; in 
CDCl3; δ in ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 64.6 4.18 (2H, t, J = 7) 1.67 1.67 1.67
Φ
 
2 28.8 1.67  
(2H, quintet, J = 8) 
4.18 4.18 1.25* 
4.18
 Φ
 
3 26.0 1.38 (2H, m) 1.67 - 1.67 
4.18 
4-20 29.3-31.9 1.25* (34H) * * * 
1.38 
21 22.7 1.25* (2H) 0.86 - 0.86
 Φ
 
1.25* 
22 14.1 0.86 (3H, t, J = 7) 1.25* - 1.25* 
1' 127.1 - - - 6.27 
6.90 
2' 109.3 7.03 (d, J = 2) - 3.92 
6.27 
6.27 
7.06 
7.58 
3' 146.7
§
 - - - 3.92 
5.82 
6.90 
7.03 
4' 147.9
§
 5.82 (OH, s) - - 5.82 
7.03 
7.06 
5' 114.7 6.90 (d, J = 8) 7.06 7.06 5.82 
7.06
 Φ
 
6' 123.0 7.06 (dd, J = 8, 2) 6.90 6.90 6.90
 Φ
 
7.03 
7.58 
7' 144.6 7.58 (d, J = 16) 6.27 6.27 
7.03 
6.27
 Φ
 
7.03 
7.06 
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Table 3.32 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
8' 115.7 6.27 (d, J = 16) 7.58 7.03 
7.58 
7.58
 Φ
 
9' 167.4 - - - - 
Methoxyl 
group 
55.9 3.92 (3H, s) - 7.03 - 
*
Overlapped signal; 
Φ 
H2BC; 
§
 Interchangeable 
 
 
 
3.8.2 Diterpenoids 
 The main components in the less polar fractions from the roots (RAP and RAE crude 
fractions) were a series of diterpenoids. 
1
H NMR of all these compounds showed a one 
proton septet coupled to two methyl doublets typical of the isopropyl side chain of the 
abietane or rearranged abietane skeleton. 
 
3.8.2.1 Ferruginol 
The MS data of ferruginol (Figure 3.104) gave a molecular mass of 286 and a 
molecular formula of C20H30O. 
1
H and 
13
C NMR data are shown in Table 3.33 and NMR 
spectra are given in Appendix 23.  
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          Figure 3.104 Ferruginol 
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Table 3.33 1D and 2D-NMR data of ferruginol (
1
H, 500 MHz; 
13
C, 125 MHz; CDCl3; δ in 
ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 38.8 α1.37* (m) 0.93 
2.15 
2.15 
6.62 
0.91 
0.93 
1.16 β2.15 
(dt, J = 12.5, 4, 1) 
1.37 1.16 
1.37 
6.62 
2 19.3 α1.73 
(ddd, J = 13.5, 6.5, 3)  
- - 0.93 
β1.59 
(ddd, J = 14, 10, 3.5) 
- - 
3 41.7 1.19* (m) 1.46 - 0.91 
0.93 β1.46  
(ddd, J = 13.5, 3.5, 1.5) 
1.19* - 
4 33.4 - - - 0.91 
0.93 
5 50.3 α1.31*  
(dd, J = 12.5, 2) 
1.59 - 0.91 
0.93 
1.16 
1.65 
2.83 
6 19.2 α1.85 
(dddd, J = 17, 6, 3.5,2) 
1.31* 
1.65 
2.76 
- 0.93 
1.31* 
2.76 
2.83 β1.65 (m) 1.85 
2.76 
- 
7 29.7 α2.76 
(ddd, J = 17, 11, 7.5) 
1.65 
1.85 
2.83 
1.85 
6.82 
1.31* 
6.82 
β2.83 (ddd, J = 17, 6, 1.5) 2.76 6.82 
8 127.3 - - - 1.85 
2.76 
2.83 
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Table 3.33 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
9 148.7 - - - 1.16 
2.76 
2.83 
6.82 
10 37.5 - - - 1.85 
1.16 
11 110.9 6.62 (s) - 1.16 
2.15 
4.46 
4.46 
12 150.6 4.46 (OH, s) - 6.62 3.10 
4.46 
6.62 
6.82 
13 130.9 - - - 1.21 
1.23 
3.10 
4.46 
6.62 
14 126.6 6.82 (s) - 1.21 
1.23 
2.76 
2.83 
3.10 
6.62 
15 26.8 3.10 (septet, J = 7) 1.21 
1.23 
1.21 
1.23 
1.21 
1.23 
16 22.7
§
 1.23 (3H, d, J = 7) 3.10 3.10 1.21 
3.10 
17 22.5
§
 1.21 (3H, d, J = 7) 3.10 3.10 1.23 
3.10 
18 33.3 α0.93 (3H, s) 1.37 - 0.91 
19 21.6 β0.91 (3H, s) 1.37 - 0.93 
1.31* 
20 24.8 β1.16 (3H, s) 1.73 6.62 1.37 
*Overlapped signal; 
§ 
Interchangeable 
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13
C NMR displayed 20 signals which comprised five methylene groups, six 
quaternary carbon atoms, and nine positive signals of methyl and methine groups from 
DEPT-135. In the 
1H NMR spectrum, COSY and NOESY correlations of the septet signal, δ 
3.10 ppm, and pair of three proton doublets, δ 1.21 ppm and 1.23 ppm, implied the isopropyl 
group in this structure. There were also three singlet signals of one hydrogen atom in the low 
field at δ 4.46 ppm, 6.62 ppm, and 6.82 ppm. While HMQC correlated the two signals of δ 
6.62 ppm, and 6.82 ppm to two aromatic carbons at δ 110.9 ppm, and 126.6 ppm 
respectively, there was no correlation of signal δ 4.46 ppm to any carbon atom. This signal, δ 
4.46 ppm, was exchanged by D2O which indicated that it was the hydroxyl-OH. In addition, 
HMQC correlated a carbon signal at δ 50.3 ppm to a proton at δ 1.31 ppm which inferred the 
methine proton of C-5. The presence of three singlet signals and two doublet signals of 
methyl groups plus the septet signal in 
1
H NMR indicated an abietane diterpenoid. The 
double-bond equivalent (DBE) of C20H30O is six, therefore, the structure is likely comprised 
of one aromatic and two aliphatic rings. 
 
 An aromatic proton signal at δ 6.62 ppm (H-11) had NOESY correlations to the 
hydroxyl signal at δ 4.46 ppm, and also to a methylene signal at δ 2.15ppm (H-1) and methyl 
protons δ 1.16 ppm (H-20) as shown in Figure 3.105. The other aromatic proton at δ 6.82 
ppm (H-14) showed NOESY correlation to a pair of isopropyl side chain (H-16 and H-17). 
COSY also correlated H-7 at δ 2.76 ppm and 2.83 ppm to H-6 at δ 1.65 ppm, and 1.85 ppm.  
                                  
 
     Figure 3.105 H-H COSY (bold line), and NOESY (arrow) of salient signals of ferruginol 
  
The carbon signal at δ 50.3 ppm (C-5) had HMBC correlations to H-7 (δ 2.83 ppm), 
and H-20. Additionally, the coupling pattern with large J value (12.5 Hz) revealed the α-axial 
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orientation of H-5 due to 180° vicinal dihedral angle to a proton of H-6β. H-7β at δ 2.83 ppm 
has a coupling pattern as ddd with J values 17, 6, and 1.5 Hz which indicated an equatorial 
orientation. On the other hand, H-7α with axial orientation showed a large vicinal coupling 
constant at 11, and 7.5 Hz. The coupling constant of axial-equatorial (H-7α and H-6α; 7.5 Hz 
or H-7β and H-6β; 6 Hz) was larger than equatorial-equatorial (H-7β and H-6α; 1.5 Hz) as 
can be seen from Figure 3.106; usually there is not much difference. The geminal coupling 
constant (
2
J) between H7α and H7β was 17 Hz. 
          
 Figure 3.106 Newman projections of C-6 and C-7 of ferruginol 
  
The chemical shift value and number of coupled protons and their coupling constants 
affected a shape of signal as shown in Figure 3.107. The coupling pattern of 3 non-equivalent 
neighboring protons is seen as a doublets of doublet of doublet (ddd). Both H-7β and H-7α 
displayed the ddd, but their shape was dissimilar due to different coupling constants. While 
the H-7β at δ 2.83 ppm (equatorial) is like four broad singlet, H-7α at δ 2.76 ppm (axial) is 
seen as multiplet. Methylene proton (H-6β and H-2α) displayed somewhat as a multiplet 
signal because it was coupled to 4-5 protons nearby, and also overlapping signal between 
them. As H-6 resonated more downfield than others, a coupling pattern of H-6α at δ 1.85 
ppm is seen as a doublet of doublet of doublet of doublet (dddd) as shown in Figure 3.107. H-
6α at δ 1.85 ppm (equatorial) was coupled to H-6β at δ 1.65 ppm with 2J value 17 Hz, and 
then was further coupled to H-7α, H-5α, and H-7β with 3J values 6, 3.5 and 2 Hz 
respectively. 
 
The chemical shifts of the quaternary carbon atoms were resolved by HMBC 
correlations. C-13 at δ 130.9 ppm correlated to the septet signal (H-15) and dimethyl groups 
(H-16, and H-17), and also to a singlet aromatic proton at δ 6.62 ppm (H-14). Two carbon 
signals at δ 148.7 ppm, and 150.6 ppm correlated to both aromatic protons at δ 6.82 ppm (H-
11) and 6.62 ppm (H-14), but only the signal at δ 148.7 ppm had a correlation to a methyl 
3J = 7.5 Hz  
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proton at δ 1.16 ppm (H-20). Therefore, the signal at δ 148.7 ppm was assigned as C-9 while 
the other one was C-12 which was substituted by a hydroxyl group. Another peak at δ 127.3 
ppm (C-8) was correlated to a dddd of H-6α. Two methyl carbons at δ 33.3 ppm, and 21.6 
ppm had HMBC correlation to protons of each other which indicated 3-4 bond range 
relationship. In addition, axial methyl groups resonate upfield from equatorial methyl group 
on the same carbon atoms in a cyclohexane ring (Williams and Fleming, 2008). Therefore, C-
19 (β-axial) would resonate at δ 21.6 ppm while equatorial methyl group (C-18) was at δ 33.3 
ppm. HMBC assignments are shown in Figure 3.108. 
 
 Figure 3.107 Selected 
1
H coupling patterns of ferruginol (500 MHz in CDCl3; δ in ppm) 
                              
                                       
Figure 3.108 Key HMBC assignment of ferruginol  
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  Ferruginol has previously been isolated from root parts of plants in the genus Salvia, 
for instance S. viridis L. (Ulubelen et al., 2000), S. miltiorrhiza Bunge (Lee et al., 2005), S. 
cilicica Boiss and Kotschy (Tan et al., 2002), S. deserta Schang (Tezuka et al., 1998). The 
spectroscopic data of this compound are identical to those reports.  
 
 
3.8.2.2 Salvinolonyl 12-methyl ether 
The MS data of salvinolonyl 12-methyl ether (Figure 3.109) gave a molecular mass 
of 328 and a molecular formula of C21H28O3. 
1
H and 
13
C NMR data are shown in Table 3.34 
and NMR spectra are given in Appendix 24.  
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           Figure 3.109 Salvinolonyl 12-methyl ether  
 
 
13
C NMR displayed 21 signals, and corresponding DEPT-90 and DEPT-135 showed 
three methylene groups, nine quaternary carbon atoms, six methyl groups and three methine 
groups. There were three singlet signals in the deshielded region of 
1H NMR at δ 6.25 ppm, 
6.47 ppm, and 7.73 ppm. Deuterium exchange indicated a hydroxyl group at δ 6.25 ppm. 
HMQC correlated two aromatic or alkene carbon signals at δ 115.9 ppm (C-14), and 123.6 
ppm (C-6) to proton signals at δ 7.73 ppm (H-14), and 6.47 ppm (H-6) respectively. The 
septet signal at δ 3.25 ppm (H-15) implied the methine group of isopropyl side chain because 
it had COSY, and NOESY correlations to a pair of doublets at δ 1.26 ppm (H-16), and 1.28 
ppm (H-17). Therefore, three out of nine positive signals from DEPT-135 were methine 
groups. The deshielded methyl signal at δ 3.83 ppm had a HMQC correlation to carbon at δ 
61.9 ppm which indicated the methoxy substitution in this molecule. All above suggestions 
inferred an abietane diterpenoid skeleton. 
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Table 3.34 1D and 2D NMR data of salvinolonyl 12-methyl ether (
1
H 500 MHz; 
13
C 125 
MHz in CDCl3; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 34.2 β3.27 
(ddd, J = 14, 4, 2) 
1.43* 1.43* 
1.62 
1.65 
α1.43* 
(ddd, J = 14, 12, 4) 
3.27 3.27 
2 18.7 1.62 (m) 1.97 3.27 - 
1.97 (m) 1.43 
1.62 
3.27 
3 40.4 α1.43* 
(ddd, J = 14, 12, 4) 
1.73 - 1.27 
1.36 
β1.73 
(ddd, J = 13, 7, 2) 
1.43* - 
4 38.1 - - - 1.27 
1.36 
6.47 
5 175.3 - - - 1.27 
1.36 
1.65 
6 123.6 6.47 (s) - 1.27 1.27 
7 185.4 - - - 7.73 
8 127.4 - - - 6.47 
9 136.7 - - - 1.65 
6.25 
7.73 
10 42.2 - - - 1.65 
6.47 
11 145.8 6.25 (OH, s) - 3.83 6.25 
12 148.2 - - - 3.83 
6.25 
7.73 
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Table 3.34 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
13 139.7 - - - 1.26 
1.28 
3.25 
14 115.9 7.73 (s) - 1.26 
1.28 
- 
15 26.8 3.25 (septet, J = 7) 1.26 
1.28 
1.26 
1.28 
1.26 
1.28 
7.73 
16 23.6
§
 1.28 (3H, d, J = 7) 3.25 3.25 1.26 
3.25 
17 23.5
§
 1.26 (3H, d, J = 7) 3.25 3.25 1.28 
3.25 
18 33.1 α1.27 (3H, s) - - 1.36 
19 29.3 β1.36 (3H, s) - 1.65 1.27 
20 24.8 β1.65 (3H, s) - 1.36 1.27 
Methoxyl 
group 
61.9 3.83 (3H, s) - 6.25 - 
* Overlapped signal; 
§ 
Interchangeable 
 
 The other singlet proton at δ 6.47 ppm (H-6) showed a NOESY correlation to a 
methyl signal at δ 1.27 ppm (H-19). Moreover, two quaternary carbon signals at δ 38.1 ppm 
(C-4), and δ 42.2 ppm (C-10) displayed HMBC correlations to H-6. The proton at δ 6.47 ppm 
(H-6) likely attached to the cyclohexane ring, however, it still had a HMBC correlation to an 
aromatic or alkene carbon at δ 127.4 ppm. These observations suggested the two aromatic 
protons were in the adjacent aromatic ring system with the oxo group in between.       
 
 Figure 3.110 shows certain noticeable 2D correlations of salvinolonyl 12-methyl 
ether. Two singlet signals of two aromatic protons suggested no correlation to each other. A 
singlet signal at δ 7.73 ppm (H-14) was correlated to the methine carbon of the isopropyl 
group at δ 26.8 ppm (C-15) by HMBC. It also had NOESY correlations to those pair of 
doublets at δ 1.28 ppm (H-16), and 1.26 ppm (H-17) which indicated the position of this 
proton in the same ring system. The methoxyl protons had a NOESY correlation to a singlet 
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of hydroxyl group which implied the adjacent substitution. Furthermore, NOESY also 
correlated this methoxyl proton signal to the septet signal. Therefore, the hydroxyl group, the 
methoxy group, and an aromatic proton at δ 7.73 ppm were in the same ring with isopropyl 
side chain attachment. In addition, the proton signal at δ 7.73 ppm (H-14) also had a HMBC 
correlation to a carbon signal at 185.4 ppm (C-7) which implied the ketone carbon nearby.  
  
                                                 
 
A. H-H COSY (bold line), and NOESY (arrow) correlations 
                                                        
                                                            B. HMBC correlations 
 
        Figure 3.110 2D-NMR assignments from salient signals of salvinolonyl 12-methyl ether   
  
Quaternary carbon atoms were assigned by HMBC as shown in Figure 3.111. A 
signal at δ 175.3 had correlations to three methyl groups at δ 1.27 ppm (H-18), 1.36 ppm (H-
19), and 1.65 ppm (H-20) which implied the position of C-5. H-6 at δ 6.47 ppm exhibited 
HMBC correlation to a signals at δ 127.4 ppm (C-8) while C-9 at δ 136.7 ppm had 3 
correlations to H-14 (7.73 ppm), hydroxyl group, and a methyl group at δ 1.65 ppm (H-20).  
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A carbon signal at δ 139.7 ppm was assigned as C-13 due to correlations to isopropyl side 
chain, H-15, H-16, and H-17.  
  
Three methylene carbon atoms resonated at δ 18.7 ppm, 34.2 ppm, and 40.4 ppm. 
They correlated to six non equivalent proton signals in HMQC. Three protons coupling 
patterns which indicated three neighboring protons were seen in four signals from two carbon 
atoms at δ 34.2 ppm, and 40.4 ppm. As HMBC correlated a signal at δ 40.4 ppm to proton H-
18, and H-19 as shown in Figure 3.111, therefore, this signal was assigned as C-3. 
Accordingly, a signal at δ 34.2 ppm would be C-1.  
                              
 
Figure 3.111 Key HMBC correlations of salvinolonyl 12-methyl ether  
 
Each proton of C-2 (δ 18.7 ppm), at δ 1.62 ppm, and 1.97 ppm, was coupled to five 
adjacent protons as multiplet (m) signal as shown in Figure 3.112. Coupling patterns of three 
protons are seen in doublets of doublet of doublet (ddd) shape for axial-axial orientation, and 
doublets of triplet (dt) for equatorial-axial/equatorial one. Figure 3.112 shows the coupling 
shape of H-3α (axial), and H-3β (equatorial). However, two protons signals of H-1, and H-3 
resonated at δ 1.43 ppm with α-axial orientation which can be seen an overlapping signal of 
ddd (J values = 14, 12, 4).  
 
Salvinolonyl 12-methyl ether was previously reported from S. montbretii Benth. (Gil 
et al., 1994).  
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          Figure 3.112 
1
H coupling pattern of salvinolonyl 12-methyl ether (500 MHz in CDCl3) 
 
 
3.8.2.3 7α-Acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
The MS data of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione (Figure 3.113) 
gave a molecular mass of 374 and a molecular formula of C22H30O5. 
1
H and 
13
C NMR data 
are shown in Table 3.35 and NMR spectra are given in Appendix 25. 
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               Figure 3.113  7α-Acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
  
 
13
C NMR displayed 22 signals, and corresponding DEPT-90 and DEPT-135 
exhibited four methylene signals, nine quaternary carbon atoms, three methine groups and six 
methyl groups. Four singlet signals each integrating to three proton atoms were seen in 
1
H 
NMR and two (3H) doublet signals. A (1H) septet at δ 3.15 ppm implied a methine proton of 
an isopropyl unit. There were also two signals at δ 5.92 ppm (dd), and 7.12 ppm (s). 
Deuterium exchange indicated that the peak at δ 7.12 ppm was a hydroxyl proton. Two 13C 
signals at δ 183.7 ppm, and 185.4 ppm implied two carbonyl groups. A quaternary signal at δ 
169.4 ppm correlated to a methyl signal at δ 2.03 ppm by HMBC suggesting an acetyl group. 
The presence of the isopropyl side chain and five methyl groups showed the characteristic of 
an abietane type diterpenoid. The molecular formula of this compound, C22H30O5, 
corresponds to eight unsaturation numbers (DBE). Therefore, the above observations of four 
H-2 H-2 H-3β H-1α and H-3α  
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methylene groups, three carbonyl carbon atoms with one hydroxyl group can be concluded to 
an abietane type containing an aromatic ring. 
 
 The key peak was the doublet of doublet 
1H signal at δ 5.92 ppm (H-7; 3J = 4, 1.5 
Hz). The small vicinal coupling constants implied the equatorial orientation of this proton. 
HMQC correlated this signal to a carbon signal at δ 64.5 ppm (C-7) which inferred the 
substitution of electronegative group, for example a hydroxyl group. The α-axial substitution 
of the acetyl group was verified by NOESY correlation of the -CH3 at δ 2.03 ppm to H-5 at δ 
1.49 ppm as shown in Figure 3.114A.  
              
A. H-H COSY (bold line), and NOESY (arrow) correlations 
                                                                 
B. HMBC correlations 
Figure 3.114 2D NMR assignments from salient signals of 7α-acetoxy-14-hydroxy-8,13-
abietadiene-11,12-dione   
O
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7.12 
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0.88 
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1.22 
35.8 
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5.92 
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1.92 
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2.71 
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Table 3.35 1D and 2D NMR data of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
(
1
H 500 MHz; 
13
C 125 MHz in CDCl3; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 35.8 α1.20* 1.22* 
1.72 
 1.22 
β2.71 (dt, J = 13, 4, 1) 
2 18.8 α1.72 (dddd, J = 13, 6, 2) 1.57 - 1.49 
β1.57* 1.72 - 
3 41.0 α1.49* (br d, J = 13, 1) - - 0.87 
0.88 β1.20* - - 
4 32.9* - - - 0.87 
0.88 
1.22 
1.49 
5 46.1 α1.49* 
( br d, J = 13, 1) 
- 2.03 0.87 
0.88 
1.22 
1.59* 
1.92 
6 24.6 β1.59* 
(ddd, J = 15, 11, 1.5 ) 
5.92 1.92 
5.92 
1.49 
α1.92 
( br d, J = 15 ) 
1.59* 1.59* 
5.92 
7 64.5 β5.92  
(dd, J = 4, 1.5) 
1.59* 
1.92 
1.59* 
1.92 
1.49 
1.92 
8 139.4 - - - 1.92 
5.92 
9 149.9 - - - 1.22 
10 39.0 - - - 1.22 
1.49 
1.57 
1.59 
1.92 
11 185.4 - - - 3.15 
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Table 3.35 (continued)
 
   
Position 
13
C 
 
1
H COSY NOESY HMBC 
12 183.7 - - - 7.12 
13 124.6 - - - 1.18 
1.20 
3.15 
7.12 
14 150.7 7.12 (OH, s) - - 3.15 
5.92 
7.12 
15 24.1 3.15  
(septet, J = 7) 
1.18 
1.20 
1.18 
1.20 
1.18 
1.20 
16 19.8
§
 1.20  
(3H, d, J = 7) 
3.15 3.15 1.18 
3.15 
17 19.7
§
 1.18  
(3H, d, J = 7) 
3.15 3.15 1.20 
3.15 
18 32.9* α0.88 (3H, s) - - 0.87 
1.22 
1.49 
19 21.6 β0.87 (3H, s) - - 0.88 
1.22 
1.49 
20 18.5 1.22 (3H, s) - - 1.49 
Acetyl 
group 
169.4 - - - 2.03 
5.92 
21.1 2.03 (3H, s) - 1.49 - 
*Overlapped signal; 
§
 Interchangeable 
 
 
COSY and NOESY correlated 
1H signal at δ 5.92 ppm to a metheylene proton at δ 
1.92 ppm which further correlated to a carbon signal at δ 139.4 ppm by HMBC. Therefore, a 
carbon signal at δ 64.5 ppm (C-7) was in between the aromatic ring and cyclohexane ring.  
H-7 also had HMBC correlations to carbon signals at δ 150.7 ppm, and 169.4 ppm as shown 
in Figure 3.114B.  
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A singlet signal at δ 7.12 was assigned as a hydroxyl substitution at C-14 (δ 150.7 
ppm), and correlated to ketone carbon signal at δ 183.7 ppm (C-12) by HMBC. Another 
ketone carbon at δ 185.4 ppm (C-11) was correlated to the septet at δ 3.15 ppm. Additionally, 
HMBC also displayed correlations of the septet to carbon signals at δ 150.7 ppm, and 124.6 
ppm. Methyl proton at δ 1.22 ppm (H-20) displayed a HMBC correlation to a quaternary 
carbon at δ 149.9 ppm (C-9), and also had correlations to carbon signals at δ 35.8 ppm (C-1), 
39.0 ppm (C-10), and 46.1 ppm (C-5).  
 
Figure 3.115 shows coupling pattern of H-7 at δ 5.92 ppm. It exhibited the doublet of 
doublet signal with 
3
J value 4, and 1.5 Hz which indicated the equatorial orientation. As H-5 
had an α-axial orientation; therefore, H-7 would be a β-equatorial.  
 
 
Figure 3.115 H-7 coupling pattern of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
(
1
H NMR 500 MHz; CDCl3) 
  
A 
1H signal at δ 2.71 ppm (H-1) was assigned as the β-equatorial because the vicinal 
coupling constant were 4 and 1 Hz which referred the small dihedral angle to H-2 around 60°. 
Another proton of H-2 at δ 1.72 ppm (α-equatorial) exhibited a dddd (or quartet of triplet) 
shape which resembled to a shape of a proton (H-6α-equatorial) of ferruginol as shown in 
Figure 3.107.  Certain signals of the methylene protons were overlapped; therefore, coupling 
constants were undefined. However, the orientatation (α or β) of some protons were possibly 
assigned from the shape of their signals. H-5 at δ 1.49 ppm displayed a broad doublet with 3J 
value 13 Hz. The large dihedral angle (180°) indicated the axial-axial coupling constant.  
H6
H6
C5
C8
OCCCH3
H7
H-7 
~ 60° 
~ 60° 
H-7 
3J = 4, 1.5 Hz 
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3.8.2.4  7α,14-Dihydroxy-8,13-abietadiene-11,12-dione 
The MS data of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione (Figure 3.116) gave a 
molecular mass of 332 and a molecular formula of C20H28O4. 
1
H and 
13
C NMR data are 
shown in Table 3.36 and NMR spectra are given in Appendix 26. 
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            Figure 3.116  7α,14-Dihydroxy-8,13-abietadiene-11,12-dione 
 
7α,14-Dihydroxy-8,13-abietadiene-11,12-dione and 7α-acetoxy-14-hydroxy-8,13-
abietadiene-11,12-dione occurred in the same fraction in column chromatography but were 
separated by the solubility of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione in methanol. 
NMR data of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione showed the same pattern as 7α-
acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione except for a singlet 
1H proton signal at δ 
3.00 ppm which was exchanged with D2O and a signal at δ 4.72 ppm which replaced on at δ 
5.92 ppm in 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione. Therefore, this compound 
could be comprised of a hydroxyl group at C-7 instead of acetyl group as 7α-acetoxy-14-
hydroxy-8,13-abietadiene-11,12-dione. This is confirmed by the MS data which shows a 
molecular weight of 42 mass units less than 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-
dione. 
 
Figure 3.117 shows key signals of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione. 
The hydroxyl signal at δ 3.00 ppm had a COSY correlation to H-7 at δ 4.72 ppm, also a 
HMBC correlation to C-6 at δ 25.8 ppm. In comparison with 7α-acetoxy-14-hydroxy-8,13-
abietadiene-11,12-dione, a hydroxyl group substitution caused shielded effect. C-7 and H-7 
resonated more upfield at δ 63.2 ppm, and δ 4.72 ppm respectively as opposed to δ 64.5 ppm, 
and δ 5.92 ppm in 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione.  
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Table 3.36 1D and 2D NMR data of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione (1H 500 
MHz; 
13
C 125 MHz in CDCl3; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 35.8 α1.18* - - 1.22* 
β2.70 (dt, J = 13.5, 2.5) 1.18* 
2 18.8 1.70* 
 
- - 1.46* 
1.53* - - 
3 41.0 1.46* 
 
- - 0.90 
0.98 
1.25* - - 
4 32.9 - - - 0.90 
0.98 
1.49* 
5 45.7 α1.49* 
( br d, J = 10.5) 
- - 0.90 
0.98 
1.22* 
1.60* 
1.94 
6 25.8 α1.60* 
 
1.94 4.72 1.49* 
3.00 
β1.94 ( ddd, J = 15 ) 1.60* - 
7 63.2 β4.72 
(br s, J = 3.5, 2) 
1.60* 
3.00 
1.60* 1.49* 
1.94 
α3.00 
(OH, s) 
4.72 1.60* 
7.20 
- 
8 143.2 - - - 1.94 
 
9 147.8 - - - 1.22* 
10 39.1 - - - 1.22* 
1.49* 
1.53 
1.92 
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Table 3.36 (continued)
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
11 185.0
¶
 - - - 3.15 
12 189.1
¶
 - - - 3.15 
13 124.2 - - - 1.20* 
3.15 
 
14 151.0 7.20 (OH, s) - 3.00 
4.72 
3.15 
 
15 24.0 3.15 (septet, J = 7) 1.20* 
 
1.20* 1.20* 
16 19.9
§
 1.20*  (3H, d, J = 7) 3.15 3.15 1.20* 
3.15 
17 19.8
§
 1.20* (3H) 
 
3.15 3.15 1.20* 
3.15 
18 33.1 α0.98 (3H, s) - - 0.90 
1.22* 
1.49* 
1.94 
19 21.7 β0.90 (3H, s) - - 0.98 
1.22* 
1.49 
20 18.4 1.22* (3H) - - 1.49* 
*Overlapped signal; 
¶, §
 Interchangeable 
                           
Figure 3.117 NMR assignments from salient signals of 7α,14-dihydroxy-8,13-abietadiene-
11,12-dione. H-H COSY (bold line), NOESY (dot arrow), HMBC (arrow) 
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 NMR data for 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione and 7α,14-
dihydroxy-8,13-abietadiene-11,12-dione are identical to published data for 7-O-
acetylhorminone and horminone (Table 3.37) which is usually drawn as the p-quinone 
tautomer. HMBC correlations of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
clearly exhibited the correlation of C-14 (δ 150.4 ppm) to H-7 (δ 5.92 ppm). NOESY of 
7α,14-dihydroxy-8,13-abietadiene-11,12-dione showed a correlation between the hydroxyl 
groups at C-14 (δ 7.20 ppm) and H-7 (δ 4.72 ppm). Both these observation are consistent 
with the o-quinone structures for 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione and 
7α,14-dihydroxy-8,13-abietadiene-11,12-dione which are tautomeric with 7-O-
acetylhorminone and horminone respectively. The data presented here suggests that a 
significant proportion of the equilibrium mixture exists as the o-quinone tautomer. 7-O-
Acetylhorminone and horminone have been reported in many Salvia species (Oztekin et al., 
2010). 
O
O
OH
R
H
O
O
O
R
H
H+
H
 
              
               7-Acetylhorminone: R = OCOCH3                      7α-Acetoxy-14-hydroxy-8,13- abietadiene-11,12-dione:  
                                                                                                                                                              R = OCOCH3                
                            Horminone: R = OH                               7α,14-Dihydroxy-8,13-abietadiene-11,12-dione: R = OH                                                   
 
                    Figure 3.118 Tautomers of abietane diterpenoid with quinone substitution 
 
 It is noteworthy that quinones such as these and other α,β-unsaturated carbonyl 
compounds, such as those depicted in Figure 1.25 (p 31), are efficient 1,4-Michael acceptors 
(Sharma et al., 1994) and this might explain their biological activity. In this case, a reactive 
nucleophile such as the cysteine–SH of a protein might attack at position 8 to yield a covalent 
product. As horminone is a fully substituted quinone, it is possible that this can act as a 
reversible 1,4-Michael acceptor as described by Avonto et al. (2011).   
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Table 3.37 Comparison NMR data of abietane diterpenoids with quinone substitution (δ in 
ppm) 
 
Position 7α-Acetoxy-14-
hydroxy-8,13-abieta-
diene-11,12-dione
 a 
7α,14-Dihydroxy-
8,13-abietadiene-
11,12-dione
 a 
7-O-Acetylhorminone
b
 
(Tezuka et al., 1998)
 
Horminone
b
 
(Tezuka et al., 1998)
 
δC δH δC δH δC
 δH
 δC
 δH
 
1 35.8 1.20* 35.8 1.18* 35.8 1.22  35.8 1.18  
2.71 2.70 2.73  2.70 
2 18.8 1.72 18.8 1.70* 18.8 1.75 18.9 1.73 
1.57* 1.53* 1.57  1.47 
3 41.0 1.49* 41.0 1.46* 41.0 1.49 41.1 1.56 
1.20* 1.25* 1.23 1.25 
4 32.9* - 32.9 - 33.0 - 33.0 - 
5 46.1 1.49* 45.7 1.49* 46.1 1.48 45.7 1.54 
6 24.6 1.59* 25.8 1.60* 24.6 1.61 25.8 1.61 
1.92 1.94 1.95 1.97 
7 64.5 5.92 63.2 4.72 64.5 5.94 63.2 4.73 
- 3.00 (OH) - 3.07 (OH) 
8 139.4 - 143.2 - 139.4 - 143.2 - 
9 149.9 - 147.8 - 150.0 - 147.8 - 
10 39.0 - 39.1 - 39.1 - 39.1 - 
11 183.7 - 185.0 - 183.7 - 183.9 - 
12 185.4 - 189.1 - 150.8 7.18 (OH) 151.1 7.33 (OH) 
13 124.6 - 124.2 - 124.7 - 124.2 - 
14 150.7 7.12 (OH) 151.0 7.20 (OH) 185.4 - 189.1 - 
15 24.1 3.15  24.0 3.15 24.1 3.16 24.0 3.16 
16 19.8
§
 1.20  19.9
¶
 1.20*  19.7 1.19 19.8 1.21 
17 19.7
§
 1.18 19.8
¶
 1.20*  19.9 1.23 19.9 1.22 
18 32.9* 0.88  33.1 0.98  33.0 0.89 33.1 0.98 
19 21.6 0.87  21.7 0.90  21.6 0.88 21.7 0.90 
20 18.5 1.22  18.4 1.22* 18.5 1.24 18.4 1.21 
Acetyl 
group 
169.4 - - - 169.4 - - - 
21.1 2.03  - - 21.1 2.03 - - 
*Overlapped signal; 
§  ¶ Interchangeable; 
a
 in CDCl3 500 MHz; 
b
 in CDCl3 400 MHz 
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3.8.2.5 Microstegiol 
The MS data of microstegiol (Figure 3.119) gave a molecular mass of 298 and a 
molecular formula C20H26O2. 
1
H and 
13
C NMR data are shown in Table 3.38 and NMR 
spectra are given in Appendix 27. 
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    Figure 3.119 Microstegiol 
 
 The 1H NMR, COSY, and NOESY correlations showed the characteristics of 
abietane diterpene skeleton type which are the septet signal of the methine proton at C-15, 
and two doublet signals of the methyl groups at C-16, and C-17. 
13
C spectra displayed 20 
signals with three methylene groups and eight signals of quaternary carbon atoms from 
DEPT-135. In the aromatic region, two protons coupled to each other as two doublet signals 
at δ 6.88 ppm, and 7.05 ppm (3J value 7.5 Hz). A further singlet proton signal at δ 6.95 ppm 
showed a COSY correlation to the methine proton of the isopropyl group and a NOESY 
correlation to one of the doublet pair (H-16) as shown in Figure 3.120. In addition, this 
singlet proton correlated by HMBC to a carbon signal at δ 126.7 ppm which was directly 
attached to the aromatic proton δ 6.88 ppm (HMQC) which implied that these two rings are 
attached. The signal of a quaternary carbon atom at δ 206.1 ppm pointed to a ketone carbon 
atom which correlated (HMBC) to the septet signal at δ 3.00 ppm, an aromatic proton at δ 
6.95 ppm and a singlet signal at δ 4.50 ppm which was shown to be –OH by D2O exchange. 
HMBC correlations between this singlet at δ 4.50 ppm and C-11 (δ 84.4 ppm) were also 
observed. In addition, C-11 was further correlated to two signals of methyl groups of H-18 
and H-19 by HMBC. 
    
 The aromatic proton at δ 7.05 ppm exhibited a H-H COSY correlation to a methyl 
singlet signal at δ 2.31 ppm. The rearranged abietane framework was assigned due to all 
those corresponding data. Selected 2D-NMR assignments are presented in Figures 3.120-
3.121.     
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Table 3.38 1D and 2D NMR data of microstegiol (
1
H 500 MHz; 
13
C 125 MHz in CDCl3; δ in 
ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 27.0 α2.79 
(ddd, J = 14, 6, 2.5) 
1.41 
1.78 
3.59 
2.31 0.78 
0.79 
β3.59 
(ddd, J =  14, 12, 2) 
1.41 
2.79 
2.79 
2 23.5 α1.41 (m) 1.78 
2.79 
3.59 
1.78 
4.50 
 
0.78 
0.79 
1.78 (m) 1.24* 
1.41 
2.35 
2.79 
3.59 
1.41 
3 42.9 2.35* (m) 1.41 
1.78 
- 0.78 
0.79 
2.79 1.24* (m) - - 
4 39.0 - - - 0.78 
0.79 
5 137.4 - - - 2.31 
2.79 
6.88 
6 130.1 7.05  
(d, J = 7.5) 
2.31 
6.88 
6.88 2.31 
6.88 
7 126.6 6.88  
(d, J = 7.5) 
7.05 7.05 6.95 
7.05 
8 129.0 - - - 6.95 
7.05 
9 139.3 - - - 2.79 
4.50 
6.88 
6.95 
 
  
   
  - 231 - 
Table 3.38 (continued) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
10 143.3 - - - 2.31 
2.79 
3.59 
7.05 
11 84.4 4.50 (OH, s) - - 0.78 
0.79 
12 206.1 - - - 3.00 
4.50 
6.95 
13 141.0
§
 - - - 1.14 
1.19 
3.00 
6.88 
6.95 
14 140.9
§
 6.95 (s) 3.00 1.14 
 
1.14 
1.19 
3.00 
6.88 
15 26.8 3.00  
(septet, J = 6) 
1.14 
1.19 
6.95 
1.14 
1.19 
1.14 
1.19 
16 22.1
¤
 1.14  
(3H, d, J = 7 Hz) 
- - 1.19 
3.00 
17 21.1
 ¤
 1.19  
(3H, d, J = 7) 
- - 1.14 
3.00 
18 21.4 α0.79 (3H, s) - - 0.78 
19 28.0 β0.78 (3H, s) - - 0.79 
20 21.4 2.31 (3H, s) 7.05 7.05 7.05 
* Overlapped signals; 
§ , ¤
 Interchangeable signals 
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A. H-H COSY (bold line), and NOESY (arrow) correlations 
 
                                            
                         B. H-H COSY (bold line), and HMBC (arrow) correlations 
               Figure 3.120 2D-NMR assignments from salient signals of microstegiol.  
 
13
C signals of three methylene groups correlated to 6 non-equivalent protons in 
HMQC. Four of them showed unclear coupling constants due to multiplet overlapping 
patterns. Two noticeable 
1H peaks at δ 2.79 ppm and δ 3.59 ppm belonged to non-equivalent 
proton atoms of methylene group at C-1. Each of them was coupled to only three nearby 
protons, and the signal at δ 2.79 ppm also had a NOESY correlation to a singlet signal at δ 
2.31 ppm of C-20 (Figure 3.120A). Additionally, HMBC correlations exhibited the relation 
between these two protons and C-5, C-9, and C-10 (Figure 3.120B). The proton at δ 2.79 
ppm was coupled as ddd (J = 14, 6, 2.5 Hz) while the other proton signal was at δ 3.59 ppm 
(J = 14, 12, 2 Hz). These distinctive patterns allow the configuration of these protons to be 
established as shown Figure 3.122. According to Karplus equation in rigid systems, the axial-
axial coupling constant is large in range of 9-13 Hz due to wide dihedral angle (180°). On the 
other hand, the axial-equatorial and equatorial-equatorial dihedral angle is around 60°, and 
the vicinal coupling constant is smaller in range of 2-5 Hz (Williams and Fleming, 2002).  
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The other quaternary carbon atoms at δ 39.0 ppm, 84.4 ppm, 129.0 ppm, 137.4 ppm, 
139.3 ppm, 141.0 ppm, and 143.3 ppm, were assigned according to HMBC correlations as 
shown in Figure 3.121.   
                            
     Figure 3.121 Selected HMBC correlations of microstegiol 
                        Figure 3.122 
1
H NMR splitting patterns of microstegiol (500 MHz in CDCl3) 
 
Microstegiol was first isolated from the aerial part of S. microstegia Boiss. Et Bal. 
(Ulubelen et al., 1992). It was also reported in root part of S. montbretii Benth. (Topcu and 
Ulubelen, 1996) and S. viridis L. (Ulubelen et al., 2000).  
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3.8.2.6 Compound 3 (1-Oxomicrostegiol; 10aS-8,9,10,10a-tetrahydro-10a-hydroxy-
6,10,10-trimethyl-2-(1-methylethyl)-cyclohepta[de]naphthalene-1,7-dione)  
The MS data of compound 3 (Figure 3.123) gave a molecular mass of 312 and a 
molecular formula of C20H24O3. 
1
H and 
13
C NMR data are shown in Table 3.39 and NMR 
spectra are given in Appendix 28. 
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                                           Figure 3.123A-B  Compound 3 (1-Oxomicrostegiol) 
  
 
13
C NMR displayed 20 signals, and corresponding DEPT-90 and DEPT-135 showed 
four methine groups, two methylene groups, five methyl groups and nine quaternary carbon 
atoms. Two signals of quaternary carbon atom at δ 203.5 ppm, and 207.2 ppm implied two 
ketone groups. Three aromatic protons indicated two separate conjugated ring system 
because only two aromatic protons, δ 7.20 ppm, and 7.22 ppm, are coupled to each other as 
doublet with J value 7.5 Hz. A third proton in the aromatic/alkene region gave a singlet at δ 
7.07 ppm. This was assigned as H-14 and showed an HMBC correlation to C-7 in the 
adjacent ring. In addition, the presence of two doublets of methyl group plus a septet splitting 
pattern indicated the isopropyl group of an abietane diterpenoid.  
  
 Deuterium exchange revealed a hydroxyl group peak as a singlet at δ 3.88 ppm. 
HMBC showed the correlation between a ketone peak at δ 203.5 ppm (C-12) and the 
hydroxyl signal. It also connected this ketone carbon to the proton singlet at δ 7.07 ppm (H-
14). There was a NOESY correlation between aromatic proton at δ 7.22 ppm (H-6) and 
methyl group at δ 2.34 ppm (H-20). While COSY exhibited the correlation between two 
geminal methyl group at δ 0.80 ppm (H-19), and 1.05 ppm (H-18), one of them, δ 1.05 ppm 
signal, had a NOESY correlation to the hydroxyl group as shown in Figure 3.125. All 
assignments above suggested a rearranged abietane type which is likely to be a microstegiol 
framework. Key assignments of HMBC, COSY, and NOESY are shown in Figures 3.124-
3.125.  
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Table 3.39 1D and 2D NMR data of compound 3 (1-oxomicrostegiol) (
1
H 500 MHz; 
13
C 125 
MHz in CDCl3; δ in ppm; J in Hz) 
 
Position
a
 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 207.2 - - - 3.11 
2 38.2 α3.11 
(ddd, J = 14, 11.5, 2.5) 
1.42 
1.54 
2.30 
1.05 
2.30 
0.80 
1.05 
β2.30* 
(ddd, J = 14, 5, 3) 
1.42 
1.54 
3.11 
3.11 
3 37.5 α1.42 
(ddd, J = 14, 5, 3) 
1.54 
2.30 
3.11 
- 0.80 
1.05 
β1.54* 
(dd, J = 14, 3) 
1.42 
2.30 
3.11 
- 
4 40.9 - - - 0.80 
1.08 
5 136.9 - - - 2.34 
7.20 
6 131.2 7.22 (d, J = 7.5) 2.34 2.34 2.34 
7 129.6 7.20 (d, J = 7.5) 2.34 2.34 2.34 
7.07 
8 127.6 - - - 2.34 
7.20 
7.22 
9 138.1 - - - 2.30 
2.34 
7.07 
10 137.6 - - - 2.30 
2.34 
7.20 
7.22 
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Figure 3.39 (continued) 
Position
a
 
13
C 
 
1
H 
 
COSY NOESY HMBC 
11 81.5 3.88 (OH, s) - 1.05 0.80 
1.05 
3.88 
12 203.5 - - - 3.88 
7.07 
13 141.5 - - - 1.16 
1.18 
2.98 
14 139.1 7.07 (s)  1.16 
1.18 
2.98 
7.20 
15 26.9 2.98 (septet, J = 7) 1.16 
1.18 
1.16 
1.18 
1.16 
1.18 
7.07 
16 21.9
§
 1.16 (3H, d, J = 7) - - 1.18 
2.98 
17 21.5
§
 1.18 (3H, d, J = 7) - - 1.16 
2.98 
18 17.4 α1.05 (3H, s) 0.80 0.80 
3.88 
0.80 
3.11 
19 26.9 β0.80 (3H, s) 1.05 1.05 1.05 
20 19.9 2.34 (3H, s) 7.20 
7.22 
7.20 
7.22 
7.20 
7.22 
a
Diterpenoid numbering ; * Overlapped signal; 
§
 Interchangeable 
 
 
Each proton of the methylene groups showed the three proton coupling pattern which 
implied the attachment of these two methylene groups. Furthermore, HMBC correlated 
another ketone carbon at δ 207.2 ppm (C-1) to a proton of CH2 group (H-2α), δ 3.11 ppm, 
which implied the attachment in the same ring system (Figure 3.124A). The oxo-carbon at 
position 1 was verified by the HMBC correlation between H-2β at δ 2.30 ppm and the 
aromatic carbon signal at δ 138.1 ppm (C-9).  
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 Quaternary carbon atoms were assigned according to HMBC correlations as follows: 
δ 136.9 ppm (C-5), 127.6 ppm (C-8), 138.1 ppm (C-9), 137.6 ppm (C-10), 81.5 ppm (C-11), 
and 141.5 ppm (C-13). Selected HMBC correlations are shown in Figure 3.124. 
 
      A.                                     
   
          B.                      
                            
Figure 3.124A-B Selected HMBC correlations of compound 3 (1-oxomicrostegiol) 
 
O
H3C
H3C
OH
O
CH3
H
H
H
H
CH3
CH3
H
H
7.22 
19.9 
2.34 
7.20 
7.07 
 
2.98, septet 
1.18 
1.16 
203.5 
0.80 1.05 
207.2 
139.1 
129.6 
131.2 
141.5 
138.1 
127.6 
2.30 
137.6 
3.11 
81.5 
40.9 
O
H3C
H3C
OH
O
CH3
H
H
H
H
CH3
CH3
H
H
7.22 
19.9 
2.34 
7.20 
7.07 
 
2.98, septet 
1.18 
1.16 
203.5 
0.80 
1.05 
207.2 
139.1 
129.6 
131.2 
141.5 
138.1 
127.6 2.30 
136.9 
3.11 
81.5 
37.5 
38.2 
  - 238 - 
                                
           Figure 3.125 H-H COSY (bold line), and NOESY (arrow) correlations of compound 3 
 
The 
1
H peak at 3.11 ppm as ddd (H-2α; J values = 14, 11.5, 2.5 Hz) indicated an 
axial-axial coupling pattern as shown in Figure 3.126. The α-configuration of methyl protons 
(H-19) at δ 1.05 ppm was further assigned because of a NOESY correlation to H-2α. 
 
 
 
Figure 3.126 
1
H NMR expansion of compound 3 (500 MHz; CDCl3) 
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Compound 3 was thus identified as 1-oxomicrostegiol established by its molecular 
formula C20H24O3 (MW 312) and NMR data. It is now reported here for the first time. An 
isomer of this compound, 3-oxomicrostegiol, was reported from root part of Taiwania 
cryptomerioides, family Taxodiaceae (Chyu et al., 2005). Comparison of NMR spectral data 
of microstegiol, 1-oxomicrostegiol, and 3-oxomicrostegiol are presented in Table 3.40.  
 
Table 3.40 Comparison NMR data of 1-oxomicrostegiol and related compounds (δ in ppm; J 
in Hz) 
 Microstegiol
a
 1-Oxomicrostegiol
a 
(compound 3) 
3-Oxomicrostegiol
b 
(Chyu et al., 2005) 
δC δH δC δH δC
 δH
 
1 27.0 2.79 207.2 - 24.7 3.00 
3.59  3.68 
2 23.5 1.41 38.2 3.11  40.3 3.00 
1.78 2.30* 2.48 
3 42.9 2.35*  37.5 1.42  210.5 - 
1.24*  1.54*  - 
4 39.0 - 40.9 - 55.7 - 
5 137.4 - 136.9 - 137.9 - 
6 130.1 7.05 (d, 7.5) 131.2 7.22 (d, 7.5) 130.8 7.16 (d, 7.6) 
7 126.7 6.88 (d, 7.5)  129.6 7.20 (d, 7.5) 127.5 7.00 (d, 7.6) 
8 129.0 - 127.6 - 129.1 - 
9 139.3 - 138.1 - 138.3 - 
10 143.3 - 137.6 - 140.5 - 
11 84.4 4.50 (OH, s) 81.5 3.88 (OH, s) 81.9 4.86 (OH, s) 
12 206.1 - 203.5 - 203.5 - 
13 141.0
¤
 - 141.5 - 141.2 - 
14 140.9
¤
 6.95 (s) 139.1 7.07 (s) 141.1 7.04 (d, 1.2) 
15 26.8 3.00 (septet, 6) 26.9 2.98 (septet, 7) 27.3 2.98 (septet, 7.2) 
16 22.1
§
 1.14 (d, 7) 21.9
¶
 1.16 (d, 7) 21.5 1.17 (d, 7.2) 
17 21.1
§
 1.19 (d, 7)  21.5
¶
 1.18 (d, 7) 22.0 1.20 (d, 7.2) 
18 21.4 0.79 (s) 17.4 1.05 (s) 21.4 1.00 (s) 
19 28.0 0.78 (s) 26.9 0.80 (s) 21.2 0.83 (s) 
20 21.4 2.31 (s) 19.9 2.34 (s) 21.2 2.37 (s) 
a
 500 MHz in CDCl3; 
b
 400 MHz in CDCl3; * Overlapped signal; 
§ , ¤, ¶  
Interchangeable 
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3.8.2.7 Compound 4 (viroxocane; 3,4-dihydro-11-hydroxy-10-(1-methylethyl)-2,2,6-
trimethyl-naphtha[1,8-bc]oxocin-5(2H)-one) 
The MS data of compound 4 (Figure 3.127) showed a molecular mass of 312 and a 
molecular formula of C20H24O3, and thus this compound is an isomer of compound 3. 
1
H and 
13
C NMR are shown in Table 3.41 and NMR spectra are given in Appendix 29. 
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                                          Figure 3.127A-B Compound 4 (viroxocane) 
 
 Compound 4 showed the same molecular formula as compound 3 (1-
oxomicrostegiol) but a difference in the quaternary carbon signals. There was the only one 
ketone carbon at δ 210.85 ppm, and the signal of the geminal methyl quaternary carbon atom 
(C-4) around δ 40 ppm was missing whilst a new quaternary signal was observed at δ 84.27 
ppm. 
13
C NMR displayed 20 signals comprised two methylene groups, four methine groups, 
five methyl groups, and nine quaternary carbon atoms from DEPT-90 and DEPT-135 
experiments. The COSY and NOESY correlations of a septet signal at δ 3.34 ppm, and two 
doublets of methyl groups indicated the presence of an isopropyl side chain. The correlations 
between three aromatic protons at δ 7.11 ppm, 7.61 ppm, and 7.41 ppm implied two adjacent 
aromatic rings (Figure 3.128).  
 
   Compound 4 also showed a NOESY correlation between an aromatic proton (H-6) 
at δ 7.11 ppm and a methyl group (H-20) at δ 2.33 ppm (Figure 3.128A). Furthermore, the 
only ketone carbon at δ 210.85 ppm correlated to a methylene proton at δ 2.60 ppm by 
HMBC (Figure 3.129). All the above implied a rearranged abietane type which is likely an 
isomer of 1-oxomicrostegiol. In addition, a 
1
H peak at δ 5.90 ppm showed no HMQC 
correlation, and disappeared on D2O exchange. It was assigned as a hydroxyl substitution 
group at C-12 (δ 147.38 ppm).  
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Table 3.41 1D and 2D NMR data of compound 4 (
1
H 500 MHz; 
13
C 125 MHz in CDCl3, δ in 
ppm; J in Hz) 
 
Position
a
 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 210.85 - - - 2.60 
2 41.20 α3.02 
(ddd, J = 14, 10.5, 3.5) 
 
1.60* 
2.17 
2.60 
1.60* 
2.60 
- 
β2.60 
(ddd, J = 14, 4, 4) 
1.60* 
2.17 
3.02 
1.60* 
3.02 
3 35.10 α1.60* (m) 2.17 
2.60 
3.02 
2.13 
3.02 
 
1.23 
1.60* 
1.62 
2.60 β2.17 
(ddd, J = 14, 10.8, 4) 
 
1.60* 
2.60 
3.02 
1.60* 
1.62 
4 84.27 - - - 1.23 
1.62 
5 130.37 - - - 2.33 
7.61 
6 126.27 7.11 
(d, J = 8) 
7.61 2.33 
7.61 
2.33 
7.11 
7.41 
7.61 
7 128.15 7.61 
(d, J = 8) 
7.11 7.11 2.33 
7.41 
8 126.77
¤
 - - - 7.41 
9 126.96
¤
 - - - 7.41 
10 132.20
¶
 - - - 2.33 
5.90 
7.11 
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Table 3.41 (continued) 
 
   
Position
a
 
13
C 
 
1
H 
 
COSY NOESY HMBC 
11 132.08
¶
 - - - 2.33 
5.90 
7.11 
7.41 
12 147.38 5.90 (OH, s) - - 5.90 
7.41 
13 136.58 - - - 1.28 
1.33 
3.34 
5.90 
14 121.16 7.41 (s) - 1.28 
1.33 
7.61 
3.34 
7.61 
15 27.82 3.34 
(septet, J = 7) 
1.28 
1.33 
1.28 
1.33 
1.28 
1.33 
7.41 
16 22.33
§
 1.33  
(3H, d, J = 7) 
- - 1.28 
3.34 
17 22.29
§
 1.28 
(3H, d, J = 7) 
- - 1.33 
3.34 
18 
 
26.02 α1.23 (3H, s) 1.62 - 1.60* 
1.62 
19 26.24 β1.62 (3H, s) 1.23 
2.17 
2.30 
3.02 
2.17 1.23 
20 18.89 2.33 (3H, s) 1.60* 1.60* 
7.11 
7.11 
a
Diterpenoid numbering; *Overlapped signal, 
¤ , §, ¶ Interchangeable  
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A. H-H COSY (bold line), and NOESY (arrow) correlations 
                                                                
B. HMBC correlations 
                 Figure 3.128 1D and 2D NMR assignments from salient signals of compound 4 
 
 Four 
1
H signals of the two methylene groups indicated four non-equivalent protons. 
The ddd proton signal at δ 3.02 ppm was coupled to three protons nearby with coupling 
constant 14 Hz, 10.5 Hz, and 3.5 Hz. Both COSY correlations of these four protons and the 
coupling patterns indicated the adjacent attachment of two methylene groups (Figure 
3.128A). The large coupling constants, 14 Hz, and 10.5 Hz inferred the geminal coupling and 
an axial-axial coupling constant respectively. In contrast, the geminal proton at δ 2.60 ppm, 
showed two smaller vicinal coupling constants at 4 Hz, and 4 Hz which implied the 
equatorial-axial coupling constant as described above from 1-oxomicrostegiol (Figure 3.126). 
In addition, H-3β at δ 2.17 ppm showed NOESY correlation to methyl protons at δ 1.62 ppm 
(H-18β). Therefore, the two protons (H-2) at δ 3.02 ppm, and 2.60 ppm were further assigned 
as H-2α (axial), and H-2β (equatorial) respectively.  
1.28 
5.90 
O
H3C
CH3
O
OH
CH3
H3C
H
H
H
CH3
7.11 
2.33 
18.89 
7.61 
27.82 
1.23 
210.85 
126.27 
84.27 
7.41 
1.62 
121.16 
128.15 
136.58 
1.33 
7.11 
2.33 
18.89 
7.61 
3.34, septet 
1.28 
1.33 
1.62 
210.85 
126.27 
7.41 
1.23 
121.16 
128.15 
O
H3C
CH3
O
OH
CH3
H3C
H
H
H
H
CH3
H
H
H
H
2.17 
  - 244 - 
 The quaternary carbon atom at δ 84.27 ppm was assigned to the C-4 position because 
it had HMBC correlation to two methyl groups at δ 1.62 ppm, and 1.23 ppm (Figure 3.128B). 
However, the C-4 chemical shifts of microstegiol and 1-oxomicrostegiol are at δ 39.0 ppm, 
and 40.9 respectively (Table 3.40). The higher value indicates attachment to an 
electronegative atom which induces the deshielded effect. Quaternary carbon atoms were 
assigned by HMBC correlation as shown in Figure 3.129.  
                     
           Figure 3.129 Selected HMBC correlations of compound 4 
 
Compound 4 was thus identified as viroxocane established by its molecular formula 
C20H24O3 (MW 312) and NMR data. It is now reported here for the first time. A derivative of 
compound 4, rabdosin D, was recently isolated from whole plant part of Rabdosia 
iophanthides (Buch.-Ham. Ex. D. Don) Hara. var. gerardiana (Benth.) Hara. in this family 
(Li et al., 2010). Another one, 10-isopropyl-2,2,6-trimethyl-2,3,4,5- tetrahydronaphtha-[1,8-
bc]oxocine-5,11-diol, was reported from the roots and rhizomes of Nardostachys chinensis 
Batalin, family Valerianaceae (Zhang et al., 2005). Comparison of NMR data of compound 4 
and its derivatives are shown in Table 3.42. 
                
O
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O
HO
OH
 
                         Rabdosin D                             10-isopropyl-2,2,6-trimethyl-2,3,4,5-     
                                                                                tetrahydronaphtha[1,8-bc]oxocin-5,11-diol 
                            Figure 3.130 Derivatives of compound 4  
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Table 3.42 Comparison NMR data of compound 4 and its derivatives (δ in ppm; J in Hz)  
 
Position Compound 4
a 
 
Rabdosin D
b 
(Li et al., 2010) 
10-isopropyl-2,2 6-trimethyl-2, 3, 
4, 5- tetrahydronaphtha-[1, 8-
bc]oxocine-5,11-diol
c
 
(Zhang et al., 2005) 
δC δH δC δH δC
 δH
 
1 210.85 - 210.2 - 69.8 5.46  
(dd, 6.6, 1.2) 
2 41.20 α3.02 (ddd, 14, 
10.5, 3.5) 
41.2 3.01  
(td, 14.7, 3.6) 
30.6 2.03 (m) 
β2.60   
(ddd, 14, 4, 4) 
2.56   
(dt, 15, 4.2) 
2.41 (m) 
3 35.10 α1.60* (m) 35.4 1.56-1.60 (m) 34.9 1.42 (m) 
β2.17   
(ddd, 14, 10.8, 4) 
2.07  
( td, 14.6, 3.5) 
1.60 (m) 
4 84.27 - 84.3 - 85.1 - 
5 130.37 - 131.2 - 132.8 - 
6 126.27 7.11 (d, 8 ) 126.6 7.03 (d, 8.4 ) 127.1 7.08 (d, 8.4) 
7 128.15 7.61 (d, 8) 128.6 7.50 (d, 8.4 ) 128.4 7.56 (d, 8.4) 
8 126.77
¤
 - 126.1 - 129.0 - 
9 126.96
¤
 - 128.2 - 128.1 - 
10 132.20
¶
 - 132.3 - 131.6 - 
11 132.08
¶
 - 133.4 - 131.6 - 
12 147.38 - 147.4 - 148.9 - 
13 136.58 - 134.5 - 136.4 - 
14 121.16 7.41 (s) 120.8 7.43 (s) 123.2 7.45 (s) 
15 27.82 3.34 (septet, 7) 73.6 - 28.1 3.33 (m) 
16 22.33
§
 1.33 (d, 7) 29.5 1.73 (s) 22.5 1.31 (d, 6.6) 
17 22.29
§
 1.28 (d, 7) 29.3 1.68 (s) 22.5 1.34 (d, 6.6) 
18 26.02 α1.23 (s) 25.8 1.24 (s) 26.1 1.21 (s) 
19 26.24 β1.62 (s) 26.1 1.61 (s) 25.6 1.72 (s) 
20 18.89 2.33 (s) 19.0 2.32 (s) 21.1 2.29 (s) 
a
500 MHz for 
1
H, 125 MHz for 
13
C in CDCl3 ; 
b
400 MHz for 
1
H, 100 MHz for 
13
C in CDCl3 
c
600 MHz for 
1
H, 150 MHz for 
13
C in CDCl3 ; 
*
Overlapped signal;  
¤ , ¶, § Interchangeable  
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3.8.2.8 Compound 5 (viridoquinone; 5-Methyl-20-nor-abieta-1(10),6,8,13-tetraen-11,12-
dione) 
The MS data of compound 5 (Figure 3.131) showed a molecular mass of 296 and a 
molecular formula of C20H24O2. 
1
H and 
13
C NMR data are shown in Table 3.43 and NMR 
spectra are given in Appendix 30. 
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               Figure 3.131 Compound 5 (viridoquinone) 
 
13
C NMR displayed 20 signals, and DEPT-135 showed two methylene groups, eight 
quaternary carbon atoms, and 10 signals of methine and methyl groups. There were four 
1
H 
signals that resonated in aromatic and alkene region, δ 5.97 ppm (d), 6.46 ppm (d), 6.58 ppm 
(s) and 6.72 ppm (t). 
1
H NMR also showed the septet methine and a pair of doublet methyl 
groups which had correlations to each other. The presence of the isopropyl side chain and 
five methyl groups implied the abietane diterpenoid skeleton.  
 
As double-bond equivalents (DBE) of the formula C20H24O2 are nine, the structure 
must be an abietane diterpenoid plus 6 double bonds. Two doublet signals, δ 5.97 ppm (H-7) 
and 6.46 ppm (H-6) were coupled to each other with coupling constant 9.5 Hz. NOESY 
correlated the signal of δ 5.97 ppm (H-7) to a singlet signal at δ 6.58 ppm (H-14) which 
indicated adjacent rings (Figure 3.132A). There were also two quaternary carbon signals at δ 
180.53 ppm, and δ 180.48 ppm which had a HMBC correlation to 1H signal δ 6.58 ppm (H-
14) as shown in Figure 3.132B. In addition, HMBC also correlated the signal C-14 (δ 137.01 
ppm) to the septet signal at δ 2.95 ppm (H-15).  
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Table 3.43 1D and 2D NMR data of compound 5 (
1
H 500 MHz; 
13
C 125 MHz in CDCl3; δ in 
ppm; J in Hz) 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
1 134.35 6.72 (t, J = 4.50) 2.30* 2.30* 2.30* 
2 23.84 2.30* (m) 1.26* 
1.86 
2.30* 
0.91 
1.26* 
1.86 
6.72 
0.91 
1.02 
1.86 
6.72 
2.30* (m) 
3 31.83 β1.86  
(ddd, J = 14, 10, 5) 
1.26* 
2.30* 
 
1.02 
1.08 
1.26* 
2.30* 
0.91 
1.02 
2.30* 
 
α1.26* (m) 1.86 
2.30* 
2.30* 
 
4 33.10 - - - 0.91 
1.02 
1.08 
1.86 
2.30* 
6.46 
5 43.37 - - - 0.91 
1.02 
1.08 
5.97 
6.46 
6 146.57 6.46 (d, J = 9.5) 5.97 0.91 
1.02 
1.08 
5.97 
1.08 
6.58 
7 123.90 5.97 (d, J = 9.5) 6.46 6.46 
6.58 
6.58 
8 137.17
ψ
 - - - 2.30* 
5.97 
6.46 
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Table 3.43 (continued) 
 
   
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
9 125.41 - - - 2.30* 
5.97 
6.58 
6.72 
10 132.44 - - - 1.08 
2.30* 
6.46 
11 180.53
¤
 - - - 6.58 
12 180.48
¤
 - - - 6.58 
13 146.90 - - - 1.10 
1.12 
2.95 
14 137.01
ψ
 6.58 (s) - 5.97 
1.10 
1.12 
2.95 
5.97 
6.46 
15 27.18 2.95 (septet, J = 6) 1.10 
1.12 
1.10 
1.12 
1.10 
1.12 
6.58 
16 21.55
§
 1.12 (3H, d, J = 7) 2.95 2.95 1.10 
2.95 
17 21.41
§
 1.10 (3H, d, J = 7) 2.95 2.95 1.12 
2.95 
18 25.74 α0.91 (3H, s) 1.02 6.46 1.02 
1.86 
19 24.51 β1.02 (3H, s) 0.91 6.46 0.91 
20 23.44 β1.08 (3H, s) - 6.46 2.30* 
6.72 
*Overlapped signal; 
ψ, ¤ , § 
Interchangeable  
 
 
The remaining 
1H signal at δ 6.72 ppm showed no correlation to those described 
signals above. However, it resonated as triplet signal with coupling constant 4.50 Hz which 
referred to another two protons nearby. COSY, NOESY, and HMBC showed a strong 
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correlation of this triplet to methylene protons at δ 2.30 ppm (Figure 3.132A) which also 
showed a HMBC correlation to an adjacent methylene carbon signal at δ 31.83 ppm. The 
alkene proton at δ 6.72 ppm was accordingly assigned to H-1 and the double bond as Δ1(10). 
This implied that the C-20 methyl group, normally located at C-10 had been shifted. 
 
Unlike the typical abietane type, a methyl singlet proton at δ 1.08 ppm (H-20) had a 
NOESY correlation to the alkene proton H-6 (δ 6.46 ppm) while C-20 (δ 23.44 ppm) still had 
HMBC correlation to methylene protons at δ 2.30 ppm. This observation suggested the 
rearrange diterpenoid with the substitution of C-20 at C-5 instead of C-10. Figure 3.132 
shows salient correlations of this compound.   
 
                  
 
A. H-H COSY (bold line), and NOESY (arrow) correlations 
  
                          
B. HMBC correlations 
 
Figure 3.132 A-B NMR assignments from salient signals of compound 5  
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 A quaternary carbon atom at δ 33.10 ppm (C-4) had HMBC correlations to three 
methyl signals, and also H-6 and H-7. A deshielded quaternary carbon atom at δ 146.90 ppm 
was assigned as C-13 due to HMBC correlation to isopropyl side chain, H-14, H-15, and H-
16. C-9 at δ 125.41 ppm had a long range HMBC correlation to methelene protons at δ 2.30 
ppm (H-2), and also to a singlet proton H-14. Figure 3.133 shows assigned HMBC 
correlations of compound 5. 
                          
   Figure 3.133 Selected HMBC (arrow), and NOESY (dot arrow) correlation of compound 5 
 
 Two carbon signals at δ 23.84 ppm, and 31.83 ppm were assigned as C-2, and C-3 
respectively from NOESY and HMBC correlations. These two methylene groups comprised 
four non-equivalent protons. The coupling constants of H-2 were not determined due to the 
overlapping signals. However, one of H-3, δ 1.86 ppm, showed the coupling pattern as ddd 
with J values 14, 10 and 5 Hz. The large vicinal coupling constant indicated the axial-axial 
orientation to an adjacent proton. In addition, there were NOESY correlations between H3-19, 
H3-20, and H-3 which implied the β-axial orientation of signal H-3 at δ 1.86 ppm. 
 
Compound 5 was thus identified as viridoquinone established by its molecular 
formula C20H24O2 (MW 296) and NMR data. It is now reported here for the first time. A 
related skeleton of compound 5, salviskinone A, was recently reported from roots of S. 
przewalskii Maxim. (Ohsaki et al., 2011). It comprises p-quinone and a hydroxyl group as 
shown in Figure 3.134. NMR data are compared in Table 3.44. 
CH3
O
O
H3C CH3
CH3
H
H
H
H
H
H
H
H
H
CH3
1.12 
21.55 
1.10 
21.41 
2.95, 
septet 
27.18 
6.58 
5.97 
6.46 
1.08 
23.44 
1.02 
24.51 
0.91 
25.74 
2.30 
2.30 
6.72 
1.86 
1.26 
146.90 
125.41 
137.17 
132.44 
43.37 
33.10 
31.83 
134.35 
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OH
O
O
 
                                                   Figure 3.134 Salviskinone A 
 
Table 3.44 Comparison NMR data of compound 5 and salviskinone A (in CDCL3; δ in ppm; 
J in Hz) 
Position Compound 5 Salviskinone A 
(Ohsaki et al., 2011)
 
δC δH δC
 δH
 
1 134.35 6.72 (t, J = 4.5) 137.1 6.85 (t, J = 4.2) 
2 23.84 2.30* (m) 24.2 2.33 (m) 
2.30* (m) 2.33 (m) 
3 31.83 α1.26* (m) 31.8 α1.27 (m) 
β1.86  
(ddd, J = 14, 10, 5) 
β1.88  
(ddd, J = 13.8,10.6, 7.4) 
4 33.10 - 33.0 - 
5 43.37 - 43.5 - 
6 146.57 6.46 (d, J = 9.5) 144.6 6.46 (dd, J = 10, 0.7) 
7 123.90 5.97 (d, J = 9.5) 117.5 6.66 (br d, J = 10) 
8 137.17
ψ
 - 133.4 - 
9 125.41 - 126.2 - 
10 132.44 - 131.6 - 
11 180.53
¤
 - 183.5 - 
12 180.48
¤
 - 151.1 - 
13 146.90 - 123.3 - 
14 137.01
ψ
 6.58 (s) 185.7 - 
15 27.18 2.95 (septet, J = 6) 24.2 3.22 (septet, J = 7.1) 
16 21.55
§
 1.12 (d, J = 7) 19.8 1.24 (d, J = 7.1) 
17 21.41
§
 1.10 (d, J = 7) 19.9 1.24 (d, J = 7.1) 
18 25.74 α0.91 (s) 25.6 α0.90 ( br s) 
19 24.51 β1.02 (s) 24.5 β1.03 (s) 
20 23.44 β1.08 (s) 23.2 β1.08 (s) 
*Overlapped signal; 
ψ ,¤ , § 
Interchangeable 
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3.8.3 Miscellaneous 
3.8.3.1 A mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates  
GC-CI-MS analysis of this compound was carried out by the EPSRC National Mass 
Spectrometry Service Centre, School of Medicine, University of Swansea. GC-CI data of this 
sample gave three main components of molecular mass 460, 488 and 516 which 
corresponded to molecular formula C30H52O3, C32H56O3 and C34H60O3 respectively (Figure 
3.135). 
1
H and 
13
C NMR data are shown in Table 3.45 and NMR spectra are given in 
Appendix 31.  
 
                                       
O
O
O
1' 1
4'
2
6'
3'
2'
5'
m
n
    
 
Figure 3.135  2-(4'-alkoxyphenyl) ethyl alkanoate; where m and n are the number of 
methylene groups of each chain. GC-CI denoted that m+n were 19 for C30H52O3, 21 for 
C32H56O3 and 23 for C34H60O3.  
 
 
1
H NMR exhibited five triplet signals, two doublet signals and peaks in alkane region 
as shown in Figure 3.136. The pair of doublets had COSY and NOESY correlations, and they 
were coupled to each other with 
3
J value 8.5 Hz. 
13
C NMR and DEPT-135 displayed two 
signals of methine groups at δ 115.28 ppm and 130.04 ppm which had cross-peaks to those 
doublets by HMQC at δ 6.75 ppm and 7.07 ppm respectively. The coupling pattern and 2D-
NMR correlations implied the para-substitution at an aromatic ring. The chemical shifts of 
these protons were shielded with respect to benzene which implied the presence of a 
shielding substituent. 
 
 
1H NMR displayed four triplets of methylene signals at δ 2.27 ppm, 2.85 ppm, 3.64 
ppm and 4.63 ppm. Two of them, δ 2.85 ppm and 4.23 ppm had COSY, NOESY, HMBC 
correlations, and were coupled to each other with 
3
J value 7 Hz. Moreover, the triplet signal 
at δ 2.85 ppm had a HMBC crossed-peak to the aromatic proton at δ 7.07 ppm while the 
other at δ 4.23 ppm had a HMBC correlation to the only carbonyl carbon at δ 173.85 ppm. 
These observations implied the attachment of an ester bond to a side chain C2H4 of an 
aromatic ring. Therefore, two signals at δ 2.85 ppm and 4.23 ppm was assigned H-2 and H-1 
respectively.  
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The carbonyl signal at δ 173.85 ppm (C-α-alkanoate) also had a HMBC correlation 
to a triplet signal of methylene protons at δ 2.27 ppm. This triplet was correlated to an alkane 
signal at δ 1.56 ppm by COSY and NOESY correlations which further had COSY and 
NOESY correlations to another alkane signal at δ 1.25 ppm. These two broad singlets were 
correlated to a group of carbon signals around δ 29-30 ppm by HMQC which were observed 
as methylene carbons by DEPT-135 NMR.  
 Figure 3.136 
1
H NMR of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (500 MHz;  
CDCl3) 
 
 A triplet signal at δ 3.64 ppm showed no correlation to the other triplets but a broad 
singlet of alkane signals at δ 1.56 ppm. The downfield chemical shift referred an attachment 
to an electronegative atom and this was considered to be an oxygen atom directly attached to 
the aromatic ring and responsible for the shielding noted above. The integration of an upfield 
triplet at δ 0.88 ppm was shown as two methyl groups (6H). These observations suggested 
two alkane chains, one substituted via an ether link to the aromatic ring and the other as part 
of an alkanoate acyl moiety.  
                   
              
                   Figure 3.137 Salient correlations of 2-(4'-alkoxyphenyl) ethyl alkanoate                              
                         H-H COSY (bold line), NOESY (dot arrow), HMBC (arrow) 
 
 A fatty acid ester, 2-(4'-pentoxyphenyl) ethyl stearate, was reported from leaves and 
stems of Stemodia foliosa Benth (Scrophulariaceae) (Silva et al., 2002). In addition, a 
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phenolic ester, p-hydroxyphenylethyl docosanate was also found in the aerial of Salvia 
cedronella Boiss. (Yesilyurt et al., 2008). NMR data of this compound were identical to those 
published literature. 
 
Table 3.45 1D and 2D NMR data of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (
1
H, 
500 MHz; 
13
C, 125 MHz; CDCl3; δ in ppm; J in Hz) 
 
Position 
13
C 
 
1
H 
 
COSY NOESY HMBC 
α-alkanoate 173.85 - - - 2.27 
4.23 
β-alkanoate 34.26 2.27 (2H, t, J = 7.5) 1.56* 1.56* - 
γ-alkanoate 24.94 1.56* (2H) 1.25* 
2.27 
1.25* 
2.27 
1.25* 
2.27 
-CH2-of alkanoate 29.45 1.25*  0.88 * 0.88 
-CH3 of alkanoate 14.11 0.88 (3H, t, J = 7) 1.25* - 1.25* 
1' 130.04* - - - 2.85 
4.23 
6.75 
7.07 
2', 6' 130.04* 7.07 (d, J = 8.5) 6.75 6.75 2.85 
4.23 
6.75 
7.07 
3', 5' 115.28 6.75 (d, J = 8.5) 7.07 7.07 6.75 
4' 154.16 - - - 6.75 
7.07 
1 34.34 2.85 (t, J = 7) 4.23 4.23 4.23 
7.07 
2 64.89 4.23 (t, J = 7) 2.85 2.85 2.85 
α-alkoxy 63.12 3.64 (t, J = 6.5) 1.56* 1.56* 1.56* 
β-alkoxy 32.80 1.56* (2H) 3.64 1.25* 3.64 
-CH2- of alkoxy 22.68 1.25-1.31*  0.88 * 0.88 
1.25* 
-CH3 of alkoxy 14.11 0.88 (3H, t, J = 7) 1.25* - 1.25* 
*Overlapped signal 
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Chapter 4 
In vitro testing: the protective effect of caffeic acid derivatives 
against UVA induced damage in human skin fibroblasts 
 
 
4.1 Introduction 
Solar light is the main source of the radiation which can be subdivided into three 
ranges of wavelengths; ultraviolet (190-400 nm), visible (400-780 nm), and infrared (780-
5000 nm) radiations (Gasparro et al., 1998). More than 90% of the ultraviolet radiation in 
sunlight that reaches the earth is UVA (wavelength 320-400nm) whilst the rest is UVB 
(wavelength 290-320 nm) (Svobodova et al., 2003). Because the shorter wavelength radiation 
up to 310 nm can be absorbed by the ozone layer, UVC (wavelength 190-290 nm) is entirely 
filtered out (De Gruijl and Van de Leun, 2000). However, both UVA and UVB are 
potentially harmful to human health, particularly the skin (Svobodova et al., 2003). Human 
skin is the first barrier that comes into contact with the radiation. Acute responses include 
sunburn, pigmentation, hyperplasia and immunosuppression while the delayed effects such as 
skin ageing and cancer may occur due to chronic exposure. Nevertheless, those effects are 
subject to dose, time and wavelength (Gasparro et al., 1998). The intensity of radiation also 
varies according to latitude, altitude, season, time of day and surface reflections (Diffey, 
2002). During a clear summer’s day, 50-60% UV exposure occurs in the 4 hour period 
around noon (Diffey, 2002). UVB is considered highest during 11.00-15.00 on a daily basis 
while the UVA intensity is consistent throughout the day compared to UVB (Gasparro et al., 
1998).  
 
Biological peroxides, for instance, superoxide anion (O2·
-
) arise from the electron 
transport system in mitochodria and the enzyme xanthine oxidase (XO) (Trenam et al., 1992) 
and occur during cellular respiration and cell signaling mechanisms in all cells (Perron and 
Brumaghim, 2009). Reactive oxygen and nitrogen species can also be generated by skin cells, 
keratinocytes, fibroblasts, macrophages and melanocytes to carry out certain roles in 
physiological processes (Korkina and Pastore, 2008). These free radicals are automatically 
quenched by defense mechanisms with the aid of the natural antioxidants as shown in Figure 
4.1.  
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                    Figure 4.1 Reactive oxygen species (ROS) pathways 
 
Superoxide dismutase (SOD) can convert superoxide anion (O2·
-
) to H2O2 which is 
subsequently degraded by glutathione (GSH) system and enzyme catalase into water (Bickers 
and Athar, 2006). Superoxide anion and hydrogen peroxide are less reactive compared to the 
hydroxyl radical (·OH) (Trenam et al., 1992) which can be generated from H2O2 by cellular 
reductants (NADH) involving iron (Perron and Brumaghim, 2009). The highly active 
hydroxyl radical reacts with lipid in plasma membrane and initiates the lipid peroxidation 
process (Bickers and Athar, 2006).  
 
After UVA exposure, reactive oxygen species (ROS) such as singlet oxygen (
1
O2) are 
generated and promote biological damage to lipids and proteins in human skin fibroblasts 
(Vile and Tyrrell, 1995). In addition, the oxidative induction of heme oxygenase-1(HO-1), an 
anti-inflammatory inducible enzyme in mammalian skin, related to glutathione depletion 
level and singlet oxygen was observed after UVA irradiation (Tyrrell and Reeve, 2006). The 
transcriptional activation of HO-1 is considered as a marker of oxidative stress (Pourzand and 
Tyrrell, 1999). UVA also stimulated the degradation of the iron storage protein ferritin 
leading to iron release which could further initiate free radicals and induce oxidative damage 
to skin (Pourzand et al., 1999). The increase of the intracellular labile iron pool from UVA 
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induced membrane damage could lead to necrotic cell death in both fibroblast and 
keratinocyte skin cells (Zhong et al., 2004). Excess free iron could also impair the function of 
cells, tissues, and organs which cause iron-loading diseases such as β-thalassemia 
(Kalinowski and Richardson, 2005). 
 
In the skin, natural antioxidants are distributed in the epidermal layer with the highest 
concentration in the deepest stratum corneum. The uppermost layer comprises mostly lipid 
soluble compounds, for instance, vitamin E, squalene, sterols and ubiquinol while water-
soluble molecules such as vitamin C, glutathione and uric acid as well as the antioxidant 
enzymes, i.e. catalase, glutathione peroxidase, and superoxide dismutase (SOD) are 
underneath (Korkina and Pastore, 2008). Shindo et al. (1993) reported the reduction of 
epidermal and dermal catalase and superoxide dismutase activities and reduced levels of α-
tocopherol, ubiquinol, ascorbic acid and reduced glutathione after UV irradiation in mice. 
Exogeneous antioxidants are required for protection if the decrease in endogeneous 
antioxidant levels allows a significant level of endogeneous reactive oxygen species (ROS), 
and hydroxyl radical formation (Trenam et al., 1992).  
 
Radical scavenging activity and metal chelating activity of polyphenols have been 
extensively reported (Moridani et al., 2003; Psotova et al., 2003; Perron and Brumaghim, 
2009). Both Fe(II) and Fe(III) can form complexes to deprotonated polyphenol ligands but 
Fe(III)-ligand complex was found to posses a greater stability over Fe(II) (Perron and 
Brumaghim, 2009). Figure 4.2 shows the octahedral geometry of the catechol-iron complex 
with three catechol groups to each ferric ion.  
 
  
 
Figure 4.2 Proposed a catechol-iron complex 
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In this present phytochemical study, certain polyphenolic compounds were isolated 
from S. viridis L. cv. Blue Jeans that included verbascoside, rosmarinic acid, and caffeic acid. 
Many findings have showed the radical scavenging activity of verbascoside (Gao et al., 1999; 
Chiou et al., 2004; Obied et al., 2009). It was reported to protect against DNA damage from 
iron (II) and H2O2 by forming an iron-ligand complex (Zhao et al., 2005). Verbascoside 
protection against UVC induced necrosis was observed in keratinocytes cells (Pastore et al., 
2009). Rosmarinic acid has also been reported to possess photoprotective properties on 
human keratinocytes against UVA (Psotova et al., 2006).   
 
UV exposure affects keratinocytes in the epidermal skin layer as well as fibroblasts 
in the dermal connective tissue which may contribute to premature skin ageing (Fisher et al, 
1997). Human skin has more extensive contact with UVA than with UVB or UVC. UVA can 
penetrate deeper into the dermal layer unlike UVB which is limited only to the epidermis 
(Tyrrell and Reeve, 2006). Accordingly, three isolated phenolic compounds of this plant, 
verbascoside, caffeic acid, and rosmarinic acid, were evaluated for their protective effect 
against UVA induced cell damage in human skin fibroblasts (FEK4) pretreated with those 
compounds.  
 
 
4.2 Materials 
4.2.1 Cell cultures 
Human primary foreskin fibroblasts (FEK4 cells) were received from Professor Rex 
M. Tyrrell (University of Bath). Passages 11-16 of the FEK4 were employed in all 
experiments.  
 
4.2.2 Chemicals 
100% Ethanol was purchased from Fisher. Annexin V-FITC Apoptosis detection kit, 
sterile DMSO, and MTT were supplied from Sigma-Aldrich. Trypsin, Phosphate buffered 
saline (PBS), Earle’s modified minimum essential medium (EMEM), 0.25% sodium 
bicarbonate, 2 mM L-glutamine and 50 IU/ml penicillin/ streptomycin (P/S) were obtained 
from Gibco (Germany). Foetal Calf Serum (FCS) was purchased from PAA Laboratories 
(Austria). Water was purified by Milli Q Plus PF.  
 
 
  - 259 - 
4.2.3 Tested compounds 
Desferrioxamine mesylate (DFO) was purchased from Ciba-Geigy laboratories 
(Basel, Switzerland). Rosmarinic acid, caffeic acid, and hemin were commercially supplied 
from Sigma-Aldrich. Verbascoside was isolated from the aerial part of S. viridis L. cv. Blue 
Jeans as described in Chapter 2. The purity of verbascoside was more than 95% monitored by 
1
H NMR (400 MHz).  
 
4.3 Experimental 
4.3.1 Cell culture preparation procedures 
  All procedures were carried out under sterile conditions and equipment and fume 
cupboard were sterilized by spraying with 70% Ethanol. The FEK4 cell line was cultured and 
incubated in a humidified atmosphere at 37ºC with 5% CO2. The FEK4 growth medium 
comprised 15% FCS, 10% EMEM, 2.7% sodium bicarbonate (0.25%), 1% L-glutamine (2 
mM), 0.5% P/S (50 IU/ml), and 70.8% water.  
 
4.3.1.1 Seeding FEK4 cells 
A flask containing medium and FEK4 cells was placed in the fume cupboard and all 
the medium removed by aspiration. The cells remained adhered within the flask and were 
washed with 2 x 5 ml of PBS. 2.5 ml of 0.25% Trypsin solution was then added into the 
flask, and the flask incubated to allow all cells to detach. After 10 minutes incubation time, 
the cells were observed under a microscope to ensure that they were completely detached.  
Immediately, 5 ml of medium was added into the flask and the whole contents transferred to 
a falcon tube. This was centrifuged at 1200 rpm for 5 minutes. The medium was aspirated out 
without touching the pellet at the bottom of the tube which was carefully resuspended in 8 ml 
of medium to seed. 
     
In order to control the quantity of cells on each plate, a haemocytometer was 
employed to determine cell number before seeding. Fifty µl of the mixture of resuspened 
cells and 50 µl Trypan Blue dye were added into an eppendorf tube and mixed thoroughly. 
Fifty µl of that mixture were dropped on to a haemocytometer slide, and observed under a 
microscope. The volume of cell suspension required for seeding the plate was calculated 
according to the number of cells counted per ml. The FEK4 were seeded onto the sterile 
plates as follows: 50000 cells to a 3 cm plate with 2.5 ml medium for cytotoxic, MTT and 
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neutral red assays and 120,000 cells to a 10 cm plate with 12 ml medium for flow cytometric 
analysis.  
 
4.3.1.2 Adding compounds 
Compounds were added into the medium 48 h after seeding. DFO was dissolved in 
water as positive control. Rosmarinic acid, caffeic acid and verbascoside were dissolved in 
DMSO. The final concentration of DMSO in the culture medium was less than 0.1%. 
 
Under sterile conditions, the seeded plates were brought into the fume cupboard and 
the culture medium collected into a falcon tube. Compounds were added into the collected 
medium to the appropriate concentration. Two ml of medium with each compound was added 
back to each plate. All plates were further incubated for 18 h at 37ºC.  
   
4.3.1.3 UVA treatment 
All irradiations were performed with a broad-spectrum Sellas 4kW UVA lamp 
emission range 350-400 nm (Sellas, Germany). The UVA doses were measured using an 
IL1700 radiometer (International Light, Newbury, MA). Prior to irradiation, the medium 
from each plate was separately collected into a falcon tube. Then, all plates were washed by 2 
ml PBS and 1 ml fresh PBS was added into each plate in order to maintain isotonic 
conditions during irradiation. Three sets of plates were treated with the same amount of each 
compound for 3 doses of UVA 0, 250, and 500 kJ/m
2
. After irradiation, the PBS was 
aspirated out, and 2 ml of medium with compound from the falcon tube was added back into 
each plate. All plates were further incubated for a specific time post UVA treatment, e.g. 4 h 
and 24 h before performing an assay. 
 
 
4.3.2 Cytotoxic testing 
Three compounds, verbascoside, caffeic acid and rosmarinic acid, were dissolved in 
DMSO. Six concentrations of each compound, i.e. 12.5 µM, 50 µM, 100 µM, 200 µM, and 
500 µM, were added into each plate. All plates were further incubated at 37ºC. % Enzyme 
activity was observed after 4 h and 18 h without irradiation by the MTT assay. The 
absorbance of each sample was expressed as a percentage of enzyme activity with respect to 
the control, and plotted on a graph of activity against concentration. Cytotoxicity of 
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compounds against FEK4 was reported as IC50 determined from the 50% enzyme activity 
concentration from this dose-response curve. 
 
 
4.3.3 MTT assay 
The MTT assay was performed under dark conditions. MTT was dissolved in PBS (5 
mg/ml), and sterilized by being filtered through a 0.2 μm disposable filter unit (Ministart®, 
Germany). This MTT stock solution was stored at –20ºC. Serum free media (SFM) was 
prepared in the same way as growth medium except that no FCS was added. MTT solution 
was freshly prepared by mixing MTT stock solution and SFM (1:9) in a falcon tube to give a 
final concentration of 0.5 mg/ml. All plates were taken out of the incubator after the specified 
incubation time post UVA (4 h, 12 h, 18 h, and 24 h). The medium was aspirated out, 3 ml 
PBS was added to each plate in order to wash the residue and then aspirated out. Cells were 
further incubated with 0.5 ml MTT solution for 3 hours. After the incubation time, the MTT 
solution was aspirated out and then 0.5 ml DMSO was added to each plate. All plates were 
swirled by 3D rocking platform (Stuart Scientific, UK) for 5 minutes. To detect % enzyme 
activity, 100 µl solution from each plate was added into a 96 well microplate and the 
absorbance was read by VERSAmaxTM (Molecular devices, California) at 570 nm. DMSO 
was used as a blank. The absorbance of each sample was expressed as a percentage of 
enzyme activity with respect to the control without irradiation, and presented in a graph 
comparing activity against the intensity of UVA dose. 
 
 
4.3.4 Neutral red assay 
Neutral red conditioned medium (NR media) was prepared by mixing 0.5 ml of 
neutral red solution (0.4% in water) and 39.5 ml fresh medium, and further incubated at 37ºC 
for 24 h under dark conditions. Prior to using, the solution was centrifuged and filtered 
through a 0.2 μm disposable filter unit. The plates were taken out of the incubator at a 
specific incubation time post UVA (4 and 14 h). The medium was aspirated out, 3 ml PBS 
was added to each plate in order to wash the residue and then aspirated out. Cells were 
further incubated with 0.5 ml NR medium for 90 minutes at 37ºC. Fixing buffer and Lysis 
buffer were prepared and stored at room temperature. Fixing buffer is comprised of 10% 
calcium chloride and 1% formaldehyde (38%) in water. For Lysis buffer, 50 ml absolute 
ethanol and 19 ml glacial acetic acid were added to water to make 100 ml. After the 
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incubation time, the NR media was aspirated out, 0.5 ml Fixing buffer was added and left for 
1 minute before being aspirated. 0.5 ml Lysis buffer was then added, and swirled by 3D 
rocking platform (Stuart Scientific, UK) for 10 minutes. To detect % lysosomal integrity, 200 
µl solution from each plate was added into a 96 well microplate, and the absorbance was read 
by VERSAmaxTM (Molecular devices, California) at 560 nm. Lysis buffer was used as a 
blank. The absorbance of each sample was expressed as a percentage of lysosomal integrity 
with respect to the control without irradiation, and presented in a graph comparing activity 
against the intensity of UVA dose. 
 
4.3.5 Flow cytometric analysis 
At specific incubation times post UVA (4 h and 24 h), cells were collected and 
washed with incubation buffer (10 mM Hepes/NaOH, pH 7.4, 5 M NaCl, 100 mM CaCl2). 
The apoptosis detection protocol was carried out as described in the Annexin V-FITC 
Apoptosis detection kit (Sigma). 5 x 10
5
 Treated cells in 0.5 ml incubation buffer were 
removed into a 5 ml polystyrene round-bottom tube. 5 µl Annexin V-FITC and 10 µl 
Propidium iodide solution were added to each tube. The cells with both dyes were left at 
room temperature for 10 minutes under dark condition prior to analysis by Flow cytometry. 
Data analysis was performed using FACSDiva software (Becton-Dickinson, Erembodegem, 
Belgium). 
 
4.3.6 Statistical analysis  
Results are given as means of replicated experiments with standard deviation (SD). 
Statistical analysis was performed using Microsoft Excel 2003. Student’s one tailed t-test was 
used to compare between sample data and control in each UVA dose unless stated otherwise. 
Significant difference from untreated control was reported when the p-value was less than 
0.05. 
 
 
 
 
 
 
 
 
  - 263 - 
4.4 Results and discussion 
Three assays were performed to detect the protective effect of compounds against 
UVA induced cell damage. The MTT and neutral red assays are techniques for evaluating 
organelle function whilst flow cytometry is a precise method for analyzing the mechanism of 
cell death by either apoptosis or necrosis as shown in Figure 4.3.  
 
 
        
Figure 4.3 Mechanisms of action of each assay 
a
Flow cytometric analysis: Dual stained by Annexin V-FITC and propidium idodide (PI) to evaluate 
necrosis and apoptosis. PI enters dead cells and binds to DNA (necrosis). Annexin V is a phospholipid 
binding protein with a high affinity to phosphatidylserine (dark circle) which is translocated from the 
inner layer to the outer layer of the plasma membrane when cells are in the early stage of apoptosis 
(Koopman et al., 1994; van Engeland et al., 1998; Fadok et al., 2001). 
b
MTT assay: The tetrazolium salt MTT is converted into a formazan product by mitochondrial 
dehydrogenase enzyme of living cells (Mosmann, 1983). 
c
Neutral red assay: Neutral red is taken up by living cells and accumulated in the lysosomes (Bulychev 
et al., 1978).  
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Figure 4.4A-C. % Enzyme activity by MTT assay after pretreatment with compounds without 
irradiation   
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4.4.1 MTT assay 
MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide), has been 
extensively used in cell proliferation and cytotoxicity assays (Berridge et al., 1996). This 
colorimetric assay was first performed by Mosmann (1983). The tetrazolium salt MTT is 
converted into a deep blue formazan product by mitochondrial dehydrogenase enzyme of 
living cells as shown in Figure 4.3.  
 
Verbascoside, rosmarinic acid, and caffeic acid were tested for their cytotoxicity 
against FEK4 cells without irradiation by the MTT assay. All these compounds exhibited 
cytotoxicity at high concentration after 18 h incubation time as shown in Figures 4.4A-C. 
Results show that all three compounds are cytotoxic with IC50 of 125 µM for verbascoside, 
150 µM for rosmarinic acid, and 195 µM for caffeic acid. In addition, decreased % enzyme 
activity was observed at the highest concentration (more than 200 µM) after 4 h incubation 
time in all tested compounds. 
 
 Two doses of UVA irradiation, 250 and 500 kJ/m
2
, were used to compare the 
oxidative damage to human skin fibroblasts. The amount of UVA at 250 kJ/m
2
 is equivalent 
to 70 minutes exposure to sunlight at noon during a cloudless summer day at northern latitude 
of 35º (Frederick and Lubin, 1988) which was considered as a physiological dose of UVA 
radiation (Vile and Tyrrell, 1995). After UVA irradiation, percentages of enzyme activity 
were decreased especially at 500 kJ/m
2
 as shown in Figures 4.5-4.6. In respect of time after 
irradiation 4 h and 24 h, UVA at 500 kJ/m
2
 killed normal cells 51.8±7.7 % at 4 h after 
irradiation and 78.8±8.6 % at 24 h after irradiation. Verbascoside (50 µM) pretreatment 
showed significant protection 24 h post UVA with 41.3±9 % enzyme activity as opposed to 
the control activity of 21.2±8.6 % (Figure 4.6). Caffeic acid and rosmarinic acid failed to 
protect the cells from UVA induced damage against UVA 500 kJ/m
2
.  
 
Since UVA induces ferritin (Ft) degradation and increases the labile iron pool (LIP) 
in the cytosol (Pourzand et al., 1999), DFO, which is known to be a strong iron chelator, was 
used as a positive control. DFO (100 µM) pretreatment for 18 h has been reported to achieve 
a significant reduction of Ft iron of FEK4 cells whereas hemin pretreatment (20 µM) caused 
iron overload and remarkably increased the intracellular level of Ft molecules (Zhong et al., 
2004).  
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Figure 4.5 Effect of pretreatment with compounds on percentage of enzyme activity by MTT 
assay (n = 4) 4 hr post UVA exposure. *Significantly different from untreated control 
(p<0.05), two tailed. VB: verbascoside 25, 50 µM, CA: caffeic acid 25, 50 µM, RA: 
rosmarinic acid 25, 50 µM, DFO: desferrioxamine 100 µM and hemin 20 µM. 
 
 
Figure 4.6 Effect of pretreatment with compounds on percentage of enzyme activity by MTT 
assay (n = 4) 24 hr post UVA exposure. *Significantly different from untreated control 
(p<0.05), two tailed. VB: verbascoside 25, 50 µM, CA: caffeic acid 25, 50 µM, RA: 
rosmarinic acid 25, 50 µM, DFO: desferrioxamine 100 µM and hemin 20 µM. 
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Figures 4.5-4.6 shows the corresponding protective effect of DFO. Without 
irradiation, percentage of enzyme activity decreased 26.2±2.8 % in DFO pretreated cells in 
comparison with control (100%). This result suggests that DFO depletes iron in the cell 
culture system and causes a reduction of enzyme activity in the normal state without 
irradiation. In contrast, DFO significantly protected the cell with % enzyme activity 39.7±3.5 
at UVA 500 kJ/m
2 
while control was at 21.2±8.6 % (Figure 4.6). This result suggests that 
DFO chelates a certain amount of the increased iron in the system as a result of irradiation, 
and shows a protective effect. On the other hand, hemin greatly showed a negative effect with 
less than 5% enzyme activity in any time post UVA at 500 kJ/m
2
. 
 
 
Figure 4.7 The DFO-iron complex. A strong metal chelator, desferrioxamine (DFO), binds to 
iron (III) in the ratio 1:1 complex which decreased the production of ROS and the oxidative 
stress in iron-overloaded cells (Kalinowski and Richardson, 2005). 
 
In comparison with DFO (100 µM), a lower dose of verbascoside (50 µM) gave a 
similar positive result at high UVA intensity. Although the precise protective mechanism of 
verbascoside is still in question, the pattern of activity is somewhat consistent with iron 
chelation. Without irradiation, a high concentration kills cells by iron depletion (Figure 
4.4A), but at lower concentrations it prevents the build up of free iron in the irradiated cells, 
and concomitant generation of ROS (Figure 4.6). 
 
As can be seen in Figures 4.5-4.6 at UVA dose 250 kJ/m
2
, only DFO and hemin 
affected cell survival. These results suggest that fibroblasts can tolerate moderate levels of 
UVA. In fact, Zhong et al. (2004) reported that the LIP increased 2 fold immediately after 
UVA irradiation at 250 kJ/m
2 
but this high level gradually returned to control value within 6 
h post irradiation in a fibroblast model. Therefore, injured cells could well have recovered 
their normal state by the time the MTT assay was carried out. However, under the iron 
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overload condition produced by the addition of hemin, irradiation damage seems to be 
irreversible as 30% enzyme activity was recorded both 4 h and 24 h post treatment with UVA 
at 250 kJ/m
2
 (Figures 4.5-4.6).  
 
 
 
Figure 4.8 Time course of percentage enzyme activity by MTT assay (n = 4) post UVA 
exposure at dose of 500 kJ/m
2
 after pretreatment with compounds. VB: verbascoside 50 µM, 
CA: caffeic acid 50 µM, RA: rosmarinic acid 50 µM, DFO: desferrioxamine 100 µM. 
 
 Figure 4.8 shows the reduction of % enzyme activity in time course experiments after 
irradiation at dose of 500 kJ/m
2
. Caffeic acid and rosmarinic acid exhibited insignificant 
differences from untreated control while verbascoside and DFO showed a similar positive 
effect. % enzyme activity was dramatically decreased to steady state at 8 h post UVA.  
 
 The radical scavenging activity of verbascoside in vitro against DPPH (Gao et al., 
1999; Chiou et al. 2004; Galvez et al., 2005; Ono et al., 2008), superoxide anion radical (Gao 
et al., 1999; Lee et al., 2004; Obied et al., 2009; Georgiev et al., 2011) and H2O2 (Obied et 
al., 2009) has been extensively reported. This included the inhibition of hydroxyl radical 
(·OH) mediated damage to pBR322 plasmid DNA via the Fenton reaction (Zhao et al., 2005), 
and damage to endothelial cell culture induced by Fenton’s reagent (H2O2/Fe
2+
) (Chiou et al., 
2004). Verbascoside can form complexes with Fe(II) or Fe(III) (Zhao et al., 2005). As UVA 
generates both free radicals, and free labile iron (Figure 4.1), verbascoside may prevent the 
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increase of both deleterious factors that induce damage in cells. A lower concentration of 
verbascoside exhibited the same significant protection as DFO which is an iron chelator only. 
 
 
4.4.2 NR assay 
 Neutral red (NR) is a weakly basic dye that has affinity to lysosomes of living cells 
(Bulychev et al., 1978). When lysosomes suffer membrane damage they are unable to retain 
the dyes (Basu-Modak et al., 2003). It is believed that UVA induced oxidative damage to 
lysosome membranes leading to ferritin (Ft) degradation and an increase in labile iron is an 
important contribution to cell damage by UVA (Pourzand et al., 1999). The neutral red assay 
was performed to evaluate any protection of lysosomes against such damage.  
 
   
 
Figure 4.9 Effect of pretreatment with compounds on lysosomal integrity of cells measured 4 
h post UVA by NR assay (n = 3). VB: verbascoside 50 µM, CA: caffeic acid 50 µM, RA: 
rosmarinic acid 50 µM, DFO: desferrioxamine 100 µM. *Significant difference from 
untreated control (p<0.05).  
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Figure 4.10 Effect of pretreatment with compounds on lysosomal integrity of cells measured 
at 4 h and 24 h post UVA at 500 kJ/m
2
 by NR assay (n = 3). VB: verbascoside 50 µM, CA: 
caffeic acid 50 µM, RA: rosmarinic acid 50 µM, DFO: desferrioxamine 100 µM. 
 
   
 
Figure 4.11 Comparison of MTT assay with NR assay to measure the effect of pretreatment 
with compounds on the residual activity of cells after UVA irradiation at 500 kJ/m
2
. MTT 
assay was perform 24 h post UVA (n = 4), and NR assay was performed 4 h post UVA (n = 
3). VB: verbascoside 50 µM, CA: caffeic acid 50 µM, RA: rosmarinic acid 50 µM, DFO: 
desferrioxamine 100 µM. *Significantly difference from untreated control (p < 0.05). 
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 Figure 4.9 shows percentage of lysosomal integrity assessed by NR assay after 
irradiation 4 h. In comparison with the MTT assay, NR assay showed more cell damage from 
UVA irradiation at a dose of 250 kJ/m
2
. Of the compounds used to treat the cells prior to 
UVA exposure, only DFO showed a significant though small level of protection. At the same 
UVA dose 500 kJ/m
2
, the untreated control damage was 80.7±6.4 % determined by NR assay 
4 h post UVA while MTT assay was 78.8±8.6 % assessed 24 h post UVA (Figure 4.11). 
However, the rate of survival at 24 h post UVA was steadily decreased to 15% in control 
cells as shown in Figure 4.10.  
 
Verbascoside exhibited non-significant protection after 4 h post UVA (Figure 4.9) 
though it clearly showed less lysosomal protective effect after a longer incubation time post 
UVA (Figure 4.10). In comparison with untreated control, rosmarinic acid exhibited superior 
lysosomal protection among tested polyphenols though was not statistically significant at the 
number of replicates performed. On the contrary in MTT assay, verbascoside showed 
significant protection against mitochondrial damage induced by high UVA intensity. Figure 
4.11 compares the effects of the tested compounds in the two test systems. DFO shows 
significant protection in both assays; verbascoside only in the MTT assay. As can be seen, 
lysosomes were fairly sensitive to UVA induced damage in respect of time post UVA.  
 
 
4.4.3 Flow cytometric analysis 
Flow cytometry is a method to analyze an individual cell by monitoring the 
interaction of the cell and the laser beam based on light-scattering, fluorescence and 
absorbance techniques (Rieseberg et al., 2001). A cell in the fluid stream flows through the 
focus of the laser beam and scatters the laser light. Analyzing the scattered light gives 
information about cell size and structure which can be changed during cell death 
(Darzynkiewicz et al., 1997). Morphological changes observed in cell death involve swelling, 
blebbing, budding, permeability alteration and shrinkage (Majno and Joris, 1995). Changes in 
plasma membrane properties can provide information about apoptosis, necrosis and live cells 
with the aid by certain dyes (Van Engeland et al., 1998). 
 
Apoptosis, programmed cell death, is a general mechanism for removal of unwanted 
cells (Koopman et al., 1994). It is characterized by the shrinkage of cell with intact plasma 
membrane in the early stage followed by malfunctioning of the plasma membrane in the late 
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stage (Darzynkiewicz et al., 1997). On the other hand, necrosis (accidental cell death) is 
characterized by cell and mitochondrial swelling followed by the rupture of the plasma 
membrane (Darzynkiewicz et al., 1997). Necrosis can occur in the late stage of apoptosis 
(Majno and Joris, 1995). 
 
Fadok et al. (2001) reported the role of phospholipid asymmetry for triggering 
recognition and removal by phagocytosis in the early stage of apoptosis. Phosphatidylserine 
(PS) translocates from the inner layer to the outer layer of the plasma membrane when cells 
are undergoing apoptosis. PS expression on the outer membrane has a high affinity with 
anticoagulant annexin V which can be applied to detect apoptosis by flow cytometry 
(Koopman et al., 1994). Annexin V labeled with fluorescein isothiocyanate (FITC) and 
certain dyes such as propidium iodide (PI), and ethidium bromide (EB) are used as a dual 
stain to differentiate between dead and apoptotic cells.  Annexin V-FITC is not able to bind 
to the phospholipids of the plasma membrane of normal vital cells while necrotic and dead 
cells lose their cell membrane and take up the DNA-specific stain (PI)  (Van Engeland et al., 
1998).  
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Figure 4.12 Fluorescence dyes in flow cytometric analysis. FITC (fluorescein isothiocyanate) 
covalently bound to primary amine of annexin V (Ormerod, 1994; Gerke and Moss, 2002). 
Excitation/Emission wavelengths (nm) are 495/519 for FITC and 536/617 for PI (Rieseberg 
et al., 2001). 
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The annexin V-FITC/PI apoptotic assay can quantify three kinds of cell population 
from a dot plot graph as demonstrated in Figure 4.13. Living cells are negative for both 
annexin V-FITC (AV) and PI (Q3) while the apoptotic cells are negative to PI but positive to 
AV (Q4). Necrotic/dead cells are positive to PI (Q1+Q2). 
 
                 
        Figure 4.13 Dot plot analysis of AV/PI apoptotic assay from flow cytometry 
 
 
Figure 4.14 Flow cytometric analysis of control (left), and 50 µM verbascoside pretreated 
cells (right). Analysis was performed 24 h post UVA. Cells were irradiated by UVA at 500 
kJ/m
2
, and dual stained with AV and PI immediately before measurement. % Cells 
populations were expressed as means±SD (n = 3). Live cells (Q3), apoptotic cells (Q4), and 
necrotic cells (Q1+Q2). Cells without UVA (upper), Cells irradiated by UVA (lower). 
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Figure 4.15 The percentages of live, necrotic, and apoptotic cells population. Flow cytometric 
analysis of control and 50 µM verbascoside pretreated cells. Analysis was performed 24 h 
post UVA. Cells were irradiated by UVA at 500 kJ/m
2
, and dual stained with AV and PI 
immediately before measurement (n = 3). *Significantly difference from untreated control 
(p<0.05). 
 
           
Figure 4.16 Fold protection of 50 µM verbascoside over control without UVA and irradiated 
by UVA at 500 kJ/m
2
. Flow cytometric analysis was perform 24 h post UVA (n = 3).  
* Significantly different between irradiated and non-irradiated cells (p<0.05). 
 
 
 Results of flow cytometric analysis are shown in Figures 4.14-4.15. Verbascoside 
pretreatment provided significant protective effect over control in terms of higher % live 
cells, and lower % necrotic cells. Figure 4.16 displays 1.4 fold protection accompanied by 1.4 
fold anti-necrosis. Both treated- and untreated cells exhibited comparable apoptotic effect not 
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only without UVA irradiation but also after being irradiated as seen in Figure 4.15.  % Apop-
totic cells were unchanged after irradiation (Figure 4.14). This result corresponds to previous 
observations by the C. Pourzand and R. M. Tyrrell group (unpublished data). A higher dose 
of UVA failed to induce morphological changes associated with apoptosis in a human 
foreskin fibroblast cell line (FEK4). The resistance of skin fibroblasts to UVA mediated 
apoptosis was exhaustively reviewed by Pourzand and Tyrrell (1999). This could possibly be 
due to the increased expression of Fas receptor in adult fibroblasts, a higher level of SOD 
activity, the higher antioxidant capacity of the FEK4 cell and the induction of the nuclear 
factor kappa B (NF-κB) in this cell line. 
  
The protective effects of verbascoside against UVC-induced and free radical 
mediated necrosis in a HaCaT cell model has recently been reported (Pastore et al., 2009). It 
inhibited cytokine-induced release of proinflammatory mediators, IP-10 and IL-8, and 
suppressed NF-κB and AP-1 DNA binding activity in a dose dependent manner. Therefore, 
the anti-necrotic effect against UVA may partly involve anti-inflammatory activity. Although 
short wavelength UV radiation (UVB/UVC) activated AP-1 and NF-κB and stabilized p53 
transcription factor (Tyrrell, 1999), ROS may act as intracellular second messengers through 
the activation of certain inflammatory mediators such as nuclear factor kappa B and induce 
an inflammatory response (Trenam et al., 1992). However, the effective concentration of 
verbascoside against UVC was 200 µM which was considered a high concentration in our 
study. Our cytotoxicity testing showed an IC50 125 µM for verbascoside in the human skin 
fibroblast model (FEK4). 50 µM Verbascoside was an optimum concentration for protection 
against UVA induced necrosis. 
 
 
4.5 In vitro testing conclusions   
 This study showed the protective effect of verbascoside against UVA induced 
damage in a human skin fibroblast (FEK4) model. Two assays were introduced to detect cell 
function but with different sites of action. The MTT assay depends on mitochondrial 
enzymes of living cells while NR assay is focused at the lysosome compartment. Moreover, 
the precise mechanism of cell death was also analyzed by the sensitive technique of flow 
cytometry. Among three tested polyphenols, a major compound from S. viridis L. cv. Blue 
Jeans, verbascoside, exhibited significant protection against UVA induced mitochondrial 
damage and necrosis at a high intensity UVA dose (500 kJ/m
2
). It exhibited 1.4 fold 
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protective effect against UVA induced necrosis. 50 µM Verbascoside showed the same 
protective effect as 100 µM DFO at UVA 500 kJ/m
2
 by MTT assay. Although the precise 
mechanism of this action has not yet been determined, the pattern of activity is consistent 
with a metal chelating, radical scavenging, and anti-inflammatory activities. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  - 277 - 
Chapter 5 
Conclusions 
 
 
As described in Chapter 2, dried plant part of S. viridis L. cv. Blue Jeans, aerial and 
root, was extracted by two steps of solvents, acetone and methanol, collected separately, and 
evaporated to dryness. Both acetone and methanol crude extracts were further partitioned by 
three steps with petroleum ether, ethyl acetate and 1-butanol in order to classify compound 
corresponding to the solvent use. Eight crude fractions for each of the aerial and root parts 
were finally obtained from this process and certain fractions were further separated by either 
semi-preparative reversed-phase HPLC or open column chromatography. Three crude 
fractions from the aerial parts, AE (Acetone-Ethyl acetate), ME (Methanol-Ethyl acetate), 
and MB (Methanol-1-Butanol) were subject to further separation while four root crude 
fractions, RAE (Acetone-Ethyl acetate), RAP (Acetone-Petroleum ether), RME (Methanol-
Ethyl acetate), and RMB (Methanol-1-Butanol), were successfully separated.  
 
These separations yielded thirty compounds from both aerial and root parts which 
can be classified into three broad biosynthetic groups, terpenoids, polyphenolics, and 
miscellaneous. Two novel triterpenoids, lup-20(29)-ene-2α-acetate-3β-ol (compound 1) and 
lup-20(29)-ene-2α-ol-3β-acetate (compound 2), were isolated from the aerial parts as well as 
three known triterpenoids, ursolic acid, oleanolic acid and lup-20(29)-ene-2α,3β-diol. β-
Sitosterol and its glucoside were also found in aerial part. Phenolic compounds comprised 
seven caffeic acid derivatives, five flavonoids, and a phenylethyl glycoside (salidroside) as 
shown in Figure 5.1. A new flavone glycoside, luteolin-7-O-α-rhamnopyranosyl-(1→6)-β-
galactopyranoside, is reported for the first time. The major phenylpropanoid in aerial parts, 
verbascoside (acteoside), is also new to the genus Salvia as well as its methylated derivatives, 
leucosceptoside A and martynoside.  
 
Three new diterpenoids, 1-oxomicrostegiol (compound 3), viroxocane (compound 4), 
and viridoquinone (compound 5), were found in the root part together with five known 
diterpenoids, ferruginol, salvinolonyl 12-methyl ether, 7α-acetoxy-14-hydroxy-8,13-abieta-
diene-11,12-dione, 7α,14-dihydroxy-8,13-abietadiene-11,12-dione and microstegiol. Two 
caffeic acid derivatives, 1-docosyl ferulate, and 2'',3''-di-O-acetyl-martynoside, and a mixture 
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of 2-(4'-alkoxyphenyl)ethyl alkanoates were isolated from the roots. Isolated compounds 
from roots are presented in Figure 5.2. 
      
 
 
                  Figure 5.1 Isolated compounds from aerial part of S. viridis L. cv. Blue Jeans 
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                 Figure 5.2 Isolated compounds from the root part of S. viridis L. cv. Blue Jeans 
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TLC-bioautographic techniques were used to screen certain activity of the eight 
crude fractions on a TLC plate. Antioxidant activity was based on scavenging DPPH (2, 2-
Diphenyl-1-picrylhydrazyl) radical. Compounds with antiradical scavenging activity were 
seen a yellow band on a purple background. The strongest DPPH scavenging activity was 
seen in the AB (Acetone-1-Butanol) and MB (Methanol-1-Butanol) crude fractions. 
  
Verbascoside was found as the main component in the aerial part (104 mg/ 2 g MB 
crude fraction; 0.06% in dried aerial). Radical scavenging activity against DPPH (Gao et al., 
1999; Galvez et al., 2005), superoxide anion radical (Gao et al., 1999; Lee et al., 2004; Obied 
et al., 2009; Georgiev et al., 2011), H2O2 (Obied et al., 2009), and hydroxyl radical (·OH) 
(Zhao et al., 2005) have been reported. Verbascoside can also form complexes with Fe(II) or 
Fe(III) (Zhao et al., 2005). After UVA exposure, free radicals are generated, and could cause 
various biological damage such as DNA impairment leading to cancer (Svobodova et al., 
2003). UVA also stimulated ferritin degradation, and leading to iron release which could 
further initiate free radicals and skin disorders such as psoriasis (Pourzand et al., 1999). 
Therefore, the protective effect of verbascoside against UVA induced damage in a human 
skin fibroblast model was subsequently evaluated. Other antioxidant compounds isolated 
from this species, rosmarinic acid and caffeic acid, were also tested to compare the protection 
activity. 
 
Results showed that pretreatment with verbascoside does protect cells against UVA 
induced damage in a human skin fibroblast (FEK4) model. Two assays were introduced to 
detect cell function with different sites of action. The MTT assay depends on mitochondrial 
enzyme of living cells while NR assay is focused at the lysosome compartment. The precise 
mechanism of cell death was also analyzed by flow cytometry. Among three tested 
polyphenols, verbascoside exhibited the significant protection against UVA induced 
mitochondrial damage and necrosis at a high intensity dose of UVA (500 kJ/m
2
). It exhibited 
1.4 fold protective effect against UVA induced necrosis. 50 µM Verbascoside showed the 
same protective effect as 100 µM DFO at UVA 500 kJ/m
2
 measured by MTT assay. 
Rosmarinic acid also showed a non-significant protective effect at high intensity UVA dose 
(500 kJ/m
2
) while caffeic acid exhibited weak activity. Verbascoside was recently reported to 
posses protective effects against UVC-induced and free radical mediated necrosis in a HaCaT 
cell model (Pastore et al., 2009). This is the first report of verbascoside in this plant and its 
significant protective effect against UVA induced damage in a human skin fibroblast model. 
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These promising results could lead to the expansion of research and development in 
pharmaceutical and cosmetic areas related to dermatology. Although quite widely distributed 
amongst plant species, commercial verbascoside costs €115/5 mg (Extrasynthese, France, 
Product catalogue 2011, p 246). As a cultivated plant with a significant content of verbas-
coside, S.  viridis L. could be a suitable commercial source if required. 
    
A TLC-bioautographic technique for antibacterial activity against three Gram-
positive, Staphylococcus aureus (ATCC 6571), Enterococcus faecalis (ATCC 775), Bacillus 
cereus (ATCC 2599), and three Gram-negative bacteria, Klebsiella pneumoniae (ATCC 
9633), Proteus vulgaris (ATCC 4636), and Escherichia coli (ATCC 86), was also used to 
monitor the crude fractions. Aerial AE crude fraction displayed clear zones against all three 
Gram-positive bacteria on the agar overlay TLC plates (Figures 3.10-3.12, plate B, track 2). 
Further isolation of this crude fraction revealed a new antibacterial compound (lup-20(29)-
ene-2α-acetate-3β-ol, compound 1) with MIC 50 µM against Enterococcus faecalis (ATCC 
775), and 100 µM against Staphylococcus aureus (ATCC 6571) and Bacillus cereus (ATCC 
2599). A new isomer, lup-20(29)-ene-2α-ol-3β-acetate (compound 2), was also active against 
all three Gram-positive with MIC 100 µM (Table 3.4). Two known triterpenoids, ursolic acid 
and oleanolic acid, also showed markedly antibacterial activity against the Gram-positive 
species with MIC 12.5-50 µM. Though MB crude fraction showed no clear zone, the main 
component, verbascoside, showed antibacterial activity against three Gram-positive with 
MIC 100 µM. In addition, none of crude fractions showed antibacterial activity against 
Gram-negative bacteria by the TLC-agar overlay assay. 
 
Eight diterpenoids were isolated from the root crude fractions, RAE and RAP. Both 
these fractions showed a clear zone against three Gram-positive bacteria on the agar overlaid 
TLC plates (Figures 3.10-3.12, plate A, tracks 1-2). On further determination of MIC, 7α,14-
dihydroxy-8,13-abietadiene-11,12-dione exhibited antibacterial against Enterococcus faecalis 
(ATCC 775) with MIC 50 µM (Table 3.4). Ferruginol also showed appreciable activity 
against those three Gram-positive bacteria with MIC 25-50 µM. Microstegiol was active 
against Staphylococcus aureus (ATCC 6571) with MIC 50 µM. The others were active 
against all three Gram-positive bacteria with MIC 100-200 µM.    
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Appendix 4 NMR spectra of leucosceptoside A  
*Judging from the NMR spectra, this material was about 90% pure.  
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Appendix 5 NMR spectra of martynoside  
*Judging from the NMR spectra, this material was about 90% pure.  
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Appendix 7 NMR spectra of 6-O-caffeoyl-glucose 
*Judging from the NMR spectra, this material was about 80% pure.  
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1
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Appendix 8 NMR spectra of luteolin-7-O-glucopyranoside 
*Judging from the NMR spectra, this material was about 85% pure.  
Appendix 8.1 
1
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*Judging from the NMR spectra, this material was about 90% pure.  
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Appendix 14 NMR spectra of oleanolic acid  
*Judging from the NMR spectra, this sample was about 70% pure, with ursolic acid as the 
major impurity. 
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1
H NMR spectrum of oleanolic acid (500 MHz; a mixture of CD3OD and 
CDCl3) 
 
 
Appendix 14.2 COSY spectrum of oleanolic acid (500 MHz; a mixture of CD3OD and 
CDCl3) 
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Appendix 14.3 
13
C NMR spectrum of oleanolic acid (125 MHz; a mixture of CD3OD and 
CDCl3) 
                
 
Appendix 14.4 HMQC spectrum of oleanolic acid (500 MHz for 
1
H, 125 MHz for 
13
C 125 
MHz; a mixture of CD3OD and CDCl3) 
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Appendix 14.5 HMBC spectrum of oleanolic acid (500 MHz for 
1
H, 125 MHz for 
13
C 125 
MHz; a mixture of CD3OD and CDCl3) 
                        
Appexdix 14.6 NOESY spectrum of oleanolic acid (500 MHz; a mixture of CD3OD and 
CDCl3) 
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Appendix 15 NMR spectra of lup-(20)29-ene-2α,3β-diol 
Appendix 15.1 
1
H NMR spectrum of lup-(20)29-ene-2α,3β-diol (500 MHz; CDCl3) 
   
Appendix 15.2 COSY spectrum of lup-(20)29-ene-2α,3β-diol (500 MHz; CDCl3) 
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Appendix 15.3 
13
C NMR spectrum of lup-(20)29-ene-2α,3β-diol (125 MHz; CDCl3) 
             
Appendix 15.4 HMQC spectrum of lup-(20)29-ene-2α,3β-diol (500 MHz for 1H, 125 MHz 
for 
13
C 125 MHz; CDCl3) 
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Appendix 15.5 HMBC spectrum of lup-(20)29-ene-2α,3β-diol (500 MHz for 1H, 125 MHz 
for 
13
C 125 MHz; CDCl3) 
                    
Appendix 15.6 NOESY spectrum of lup-(20)29-ene-2α,3β-diol (500 MHz; CDCl3)  
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Appendix 16 NMR spectra of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) 
*Judging from the NMR spectra, this sample was about 95% pure. 
Appendix 16.1 
1
H NMR of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) (500 MHz; 
CDCl3) 
 
 
Appendix 16.2 COSY spectrum of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) (500 MHz 
in CDCl3)  
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Appendix 16.3 
13
C NMR of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) (125 MHz; 
CDCl3)        
   
Appendix 16.4 HMQC spectrum of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) (500 
MHz for 
1
H, 125 MHz for 
13
C 125 MHz; CDCl3) 
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Appendix 16.5 HMBC spectrum of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) (500 MHz 
for 
1
H, 125 MHz for 
13
C 125 MHz in CDCl3) 
                      
Appendix 16.6 NOESY spectrum of compound 1 (lup-(20)29-ene-2α-acetate-3β-ol) (500 
MHz; CDCl3) 
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Appendix 17 NMR spectra of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate)   
*Judging from the NMR spectra, this sample was about 95% pure. 
Appendix 17.1 
1
H NMR spectrum of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate) (500 
MHz; CDCl3)   
  
Appendix 17.2 COSY spectrum of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate) (500 MHz 
in CDCl3)   
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Appendix 17.3 
13
C NMR spectrum of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate) (125 
MHz; CDCl3)      
 
 
Appendix 17.4 HMQC spectrum of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate) (500 
MHz for 
1
H, 125 MHz for 
13
C; CDCl3) 
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Appendix 17.5 HMBC spectrum of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate) (500 MHz 
for 
1
H, 125 MHz for 
13
C; CDCl3) 
                            
Appendix 17.6 NOESY spectrum of compound 2 (lup-(20)29-ene-2α-ol-3β-acetate) (500 
MHz; CDCl3) 
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Appendix 18 NMR spectra of β-sitosterol 
Appendix 18.1 
1H NMR spectrum of β-sitosterol (500 MHz; CDCl3) 
          
         
 
Appendix 18.2 COSY spectrum of β-sitosterol (500 MHz; CDCl3)  
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Appendix 18.3 
13C NMR spectrum of β-sitosterol (125 MHz; CDCl3)   
 
Appendix 18.4 HMQC spectrum of β-sitosterol (500 MHz for 1H, 125 MHz for 13C; CDCl3)  
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Appendix 18.5 HMBC spectrum of β-sitosterol (500 MHz for 1H, 125 MHz for 13C; CDCl3) 
                          
Appendix 18.6 NOESY spectrum of β-sitosterol (500 MHz; CDCl3)   
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Appendix 19 NMR spectra of β-sitosterol glucoside 
Appendix 19.1 
1H NMR spectrum of β-sitosterol glucoside (500 MHz; mixture of CDCl3 and 
CD3OD)       
    
Appendix 19.2 COSY spectrum of β-sitosterol glucoside (500 MHz; mixture of CDCl3 and 
CD3OD) 
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Appendix 19.3 
13C NMR spectrum of β-sitosterol glucoside (125 MHz; mixture of CDCl3 and 
CD3OD)              
 
 
Appendix 19.4 HMQC spectrum of β-sitosterol glucoside (500 MHz for 1H, 125 MHz for 
13
C; mixture of CDCl3 and CD3OD) 
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Appendix 19.5 HMBC spectrum of β-sitosterol glucoside (500 MHz for 1H, 125 MHz for 
13
C; mixture of CDCl3 and CD3OD) 
                           
Appendix 19.6 NOESY spectrum of β-sitosterol glucoside (500 MHz in mixture of CDCl3 
and CD3OD) 
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Appendix 20 NMR spectra of salidroside 
*Judging from the NMR spectra, this sample was about 80% pure. 
Appendix 20.1 
1
H NMR spectrum of salidroside (500 MHz; CD3OD)  
    
Appendix 20.2 COSY spectrum of salidroside (500 MHz; CD3OD)  
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Appendix 20.3 
13
C NMR spectrum of salidroside (125 MHz; CD3OD)  
 
                 
 
Appendix 20.4 HMQC spectrum of salidroside (500 MHz for 
1
H, 125 MHz for 
13
C; CD3OD) 
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Appendix 20.5 HMBC spectrum of salidroside (500 MHz for 
1
H, 125 MHz for 
13
C; CD3OD)        
                     
Appendix 20.6 NOESY spectrum of salidroside (500 MHz; CD3OD) 
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Appendix 21 NMR spectra of 2'',3''-di-O-acetyl-martynoside 
*Judging from the NMR spectra, this sample was about 95% pure. 
Appendix 21.1 
1
H NMR spectrum of 2'',3''-di-O-acetyl-martynoside (500 MHz; CDCl3) 
 
 
Appendix 21.2 COSY spectrum of 2'',3''-di-O-acetyl-martynoside (500 MHz ; CDCl3) 
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Appendix 21.3 
13
C NMR spectrum of 2'',3''-di-O-acetyl-martynoside (125 MHz; CDCl3) 
             
Appendix 21.4 HMQC spectrum of 2'',3''-di-O-acetyl-martynoside (
1
H, 500 MHz; 
13
C, 125 
MHz in CDCl3) 
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Appendix 21.5 HMBC spectrum of 2'',3''-di-O-acetyl-martynoside (
1
H, 500 MHz; 
13
C, 125 
MHz in CDCl3) 
                      
Appendix 21.6 NOESY spectrum of 2'',3''-di-O-acetyl-martynoside (500 MHz in CDCl3) 
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Appendix 22 NMR spectra of 1-docosyl ferulate 
Appendix 22.1 
1
H NMR spectrum of 1-docosyl ferulate (500 MHz; CDCl3) 
    
 
 
Appendix 22.2 COSY spectrum of 1-docosyl ferulate (500 MHz; CDCl3) 
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Appendix 22.3 
13
C NMR spectrum of 1-docosyl ferulate (125 MHz; CDCl3) 
 
 
 
 
Appendix 22.4 HMQC spectrum of 1-docosyl ferulate (500 MHz for 
1
H, 125 MHz for 
13
C; 
CDCl3) 
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Appendix 22.5 HMBC spectrum of 1-docosyl ferulate (500 MHz for 
1
H, 125 MHz for 
13
C; 
CDCl3) 
                 
Appendix 22.6 NOESY spectrum of 1-docosyl ferulate (500 MHz; CDCl3) 
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Appendix 23 NMR spectra of ferruginol 
*Judging from the NMR spectra, this material was about 90% pure, with plasticiser 
(phthalate) as the major impurity.  
Appendix 23.1 
1
H NMR spectrum of ferruginol (500 MHz; CDCl3) 
 
 
Appendix 23.2 COSY spectrum of ferruginol (500 MHz; CDCl3) 
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Appendix 23.3 
13
C NMR spectrum of ferruginol (125 MHz; CDCl3)      
             
 
Appendix 23.4 HMQC spectrum of ferruginol (500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3)  
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Appendix 23.5 HMBC spectrum of ferruginol (500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3) 
           
 
Appendix 23.6 NOESY spectrum of ferruginol (500 MHz; CDCl3) 
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Appendix 24 NMR spectra of salvinolonyl 12-methyl ether  
Appendix 24.1 
1
H NMR spectrum of salvinolonyl 12-methyl ether (500 MHz; CDCl3) 
 
    
 
Figure 24.2 COSY spectrum of salvinolonyl 12-methyl ether (500 MHz; CDCl3)     
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Appendix 24.3 
13
C NMR spectrum of salvinolonyl 12-methyl ether (125 MHz; CDCl3)      
           
 
Appendix 24.4 HMQC spectrum of salvinolonyl 12-methyl ether (500 MHz for 
1
H, 125 MHz 
for 
13
C; CDCl3)  
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Appendix 24.5 HMBC spectrum of salvinolonyl 12-methyl ether (500 MHz for 
1
H, 125 MHz 
for 
13
C; CDCl3) 
         
 
Appendix 24.6 NOESY spectrum of salvinolonyl 12-methyl ether (500 MHz; CDCl3)     
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Appendix 25 NMR spectra of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
Appendix 25.1 
1H NMR spectrum of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
(500 MHz; CDCl3) 
 
   
Appendix 25.2 COSY spectrum of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
(500 MHz; CDCl3) 
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Figure 25.3 
13C NMR spectrum of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
(125 MHz; CDCl3)   
     
 
Appendix 25.4 HMQC spectrum of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione  
(500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3)   
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Appendix 25.5 HMBC spectrum of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione  
(500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3)         
                     
Appendix 25.6 NOESY spectrum of 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-dione 
(500 MHz; CDCl3)   
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Appendix 26 NMR spectra of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione 
*This material was about 60% pure, with 7α-acetoxy-14-hydroxy-8,13-abietadiene-11,12-
dione and plasticiser (phthalate) as the major impurities. 
Appendix 26.1 
1H NMR spectrum of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione  
(500 MHz; CDCl3) 
 
Appendix 26.2 COSY spectrum of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione  
(500 MHz; CDCl3) 
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Appendix 26.3 
13C NMR spectrum of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione  
(125 MHz; CDCl3) 
        
Appendix 26.4 HMQC spectrum of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione  
(500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3) 
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Appendix 26.5 HMBC spectrum of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione  
(500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3) 
                    
Appendix 26.6 NOESY spectrum of 7α,14-dihydroxy-8,13-abietadiene-11,12-dione  
(500 MHz; CDCl3) 
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Appendix 27 NMR spectra of microstegiol 
*This material was about 95% pure, with plasticiser (phthalate) as the major impurity. 
Appendix 27.1 
1
H NMR spectrum of microstegiol (500 MHz; CDCl3) 
 
 
Appendix 27.2 COSY spectrum of microstegiol (CDCl3; 500 MHz) 
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Appendix 27.3 
13
C NMR spectrum of microstegiol (125 MHz; CDCl3)  
       
    
Appendix 27.4 HMQC spectrum of microstegiol (500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3)  
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Appendix 27.5 HMBC spectrum of microstegiol (500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3)                
                    
 
Appendix 27.6 NOESY spectrum of microstegiol (500 MHz; CDCl3) 
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Appendix 28 NMR spectra of compound 3 (1-oxomicrostegiol)  
Appendix 28.1 
1
H NMR spectrum of compound 3 (1-oxomicrostegiol) (500 MHz; CDCl3) 
 
 
Appendix 28.2 COSY spectrum of compound 3 (1-oxomicrostegiol) (500 MHz; CDCl3) 
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Appendix 28.3 
13
C NMR spectrum of compound 3 (1-oxomicrostegiol) (125 MHz; CDCl3) 
       
 
Appendix 28.4 HMQC spectrum of compound 3 (1-oxomicrostegiol) (500 MHz for 
1
H, 125 
MHz for 
13
C; CDCl3) 
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Appendix 28.5 HMBC spectrum of compound 3 (1-oxomicrostegiol) (500 MHz for 
1
H, 125 
MHz for 
13
C; CDCl3) 
                   
Appendix 28.6 NOESY spectrum of compound 3 (1-oxomicrostegiol) (500 MHz; CDCl3) 
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Appendix 29 NMR spectra of compound 4 (viroxocane) 
*Judging from the NMR spectra, this sample was about 95% pure. 
Appendix 29.1 
1
H NMR spectrum of compound 4 (viroxocane) (500 MHz; CDCl3) 
     
 
Figure 29.2 COSY NMR spectrum of compound 4 (500 MHz; CDCl3)   
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Appendix 29.3 
13
C NMR spectrum of compound 4 (viroxocane) (125 MHz; CDCl3)     
    
 
 
Appendix 29.4 HMQC spectrum of compound 4 (viroxocane) (500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3)   
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Appendix 29.5 HMBC spectrum of compound 4 (viroxocane) (500 MHz for 
1
H, 125 MHz for 
13
C; CDCl3)   
       
Appendix 29.6 NOESY spectrum of compound 4 (viroxocane) (500 MHz; CDCl3)  
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Appendix 30 NMR spectra of compound 5 (viridoquinone)  
*This material was about 85% pure, with plasticiser (phthalate) as the major impurity. 
Appendix 30.1 
1
H NMR spectrum of compound 5 (viridoquinone) (500 MHz; CDCl3)  
 
 
Appendix 30.2 COSY spectrum of compound 5 (viridoquinone) (500 MHz; CDCl3)  
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Appendix 30.3 
13
C NMR spectrum of compound 5 (viridoquinone) (125 MHz; CDCl3)  
       
 
Appendix 30.4
 
HMQC spectrum of compound 5 (viridoquinone) (500 MHz for 
1
H, 125 MHz 
for 
13
C; CDCl3)  
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Appendix 30.5 HMBC spectrum of compound 5 (viridoquinone) (500 MHz for 
1
H, 125 MHz 
for 
13
C; CDCl3)  
                    
Appendix 30.6 NOESY spectrum of compound 5 (viridoquinone) (500 MHz; CDCl3)  
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Appendix 31 NMR spectra of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates 
Appendix 31.1 
1
H NMR spectrum of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (500 
MHz; CDCl3) 
 
 
 
Appendix 31.2 COSY spectrum of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (500 
MHz; CDCl3) 
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Appendix 31.3 
13
C NMR spectrum of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (125 
MHz; CDCl3) 
 
 
 
Appendix 31.4 HMQC spectrum of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (500 
MHz for 
1
H, 125 MHz for 
13
C; CDCl3) 
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Appendix 31.5 HMBC spectrum of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (500 
MHz for 
1
H, 125 MHz for 
13
C; CDCl3) 
                      
Appendix 31.6 NOESY spectrum of a mixture of 2-(4'-alkoxyphenyl) ethyl alkanoates (500 
MHz in CDCl3) 
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Appendix 32 Abstracts and presentations from this work 
Appendix 32.1 Trends in natural products research (12
th
-14
th
 April 2010), The Phytochemical 
Society of Europe, De Montfort University, Leicester, UK.  
 
 
                   Phenylpropanoid glycosides from Salvia horminum L. 
Supattra Rungsimakan, Charareh Pourzand, Michael G Rowan,  
         Department of Pharmacy and Pharmacology,University of Bath, Bath BA2 7AY, United Kingdom 
    sr322@bath.ac.uk 
     
Many plants of genus Salvia in family Lamiaceae have been extensively investigated for their 
active biological compounds. Salvia horminum L. (Synonym S. viridis L.) is one of many sages that is 
used as traditional medicine, for example, an infusion of leaves as a gargle for sore gums
[1]
. In this 
study, S. horminum L. was investigated for its compounds as well as bioactivity. A TLC-
chemoautographic method was used as a preliminary test for antioxidant activity of a crude extract. 
Compounds that possess this activity were seen as yellow bands or spots on a purple background in 
visible light shortly after a developed TLC plate was sprayed with DPPH (2, 2-Diphenyl-1-
picrylhydrazyl) solution
[2]
. Verbascoside (acteoside) was the major compound isolated from this 
bioactivity-guided fractionation by using semi-preparative HPLC on a C-18 reversed-phase column. 
Cis-verbascoside was further separated by semi-preparative HPLC on a pentafluorophenyl column. 
Their structures were elucidated by HRMS and Nuclear Magnetic Resonance spectroscopy. They are 
now reported in Salvia species for the first time. Preliminary in vitro testing of verbascoside has been 
carried out in human skin fibroblast (FEK4) cell cultures. Fifty µM verbascoside showed protection 
against UV-A (wavelength 320-400 nm) induced cell damage.   
 
[1]   Dweck, A. C. (2000) The folklore and cosmetic use of various Salvia species, in: Kintzios, S. E. (Ed.), Sage;  
       The Genus Salvia. Harwood Academic Publishers, Amsterdam. 
[2]   Cimpoiu, C. (2006) Analysis of some natural antioxidants by Thin-Layer Chromatography and High  
        Performance Thin-Layer Chromatography. J. Liq. Chromatogr. Relat. Technol.29: 1125-1142. 
 
 
 
 
 
 
                                                                  Figure 1. Verbascoside 
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Appendix 32.2 The international conference on natural products (24
th
-27
th
 May 2011), 
University Paul Sabatier, Toulouse, France.            
       
 
                 Protective effect against UVA induced cell damage of  
              phenolic compounds from Salvia viridis L. cv. Blue Jeans 
 
        Supattra Rungsimakan, Charareh Pourzand, and Michael G Rowan  
        Department of Pharmacy and Pharmacology,University of Bath, Bath, BA2 7AY, United Kingdom 
    sr322@bath.ac.uk 
     
Plants of the genus Salvia are well known to possess a wide range of phenolic compounds of 
various structural types. Many of which have shown interesting biological properties such as anti-
inflammatory
[1]
, antibacterial
[1]
, antiviral
[1]
,  cardiovascular
[2]
, and anti-lipid-peroxidation
[2] 
activities. 
Dihydroxy phenols of the catechol type are known to form co-ordination complexes with iron in both 
the Fe(II), and Fe(III) oxidation states
[3]
. Ultraviolet light present in sunlight is known to cause 
oxidative damage to cells, a process that is also thought to involve iron catalysed reactions of the 
Fenton type
[4]
. Thus polyhydroxy phenols that possess both antioxidant and iron chelating activity may 
afford protection against such damage.  
In this study, we have isolated, and identified a wide range of phenolic compounds from 
aerial parts of the species Salvia viridis L. cv. Blue Jeans (Synonym S. horminum L.) using column 
chromatography, semi-preparative reversed phase HPLC and spectroscopic methods of structure 
elucidation. Compounds isolated include: caffeic acid, rosmarinic acid, 6-O-caffeoyl-glucose, 
verbascoside (acteoside), leucosceptoside A, martynoside, apigenin-7-glucoside, luteolin-7-glucoside, 
luteolin-5-glucoside, luteolin-5-rutinoside and salidroside. We have tested three of these compounds, 
caffeic acid, rosmarinic acid and verbascoside for their cytotoxicity and for their protective effect 
against UVA (wavelength 320-400 nm) damage of cultured human fibroblast cells. All compounds 
were added into cell cultures 18 hours before UVA irradiation. % Cell viability was detected 24 hours 
after irradiation by MTT method, and flow cytometry analysis. 50% Growth inhibition concentration 
(IC50) was also determined after 18 hours incubation period without irradiation. 
Results show that all these compounds are cytotoxic with IC50 of 180 µM for caffeic acid, 150 
µM for rosmarinic acid, and 125 µM for verbascoside. However, at lower concentrations all protect the 
cells against the effects of UV irradiation; survival of the cells is significantly higher than control at 
concentration of 50 µM for verbascoside. Flow cytometry analysis showed 1.5 fold protection of 
verbascoside pretreated cells over control at UVA dose 500 kJ/m
2
. Furthermore, percentage of necrosis 
was 1.4 fold less than control while percentages of apoptosis were comparable. Although we have not 
yet determined the precise mechanism of action, this pattern of activity is consistent with iron 
chelation which at high concentration kills cells by iron depletion, but at lower concentrations prevents 
the build up of free iron in the cells, and concomitant generation of reactive oxygen species (ROS). 
 
 
[1]   Petersen, M., and Simmonds, M. S. J., 2003. Rosmarinic acid. Phytochemistry, 62, 121-125. 
[2]   Jiang, R. W., Lau, K. M., Hon, P. M., Mak, T. C., Woo, K. S., and Fung, K. P., 2005. Chemistry 
        and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr. Med. Chem.,  
        2, 237-246. 
[3]   Perron, N. R., and Brumaghim, J. L., 2009. A review of the antioxidant mechanisms of  
        polyphenol compounds related to iron binding. Cell Biochem. Biophys., 53, 75-100. 
[4]   Pourzand, C., Watkin, R. D., Brown, J. E. and Tyrrell, R. M., 1999. Ultraviolet A radiation  
        induces immediate release of iron in human primary skin fibroblasts: The role of ferritin. Proc.      
        Natl. Acad. Sci. USA, 96, 6751-6756.    
